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 Zusammenfassung 
 
Funktionelle Charakterisierung der ArcA- und HlyX-Regulons von A. pleuropneumoniae 
             
 
Das gram-negative Bakterium Actinobacillus (A.) pleuropneumoniae ist der Erreger der 
Porcinen Pleuropneumonie. Die Anpassung der Genexpression an anaerobe Bedingungen ist 
eine virulenzassoziierte Eigenschaft von A. pleuropneumoniae und erfolgt durch HlyX (das FNR-
Homolog von A. pleuropneumoniae) und das ArcAB Zweikomponentensystem. Ziel dieser Arbeit 
war die Identifizierung der ArcA- und HlyX- Regulons und deren Bedeutung für die Virulenz.  
Das arcA-Gen von A. pleuropneumoniae wurde identifiziert, deletiert und die Mutante durch 
PCR, PFGE, Southern Blot und DNA-Sequenzierung überprüft. A. pleuropneumoniae ΔarcA 
zeigte weder einen Wachstumsdefekt noch ein reduziertes Überlebensvermögen. A. 
pleuropneumoniae bildete bei anaerobem Wachstum in Flüssigkultur Autoaggregate, die bei der 
arcA-Deletionsmutante nicht mehr zu beobachteten waren. Darüberhinaus war die 
Biofilmbildung der arcA-Deletionsmutante reduziert. Ein Tierversuch am Schwein ergab eine 
geringere Virulenz der arcA-Deletionsmutante gegenüber dem Wildtyp. Klinische Symptome, 
pathologische Lungenveränderungen und Reisolierbarkeit waren signifikant reduziert. 
Um den Phänotyp von arcA- und hlyX-Deletionsmutante auf molekularer Ebene zu klären, 
wurden beide Mutanten  mit Hilfe von „microarrays“ und durch differentielle zwei-dimensionale 
Gelelektrophorese (2D DIGE) untersucht. Die Aufklärung des ArcA-Regulons ergab, dass ArcA 
93 Gene um mehr als 1,5-fach auf- und 106 Gene um mehr als 1,5-fach abreguliert; durch HlyX 
wird die Expression von 398 Genen um mehr als 1,5-fach auf- und von 505 Genen 
entsprechend abreguliert. Die Ergebnisse der Transkriptomanalyse wurden im Wesentlichen 
durch die Proteomanalysen bestätigt. Die Auswertung der von ArcA regulierten Gene impliziert, 
dass ArcA den Stoffwechsel auf Fumarat-Atmung unter anaeroben Bedingungen einstellt. In 
einem begleitenden Projekt konnte diese Annahme inzwischen gestützt werden. Die Deletion 
der Fumarat-Reduktase führte zu einer Attenuierung von A. pleuropneumoniae.  
Ein Vergleich der „microarray“ Analysen ergab, dass ArcA und HlyX 64 Gene auf- und 39 
Gene abregulierten. Eine gegensätzliche Regulation durch die beiden Transkriptionsfaktoren 
wurde bei 11 Genen festgestellt. HlyX agierte als starker Positiv-Regulator von terminalen 
Reduktasen, die DMSO, TMAO, Nitrat oder Nitrit verwenden. Während HlyX die Expression von 
30 Genen um mehr als 7-fach aufregulierte, wurde für ArcA nur ein einziges Gen, das für eine 
putative Methylierungsuntereinheit eines Restriktions-Modifikationssystems kodiert, gefunden, 
dessen Expression so deutlich verstärkt wurde. Im Gegensatz dazu wurde kein Gen gefunden, 
das durch HlyX um mehr als 7-fach abreguliert wurde, während ArcA die Expression von 13 
Genen um mehr als 7-fach reduzierte. Diese Ergebnisse führen zu dem Schluss, dass ArcA von 
A. pleuropneumoniae als starker Positiv-Regulator und dass HlyX als starker Negativ-Regulator 
der Transkription agieren. Dadurch wird erstmalig die Bedeutung beider Regulatoren gezeigt, 
sich unter anaeroben Bedingungen in ihrem Spektrum zu ergänzen.  
Summary 
 
Functional characterization of the ArcA and HlyX regulons of A. pleuropneumoniae 
             
 
The gram-negative bacterium Actinobacillus (A.) pleuropneumoniae is the causative agent of 
Porcine Pleuropneumonia. Adaptation of gene expression to anaerobicity is a virulence-
associated trait of A. pleuropneumoniae and is mediated by HlyX (the FNR homologue of A. 
pleuropneumoniae) and the ArcAB two-component system. The objective of this study was the 
identification of the HlyX and ArcA regulons of A. pleuropneumoniae and the characterization of 
both regulons with respect to their putative role in infection.  
The arcA gene of A. pleuropneumoniae was identified and deleted, and the deletion mutant 
was confirmed by PCR, PFGE, Southern blot and nucleotide sequencing. The arcA deletion 
mutant exhibited no growth defect and aging was not affected. The characteristic 
autoaggregation of A. pleuropneumoniae wt upon growth under anaerobic conditions was 
abolished, and biofilm formation was reduced in the mutant. A pig infection experiment revealed 
that deletion of the arcA gene caused a severe attenuation. Thus, scores determined for clinical 
symptoms, lung lesion and bacterial reisolation were significantly reduced.  
In order to investigate the phenotypic characteristics of the A. pleuropneumoniae arcA and 
hlyX deletion mutant an in-depth analysis of the ArcA regulon was performed using microarrays 
and 2D DIGE. Investigation of the ArcA regulon revealed that the expression of 93 genes was 
upregulated by ArcA more then 1.5-fold and that expression of 106 genes was downregulated. 
HlyX upregulated expression of 398 genes and downregulated expression of 505 genes. By 2D 
DIGE and subsequent mass spectrometry the results of the array analyses were mostly 
confirmed. Analysis of the ArcA regulon implies that A. pleuropneumoniae anaerobically adapts 
its metabolism in order to use fumarate as a terminal electron acceptor for respiration. This 
hypothesis could be supported in an accompanying project. Thus, deletion of the fumarate 
reductase of A. pleuropneumoniae caused a significant attenuation in infection.  
Comparison of microarray results revealed that 64 genes were up- and 39 genes were 
downregulated by both ArcA as well as HlyX whereas 11 genes were identified as being 
regulated in opposite directions. HlyX acts as a positive regulator for terminal reductases using 
DMSO, TMAO, nitrate and nitrite as substrates. HlyX increases the expression of 30 genes by 7-
fold or more, compared to a single gene encoding a putative methylation subunit of a type III 
restriction-modification system, upregulated to that extend by ArcA. In contrast, no gene is 
repressed by HlyX by more then 7-fold compared to 13 genes that are repressed by ArcA more 
then 7-fold. These findings lead to the conclusion that ArcA of A. pleuropneumoniae is primarily 
acting as a strong transcriptional repressor whereas HlyX mostly acts as a strong transcriptional 
inducer. This mode of regulation underlines the supplementary functions of ArcA and HlyX 
during anaerobiosis when both factors are active.  
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A  Introduction 
 
Actinobacillus (A.) pleuropneumoniae is a gram negative rod belonging to the family of 
Pasteurellaceae. This facultative anaerobe is a highly host specific, strictly extracellular 
pathogen that causes Porcine Actinobacillus Pleuropneumonia (PAP).  PAP is a respiratory 
disease of fattening pigs occurring worldwide and causing significant economic losses. The 
natural infection in pigs begins with inhaling of A. pleuropneumoniae-containing aerosols 
originating from infected animals. Then, A. pleuropneumoniae colonizes the respiratory 
epithelium and tonsils and, when reaching the lower respiratory tract, causes a variety of 
symptoms. These range from peracute death over acute pleuropneumonia with necrotic and 
hemorrhagic lesions to development of chronic disease. Subclinical infections also occur. A 
problem in controlling PAP is the occurrence of clinical healthy carrier animals. These 
animals can carry and shed the pathogen for up to several months. 
Several virulence or virulence-associated factors such as the Apx toxins (A. 
pleuropneumoniae specific RTX-toxins), transferrin-binding proteins or capsule have been 
identified. New virulence-associated factors like DMSO reductase, aspartate ammonia lyase, 
and HlyX (the FNR analogue of A. pleuropneumoniae) were discovered recently implying an 
important role of anaerobic metabolism for virulence and persistence of A. 
pleuropneumoniae. In its natural niche, the porcine respiratory tract, A. pleuropneumoniae 
has to adapt to an anaerobic or reducing environment. However, adaptation to anaerobiosis 
at the molecular level and its contribution to virulence and persistence have not been 
investigated in A. pleuropneumoniae to date. 
Therefore the aim of this study was the identification of genes controlled by the major 
oxygen-dependent transcriptions factors ArcA and HlyX. The ArcA and HlyX regulons should 
then provide insights into the mechanisms of anaerobic adaptation of A. pleuropneumoniae 
relevant in vivo. This knowledge of the molecular adaptation to anaerobiosis should then 
result in the identification of new virulence-associated factors or pathways. 
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B  Literature Review 
 
B 1  Actinobacillus pleuropneumoniae 
 
B 1.1  Taxonomy 
 
Actinobacillus (A.) pleuropneumoniae is a gram negative rod that belongs to the family of 
Pasteurellaceae. It was originally classified as Haemophilus (H.) pleuropneumoniae (Shope 
et al., 1964). Due to its high homology to A. lignieresii on the DNA level the species was 
transferred to the genus Actinobacillus (Pohl et al., 1983). A. pleuropneumoniae strains can 
be subdivided into two biotypes based on their ability to synthesize nicotine amide adenine 
dinucleotide (NAD). The biotype 1 is NAD-dependent whereas biotype 2 is not NAD-
auxotrophic (Pohl et al., 1983; Nicolet 1992; Nielsen et al., 1997). Twelve serotypes for 
biotype 1 and six for biotype 2 are known to date, based on discrimination by differences in 
their surface polysaccharides (Bosse et al., 2002). The A. pleuropneumoniae biotype 1 
serotypes 1 and 5 are subdivided into subtypes a and b, respectively. Three additional 
serotypes (13, 14 and 15) have been proposed more recently (Nielsen et al 1997; Blackall et 
al., 2002). 
 
 
B 1.2  Infection and disease 
 
Actinobacillus pleuropneumoniae was first identified as the causative agent of porcine 
pleuropneumonia in Great Britain in 1957 (Nicolet 1992). It is highly host specific for pigs 
although a singular isolation from lambs has been described (Nielsen 1986; Hervas et al., 
1996). A. pleuropneumoniae occurs worldwide but the serotypes are not equally distributed. 
Serotypes 1, 5, and 7 are more prevalent in the United States, serotypes 1, 3, and 5 appear 
mostly in Canada. Serotypes 1, 2, 3, 5, and 9 are more frequent in Europe (Blaha 1992, 
Chiers et al., 2002).  
Infection with A. pleuropneumoniae is typically caused by inhalation of droplets at close 
range (Nicolet et al., 1969) and can occur in shared air space or due to direct contact with 
infected pigs (Taylor, 1995; Torremorell et al., 1997; Jobert et al., 2000). A. 
pleuropneumoniae has low tenacity and is not able to survive in the environment for 
prolonged periods of time. Therefore transmission via personnel rarely occurs (Fenwick and 
Henry 1994). Persistently infected clinically healthy carrier animals that are introduced into A. 
pleuropneumoniae-free herds are the major source for severe outbreaks (Rycroft and 
Garside 2000). A. pleuropneumoniae causes significant economic losses due to death in 
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acute disease on the one hand and reduced growth rates of convalescent pigs on the other 
hand (Straw et al., 1989). 
Pigs of all age groups can be infected but 10 to 16 week old animals are most susceptible 
(Fenwick and Henry 1994). The inhalation of A. pleuropneumoniae-containing aerosols can 
cause an infection with symptoms ranging from peracute to chronic depending on serotype, 
infectious dose, and immune status of the affected animal (Sebunya et al., 1983; Rogers et 
al., 1990; Cruijsen et al., 1995). Peracute and acute disease is generally accompanied by 
clinical symptoms like fever, dyspnoea, tachypnoea, anorexia and vomitus. The pathogen 
often causes fibrinous and necrotizing pleuropneumonia, sometimes associated with 
pulmonary haemorrhage, and affects pericardium and joints. In the chronic state, lung 
lesions appear as sequestered abscesses with persistent pleural adhesions (Matschullat 
1983; Bertram 1985; Liggett et al., 1987; Didier et al., 2002). Convalescent and latently 
infected pigs showing no symptoms can still harbour A. pleuropneumoniae and thereby serve 
as reservoirs (Liggett et al., 1987; Fenwick and Henry 1994). 
 
 
B 1.3   Virulence factors 
 
Virulence factors are defined as bacterial products that facilitate growth or survival of a 
pathogen in the host, contributing to infection and disease (Mekalanos 1992; Mahan et al., 
1996). Genes encoding for metabolic enzymes can contribute either to virulence or to 
general bacterial functions outside the host. These factors are designated as virulence-
associated factors. 
 
RTX toxins 
Known virulence factors of A. pleuropneumoniae are the RTX toxins that occur also in 
many other gram negative bacteria (Welch 1991). The RTX toxins are secreted by type I 
secretion systems and are capable of lysing erythrocytes (Thompson et al., 1993). The 
genome of A. pleuropneumoniae encodes four RTX toxins that have been designated ApxI to 
ApxIV. These toxins are differently distributed among the different serotypes (Schaller et al., 
1999).  
 
Type IV fimbriae 
Type IV fimbriae are multifunctional bacterial surface organelles expressed by most gram 
negative bacterial pathogens. Actinobacillus pleuropneumoniae encodes an intact gene 
cluster for the synthesis of type IV fimbriae. Fimbriae have been shown for A. 
pleuropneumoniae to mediate adherence to swine alveolar epithelial cells in vitro (Van 
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Overbeke et al., 2002), and the fimbrial promoter (Tfp) was identified as upregulated upon 
contact to cultured epithelial cells (Boekema et al., 2004). 
 
LPS and capsule 
The major adhesin of A. pleuropneumoniae has been identified as lipopolysaccharide 
(LPS, Belanger et al., 1990). LPS is exposed at the surface and binds to porcine respiratory 
tract cells (Paradis et al., 1994) and to porcine haemoglobin (Belanger et al., 1995).  
A further virulence factor of A. pleuropneumoniae is its capsule. The capsule protects A. 
pleuropneumoniae from bactericidal activity of serum and was identified to be antiphagocytic 
(Inzana et al., 1988). Comparison between virulent and non-virulent A. pleuropneumoniae 
isolates revealed a more distinct and adherent capsule in the virulent isolate. Additionally, the 
virulent isolate contained more LPS (Jensen and Bertram 1986). 
 
Iron acquisition 
The availability of iron is very low for bacterial pathogens within a mammalian host. Due to 
the poor solubility of ferric iron on the one hand and its association to iron scavenging host 
proteins on the other hand there is virtually no free iron available to support bacterial growth. 
A. pleuropneumoniae, like other members of the families Neisseriaceae and 
Pasteurellaceae, has developed a sophisticated iron uptake system which allows the 
utilization of transferrin-bound iron (Perkins-Balding et al., 2004; Gonzalez et al., 1990; 
Gerlach et al., 1992). Additionally hemoglobin (Belanger et al., 1995; Archambault et al., 
2003; Srikumar et al., 2004) and hemin (Deneer and Potter 1989; Archambault et al., 2003; 
Srikumar et al., 2004) can serve as iron sources. Mutants lacking transferrin-binding proteins 
are avirulent and unable to colonize, underlining the role of transferrin uptake for A. 
pleuropneumoniae (Baltes et al., 2002). 
 
Biofilm formation 
Biofilm formation is a virulence-associated trait of many bacterial pathogens and has been 
shown to be prevalent among field isolates of A. pleuropneumoniae (Kaplan, Mulks 2005). 
Biofilms are composed of bacterial cells embedded into an extracellular polysaccharide 
matrix. The A. pleuropneumoniae biofilm matrix has been described as a linear polymer of N-
acetyl-D-glucosamine residues in β(1,6) linkage, called PGA which also functions as the 
biofilm matrix in other phylogenetically diverse bacteria. The gene locus pgaABCD encodes 
the enzymes responsible for production of PGA in A. pleuropneumoniae. PGA itself is the 
substrate for dispersin B, a biofilm releasing glycosyl hydrolase also encoded on the A. 
pleuropneumoniae genome (Kaplan et al., 2004).  
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Anaerobic metabolism 
Deletion of genes encoding enzymes (DMSO reductase, aspartate ammonia lyase) or 
regulators (HlyX) for anaerobic metabolism of A. pleuropneumoniae did not affect aerobic 
growth in vitro but reduced virulence and persistence of A. pleuropneumoniae in a pig 
infection experiment (Baltes et al., 2005; Baltes et al.,  2003; Jacobsen et al., 2005). 
Identification of genes expressed in A. pleuropneumoniae during the chronic state of 
infection revealed several genes that have been associated with virulence in A. 
pleuropneumoniae or other bacteria. An autotransporter serine protease of A. 
pleuropneumoniae has been identified as expressed in vivo in the chronic state of infection 
and is positively regulated under anaerobic conditions by the global regulator HlyX (Baltes 
and Gerlach 2004a; Baltes et al., 2007). 
The porcine respiratory tract is a well aerated and strongly supplied with blood providing, 
on first sight, aerobic conditions for growth of A. pleuropneumoniae. However, infection with 
A. pleuropneumoniae is often accompanied by severe tissue destruction and leads to the 
formation of purulent encapsulated sequesters. This necrotic tissue is separated from the 
airways and, in addition, poorly supplied with blood. Therefore it appears likely that these 
sequesters are oxygen-deprived providing microaerophilic or anaerobic conditions. However, 
deletions in A. pleuropneumoniae genes involved in anaerobic metabolism not only reduced 
the ability to survive within these sequesters. The bacteria were also attenuated with respect 
to survival on intact lung epithelium in pig infections experiments (Baltes et al.; 2005, Baltes 
et al., 2003; Jacobsen et al., 2005). A possible reason for this observation could be the 
presence of the airway reductant glutathione that has been found in elevated levels upon 
infection of mice with Pseudomonas aeruginosa (Cantin et al., 1987; Day et al., 2004). 
 
 
B 2  Mechanism for redox control of gene expression 
 
B 2.1  Overview 
 
Bacterial gene expression in response to alterations in redox potential is controlled by 
several regulatory proteins that use different mechanism. The sulphur atoms of FNR cysteine 
residues build a [4Fe-4S] cluster under reducing conditions that mediates dimerisation and 
thereby DNA binding activity of FNR. The SoxR / SoxS regulatory proteins regulate gene 
expression in response to superoxide and provide defence against oxidative damage. SoxR 
forms a homodimer containing two stable [2Fe-2S] centres. These become oxidized and 
thereby activated when challenged with oxidative stress conditions. FixL is a histidine sensor 
kinase using heme as a cofactor for binding of oxygen. Thereby autophosphorylation activity 
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is affected. NifL contains FAD as a redox-responsive cofactor. Under oxidizing conditions 
NifL binds and inactivates NifA, a transcriptional activator of nitrogen fixation genes. A further 
transcription factor, OxyR, responds to the redox potential by breaking or forming a disulfide 
bond that affects its DNA-binding activity. ArcB is a transmembrane histidine kinase that 
reacts to reducing conditions by autophosphorylation. Then it activates ArcA, a global 
anaerobic transcription factor. The regulator of anaerobic gene expression in α-purple 
proteobacteria, RegB, senses respiratory activity of cytochrome oxidase. A redox-responsive 
cysteine residue seems to be the redox sensor in CrtJ, the aerobic repressor of 
photopigment synthesis. The FNR protein and the ArcAB two-component system play the 
major role for the general adaptation of metabolic activity to anaerobiosis (Bauer et al., 
1999). 
 
 
B 2.2  The ArcAB two-component system of bacteria 
 
Two-component signal transduction systems are common in prokaryotes and play 
important roles in adaptation to environmental changes (Hoch and Silhavy 1995). The Arc 
(anoxic redox control) two-component system allows facultative anaerobic bacteria to sense 
reducing conditions and to adapt their gene expression accordingly (Lynch and  Lin 1996; 
Iuchi and Lin 1995). The arcA gene has been initially designated as dye, because its deletion 
renders E. coli sensitive to the dye toluidine blue. E. coli Δdye was not able to form F pili 
resulting in a sterile strain (Buxton and Drury 1983); the respective gene had been identified 
before and designated as sfrA (Beutin et al., 1981). In 1988 ArcA was identified as a 
negative regulator for enzymes associated with aerobic metabolism during anaerobiosis, like 
i) several dehydrogenases of the flavoprotein class, ii) cytochrome c oxidase complex, and 
iii) members of the tricarboxylic acid cycle, the glyoxylate shunt, and the pathway for fatty 
acid degradation (Iuchi and Lin 1988). One year later the second pleiotropic control gene for 
anaerobic metabolism, arcB, was identified at a different position on the chromosome. 
Deletion of arcB in E. coli also caused sensitivity to toluidine blue and relieved anaerobic 
expression of genes for aerobic metabolism (Iuchi et al., 1989). This led to the description of 
the Arc two-component system consisting of the cytosolic response regulator ArcA and a 
transmembrane histidine sensor kinase, ArcB (Iuchi et al., 1990c). As a typical response 
regulator ArcA possesses an N-terminal receiver domain with a conserved Asp residue at 
position 54 and a C-terminal helix-turn-helix DNA binding domain. The sensor kinase ArcB 
exhibits two transmembrane domains that are connected by an unusually short periplasmic 
domain of only 16 amino acid residues (Kwon et al., 2000). ArcB contains three catalytic 
domains, namely an amino terminal transmitter domain, a central receiver domain and a 
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carboxy terminal phosphotransfer domain (Iuchi et al., 1990c; Ishige et al., 1994). Under 
reducing conditions, ArcB is autophosphorylated and then transphosphorylates ArcA via a 
[His-292 Æ Asp-576 Æ His-717]ArcB Æ [Asp-54]ArcA phosphorelay (Georgellis et al.,1997; 
Kwon et al., 2000). The direct signal that silences the kinase activity of ArcB under aerobic 
conditions of growth is the interaction with oxidized quinone electron carriers (Georgellis et 
al., 2001). The molecular mechanism of kinase silencing involves the oxidation of two 
cytosol-located redox-active cysteine residues participating in intermolecular disulfide bond 
formation (Fig. 1; Malpica et al., 2004). 
 
 
B 2.3  FNR 
 
The FNR protein was initially identified in the mid 1970s by Guest and coworkers by 
isolation and characterization of mutants not able to perform fumarate and nitrate reduction 
(Lambden and Guest 1976). FNR has been shown to activate the expression of anaerobic 
respiratory enzymes that utilize alternative terminal electron acceptors like TMAO/DMSO, 
fumarate or nitrate (Cotter and Gunsalus 1989; Jones and Gunsalus 1987; Stewart 1982). 
Several aerobic respiratory enzymes like cytochrome d and cytochrome o oxidase (Cotter et 
al., 1990) and NADH dehydrogenase (Spiro et al., 1989) are repressed by FNR under 
anaerobic growth conditions. FNR activates transcription by interacting with the α-subunit of 
the RNA polymerase (Williams et al., 1997). FNR and the catabolite activator protein (CAP) 
share striking sequence similarities (Shaw et al., 1983). Different to CAP, however, FNR 
contains a ferredoxin-like four cysteine cluster (Cys-X3-Cys-X2-Cys-X5-Cys). Three out of four 
cysteine residues in this cluster and a fourth cysteine residue about 100 amino acids away 
are required for FNR activation; this led to the hypothesis that FNR senses the redox 
potential due to an iron centre coordinated by four cysteine residues (Green et al., 1993; 
Melville and Gunsalus 1990; Sharrocks et al., 1990; Spiro and Guest 1988). FNR has been 
shown to contain, under anaerobic conditions, one [4Fe-4S]2+ cluster per subunit. These 
[4Fe-4S]2+ clusters are highly labile and rapidly disassemble when exposed to oxygen 
resulting in a [2Fe-2S]2+ cluster. This cluster is more stable to oxygen but unable to sustain 
biological activity (Khoroshilova et al., 1997; Lazazzera et al., 1996). When the cells are 
shifted back to anaerobic conditions the [4Fe-4S]2+ cluster is regenerated. Prolonged 
incubation (hours) with oxygen results in complete disassembly of the [2Fe-2S]2+ cluster and 
in formation of the apoprotein that lacks iron (Popescu et al., 1998). Under anaerobic 
conditions FNR is a dimer with specific DNA binding activity. The Fe-S cluster is disrupted by 
oxygen and FNR is converted into the inactive monomeric form (Fig. 1; Lazazzera et al., 
1996). 
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Fig. 1: HlyX and the Arc two-component system. HlyX and ArcA are transcription factors that 
become activated under reducing conditions. If no other oxidants (for example nitrate or nitrite) are 
available then reducing conditions develop by oxygen deprivation. Both systems use cysteine 
residues for redox sensing. The direct signal for HlyX is likely to be oxygen itself whereas the redox 
state of quinone electron carriers is the signal for ArcB. 
This cartoon was made using the Adobe® Illustrator® CS software. 
An A. pleuropneumoniae protein that conferred hemolytic activity to E. coli was identified 
as very similar to the E. coli FNR protein and designated as HlyX. Although HlyX induced a 
hemolytic phenotype in E. coli it exhibits no similarity with known hemolysins or cytotoxins. 
Functional homology between E. coli FNR and A. pleuropneumoniae HlyX could also been 
shown by HlyX mediated complementation of the nutritional lesion of an E. coli FNR mutant. 
The hemolytic activity in E. coli caused by expression of HlyX is supposed to be a regulatory 
rather then a direct effect (Frey et al., 1989; Lian et al., 1989; McInnes et al., 1990). HlyX of 
A. pleuropneumoniae induced expression of the hemolysin in E. coli only under anaerobic 
conditions. Additionally, HlyX activated expression of the fumarate reductase subunit A in an 
E. coli fnr deletion mutant (Soltes and McInnes 1994). Similar to FNR, HlyX can acquire a 
[4Fe-4S] cluster that promotes binding to the FNR box under anaerobic conditions. 
Furthermore, HlyX and FNR have distinct but overlapping regulons in E. coli caused by an 
enhanced activating contact between HlyX and RNA polymerase at class I promoters (Green 
and Baldwin 1997) and, therefore, HlyX is considered the FNR analogue of A. 
pleuropneumoniae. 
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C  Material and Methods 
 
In this chapter parts were adopted from earlier PhD theses performed in Prof. Gerlach’s 
laboratory.   
 
C 1  Bacterial cultures 
 
C 1.1  Bacterial strains, plasmids, and primers  
 
Table 1: Bacterial strains and primers used in this study. 
Strain, plasmid 
or primer 
Characteristic(s) Source and/or 
reference 
Strains   
E. coli DH5α F´ F´ endA1 hsdR17 (rΚ-mΚ-) supE44 thi-1 recA1 gyrA (NaIr) relA1 
Δ(lacZYA-argF)U169 deoR [Φ80dlacΔ(lacZ)M15] 
Raleigh et al., 
1989 
E. coli β2155 thrB1004 pro thi strA hsdS lacZΔM15 (F´ lacZΔM15 laqIq traD36 proA+ 
proB+)Δdap::erm (Ermr) recA::RPA-2-tet (Tcr)::Mu-km (Kmr) λ pir 
Dehio and Meyer 
1997 
E. coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 deoR 
araD139 Δ(ara leu) 7697 galU galK rpsL (Strr) endA1 nupG 
TOPO TA cloning 
Invitrogen, 
Groningen, The 
Netherlands 
(Shuman, 1994) 
A. pleuropneu-
moniae wt 
A. pleuropneumoniae serotype 7 isolate 76 (Anderson et al., 
1991) 
A. pleuropneu-
moniae ΔhlyX 
Unmarked hlyX-negative knockout mutant of A. pleuropneumoniae 
AP76 
Baltes et al., 2005
A. pleuropneu-
moniae ΔarcA 
Unmarked arcA-negative deletion mutant of A. pleuropneumoniae wt This work 
Plasmids   
pCR2.1-TOPO E. coli cloning vector for fast and efficient cloning of Taq polymerase-
amplified PCR products 
TOPO TA cloning, 
Invitrogen, 
(Shuman, 1994) 
pARC800 pCR2.1-TOPO based plasmid containing a 683-bp PCR product 
obtained with primers oArcA3 and oArcA4, starting at position 276 of 
the arcA gene and ending 221 bp downstream of the arcA stop codon 
This work 
pARC810 pCR2.1-TOPO based plasmid containing a 622-bp PCR product 
obtained with primers oArcA1 and oArcA2, starting 505 bp upstream of 
the arcA start codon and ending at position 88 of the arcA gene 
This work 
pARC820 pCR2.1-TOPO based plasmid obtained by digestion of pARC800 with 
EcoRI and BsmBI and ligation of the resulting 728-bp fragment into 
pARC810 digested with EcoRI and BsmBI  
This work 
pARC840 pCR2.1-TOPO based plasmid containing a 1715 bp PCR product 
obtained with primers oArcA9 and oArcA8, starting at position 996 bp 
upstream of the arcA start codon and ending at position 2 bp 
downstream the arcA stop codon 
This work 
pARC850 pCR2.1-TOPO based plasmid containing a 1236 bp PCR product 
obtained with primers oArcA1 and oArcA8, starting at position 505 bp 
upstream of the arcA start codon and ending at position 2 bp 
downstream the arcA stop codon 
This work 
pEMOC2 Transconjugation vector based on pBluescript SK with mobRP4, a 
polycloning site, Cmr, and transcriptional fusion of the omlA promoter 
with the sacB gene 
Accession no. 
AJ868288 (Baltes 
et al., 2003) 
pARC700 pEMOC2 based plasmid carrying the truncated arcA ORF excised from This work 
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pARC820 using NotI and PspOMI and ligated into the pEMOC2 
restricted with NotI and PspOMI  
pLS88 Broad-host-range shuttle vector from Haemophilus ducreyi; Strr Smr 
Kmr 
Willson et al., 
1989 
pHLYX1300 pLS88-based complementation plasmid containing hlyX ORF in a 5´-3´ 
orientation with respect to the vector derived sulII promoter 
Baltes et al., 2005
pARC1320 pLS88-based complementation plasmid harboring the PCR product 
generated from primers oArcA9 and oArcA8 containing arcA ORF and 
additional 996 bp upstream of the arcA gene start codon, ligated into 
plasmid pLS88 after EcoRI restriction in a 3´-5´ orientation with respect 
to the vector derived sulII promoter 
This work 
pARC1340 pLS88-based complementation plasmid carrying the PCR product of 
primers oArcA1 and oArcA8 encoding the arcA ORF and 505 bp 
upstream sequence cloned into the EcoRI restriction site. 
This work 
Primers   
oArcA1 5´ TAACGCGGCCGCCCGCAAGAACGTATTTGGCG 3´;forward 
primer containing an internal NotI site (underlined) comprising positions 
505-486 upstream of the arcA gene start codon  
This work 
oArcA2 5´ AATCCGTCTCTCCAAAACTTCATAACCTTCCGCCTCG 3´; reverse 
primer containing an internal BsmBI site (underlined) comprising 
positions 88-69 of the arcA gene 
This work 
oArcA3 5´ GATCCGTCTCTTTGGAAATCGGTGCGGACG 3´; forward primer 
containing an internal BsmBI site (underlined) comprising positions 
276-295 of the arcA gene 
This work 
oArcA4 5´ ATCGGGGCCCACGACTAACGCAGGACCGGT 3´; reverse primer 
containing an internal PspOMI site (underlined) comprising positions 
202-221 downstream of the arcA gene stop codon 
This work 
oArcA5 5´ CGCGCAATACGCTCAAAAGT 3´; forward primer comprising 
positions 44-63 of the arcA gene 
This work 
oArcA6 5´ CCGGTGTATTAGGGTGATCT 3´; reverse primer comprising 
position 660-641 of the arcA gene 
This work 
oArcA8 5´ TACTACTCTAACTCGCCGCA 3´; reverse primer comprising 
position 2 downstream the arcA stop codon to position 700 of the arcA 
gene 
This work 
oArcA9 5´ GAAATTGAGTCGCCGAGCTA 3´; forward primer comprising 
position 996-977 upstream of the arcA gene start codon 
This work 
 
a Ermr, erythromycin resistance; Tcr, tetracycline resistance; Kmr, kanamycin resistance, Strr, 
streptomycin resistance; Smr, sulfonamide resistance 
 
 
C 1.2  Growth conditions, media and supplements 
 
E. coli strains were cultured in Luria-Bertani medium (10 g peptone [Roth, Karlsruhe, 
Germany], 5 g yeast extract [Roth], 5 g NaCl ad 1000 ml) supplemented with the appropriate 
antibiotics (ampicillin, 100 µg/ml [Roth], chloramphenicol, 25 µg/ml [Roth]) at 37°C; for 
cultivation of E. coli β2155 (ΔdapA), diaminopimelic acid (1 mM; Sigma Chemical Company, 
Deisenhofen, Germany) was added. A. pleuropneumoniae parent and mutant strains were 
cultured at 37°C and 5% CO2 in PPLO medium (Difco, Augsburg, Germany), DMEM low 
glucose medium (# 31885, Invitrogen, Karlsruhe, Germany) or on PPLO agar (Difco) 
supplemented with NAD (10 µg/ml; Merck AG, Darmstadt, Germany), L-cysteine 
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hydrochloride (260 µg/ml; Sigma), L-cystine dihydrochloride (10 µg/ml; Sigma), and dextrose 
(1 mg/ml; Roth). The aerobic culture grown for experimental aerosol infection in addition 
contained Tween®80 (0.1%). For selection of A. pleuropneumoniae transconjugants (single 
crossing-overs) chloramphenicol (5 µg/ml; Roth) was added, and the medium for counter 
selection was prepared as described previously (Tonpitak et al., 2002). For cultivation of the 
complemented mutant kanamycinsulfate (25 µg/ml; Roth) was added. For anaerobic growth 
supplemented medium (PPLO or DMEM) was preincubated 48 h prior to inoculation in an 
anaerobic chamber (DonWhitley Scientific, Shipley, England) in an atmosphere containing 
5% CO2, 10% H2, and 85% N2 at 37°C. This medium was then inoculated with 1% of an 
aerobically grown log phase culture in supplemented PPLO medium with an optical density 
at 600 nm (OD600) of 0.3. Anaerobiosis of the medium was confirmed using a dissolved 
oxygen sensor (CellOx® 325; WTW, Weilheim, Germany) linked to an inoLab® instrument 
(WTW, Weilheim, Germany). For recording of growth curves bacteria were harvested at 2, 4, 
6, 8, 10 and 24 h post inoculation by centrifugation. As A. pleuropneumoniae showed heavy 
clumping upon growth under anaerobic conditions the protein content of whole-cell lysates 
was determined. Statistical analyses were performed using the Student’s T-test. For RNA 
and protein preparations the bacteria were grown anaerobically in supplemented PPLO 
medium for 6 h and then harvested by centrifugation. For identification of secreted proteins 
bacteria were grown for 24 h in supplemented DMEM medium and then removed by 
centrifugation.  
 
 
C 2  Manipulation of DNA  
 
DNA modifying enzymes were purchased from New England Biolabs (Bad Schwalbach, 
Germany) and used according to the manufacturer’s instructions. Taq polymerase was 
purchased from Gibco-BR Life Technologies (Karlsruhe, Germany). Chromosomal and 
plasmid DNA preparations, PCR, Southern blotting, transformation, and gel electrophoresis 
were done according to standard procedures (Sambrook et al., 1989), and pulsed field gel 
electrophoresis (PFGE) was performed as described previously (Oswald et al., 1999). 
 
 
C 3  Construction of an isogenic A. pleuropneumoniae arcA in-frame deletion 
mutant  
 
A 622-bp fragment containing the upstream part of the arcA gene with the flanking 
sequence was amplified from genomic A. pleuropneumoniae AP76 DNA by PCR using 
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primers oArcA1 and oArcA2 (Table 1), which contained a NotI (oArcA1) and a BsmBI 
(oArcA2) restriction endonuclease site and cloned into pCR2.1 TOPO, resulting in pARC810. 
In plasmid pARC810 the orientation of the upstream fragment is in opposite orientation to the 
interrupted lacZ gene. A 683-bp fragment containing the downstream part of the arcA gene 
with the flanking sequence was amplified from genomic A. pleuropneumoniae AP76 DNA 
using primers oArcA3 and oArcA4 (Table 1), which contained a BsmBI (oArcA3) and a 
PspOMI (oArcA4) restriction endonuclease site and cloned into pCR 2.1 TOPO resulting in 
pARC800. The 728-bp downstream fragment was removed from pARC800 using HindIII and 
BsmBI and cloned into plasmid pARC810 restricted with HindIII and BsmBI to obtain 
pARC820. Plasmid pARC820 harbours the truncated arcA sequence missing 186 bp of 
coding sequence. Plasmid pARC820 was restricted with NotI and PspOMI and the 1264-bp 
fragment was ligated into the conjugation plasmid pEMOC2 restricted with NotI and PspOMI 
resulting in plasmid pARC700. Plasmid pARC700 was used in the single-step 
transconjugation system (Oswald et al., 1999) to construct A. pleuropneumoniae ΔarcA. 
Colonies with the correct PCR profile were confirmed by Southern blot analysis (Sambrook et 
al., 1989) using the PCR product obtained with primers oArcA5 and oArcA6 from A. 
pleuropneumoniae ΔarcA as a probe, and by nucleotide sequence analysis (Seqlab, 
Göttingen, Germany). The absence of genomic rearrangements was confirmed by pulsed-
field gel electrophoresis (PFGE). 
 
 
C 4  Complementation of A. pleuropneumoniae ΔarcA 
 
A 1236 bp fragment containing the entire open reading frame (ORF) of the arcA gene of 
A. pleuropneumoniae AP76 and 505 bp upstream sequence likely including regulatory 
motives was amplified by PCR using primers oArcA1 and oArcA8 (Table 1). A 1715 bp 
fragment was obtained by PCR using A. pleuropneumoniae AP76 genomic DNA and primers 
oArcA9 and oArcA8 (Table 1). This PCR product harbours 996 bp of arcA upstream 
sequence likely including regulatory sequences crucial for arcA expression. Both PCR 
products were cloned into pCR2.1 TOPO, restricted with EcoRI, and ligated into EcoRI 
restricted plasmid pLS88 yielding: i) pARC1340 (containing the 1236 bp fragment in a 5´-3´ 
orientation with respect to the vector-derived sulII promoter [positive orientation]), and ii) 
pARC1320 (containing the 1715 bp fragment in a 3´-5´ orientation with respect to the vector-
derived sulII promoter [negative orientation]). These plasmids were electroporated into A. 
pleuropneumoniae ΔarcA. Functional complementation was tested as described below. 
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C 5  Determination of malic enzyme activity of A. pleuropneumoniae 
 
The malic enzyme activity was measured spectrophotometrically at 340 nm by 
determination of NADPH formation (Geer et al., 1979). The assay buffer contained 35 mM 
Tris-HCl (pH 7.4), 3.3 mM L-malic acid (Roth), 0.3 mM NADP (Fluka, Seelze, Germany)  and 
5 mM MnCl2 (Sigma). The reaction was initiated by the addition of whole-cell lysates of 
cultures of A. pleuropneumoniae, and the increase in absorbance at 340 nm was 
determined. Malic enzyme activity was expressed in units, with 1 U being the amount that 
converts 1.0 µmol of L-malate and NADP into pyruvate, CO2 and NADPH per minute at pH 
7.4 and 25°C. A molar extinction coefficient of 6.22 mM-1cm-1 at 340 nm was used to 
calculate the activity, and statistical analyses were performed using the Student’s T-test . 
 
 
C 6  Virulence studies  
 
Virulence of A. pleuropneumoniae ΔarcA constructed in this study was examined in an 
aerosol infection model, mimicking the natural route of infection, in pigs 7 to 9 weeks of age. 
 
 
C 6.1  Challenge experiment timeline 
 
Day -7: -Arrival at the facility, blood samples taken for enzyme linked immunosorbent 
assay (ELISA) 
Day -1: Clinical examination (including determination of body temperature) 
Day 0:  Clinical examination (including determination of body temperature); 
Aerosol infection 
Day 1-7: Clinical examination (including determination of body temperature) 
Day 7:  Collection of bronchoalveolar lavage fluid (BALF) from wt infected group; 
Taking of blood samples and euthanasia of 4 pigs of ΔarcA infected group 
Day 21: Taking of blood samples and euthanasia of 4 pigs of ΔarcA infected group 
Taking of blood samples and euthanasia of 8 pigs of wt infected group 
 
 
C 6.2  Origin and housing of the animals 
 
Sixteen outbred pigs, 8 to 9 weeks of age were purchased from an A. pleuropneumoniae-
free herd (no clinical symptoms and no serological responses in the ApxII-ELISA [Leiner et 
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al., 1999] and the deELISA [Goethe et al., 2000]) and randomly assigned to the different 
groups and cared for in accordance with the principles outlined by the European Convention 
for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes 
(European Treaty Series, No. 123 [http://conventions.coe.int/Treaty/EN/Treaties/Html/123.ht
m; ETS No. 170]). The two groups were housed in separate isolation units with controlled 
temperature and ventilation. 
  
 
C 6.3  Aerosol infection chamber 
 
Infections were carried out in an aerosol infection chamber built by Impfstoffwerk Dessau 
Tornau GmbH (Dessau, Germany) based on the descriptions of Jacobsen et al. (Jacobsen et 
al., 1996). This chamber allows the simultaneous infection of four to five pigs 7-12 weeks of 
age. The top of the chamber consists of an acrylic window allowing easy surveillance of the 
animals during aerosol exposure. The chamber has two air vents equipped with filters, one of 
which is connected to a compressor (KNF Neuberger, Freiburg, Germany) used to exchange 
the air in the chamber. All tubing is made from either autoclavable silicone or Teflon. The 
bacterial suspension is aerosolized via a nozzle (Model no. 97058, Schlick Duesen, 
Untersiemau, Germany) operated by compressed air (Linde, Hannover, Germany). 
 
 
C 6.4  Preparation of bacteria for aerosolization 
 
For aerosol infection, 45 ml supplemented PPLO medium was inoculated with 5 ml of an 
overnight liquid culture of the respective A. pleuropneumoniae strain. The resulting culture 
was then incubated for approximately 2 hours at 37°C to OD600 of about 0.4. The culture was 
placed on ice, diluted 1:300 in ice-cold NaCl (150 mM), and kept on ice until use for a 
maximum of 2 hours. Immediately prior to aerosolization, bacteria were further diluted 1:100 
in ice-cold NaCl (150 mM) resulting in a total living cell count per 13 ml dose (for four pigs) of 
approximately 1 x 105/ml; upon aerosolization, this dose corresponds to approximately 1 x 
102 A. pleuropneumoniae cells per liter of aerosol in the chamber, a dose which has been 
titrated for the A. pleuropneumoniae strain AP76 to induce severe but not fatal disease 
(Teutenberg-Riedel et al., unpublished data). 
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C 6.5  Aerosol infection 
 
Four pigs were challenged simultaneously within the chamber. In order to achieve an 
even distribution of the aerosol in the chamber, the nozzle was set to “5” and the valve 
regulating the flow of the fluid was set to “75”. The challenge dose of 13 ml diluted bacterial 
suspension was aerosolized using a pressure of 2 bar within a time of approximately 2 
minutes. Ten minutes after complete aerosolization, the air in the chamber was exchanged 
ten times over duration of 20 min using a compressor. Then the pigs were led back to their 
stable. 
 
 
C 6.6  Surveillance of the animals during the experiment 
 
Clinical examinations were performed daily or as needed. Body temperature and clinical 
symptoms were recorded daily for each individual pig in the day before and up to 7 days after 
infection or as needed. A clinical scoring system based on the directive from the European 
Pharmacopoeia for the testing of A. pleuropneumoniae vaccines (porcine actinobacillosis 
vaccine [inactivated]) was employed to asses the clinical condition of each individual animal 
as follows. A score of 1 was given for each symptom including to the occurrence of coughing, 
dyspnoea, and vomitus, resulting in a minimum clinical score of 0 and a maximum score of 3 
per day; the added daily clinical scores of day 1 to 7 were designated as the total clinical 
score. Statistical analysis of the total clinical score was performed using the Wilcoxon 
Signed-Rank Test.  
 
 
C 6.7  Determination of lung lesion scores 
 
Pigs were euthanized by intravenous injection of 10 ml pentobarbital (Eutha 77®) per pig. 
Lung lesions caused by A. pleuropneumoniae infection were determined and scored as 
described by Hannan et al. (Hannan et al., 1982) and statistically analyzed using the 
Wilcoxon Signed-Rank Test. Each lobe was separately scored. Dependent on the extent of 
pathological alterations a score from 0 (healthy) to 5 (complete pathological) was given for 
each lobe (resulting in a maximum score of 35 for the entire lung). This scoring system has 
been adopted in the European Pharmacopoeia (http://www.pheur.org) as the reference 
method in vaccine trials for A. pleuropneumoniae.   
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C 6.8  Bacteriological examination of organ samples, semi quantitative 
 
The bacteriological examination included surface swabs of palatine tonsils, bronchial 
lymph nodes, and defined positions located in the outer third of each of the seven lung lobes; 
an additional swab of diseased lung tissue was taken if it was not covered by any of the 
defined lung locations. Plating was done on Columbia Sheep Blood agar to exclude other 
bacterial infections, as well as on selective meat blood agar (Jacobsen and Nielsen 1995), 
and fractionated twice. A score for reisolation of 0 was given for either no growth or if A. 
pleuropneumoniae colonies grew only in the directly swabbed area; a score of 1 was given if 
colonies were present in the fractionated streaks. The reisolation score was determined by 
adding theses numbers for each pig in the respective group, and the arithmetic means and 
standard deviations were determined. Several individual A. pleuropneumoniae-like colonies 
were subcultured on supplemented PPLO agar and confirmed by urease assay (Jacobsen et 
al., 2005) and PCR analysis using primers oArcA5 and oArcA6.  
 
 
C 6.9  Enzyme Linked Immunosorbent Assay (ELISA) 
 
The humoral immune response of pigs was determined by two different ELISAs. Antibody 
levels directed against the A. pleuropneumoniae ApxII toxin were analysed using an ELISA 
with ApxII as the solid phase antigen (Leiner et al., 1999). Antibodies directed against outer 
membrane components were determined with an ELISA using the detergent extract of A. 
pleuropneumoniae grown under iron restriction as the solid phase antigen (Goethe et al., 
2000). The detergent extract was diluted 1:50 in carbonate buffer (50 mM; pH 9.6) and used 
for the coating of Polysorp® 96-microwell plates (Nunc, Rosklide, Denmark). Coating was 
performed with 100 µl for 16 h at 4°C. Plates were washed with PBST (8 g NaCl, 0.2 g 
KH2PO4, 1.44 g Na2HPO4, 0.2 g KCl, 0.5 ml Tween 20, ad 1000 ml) before the addition of 
serum, conjugate, and chromogen. Sera were initially diluted 1:100 and further twofold 
dilutions were performed in the plates in PBST. On each plate an internal positive control 
(pool of sera taken from pigs three weeks post infection with A. pleuropneumoniae) and a 
negative control (pool of sera taken from pigs prior to infection) was used. Serum dilutions 
and goat anti-pig peroxidase conjugate were each incubated for 1 h at room temperature. 
The ELISA was developed using 2,2’-azino-di-[3-ethylbenzthiazoline-6-sulfonate] (ABTS) as 
a substrate. The test was considered valid when the OD405 of the negative serum at a 1:100 
dilution was lower then the OD405 of the positive serum a 1:12,800 dilution. The titer is given 
by the serum dilution with an OD405 higher then twice the OD405 of the negative control serum 
at a 1:100 dilution. 
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C 7  Autoaggregation, electron microscopy and biofilm assays 
 
A. pleuropneumoniae was grown in supplemented liquid medium under anaerobic 
conditions for six hours. Then cultures were removed from the anaerobic chamber and 
transferred on ice. For photography the liquid cultures were transferred into petri dishes. To 
perform raster electron microscopy these anaerobically grown cultures were transferred onto 
0.2 µm membrane filters (Schleicher & Schuell, Dassel, Germany) and fixed with 2 N 
dimethylarsinic acid and 25 % (w/v) glutaraldehyde. Electron microscopy was performed at 
10,000 fold enlargement (raster electron microscopy was performed by Armgard 
Janczikowski from the Leibniz University Hannover). 
For the investigation of biofilm formation 20 ml of supplemented liquid PPLO medium in 
200 ml glass Erlenmeyer flasks were inoculated with colony material from an agar plate and 
incubated for 6 h, 12 h, 18 h or 24 h at 37°C and 5% CO2 without shaking. After incubation 
the OD600 was measured. The bacterial suspension was removed and the flasks were 
washed rigorously with water before staining. Then 2 ml of a 0.3% crystal violet solution 
(Merck) were added and the flasks were incubated for 5 min with gentle agitation. After 
staining the flasks were washed rigorously with water and then dried. The crystal violet-
stained biofilm on the glass surface was solubilised with 10 ml of a solution comprised of 
50% ethanol, 30% acetone and 20% acetic acid. The OD600 was determined and, using a 
calibration curve, the amount of crystal violet bound by the biofilm was calculated. All strains 
were tested in a minimum of four independent experiments. The flasks used were new and 
intensively cleaned and washed with distilled water between experiments. Statistical 
analyses were performed using the Student’s T-test. 
 
 
C 8  Microarray analysis 
 
Preparation of CyDyeTM labelled cDNA (C 8.2), microarray hybridization (C 8.3) and 
scanning of array slides was performed under supervision of Janine Bosse at the Imperial 
College of Science, London 
 
 
C 8.1  RNA extraction 
 
Bacteria were grown and harvested as described above. Bacterial RNA isolation was 
carried out using the FastRNA® Pro Blue Kit (Qbiogene) according to the manufacturer’s 
instructions. RNA was further purified using the RNeasy Mini-Kit (QIAGEN, Hilden, Germany) 
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according to the manufacturer’s recommendations. DNA contaminations were removed using 
the TURBO DNA-freeTM Kit (Ambion, Austin, USA). RNA concentration was determined 
spectrophotometrically, and, quality and integrity was confirmed by agarose gel 
electrophoresis. 
 
 
C 8.2  Preparation of CyDyeTM labelled cDNA 
 
Synthesis of cDNA and microarray hybridizations were performed as described previously 
according to the indirect labelling protocol adapted from Hughes et al., 2001 with some 
modifications. Briefly, 10 µg of total RNA in 11 µl water containing 3 µg random primers was 
heated at 70 °C for 5 min and then snap-cooled on ice. Then reverse transcription and 
simultaneous labelling followed in 25 µl 1x first strand synthesis buffer (10 mM dithiothreitol, 
460 µM deoxinucleside triphosphate mix [dATP, dGTP, dTTP], 184 µM desoxycytidin 
triphosphate, 1.7 µl CyDyeTM labelled deoxycytidin triphosphate [Amersham] and 500 units of 
Superscript II [Invitrogen]). The reaction was incubated in the dark for 10 min at 25 °C 
followed by 90 min at 42 °C. For each strain RNA was prepared from six independent 
cultures; three biological repeats each were labelled with Cy3 and three with Cy5 in order to 
avoid dye-related effects.  
 
 
C 8.3  Microarray hybridization 
 
The microarrays used in this study contained PCR products representing each of the 2025 
ORFs of the genome of A. pleuropneumoniae serotype 5b strain L20 (Deslandes et al., 
2007). Details on construction and content of the microarray (AppChip1) are available on the 
Institute for Biological Sciences website (http://ibs-isb.nrc-cnrc.gc.ca/glycobiology/appchips_ 
e.html). Equivalent amounts of Cy3- and Cy5 labelled samples from A. pleuropneumoniae wt 
and A. pleuropneumoniae ΔarcA or A. pleuropneumoniae wt and A. pleuropneumoniae ΔhlyX 
were pooled and purified using the MinElute Purification Kit (Quiagen) according to the 
manufacturer’s instructions. The purified Cy3 / Cy5 labelled samples were then added to the 
hybridization solution (4x SSC and 0.3% SDS). The hybridization solution was heated at 
95°C for 2 min, slightly cooled and applied to the microarray. Hybridization was performed at 
65°C in the dark for 16 to 20 h under glass cover slips in a high humidity chamber. The 
microarrays were then washed at 65°C for 2 min in 1x SSC and 0.05% SDS followed by two 
washing steps at RT for 2 min in 0.06x SSC. Slides were spun dry (1000 x g, 1 min) and 
stored in a light-tight box until scanning using a chip reader (GenePix 4000B, Axon 
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Instruments, now Molecular Devises, Union City, USA). Analysis of microarray data was 
performed using the software Genespring GX 7.3 (Agilent, Santa Clara, USA). In total six 
hybridizations were performed for i) six biological repeats of A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔarcA and ii) six biological repeats of A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔhlyX 
 
 
C 9  Manipulation of proteins 
 
C 9.1  Preparation of proteins 
 
C 9.1.1 Preparation of whole cell lysates 
 
Cultures were transferred on ice; bacteria were harvested by centrifugation (13,000 x g, 
10 min, 4°C) and washed once with a buffer containing 10 mM Tris-HCl (pH 8.0) and 5 mM 
magnesium acetate. Pellets were resuspended in 50 mM Tris-HCl (pH 7.3) and stored at –
70°C overnight. Cells were thawed, ruptured using the FastPrep® Instrument (Qbiogene) 
three times for 40 sec at intensity setting 5.0, and cell debris was removed by centrifugation 
(15,000 x g, 30 min). Protein concentration was determined with the MicroBC® assay (Uptima 
Interchim, Montlucon Cedex, France) and confirmed by SDS-PAGE. 
 
 
C 9.1.2 Preparation of proteins of the inner and outer bacterial membrane 
 
Whole cell lysates were ultracentrifuged (45000 rpm, SW55 Ti, 4°C, 2 h). The supernatant 
was removed and the pellet containing total membranes was resuspended in a solution 
containing 1% N-lauroylsarcosine (Sigma) and 1 mM β-mercaptoethanol (Sigma) and then 
incubated for 12 h at 4°C. The protein suspension was ultracentrifuged (45000 rpm, SW55 
Ti, 4°C, 2 h); the pellet contained integral outer membrane proteins whereas inner membrane 
and outer membrane-associated whereas were enriched in the supernatant. The outer 
membrane pellet was solubilised in lysis buffer (30 mM Tris-HCl [pH 8.0], 7 M urea [Roth, 
Karlsruhe, Germany], 2 M thiourea [Sigma], and 4% [wt/vol] CHAPS [Roth]). The protein 
concentrations were estimated by SDS PAGE. 
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C 9.1.3 Enrichment of outer membrane-associated proteins by detergent wash 
 
Upon 6 h of growth under anaerobic conditions chloramphenicol (Roth) was added to the 
cultures to a final concentration of 100 µg/ml. The cultures were incubated for further 10 min 
and then transferred on ice. Bacteria were harvested and washed as described above, 
resuspended in ice cold saline, one tablet complete protease inhibitor cocktail (Roche, 
Mannheim, Germany) chloramphenicol (Roth; 50 µg/ml [w/v]), sodium chloride (50 mM), Tris 
pH = 8 (10 mM), and sodiumdeoxycholate (0.05% [w/v], Sigma) were added, and cells were 
incubated with shaking for 1 h at 37°C. Finally cells and debris were removed by two 
centrifugation steps for 10 and 30 min respectively (13,000 x g, 4°C). Protein concentration 
of the supernatant was determined with the MicroBC® assay (Uptima Interchim, Montlucon 
Cedex, France) and confirmed by SDS-PAGE. 
 
 
C 9.1.4 Preparation of secreted proteins 
 
For preparation of secreted proteins A. pleuropneumoniae wt, A. pleuropneumoniae 
ΔarcA and A. pleuropneumoniae ΔhlyX were grown anaerobically in protein-free DMEM 
medium for 24 h upon 1% inoculation with an aerobic culture of OD = 0.3. The anaerobic 
cultures were cooled on ice and the cells were removed by two repeated centrifugations 
(13,000 x g, 10 min, 4°C). The protein concentrations were estimated by SDS PAGE. 
 
 
C 9.2  One dimensional (1D) sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) 
 
SDS-PAGE was performed following standard procedures (Sambrook et al., 1989) using a 
Protean II Minigel system (BioRad, Munich, Germany). For quantitative 1D SDS-PAGE 
proteins were labelled with CyDyesTM (C 9.3.2) and scanning of fluorescently labelled 
proteins was performed with a TyphoonTM Trio scanner (Amersham, C 9.3.5). Quantitative 
analysis of band intensities was performed using the ImageQuantTM 5.2 software. 
Preparative gels were stained with either Coomassie blue G-250 (Roth) or colloidal 
Coomassie blue G-250 (Candiano et al., 2004). Bands of interest were cut from the gel, 
digested with trypsin (C 9.3.7) and analyzed by Q-TOF or MALDI TOF mass spectrometry (C 
9.3.8) 
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C 9.3  Two-dimensional (2D) difference gel electrophoresis (DIGE) 
 
C 9.3.1 Precipitation and reconstitution of proteins  
 
2D DIGE experiments were performed for i) whole cell lysates, ii) inner membrane and 
outer membrane-associated proteins, iii) outer membrane-associated proteins, and iv) 
supernatant proteins. For each 2D DIGE experiment anaerobic growth of A. 
pleuropneumoniae wt, A. pleuropneumoniae ΔarcA and A. pleuropneumoniae ΔhlyX was 
repeated at least three times. Proteins were precipitated with TCA (10 to 20 %) over night 
and pelleted by centrifugation (15,000 x g, 30 min). The protein pellet was washed with 
acetone and solubilised in lysis buffer (30 mM Tris-HCl [pH 8.0], 7 M urea [Roth, Karlsruhe, 
Germany], 2 M thiourea [Sigma], and 4% [wt/vol] CHAPS [Roth]) to a protein concentration of 
5 mg/ml. Insoluble material was removed by centrifugation at 16,000 x g for 5 min in a 
benchtop centrifuge.  
 
 
C 9.3.2 Protein labelling with CyDyeTM 
 
The pH of the protein solution was adjusted to 8.5 using 50 mM NaOH. The protein 
preparations of the wt and the mutant strains were labelled randomly with Cy3 or Cy5 
(Amersham Biosciences AB, Uppsala, Sweden). Equal amounts of protein from each 
biological repeat of A. pleuropneumoniae wt and A. pleuropneumoniae mutant strains were 
pooled together as the internal standard and labelled with Cy2 (Amersham). Labelling was 
performed according to the manufacturer’s instructions. Briefly, a 1 nmol/µl CyDye stock 
solution was prepared by dissolving 5 nmol CyDyeTM in 5 µl dimethyl formamide (DMF 
[Sigma]). This stock solution was further diluted with DMF resulting in a 400 pmol/µl working 
dye solution. Theoretically 50 µg of protein had to be labelled with 400 pmol of Dye but 
practically the amount of dye could be reduced by up to 90% yielding in sufficiently labelled 
proteins. The protein solution was incubated for 30 min on ice in the dark with the respective 
dye. Then labelling was stopped by addition of 10 mM L-lysine (Sigma) to give a final 
concentration of about 0.2 mM L-lysine and then incubated for a further 10 min on ice in the 
dark. Labelled protein samples could now be stored at -70°C for at least 6 month. 
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C 9.3.3 First dimension focussing 
 
The Cy2, Cy3 and Cy5 labelled protein preparations were pooled and then diluted with an 
equal volume of isoelectric focusing buffer (7 M urea [Roth], 2 M thiourea [Sigma], and 4% 
[wt/vol] CHAPS [Roth], 2 % (vol/vol) IPG buffer [Amersham], 2% [wt/vol] dithiothreitol [Roth]). 
Insoluble material was removed by centrifugation at 16000 x g for 5 min in a benchtop 
centrifuge. Immobiline DryStrips (24 cm, Amersham) were rehydrated with 450 µl of 
rehydration buffer per strip containing 2 M thiourea (Sigma), 7 M urea (Roth), 4% (wt/vol) 
CHAPS (Roth), 1% (vol/vol) IPG buffer (Amersham), and 0.2% (wt/vol) dithiothreitol (Roth) 
for 12-18 h using the Immobiline DryStrip Reswelling Tray (Amersham). Strips were 
transferred into the EttanTM IPGphorTM Cup Loading Manifold (Amersham), and samples 
were loaded into anodal sample cups and subsequently focused using an EttanTM IPGphorTM 
(Amersham) for 21 h in the following series of time blocks with increasing voltage: 3 h at 150 
V, 3 h at 300 V, 6 h at a 1000 V gradient, 3 h at an 8000 V gradient, and 6 h at 8000 V. For 
second dimension, the strips were equilibrated twice for 15 min by rocking in a solution of 
100 mM Tris-HCl (pH 8.0), 6 M urea (Roth), 30% (vol/vol) glycerol (Roth), and 2% (wt/vol) 
sodium dodecyl sulfate (SDS; Serva, Heidelberg, Germany) supplemented with 0.5% (wt/vol) 
DTT (Roth) for the first equilibration step and 4.5% (wt/vol) iodoacetamide (Sigma) for the 
second equilibration step.  
 
 
C 9.3.4 Second dimension focussing 
 
The Immobiline DryStrips (Amersham) were placed on the top of 12.5% polyacrylamide 
gels containing 12.5% (vol/vol) acrylamide (Serva) and 0.33% bisacrylamide (Serva) that had 
been precasted with low-fluorescent glass plates (Amersham) using an EttanTM DALTsix gel 
caster (Amersham). The second-dimension SDS-PAGE was carried out at 12 °C and 50 V 
for 3 h followed by 100 V for 15 h using the EttanTM DALTsix Electrophoresis System 
(Amersham).  
 
 
C 9.3.5 Scanning of gels with fluorescently labelled proteins 
 
The gels were scanned on a Typhoon TrioTM scanner (Amersham) at a scan resolution of 
100 dots/cm using filters with excitation/emission wavelengths specific for Cy2 (filter: 520 BP 
40; 488 nm / 520 nm), for Cy3 (filter: 580 BP 30; 532 nm / 580 nm), and for Cy5 (filter: 670 
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BP 30; 633 nm / 670 nm). The intensity of the pixel values was adjusted such that the 
maximum volume of each image was between 50,000 and 90,000.  
 
 
C 9.3.6 Data analysis of 2D DIGE 
 
Analysis of 2D DIGE was initially performed with the ImageQuantTM 5.2 software. Detailed 
and quantitative analysis was performed using the DeCyderTM 6.5 software (GE Healthcare) 
according to the manufacturer’s instructions. Briefly, spot detection and matching of protein-
spot maps of different gels was performed using the DeCyderTM biological variation analysis 
module (BVA). Detected and matched spots were also confirmed manually. Statistical 
analysis was performed using the unpaired T-test. Spots whose intensities were statistically 
significant (p < 0.05) different between the A. pleuropneumoniae wt group and the A. 
pleuropneumoniae ΔarcA group or between the A. pleuropneumoniae wt group and the A. 
pleuropneumoniae ΔhlyX group were selected for identification. 
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Fig. 2: Example of 2D DIGE data analysis using the DecyderTM 6.5 software. A. 
pleuropneumoniae wt and A. pleuropneumoniae ΔarcA were grown four times each under 
anaerobic conditions, independently. A protein preparation obtained from whole cell lysates was 
labelled with CyDyesTM and then separated by two-dimensional gel electrophoresis. Data 
analysis was performed using DeCyderTM 6.5 software. Here the standardized intensity is shown 
for an exemplarily protein for 4 biological repeats of A. pleuropneumoniae wt and for 4 biological 
repeats of A. pleuropneumoniae ΔarcA. The average ratio of the protein spots between wt and 
ΔarcA is -8.49. The respective protein is 8.49-fold increased in A. pleuropneumoniae ΔarcA. 
Statistical analysis by T-test revealed a p-vale of 2x10-08. By subsequent mass spectrometry this 
spot was identified as fructose-1,6-bisphosphatase. 
 
Details: 
Spot on 2D DIGE gel: Fpb (1) Fig. 12A on page 62 
Ratio: Table 5 on page 69 
Preparative gel for mass spectrometry: Gel 1 on page 160 
Mass spectrometry: MS #2 Table Appendix G 6.1 on page 169  
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C 9.3.7 In-gel digestion  
 
In order to pick spots that were identified by 2D DIGE, the analytical DIGE gels were 
either directly stained with colloidal Coomassie blue G-250 (Candiano et al., 2004)  or 
preparative two-dimensional gel electrophoresis was performed loading 600 to 1500 µg 
protein per gel. Spots of interest were excised, the protein was trypsinated and removed from 
the gel according to the method of Wilm and Mann (Shevchenko et al., 1996). Briefly, the gel 
pieces were dehydrated with acetonitril (ACN, Merck), rehydrated with a 100 mM NH4HCO3 
buffer containing 10 mM DTT (Roth), and then treated with 100 mM iodoacetamide (Sigma) 
in 100 mM NH4HCO3. Dehydration and rehydration were repeated, and then dehydrated gel 
pieces were rehydrated with buffer (50 mM NH4HCO3) containing 20 ng/µl trypsin 
(sequencing grade; Promega, Mannheim, Germany) and incubated for 12 - 16 h at 37°C. 
Peptides were extracted using 50 mM NH4HCO3 followed by extraction buffer containing 50% 
(vol/vol) ACN (Merck) and 5% (vol/vol) formic acid (Merck). The solution containing the 
extracted peptides was completely evaporated in a vacuum centrifuge. Peptides were 
redissolved in 3–5 µl of 50% (vol/vol) ACN (Merck), 0.1% (vol/vol) formic acid (Merck). 
 
 
C 9.3.8 Protein identification by ESI Q-TOF MSMS or MALDI-TOF MS 
 
For Electro-Spray Injection Quadrupole Time-of-Flight mass spectrometry (ESI Q-TOF 
MS) 3 µl of the peptide solution was loaded into a sample tip (Nanoflow Probe Tip – long, 
Waters, Milford, Massachusetts, USA). Peptide sequences were determined from tandem 
mass spectrometry (MS/MS) fragmentation data recorded on ESI Q-TOF mass spectrometer 
(Q-TOF Ultima, Waters) in positive reflection mode. Proteins were identified using the 
ProteinLynx Globals Server (Version 2.1, Waters) program by searching against the National 
Centre for Biotechnology Information (NCBI) complete database 
(ftp://ftp.ncbi.nlm.nih.gov./blast/db/FASTA/nr.gz) downloaded on 12.03.2007 or the A. 
pleuropneumoniae serotype 5b strain L20 genome database 
downloaded on 10.04.2007 (ftp://ftp.ncbi.nlm.nih.gov./genomes/Bacteria/Actino-
bacillus_pleuropneumoniae_ L20/ NC_009053.faa). A background subtraction was 
performed with electrospray survey spectra but not with MSMS spectra. The Savitzky-Golay 
algorithm was applied for smoothing with 2 iterations. The smoothing window was set 3 
channels. For deisotoping and centroiding the minimum peak width of electrospray data was 
set 4 channels. Centroid top was set at 80%, resolution at setting 10,000 and the NP 
multiplier at setting 1. For MSMS spectra deisotoping was performed (type: medium) using a 
threshold of 1%.  For databank search a peptide tolerance of 100 ppm was set. The fragment 
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tolerance was set 0.1 Da with an estimated calibration error of 0.0025 Da. The molecular 
weight range was set from 0 to 400,000 Da and the pI range from 0 to 14. The minimum of 
peptides to match setting was set 1 and the maximum hits to return setting was 20. The 
primary digest reagent was set trypsin. One missed cleavage was allowed and fixed 
modifications were set as carbamidomethyl C, variable modification as oxidation M. An 
automatical validation of the results was performed.  
Alternatively Matrix Assisted Laser Desorption / Ionization Time-of-Flight (MALDI-TOF) 
mass spectrometry (MS) was carried out on a Voyager-DETM Pro (Applied Biosystems, 
Forster City, USA); 1 µl of the peptide solution was mixed with 1 µl of matrix (α-cyano-4-
hydroxy-cinnamic acid [ACHC, Bruker Daltonics, Billerica, USA], 5 mg/ml in 50% ACN with 
0.1% trifluoroacetic acid [TFA]) and then spotted on the target plate. Peptide spectra were 
acquired in positive reflection mode, averaging about 1000 laser shots per MALDI-TOF 
spectrum. Mass spectra were calibrated using the calibration mixtures CalMix1 and CalMix2 
(Applied Biosystems). The mass spectra were analyzed using the Applied Biosystems Data 
Explorer® V 4.8 software and peptide mass lists were generated. Briefly: 1. advanced 
baseline correction setting peak width = 31, flexibility = 0.5, degree = 0.1; 2. noise filter 
setting noise removal std. dev. to remove = 2; 3. peak deisotoping; 4. calibration by importing 
a calibration spectrum. The peptide masse list was then analyzed using Microsoft Office 
Excel. A manually chosen subset of peptide masses were used to search against the NCBI 
non redundant database applying the peptide mass fingerprint algorithm on the Mascot web 
site (http://www.matrixscience.com). The search algorithm was set to allow 
carbamidomethylation on cystein residues, oxidation on methionin residues and a maximum 
of 1 missed cleavage. The peptide mass tolerance was set 0.2 Da. Proteins were considered 
as identified when the probability-based score was above the significance threshold 
(p < 0.05). Identification was confirmed by comparing the calculated molecular mass and 
isoelectric point values from the identified proteins with the observed values on the 2D gel. 
 
 
C 9.4  Immunoblotting 
 
C 9.4.1 Western Blotting 
 
Western blotting was done using either the Mini Trans-Blot® system (BioRad) or the 
MultiphorTM II system (Amersham). Proteins were transferred to a nitrocellulose membrane 
(Protran BA85 0.45 µm, Schleicher and Schuell [Sambrook et al., 1989; Kyhse-Andersen 
1984]). 
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C 9.4.2 Detection of immunogenic proteins 
 
The blotting membrane was incubated with porcine sera. Preimmune sera were obtained 
from pigs before experimental infection and convalescent sera were obtained from pigs 21 
day post experimental infection with A. pleuropneumoniae. Sera were diluted 1:100 in PBST 
(8 g NaCl, 0.2 g KH2PO4, 1.44 g Na2HPO4, 0.2 g KCl, 0.5 ml Tween 20, ad 1000 ml). As 
second antibody an alkaline phosphatase-conjugated goat anti swine IgG antibody was used 
in a 1:5,000 dilution. BCIP (5-bromo-4-chloro-3-indol phosphate) and NBT (nitro blue 
tetrazolium) were used as substrates for visualization of immunogenic proteins (Sambrook et 
al., 1989). 
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Fig. 3: A: Map of A. pleuropneumoniae contig 390. The arcA gene and primers used in the present 
study are shown. Primer binding sites are indicated as arrowheads.  
B: Alignment of E. coli ArcA and A. pleuropneumoniae homologue. Alignments were made using 
the Blast 2 Sequences program at the National Centre for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov, Tatusova and Madden 1999). Both proteins are 88% similar and 80% 
identical. 
B A 
D  Results 
 
D 1  Phenotypic characterization of A. pleuropneumoniae ΔarcA 
 
D 1.1  Construction of an arcA deletion mutant of A. pleuropneumoniae  
 
The putative ArcA protein of A. pleuropneumoniae was identified by BLAST homology 
search using the E. coli anoxic redox control protein (gi:16132218) as a template. A highly 
homologous protein of A. pleuropneumoniae serotype 1 strain 4074 was found (gi:53729099) 
which is 80% identical to the E. coli ArcA. A protein entirely identical to the A. 
pleuropneumoniae serotype 1 ArcA homologue is encoded within the unfinished genome 
sequence of A. pleuropneumoniae serotype 7 (Fig. 3).  
An isogenic arcA deletion mutant of A. pleuropneumoniae AP76 was constructed by allelic 
exchange of the wild type arcA gene with an in frame deletion lacking 186 bp at position 94 
to 279 of the arcA ORF. The truncated ArcA protein lacks the phosphorylation site on Asp54. 
The resulting A. pleuropneumoniae arcA mutant was designated as A. pleuropneumoniae 
ΔarcA and verified using PCR, Southern blotting, and nucleotide sequence analysis; the 
absence of gross genomic rearrangements was confirmed by PFGE (Fig. 4). For 
complementation A. pleuropneumoniae ΔarcA was transformed with plasmid pARC1320 or 
pARC1340 and designated as A. pleuropneumoniae ΔarcA + pARC1320 or A. 
pleuropneumoniae ΔarcA + pARC1340. 
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Fig. 4: Verification of arcA deletion by PCR, 
Southern blot analysis, and PFGE. A; Agarose 
gel electrophoresis of a DNA marker (100 bp 
ladder (NEB, lane 1) and PCR products obtained 
with primers oArcA5 and oArcA6 from genomic 
A. pleuropneumoniae DNA. PCR products 
obtained from A. pleuropneumoniae wt (lane 2) 
and A. pleuropneumoniae ΔarcA (lane 3) were 
618 bp and 432 bp respectively. B; Southern blot 
analysis of genomic DNA restricted with HaeIII 
and XmaI. Digestion of A. pleuropneumoniae wt 
DNA resulted in a 915 bp fragment (lane 1), and 
a 729 bp fragment was obtained for A. 
pleuropneumoniae ΔarcA (lane 2). C; PFGE 
analysis to exclude genomic rearrangements. 
Genomic DNA of A. pleuropneumoniae wt (lanes 
1, 3, 5) and A. pleuropneumoniae ΔarcA (lanes 2, 
4, 6) was restricted with PspOMI (lanes 1, 2), 
AscI (lanes 3, 4) and NotI (lanes 5, 6). Phage 
lambda concanamers were loaded as a size 
marker (lane 7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D 1.2  Virulence studies 
 
Aerosol infection with both A. pleuropneumoniae wt (group 1) and A. pleuropneumoniae 
ΔarcA (group 2) led to an increase in body temperature above 40°C in all infected animals. 
However, animals infected with A. pleuropneumoniae ΔarcA showed a significantly lower 
clinical score (p = 0.043) than animals infected with A. pleuropneumoniae wt (Fig. 5A). 
In order to investigate if the arcA deletion mutant could persist at least one week, four 
animals in group 2 were sacrificed seven days post infection. All remaining animals were 
sacrificed on day 21 post infection. At necropsy, three out of eight pigs in group 2 had no 
macroscopically visible lung lesions compared to one out of eight animals in group 1. The 
lung lesion score of group 2 was clearly lower than that of group 1 (Fig. 5B). Histological 
examination revealed no differences in the morphology of lung lesions in both groups.  
Reisolation of the challenge strains from intact lung at necropsy 21 days post infection 
succeeded in all animals of group 1 but only in one out of four animals of group 2; at 
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Fig. 5: Virulence of A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA compared in an 
aerosol infection model. Clinical score (A), lung lesion score (B) and reisolation score (C) of pigs 
infected with A. pleuropneumoniae wt (  ) or ΔarcA (   [sacrificed on day 7];    [sacrificed on day 21]). Each 
triangle or circle represents one animal. The horizontal line represents the arithmetic mean. The asterisks 
denote statistical significance (p < 0.05) of differences between the entire A. pleuropneumoniae ΔarcA 
group (animals sacrificed at day 7 [four animals] and 21 post infection [four animals]) and A. 
pleuropneumoniae wt group (all sacrificed on day 21 post infection) as obtained using the Wilcoxon 
Signed-Rank Test. The animals sacrificed at different time points post infection were considered as a 
single group since both lung lesion and reisolation scores do not increase after day 7 of an A. 
pleuropneumoniae infection. Therefore, the approach might have resulted at the most in an 
underestimation of differences between the two groups. 
necropsy on day 7 post infection reisolation succeeded in two out of four animals of group 2 
(Table 2). The reisolation score of A. pleuropneumoniae ΔarcA was significantly reduced in 
comparison to the A. pleuropneumoniae wt group (Fig. 5C). From pneumonic lung the 
challenge strain could be reisolated in all seven animals with lesions in group 1 and in four 
out of five animals with lesions in group 2, with no difference observed between day 7 and 
day 21 post infection (Table 2). 
Serum samples were obtained 1 week before and 3 weeks after experimental infection. 
Before infection, no A. pleuropneumoniae specific antibodies could be detected. On day 21 
post challenge animals in both groups showed a strong humoral immune response, and no 
significant difference was observed (Table 2).  
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Table 2: Virulence of A. pleuropneumoniae parent and ΔarcA mutant strain following 
aerosol challenge. 
 
 
 
 
 
 
 
 
 
a Bacteria were grown aerobically in the presence of Tween®80 (0.1%) to the respective OD600 and 
diluted 1:30,000 with sterile saline; 13 ml of this dilution were aerosolized in the aerosol chamber.  
b The solid-phase antigen was prepared as described previously (Goethe et al., 2000); the number 
given is the arithmetric mean of the highest serum dilution resulting in an optical density twice as 
high as the negative control serum at a dilution of 1:100 
c Recombinant ApxIIA protein was used as solid-phase antigen as described previously (Leiner et 
al., 1999) the number given is the arithmetic mean of the serum activity in ELISA units. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D 1.3  Growth and survival of A. pleuropneumoniae ΔarcA 
 
Growth curves of A. pleuropneumoniae wt, A. pleuropneumoniae  ΔarcA and the 
complemented strain A. pleuropneumoniae ΔarcA + pARC1320 were determined under 
anaerobic and aerobic conditions. For comparison anaerobic and aerobic growth of  A. 
pleuropneumoniae  ΔhlyX, and A. pleuropneumoniae ΔhlyX + pHLYX1300 (Baltes et al., 
2005) were analyzed in parallel. The growth rates between A. pleuropneumoniae wt and A. 
pleuropneumoniae  ΔarcA exhibited no significant differences over a 24 h incubation period 
whereas A. pleuropneumoniae ΔhlyX showed a significantly reduced growth. This growth 
deficit was abrogated in the complemented strain A. pleuropneumoniae ΔhlyX + pHLYX1300. 
Complementation of the arcA gene resulted in a growth behaviour under anaerobic condition 
indistinguishable form A. pleuropneumoniae wt or A. pleuropneumoniae ΔarcA. 
Approximately two hours after inoculation all strains reached the exponential phase of growth 
which ended at 6 to 8 hours post inoculation. After reaching stationary phase (8 to 10 hours 
post inoculation) the protein content of the bacterial pellet is decreased at 24 hours after 
inoculation (Fig. 6A). Under aerobic conditions no growth difference could be observed 
between A. pleuropneumoniae wt, A. pleuropneumoniae ΔarcA and A. pleuropneumoniae 
ΔhlyX (Fig. 6B).  
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B 
A 
Survival kinetics of A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA in an 
anaerobic liquid culture under nutrient starvation are indistinguishable. Sixty hours post 
inoculation no culturable A. pleuropneumoniae wt or A. pleuropneumoniae ΔarcA were 
detectable. In contrast, A. pleuropneumoniae ΔhlyX showed a significantly increased 
survival, and aging was significantly reduced (Fig. 6C). 
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Fig. 6: Analysis of anaerobic growth (A), aerobic growth (B) and survival under anaerobic 
conditions accompanied by starvation (C) of A. pleuropneumoniae wt, ΔarcA, and ΔhlyX. 
Each experiment was repeated at least three times. Error bars represent the standard deviation. 
Asterisks denote statistical significance (one asterisk p < 0.05; two asterisks p < 0.01; three 
asterisks p < 0.001 ) of differences compared to A. pleuropneumoniae wt. Statistical analysis was 
performed using the Student’s T-test. 
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D 1.4  Effect of arcA deletion on bacterial autoaggregation and biofilm 
formation 
 
In liquid culture under aerobic or microaerophilic conditions both A. pleuropneumoniae wt 
and A. pleuropneumoniae ΔarcA grew as homogenous suspension (data not shown). Upon 
growth under anaerobic conditions A. pleuropneumoniae wt showed heavy autoaggregation. 
This phenotype was completely abolished by deletion of the arcA gene, and transformation 
of A. pleuropneumoniae ΔarcA with plasmid pARC1340 restored the autoaggregating 
phenotype (Fig. 7A).  
Raster electron microscopy of anaerobically grown cultures showed that A. 
pleuropneumoniae wt was embedded in a threadlike extracellular matrix. In A. 
pleuropneumoniae ΔarcA an exogenous threadlike compound could also be observed. 
However, it seemed not to be attached to the bacterial surface, and threads had a relaxed 
structure. Complementation of A. pleuropneumoniae ΔarcA with plasmid pARC1340 resulted 
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in a phenotype which appeared to be associated even more tightly to the extracellular matrix 
than the wt strain (Fig. 7B). 
As autoaggregation and the ability to form biofilm have been reported to be associated 
(Schembri et al., 2003), we investigated the ability of A. pleuropneumoniae ΔarcA to form 
biofilms. A. pleuropneumoniae wt attached to glass surfaces and formed biofilm. Six hours 
after inoculation no significant difference in biofilm formation on the bottom of the Erlenmeyer 
flask was observable between A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA. In 
A. pleuropneumoniae wt the biofilm further increased until 12 hours post inoculation (p. i.). 
Only at 18 p. i. a reduction of biofilm mass obtained by quantitative crystal violet staining was 
apparent. In A. pleuropneumoniae ΔarcA, however, the amount of biofilm was clearly 
reduced in comparison to the wildtype at 12 hours p. i., and the difference was statistically 
significant at 18 and 24 hours p.i. (p = 0.013 and 0.014, respectively, Fig. 7C). 
Complementation of A. pleuropneumoniae ΔarcA in trans with plasmid pARC1340 slightly 
overcompensated the defect in biofilm formation, which likely is due to the multiple copy 
number of arcA in the pARC1340 transformants; transformants containing the empty plasmid 
vector pLS88 behaved like the wild type (Fig. 7C). The lack of biofilm formation in A. 
pleuropneumoniae ΔarcA was not caused by differences in cell densities as obtained by 
determination of OD600 (data not shown). 
A. pleuropneumoniae ΔhlyX was also tested for clumping and biofilm formation. Clumping 
of A. pleuropneumoniae in an anaerobic liquid culture appeared delayed at about 8 to 10 
hours post inoculation. Biofilm formation of A. pleuropneumoniae ΔhlyX at an abiotic glass 
surface was comparable to A. pleuropneumoniae wt (data not shown). 
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Fig. 7: Autoaggregation and biofilm formation. A: Autoaggregation of anaerobically grown 
cultures. B: Raster electron microscopy of cultures shown in A. C: Biofilm formation on the bottom of 
glass Erlenmeyer flasks. The biofilm was stained with crystal violet. Crystal violet bound to the 
biofilm was solubilised and measured at OD600. Using a calibration curve the amount of crystal violet 
was calculated as ppm [w/v]. Error bars represent the standard deviation. Statistical analysis was 
performed using Student’s T-test. Asterisks denote statistical significance (p < 0.05). 
 
A 
 
B 
 
C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
   
 52 
D 1.5  Effect of arcA deletion on malic enzyme activity 
 
Initial proteomic analysis of ArcA regulated proteins revealed the malic enzyme (MaeB) as 
strongly downregulated by ArcA. An enzymatic assay for MaeB activity was employed (Geer 
et al., 1979) in order to confirm the proteomic results and to test the complementation in 
trans of A. pleuropneumoniae ΔarcA. 
Whole cell lysates of anaerobically grown cultures of the A. pleuropneumoniae wt strain 
exhibited an average activity of 1.88 units of malic enzyme per gram protein, whereas the 
average activity of malic enzyme in A. pleuropneumoniae ΔarcA was determined as 11.08 
units per gram protein (a 6-fold increase compared to the parental strain A. 
pleuropneumoniae wt). This upregulation of malic enzyme activity by deletion of arcA was 
statistically significant (p = 0.001). Complementation of A. pleuropneumoniae ΔarcA in trans 
with plasmid pARC1320 carrying the arcA gene and 977 bp upstream sequence resulted in a 
reduction of malic enzyme activity to wt-level (Fig. 8A). Deletion of the hlyX gene (Baltes et 
al., 2005) had no impact on malic enzyme activity (Fig. 8A).  
When the bacteria where grown under aerobic conditions the malic enzyme activity was 
between 20 und 25 units per gram protein with no significant differences between A. 
pleuropneumoniae wt, A. pleuropneumoniae ΔarcA or A. pleuropneumoniae ΔhlyX (Fig. 8B). 
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Fig. 8: Complementation of A. pleuropneumoniae ΔarcA in trans restored wt level of malic 
enzyme activity. A. pleuropneumoniae was grown either anaerobically (A) or aerobically (B), and malic 
enzyme activity was obtained using colorimetric measurement of NADPH formation from NADP+ when 
L-malate is oxidatively decarboxylated to pyruvate in whole cell lysates. Malic enzyme activity was 
normalized to total protein content. Each experiment was repeated at least three times. Error bars 
represent the standard deviation. Asterisks denote statistical significance (p < 0.05) of differences 
compared to A. pleuropneumoniae wt as obtained by Student’s T-test. 
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A B Fig. 9: Microarray analysis of 
anaerobically grown A. 
pleuropneumoniae wt in comparison 
to A. pleuropneumoniae ΔarcA. A: 
Readout of a microarray slide 
hybridized with Cy5 labelled cDNA of 
A. pleuropneumoniae wt and Cy3 
labelled cDNA of A. pleuropneumoniae 
ΔarcA. 
B: Labelling reactions were repeated 
six times. Each row represents all 
ORFs of the A. pleuropneumoniae 
genome as horizontal lines. 
D 2  The ArcA regulon of A. pleuropneumoniae 
 
D 2.1  Global transcription analysis of A. pleuropneumoniae ΔarcA 
 
In order to identify the regulon of the ArcAB two component signal transduction system of 
A. pleuropneumoniae a global expression profiling was performed using a DNA microarray 
analysis. The array chip used was designed for A. pleuropneumoniae serotype 5b strain L20 
(Deslandes et al., 2007). However, cDNA obtained from A. pleuropneumoniae serotype 7 
isolate 76 (A. pleuropneumoniae wt) transcripts bound to the vast majority of the array spots 
(Fig. 9A). Six independent expression profiles each of the anaerobically grown parental strain 
A. pleuropneumoniae wt and the arcA deletion mutant A. pleuropneumoniae ΔarcA were 
analysed. The gene expression ratios between A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔarcA were reproducible for the different biological repeats (Fig. 9B). Of 
the 2025 protein coding genes of A. pleuropneumoniae 5b L20 that are presented on the 
array chip the expression of 16 genes was increased greater then 2-fold and expression of a 
further 77 genes was increased by a factor between 1.5 and 2 in A. pleuropneumoniae wt 
compared to the arcA deletion mutant. These genes are either directly or indirectly 
upregulated by ArcA in the parental strain. In A. pleuropneumoniae ΔarcA the expression of 
42 genes was increased greater then 2-fold and 64 genes were increased by a factor 
between 1.5 and 2 compared to the parental strain A. pleuropneumoniae wt. The expression 
of these genes was downregulated in A. pleuropneumoniae wt by ArcA (Fig. 10; Appendix G 
1 and G 2). 
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Fig. 10: Summary of microarray results wt vs. ΔarcA. Each spot represents a gene that has been 
identified to be significantly affected by ArcA (p < 0.05). Spots appearing above the diagonal line 
represent genes that were upregulated by ArcA; those that appear below exhibited a higher expression 
level in the arcA deletion mutant caused by a downregulation due to ArcA in A. pleuropneumoniae wt. 
Green spots were upregulated significantly due to ArcA by more then 1.5-fold and red spots were 
upregulated by more then 2-fold. Light blue spots were downregulated significantly by more then 1.5-
fold and dark blue spots were downregulated by more then 2-fold due to ArcA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D 2.1.1 Functional classification of ArcA regulated genes 
 
A functional classification of the genes that were identified to be regulated by ArcA was 
performed according to the database of “Cluster of Orthologous Groups of proteins” (COGs) 
(http://www.ncbi.nlm.nih.gov/COG/; Tatusov et al., 1997). ArcA controlled the expression of 
genes of almost all prokaryotic COGs. In some functional categories differences in the 
number of upregulated and downregulated genes by ArcA were obvious. In the category 
“carbohydrate transport and metabolism (G)” seven genes were downregulated by ArcA and 
none upregulated. Twenty-one genes belonging to the category “energy production and 
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Fig. 11: Functional classification of ArcA regulated genes according to the database Cluster of 
Orthologous Groups of Proteins (COGs). The classification was adopted from the “Simple Yet 
Powerful Genome Browser” database for A. pleuropneumoniae Ser 5 L20 
(http://informatics.bio.nrc.ca/ap5b) 
number of genes 
conversion (C)” were downregulated by ArcA compared to six genes that were upregulated. 
Similarly, more then twice the number of genes in the category “inorganic ion transport and 
metabolism (P)” were downregulated by ArcA than upregulated. In the categories 
“replication, recombination and repair, transcription (L)” and “cell cycle control, cell division, 
chromosome partitioning (D)”, however, considerably more genes were upregulated than 
downregulated by ArcA (Fig. 11). 
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D 2.1.2 Analysis of the ArcA regulon 
 
The four genes upregulated strongest by ArcA (ape0761, ape0760, ape0758 and serC) 
are located side by side on the genome of A. pleuropneumoniae and exhibited a decline in 
upregulation; they belong to a putatively ArcA regulated gene cluster or operon, and three of 
the genes are homologues to E. coli DNA modification enzymes. Putative protein Ape0761 
exhibits homology to the methylation subunit of E. coli restriction endonuclease EcoP15I, 
which belongs to a type III restriction-modification system. Ape0760 is a putative 
DEAD/DEAH box helicase domain protein with homology to type I restriction-modification 
systems. Ape0758 is homologue to an E. coli DNA/RNA helicase of the SNF2 family 
containing a DEAD/DEAH box helicase motif. Two further genes, ape0309 showing 
homology to the restriction subunit of an E. coli type I restriction modification system and 
related helicases and gene ape0841, a putative ATP-dependent helicase, were slightly 
increased in A. pleuropneumoniae wt. 
Enzymes of the respiratory chain catalyzing the oxidation of high-energy substrates did 
not show a unanimous regulation by ArcA in A. pleuropneumoniae. Thus, the genes glpA, 
glpB and glpC, encoding for the anaerobic glycerol-3-phosphate dehydrogenase operon, 
were upregulated in the wt strain compared to the arcA deletion mutant. The expression of 
the anaerobic glycerol-3-phosphate repressor gene (glpR) was simultaneously decreased by 
ArcA. 
The expression of a putative NADPH oxidoreductase gene of A. pleuropneumoniae 
exhibiting homology to mdaB of E. coli which catalyzes the reduction of quinones by 
oxidation of NADPH was found to be increased by ArcA.  
However, the formate dehydrogenase was identified to be downregulated by ArcA in A. 
pleuropneumoniae wt. Six open reading frames (fdhD, fdxG [APL_0892], fdxG [APL_0893], 
fdxH, fdnI, fdhG) with homology to genes encoding for E. coli formate dehydrogenases were 
identified in A. pleuropneumoniae; they were strongly repressed by ArcA under anaerobic 
conditions of growth.  
The expression of genes encoding for either flavin mononucleotide-dependent D-lactate 
dehydrogenase (dld) or L-lactate dehydrogenase (lldD) of the A. pleuropneumoniae 
respiratory chain were downregulated by ArcA. The putative malate:qinone oxidoreductase 
(mqo) was also repressed by ArcA as well as the putA gene, encoding for a bifunctional 
protein which includes proline dehydrogenase activity transferring electrons from proline into 
the respiratory chain. The genes ykgF encoding a putative electron transport protein and 
ykgE encoding a putative dehydrogenase subunit and ape1960 encoding a protein 
homologue to a possible sulfite oxidase of Mannheimia haemolytica were also 
downregulated by ArcA. 
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Terminal reductases which transfer electrons of the respiratory chain to alternative 
electron acceptors other than oxygen under anaerobic conditions were also not regulated 
unanimously by ArcA. The operon encoding for the anaerobic dimethylsulfoxide reductase 
(dmsABC) was positively regulated by ArcA. However, all homologues to genes of the E. coli 
nitrite reductase compelex, nrfABCD were found to be negatively regulated. Likewise, five 
genes of A. pleuropneumoniae  (ccmA, ccmB, ccmC, ccmE, ccmF) showing homology to the 
E. coli type 1 cytochrome c biogenesis system which is essential for functional NrfA and NrfB 
were downregulated. This was also observed to the gene nrfE which is essential for formate 
dependent nitrite reduction, the gene napF which is part of the periplasmic nitrate reductase 
operon of E. coli, and both genes encoding the cytochrome bd-I terminal oxidase (cydA, 
cydB) of A. pleuropneumoniae which catalyzes the transfer of electrons from ubiquinol to 
oxygen. 
Proteins that facilitate membrane transport of certain compounds were also under control 
of ArcA in A. pleuropneumoniae.  The expression of genes encoding transport-associated 
proteins for zinc (znuC, znuA) and serine (sdaC) were upregulated by ArcA. In contrast, 
transport systems for L-lactate (lctP) and sulfate (cysZ) were downregulated as were the 
sodium/glutamate (gltS) and formate/nitrate (yrhG) symporter as well as oxalate/formate 
(ape0969) and sodium/proton (nhaA) antiporter. Also, expression of the genes ape1350 and 
ape1353 encoding homologues to di- and tricarboxylate transporters of Haemophilus 
influenzae, a glutathione-regulated potassium-efflux system protein encoded by kefAB, the 
gene ape0961 encoding a homologue to a possible malonate efflux carrier of Mannheimia 
haemolytica, and the gene ulaA encoding the predicted ascorbate transporter were 
downregulated by ArcA.  
Iron uptake was also controlled by ArcA of A. pleuropneumoniae. The expression of 
afuA_2, which is homologous to a putative periplasmic-iron-binding protein of E. coli and two 
adjacent ORFs (ape2007 and ape 2008) encoding homologues to E. coli outer membrane 
receptor proteins, mostly iron transport, were upregulated by ArcA. Two genes with 
homology to a putative permease component for ferric iron (afuB) and a putative periplasmic-
iron-binding protein (afuA) of E. coli, and frpB a putative iron regulated outer membrane 
protein were downregulated by ArcA. 
The genes encoding several enzymes with functions in the glycolysis, gluconeogenesis 
and citric acid cycle were affected by ArcA in A. pleuropneumoniae. Two committed steps of 
the gluconeogenesis were concerned. The genes pck encoding the phosphoenolpyruvate 
carboxykinase and fbp encoding for fructose-1,6-bisphosphatase were downregulated by 
ArcA as were the last steps of glycolysis. Thus, expression of all genes encoding for 
components of the pyruvate dehydrogenase complex (lpdA, aceF, aceE) were 
downregulated by ArcA. LpdA is also part of the 2-oxoglutarate dehydrogenase complex in 
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the citric acid cycle. The genes lpdA, aceF and aceE are likely to be transcribed as an 
operon. Malate can be converted to pyruvate by the NADP-dependent malic enzyme. The 
respective gene maeB was also downregulated by ArcA as was the already mentioned 
malate:quinone oxidoreductase (mqo) gene, whose gene product is part of the respiratory 
chain as well as of the citric acid cycle.  
The gene sucD encoding for the alpha subunit of the succinyl-CoA synthetase of A. 
pleuropneumoniae was identified to be upregulated by ArcA as were the gene accD 
encoding the acetyl-CoA carboxyltransferase which is one of the key enzymes for fatty acid 
synthesis and the genes fabA and fabZ encoding for isoenzymes that are necessary for the 
synthesis of unsaturated fatty acids. 
Several genes involved in serine metabolism of A. pleuropneumoniae were identified to be 
upregulated by ArcA. Thus, two out of three enzymes of the serine biosynthesis pathway, the 
3-phosphoserine aminotransferase and the phosphoserine phosphatase encoded by the 
genes serC and serB were upregulated by ArcA. The reaction catalyzed by SerC is under 
physiological conditions reversible whereas the SerB-catalyzed reaction prefers the 
formation of L-serine. Additionally, the gene for the L-serine transport protein, sdaC was 
identified to be upregulated by ArcA as were the genes encoding for enzymes that use L-
serine as a substrate. These were the serine acetyltransferase encoded by cysE catalyzing 
the first step of cysteine synthesis, the phosphatidylserine synthase (pssA) that is necessary 
for the formation of the phospholipid phosphatidylserine, and the L-serine dehydratase, 
catalyzing the irreversible transformation of serine into pyruvate and ammonia. The 3-
phosphoserine aminotransferase encoded by serC is also part of the vitamin B6 biosynthesis 
pathway in E. coli. Two genes that were identified to be also upregulated by ArcA, pdxT and 
pdxS, encode for the synthetase and glutaminase subunits of a glutamine amidotransferase 
that has been described for Bacillus subtilis (Belitsky 2004) to be essential for pyridoxal 5´-
phosphate biosynthesis which is the active form of vitamin B6. 
The global regulator ArcA not only increased its own expression but also effected the 
expression of several proteins involved in regulatory processes in bacterial cells. Expression 
of cyaA encoding the adenylate cyclase and icc encoding a 3´,5´-cyclic-nucleotide 
phosphodiesterase was repressed by ArcA of A. pleuropneumoniae. Thereby, synthesis of 
the second messenger cAMP was affected by ArcA. The expression of gntR was 
upregulated by ArcA. GntR, is a repressor of the Entner-Doudoroff pathway and the GntI 
system which allows the entry of glyconate into the central glycolytic metabolism (Conway 
1992). The expression of the gene encoding the sensor protein NarQ was upregulated by 
ArcA of A. pleuropneumoniae contrary to E. coli where it has been reported that ArcA is not 
required for anaerobic induction of narQ (Darwin and Stewart 1995). The main signal for the 
NarQ sensor kinase of E. coli is nitrite. This signal is then transferred to the response 
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regulators NarL as well as NarP (Rabin and Stewart 1993) that adapt the metabolism onto 
nitrite or nitrate respiration. Although narQ expression was induced by ArcA anaerobically the 
general metabolism was not adapted to nitrite or nitrate respiration. The gene cpxR encoding 
a transcriptional regulator activating the transcription of stress-combative genes was 
identified to be upregulated in A. pleuropneumoniae as was the expression of the gene 
asnC. AsnC controls the expression of the aspartate-ammonia ligase gene and expression of 
the gene ape0752 encoding for a putative HTH-type transcriptional regulator.  
All chaperone proteins of the ArcA regulon were identified to be upregulated by ArcA of A. 
pleuropneumoniae. The expression of hptG was induced as was the expression of both 
genes encoding the GroEL-GroES complex, the expression of the gene encoding for the 
chaperone ClpB, and expression of two genes, dnaK and dnaJ, which are part of the DnaK 
system. 
A cluster of genes (rpsJ, rplC, rplD and rplW) encoding for ribosomal proteins was slightly 
downregulated by ArcA. 
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D 2.2  Global protein expression analysis of A. pleuropneumoniae ΔarcA 
 
The global transcription analysis aiming for the identification of differences between gene 
expression of A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA by DNA microarray 
approach was complemented with the identification of differences in protein pattern using 
two-dimensional difference gel electrophoresis (2D DIGE) and subsequent mass 
spectrometry. Different preparation methods of A. pleuropneumoniae proteins were 
performed in order to increase the resolution of proteins for comparison between A. 
pleuropneumoniae wt and A. pleuropneumoniae ΔarcA. 2D DIGE analyses were performed 
from i) - iii) whole cell lysates (Fig. 12A, 12B, 12C), iv) inner and outer membrane-associated 
proteins (Fig. 12D), v) outer membrane-associated proteins (Fig. 12E), vi) secreted proteins 
(Fig. 12F). Outer membrane proteins were analysed by quantitative PAGE (Fig. 13). 
Altogether 177 protein spots significantly increased in A. pleuropneumoniae wt compared to 
A. pleuropneumoniae ΔarcA were identified by 2D DIGE. Mass spectrometry of 58 of these 
spots yielded 31 different proteins (Table 3, 4). 193 spots were found to be significantly 
downregulated by ArcA in A. pleuropneumoniae and mass spectrometry of 74 of these spots 
resulted in 28 different proteins (Table 3, 5). Additionally to these 132 mass spectrometry 
analyses 28 protein spots belonging to non-significant but otherwise interesting protein spots 
on 2D gels were analysed by mass spectrometry (Table 6). Of the 160 MS analyses 
performed in total, 116 were performed by Q-TOF MSMS (Appendix G 6.1) and 44 by 
MALDI-TOF MS (Appendix G 6.2). 
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Fig. 12: 2D DIGE analysis of different protein preparations for comparison of protein 
expression between A. pleuropneumoniae wt (labelled with Cy5 [red]) and A. 
pleuropneumoniae ΔarcA (labelled with Cy3 [green]). A, B and C, proteins precipitated directly 
from whole cell lysates. D, preparation of inner and outer membrane-associated proteins; E, 
preparation of outer membrane-associated proteins; F, preparation of secreted proteins. Isoelectric 
focussing was performed using Immobiline DryStrips with a pI gradient as shown on the respective 
gels. Second dimension separation of proteins was performed on 12.5 % polyacrylamide gels. For 
each protein preparation A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA were grown 
anaerobically in four independent cultures (A, B, C, D, F) or in three independent cultures (E) each. 
Using three fluorescent dyes, Cy2 (blue [internal standard]), Cy3 (green [either wt or ΔarcA]) and 
Cy5 (red [either wt or ΔarcA]) on each gel an internal standard and a protein preparation of A. 
pleuropneumoniae wt and A. pleuropneumoniae ΔarcA were separated simultaneously. The 
fluorescence was detected using a TyphoonTM Trio fluorescence scanner. Quantitative and 
statistical analysis of differences in protein expression was performed with the DeCyderTM 2D 6.5 
software. Each gel shown here represents one out of six gels (A, B, C, D, F) or one out of four gels 
(E) that were run and analyzed for the respective protein preparation. On all gels shown here A. 
pleuropneumoniae wt proteins are shown as red signals (Cy5) and A. pleuropneumoniae ΔarcA 
proteins are shown by green fluorescence (Cy3).  Arrow heads highlight protein spots that were 
significantly (p < 0.05) upregulated by ArcA. Arrows indicate protein spots that were significantly (p < 
0.05) downregulated by ArcA. Some protein spots are stressed by a line. These spots were not 
significantly regulated by ArcA. Protein spots of interest were excised from preparative gels, treated 
with trypsin for in gel digestion of proteins and, after recovery of peptides from the gel, analyzed by 
mass spectrometry. 
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Fig. 13: PAGE of an outer membrane protein preparation of A. pleuropneumoniae wt 
(labelled with Cy5 [red]) and A. pleuropneumoniae ΔarcA (labelled with Cy3 [green]). 
Both preparations were mixed and separated in one lane. Fluorescence was detected using a 
TyphoonTM Trio fluorescence scanner. From A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔarcA four independent cultures were prepared under anaerobic growth 
conditions and separate outer membrane protein preparations were performed. After labelling 
with different dyes, outer membrane proteins of A. pleuropneumoniae wt were mixed with 
outer membrane proteins of A. pleuropneumoniae ΔarcA resulting in four pairs. These were 
separated in four lanes on the same gel. Using the Fragment AnalysisTM 2.1 Software band 
intensities were calculated for the protein bands according to their fluorescence intensity. 
Including the four biological repeats a statistical analysis was performed to detect significant 
differences in band intensities between the wt and the mutant strain. Protein bands that were 
identified as significantly (p < 0.05) downregulated by ArcA are highlighted by arrows. Bands 
of interest were excised and used for protein analysis by mass spectrometry. 
LMW: Cy3 labelled low molecular weight marker (Amersham). 
13 
LMW 
mW [kDa] 
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Table 3: Overview protein preparations, DIGE results and mass spectrometry results. 
no. of differentially 
expressed spots a 
no. of proteins 
identified by mass 
spectrometry 
no. of different 
proteins identified 
figure protein preparation IPG strip pI gradient up in wt up in 
ΔarcA 
up in wt up in 
ΔarcA 
up in wt up in 
ΔarcA 
12A whole cell lysate b 4 to 7 42 37 15 (4) e 21 (16) e 13 12 
12B whole cell lysate c 4 to 7 34 33 12 (4) e 20 (16) e 6 11 
12C whole cell lysate  7 to 11 NLd 3 7 0 5 0 4 
12D inner and outer membrane- 
associated  
3 to 11 NLd 50 81 21 30 12 14 
12E outer membrane-associated  3 to 11 NLd 40 22 11 8 9 6 
12F secreted  3 to 11 NLd 8 13 3 4 3 3 
13 outer membrane  ─ ─ ─ 0 2 0 2 
 total ─ 177 193 62 (58) f 90 (74) f 30 29 
     152 (132) f 58 g 
 
a) obtained by 2D DIGE as statistical significant (Student’s T-test p < 0.05) 
b) protein precipitation with 10 % TCA 
c) protein precipitation with 15 % TCA 
d) non linear 
e) the number in parenthesis indicates the number of spots that were found on both gels (12A and 
12B). These proteins were identified once by mass spectrometry.  
f) the number in parenthesis is the number of protein spots that were analyzed by mass spectrometry. 
g) 30 different proteins upregulated plus 29 different proteins downregulated minus 1 protein (FrpB) 
up- and downregulated by ArcA dependent on protein preparation method 
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Table 4: Proteins significantly upregulated by ArcA. 
spot a protein b T-test c ratio d MS # e gel # f 
whole cell lysates (Fig. 12A) 
GdhA NADP-specific glutamate dehydrogenase 0.0019 2.33 M79 4 
PtsI (1) phosphoenolpyruvate protein phosphotransferase   7.50E-05 1.63 211 6 
PflB (1) formate acetyltransferase   0.0018 1.45 15 3 
EngD GTP dependent nucleic acid binding protein EngD   0.0077 1.43 225 6 
Pgk phosphoglycerate kinase   0.024 1.38 226 6 
PtsI (2) phosphoenolpyruvate protein phosphotransferase   0.00031 1.37 27 3 
PtsI (3) phosphoenolpyruvate protein phosphotransferase   0.00043 1.29 218 6 
GlmS 
glucosamine  fructose 6 phosphate aminotransferase  
isomerizing    0.0094 1.29 49 3 
CbiK putative periplasmic binding protein CbiK   0.00072 1.26 10 2 
DnaK chaperone protein dnaK   0.0053 1.21 212 6 
GpmA 
2 3 bisphosphoglycerate dependent 
phosphoglycerate mutase   0.0063 1.2 9 2 
SodA manganese superoxide dismutase   0.04 1.17 5 2 
Ape1259 hypothetical protein APL 1167   0.043 1.16 213 6 
DeoC deoxyribose phosphate aldolase   0.035 1.15 215 6 
Adk adenylate kinase   0.034 1.14 222 6 
whole cell lysates (Fig. 12B) 
Ape0761 (1) 
putative methylation subunit  type III restriction 
modification system   0.00061 7.13 210 6 
Ape0761 (2) 
putative methylation subunit  type III restriction 
modification system   0.00096 5.27 209 6 
GlmS 
glucosamine  fructose 6 phosphate aminotransferase  
isomerizing    0.047 1.53 49 3 
PflB (1) formate acetyltransferase   0.0021 1.51 15 3 
PflB (2) formate acetyltransferase   0.018 1.47 17 3 
PflB (3) formate acetyltransferase   0.0018 1.46 22 3 
PflB (4) formate acetyltransferase   0.029 1.42 21 3 
PflB (5) formate acetyltransferase   0.0022 1.4 18 3 
PtsI (1) phosphoenolpyruvate protein phosphotransferase   0.04 1.37 27 3 
PtsI (2) phosphoenolpyruvate protein phosphotransferase   0.039 1.34 218 6 
TorZ trimethylamine N oxide reductase precursor   0.0034 1.3 61 7 
AckA acetate kinase   0.029 1.09 36 3 
inner and outer membrane-associated proteins (Fig. 12D) 
FrpB iron regulated outer membrane protein B   0.011 6.66 260 11 
OmpA (1) outer membrane protein P5 precursor  0.004 6.65 258 11 
OmpA (2) outer membrane protein P5 precursor   0.0035 6.55 255 11 
OmpA (3) outer membrane protein P5 precursor 0.0038 6.54 256 11 
Ape0761 
putative methylation subunit  type III restriction 
modification system   0.00011 5.96 267 11 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2    0.016 5.05 254 11 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2    0.014 4.42 253 11 
NapA (1) periplasmic nitrate reductase precursor   0.047 3.24 263 11 
Adh2 aldehyde-alcohol dehydrogenase 2 0.033 2.34 M55 11 
ApxIIA RTX II toxin determinant A   0.027 2.32 275 11 
TorZ (1) trimethylamine-N-oxide reductase precursor 0.035 1.9 M56 11 
DmsA (1) 
anaerobic dimethyl sulfoxide reductase chain A 
precursor   0.017 1.85 273 11 
DmsA (2) 
anaerobic dimethyl sulfoxide reductase chain A 
precursor   0.0075 1.77 274 11 
PflB (1) formate acetyltransferase   0.00074 1.72 M42 11 
PflB (2) formate acetyltransferase   5.90E-05 1.7 M41 11 
PflB (3) formate acetyltransferase   0.0031 1.68 287 11 
PykA pyruvate kinase   0.016 1.68 262 11 
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PflB (4) formate acetyltransferase   2.10E-06 1.67 M40 11 
GlnA Glutamine synthetase   0.021 1.62 244 11 
TorZ (2) trimethylamine-N-oxide reductase precursor 0.032 1.57 M57 11 
PflB (5) formate acetyltransferase   1.50E-05 1.53 268 11 
outer membrane-associated proteins (Fig. 12E) 
OmpA (1) outer membrane protein P5 precursor   0.045 5.92 282 13 
OmpA (2) outer membrane protein P5 precursor 0.0054 5.63 M29 13 
ApxIIa (1) RTX-II toxin determinant A 0.052 5.37 M13 13 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2    0.044 2.92 278 12 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2    0.053 2.71 279 12 
PtsH PTS system phosphocarrier protein HPr  0.034 1.91 M28 13 
ZnuA 
high-affinity zinc uptake system protein ZnuA 
precursor  0.047 1.47 M26 13 
GapA glyceraldehyde-3-phosphate dehydrogenase 0.038 1.46 M27 13 
AckA acetate kinase   0.0033 1.45 235 13 
Efp Elongation factor P  0.033 1.4 M25 13 
TorZ trimethylamine-N-oxide reductase precursor 0.003 1.3 M21 13 
secreted proteins (Fig. 12F) 
RbsB D ribose binding periplasmic protein precursor   0.037 1.45 133 14 
ApxIIa (1) RTX-II toxin determinant A 0.044 1.23 M05 14 
Pgk phosphoglycerate kinase 0.035 1.14 M11 14 
 
 
Table 5: Proteins significantly downregulated by ArcA. 
spot a protein b T-test c ratio d MS # e gel # f 
whole cell lysates (Fig. 12A) 
Fbp (1) fructose 1 6 bisphosphatase 2.00E-08 -8.49 2 1 
AldA (1) putative aldehyde dehydrogenase aldA 3.10E-06 -6.9 60 5 
YkgE putative dehydrogenase subunit 1.60E-07 -5.9 4 1 
AldA (2) putative aldehyde dehydrogenase aldA 0.011 -4.05 40 3 
AspA (1) aspartate ammonia lyase 0.00029 -3.69 62 5 
AceE (1) pyruvate dehydrogenase E1 component 1.50E-05 -3.65 30 3 
AdhI alcohol dehydrogenase 1 4.80E-07 -3.62 12 2 
AceE (2) pyruvate dehydrogenase E1 component 5.60E-07 -3.61 16 3 
AceE (3) pyruvate dehydrogenase E1 component 7.00E-05 -3.13 M75 4 
LpdA (1) dihydrolipoyl dehydrogenase 2.50E-08 -2.85 13 2 
LpdA (2) dihydrolipoyl dehydrogenase 2.40E-07 -2.82 42 3 
AceE (4) pyruvate dehydrogenase E1 component 3.30E-06 -2.59 19 3 
Ape0477 hypothetical protein APL 0444 0.0053 -2.42 3 1 
AceE (5) pyruvate dehydrogenase E1 component 5.30E-05 -2.27 M77 4 
AspA (2) aspartate ammonia lyase 0.018 -2.06 55 3 
AspA (3) aspartate ammonia lyase 7.80E-05 -1.62 228 6 
PckA (1) phosphoenolpyruvate carboxykinase  ATP 0.00036 -1.43 33 3 
Pnp (1) polyribonucleotide nucleotidyltransferase 0.023 -1.43 220 6 
Mtn MTA SAH nucleosidase 0.0021 -1.39 221 6 
Pnp (2) polyribonucleotide nucleotidyltransferase 0.016 -1.34 24 3 
TktA transketolase 2 0.039 -1.33 38 3 
whole cell lysates (Fig. 12B) 
AldA (2) putative aldehyde dehydrogenase aldA 0.00019 -10.99 40 3 
Fbp (1) fructose 1 6 bisphosphatase 0.00038 -8.05 2 1 
Fbp (2) fructose 1 6 bisphosphatase 0.00019 -4.12 59 5 
AldA (1) putative aldehyde dehydrogenase aldA 0.0017 -4.05 60 5 
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AceE (1) pyruvate dehydrogenase E1 component 0.00029 -3.12 30 3 
AceF 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 0.00065 -2.99 23 3 
LpdA (1) dihydrolipoyl dehydrogenase 0.00018 -2.97 13 2 
AceE (2) pyruvate dehydrogenase E1 component 0.00067 -2.88 16 3 
LpdA (2) dihydrolipoyl dehydrogenase 0.0022 -2.78 42 3 
YkgE putative dehydrogenase subunit 0.0028 -2.65 4 1 
AdhI alcohol dehydrogenase 1 0.00018 -2.54 12 2 
MaeB NADP dependent malic enzyme  NADP ME 0.011 -2.39 1 1 
AceE (3) pyruvate dehydrogenase E1 component 0.0017 -2.33 M75 4 
AspA (1) aspartate ammonia lyase 0.0035 -1.66 62 5 
AspA (2) aspartate ammonia lyase 0.047 -1.63 55 3 
AceE (4) pyruvate dehydrogenase E1 component 0.0037 -1.58 19 3 
PckA (1) phosphoenolpyruvate carboxykinase  ATP 0.0022 -1.42 33 3 
PckA (2) phosphoenolpyruvate carboxykinase  ATP 0.018 -1.42 44 3 
Pnp (1) polyribonucleotide nucleotidyltransferase 0.029 -1.27 24 3 
Pnp (2) polyribonucleotide nucleotidyltransferase 0.011 -1.25 220 6 
whole cell lysates (Fig. 12C) 
YkgF (1) putative electron transport protein 0.0011 -11.19 172 9 
YkgF (2) putative electron transport protein 1.10E-05 -10.08 174 9 
Mqo putative malate quinone oxidoreductase 0.0074 -7.49 170 9 
RplF 50S ribosomal protein L6 0.032 -2.01 202 10 
Ape0051 hypothetical protein APL 0049 0.05 -1.81 205 10 
inner and outer membrane-associated proteins (Fig. 12D) 
Fbp fructose 1 6 bisphosphatase 5.30E-06 -10.12 266 11 
AceF (1) 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 4.00E-06 -4.51 237 11 
AceF (2) 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 6.70E-06 -4.3 M32 11 
AceF (3) 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 3.00E-05 -4.11 M33 11 
AceF (4) 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 3.20E-05 -3.88 M30 11 
AceF (5) 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 4.80E-05 -3.68 236 11 
AceF (6) 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 1.20E-05 -3.66 M31 11 
AceE (1) pyruvate dehydrogenase E1 component 5.10E-06 -3.53 M39 11 
TktA transketolase 2 1.90E-05 -3.24 M36 11 
LpdA (1) dihydrolipoyl dehydrogenase 8.60E-06 -3.12 M45 11 
AceE (2) pyruvate dehydrogenase E1 component 3.60E-05 -2.98 M38 11 
AceF (7) 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 0.00017 -2.98 283 11 
LpdA (2) dihydrolipoyl dehydrogenase 1.80E-05 -2.88 M44 11 
LpdA (3) dihydrolipoyl dehydrogenase 0.00066 -2.6 288 11 
LpdA (4) dihydrolipoyl dehydrogenase 0.00026 -2.56 290 11 
LpdA (5) dihydrolipoyl dehydrogenase 0.00011 -2.38 291 11 
RpsA (1) 30S ribosomal protein S1 0.038 -2.3 239 11 
RpsA (2) 30S ribosomal protein S1 0.049 -2.1 M34 11 
AceE (3) pyruvate dehydrogenase E1 component 0.00041 -2.07 M37 11 
Pnp polyribonucleotide nucleotidyltransferase 0.011 -1.97 238 11 
AsnA aspartate ammonia ligase 0.011 -1.79 299 11 
PckA (1) phosphoenolpyruvate carboxykinase  ATP 0.01 -1.69 M35 11 
AtpD ATP synthase subunit beta 0.032 -1.68 240 11 
MrsA phosphoglucosamine mutase 0.0012 -1.67 M43 11 
GalE (1) UDP glucose 4 epimerase   0.012 -1.65 296 11 
PckA (2) phosphoenolpyruvate carboxykinase  ATP 0.011 -1.6 252 11 
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Ape1591 (1) hybrid peroxiredoxin HyPrx5 0.036 -1.59 242 11 
TufB Elongation factor Tu 0.0041 -1.57 248 11 
Ape1591 (2) hybrid peroxiredoxin HyPrx5 0.034 -1.57 243 11 
GalE (2) UDP glucose 4 epimerase  0.014 -1.5 295 11 
outer membrane-associated proteins (Fig. 12E) 
Fbp (1) fructose 1 6 bisphosphatase 0.0034 -4.53 M23 13 
MaeB (1) NADP dependent malic enzyme  NADP ME 0.00087 -4.38 231 13 
Fbp (2) fructose 1 6 bisphosphatase 0.002 -4.08 M24 13 
MaeB (2) NADP dependent malic enzyme  NADP ME 0.0094 -2.14 M22 13 
YkgE putative dehydrogenase subunit 0.019 -1.68 234 13 
PtrA protease 3 precursor 0.0035 -1.34 M20 13 
PckA phosphoenolpyruvate carboxykinase  ATP 0.035 -1.23 M18 13 
Prc tail-specific protease precursor 0.043 -1.13 M19 13 
secreted proteins (Fig. 12F) 
OmpW outer membrane protein W precursor 0.000041 -6.27 122 14 
Ape0051 hypothetical protein APL 0049 0.023 -2.16 130 14 
TufB (1) Elongation factor Tu 0.033 -1.86 148 14 
TufB (2) Elongation factor Tu 0.035 -1.86 M09 14 
outer membrane proteins (Fig. 13) 
OmpW outer membrane protein W precursor   0.01 -6.83 78 16 
FrpB iron regulated outer membrane protein  0.046 -1.88 75 16 
 
 
Table 6: Selected proteins not significantly up- or downregulated by ArcA. 
spot a protein b T-test c ratio d MS # e gel # f 
whole cell lysates (Fig. 12C) 
NapA (1) periplasmic nitrate reductase precursor  0.54 -1.06 175 9 
NapA (2) periplasmic nitrate reductase precursor  0.98 -1 168 10 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2   0.23 1.22 183 10 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2   0.28 1.31 184 10 
OmpA (1) outer membrane protein P5 precursor  0.38 1.19 185 10 
OpmA (2) outer membrane protein P5 precursor  0.38 1.21 187 10 
FrpB iron regulated outer membrane protein B  0.24 -1.52 173 10 
inner and outer membrane-associated membrane proteins (Fig. 12D) 
NapA (2) periplasmic nitrate reductase precursor  0.057 2.81 264 11 
OmpA (4) outer membrane protein P5 precursor  OMP P5   0.093 2.74 261 11 
PplI 50S ribosomal protein L9  0.076 -10.44 269 11 
outer membrane-associated proteins (Fig. 12E) 
ApxIIa (2) RTX II toxin determinant A  0.22 4.26 230 13 
ApxIIa (3) RTX II toxin determinant A  0.21 4.67 281 13 
secreted proteins (Fig. 12F) 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2   0.082 -1.24 149 14 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2   0.059 -1.26 150 14 
OmpA (1) outer membrane protein P5 precursor  0.079 1.19 161 14 
OmpA (2) outer membrane protein P5 precursor  0.23 1.17 151 14 
OmpA (3) outer membrane protein P5 precursor  OMP P5   0.14 1.25 165 14 
OmpA (4) outer membrane protein P5 precursor  OMP P5 0.14 1.25 163 14 
OmpA (5) outer membrane protein P5 precursor  OMP P5   0.14 1.25 153 14 
ApxIIa (2) RTX-II toxin determinant A nd nd M01 14 
ApxIIa (3) RTX-II toxin determinant A nd nd M02 14 
ApxIIa (4) RTX-II toxin determinant A nd nd M03 14 
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ApxIIa (5) RTX-II toxin determinant A 0.13 1.21 M04 14 
ApxIIa (6) RTX-II toxin determinant A 0.072 1.28 M06 14 
ApxIIa (7) RTX-II toxin determinant A 0.078 1.28 M07 14 
outer membrane proteins (Fig. 13) 
OmpA (2) 
outer membrane protein P5 precursor  OMP P5; outer 
membrane protein P5 precursor   0.48 1.51 92, 93 17 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2 0.48 1.51 94 17 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2   0.34 1.49 73 15 
OmpA (1) 
outer membrane protein P5 precursor; outer 
membrane protein P5 precursor OMP P5     0.34 1.49 84, 82 16 
OmpA (3) 
outer membrane protein P5 precursor;  outer 
membrane protein P5 precursor  OMP P5 0.39 1.21 79, 80 16 
 
a) name of protein spot on gel (Fig. 12 A-F, 13) 
b) result of mass spectrometry analysis. 
c) statistical analysis using unpaired Student’s T-test 
d) ratio between A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA. Positive values indicate 
upregulation by ArcA, negative values indicate downregulation by ArcA. 
e) number of the mass spectrometric analysis (Appendix G 6) that was performed for the identification 
of the protein of interest from the respective preparative gel f. Simple numbers indicate analysis by 
Q-TOF MSMS; numbers beginning with the capital letter M indicate analysis by MALDI-TOF MS. 
f) this number indicates the preparative gel (Appendix G 5) from which the respective protein spot was 
obtained. 
 
 
D 2.2.1 Analysis of differentially expressed proteins 
 
Several enzymes catalyzing reactions of glycolysis or gluconeogenesis and at the 
interface of these pathways to the citric acid cycle were found to be affected anaerobically by 
ArcA using 2D DIGE and subsequent mass spectrometry. A protein homologue to the UDP 
glucose-4-epimerase (GalE) necessary for introduction of galactose into the glycolysis was 
identified as upregulated by ArcA in A. pleuropneumoniae. The glycolysis enzymes 
glyceraldehyde-3-phosphate dehydrogenase (GapA), 3-phosphoglycerate kinase (Pgk) and 
the 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase (GmpA) were identified by 
2D DIGE of either whole cell lysate proteins, outer membrane-associated proteins or 
secreted proteins (Fig. 12A, 12E, 12F) to be slightly upregulated by ArcA of A. 
pleuropneumoniae. The pyruvate dehydrogenase complex catalyzes the irreversible 
transformation of the last glycolysis metabolite pyruvate into acetyl-CoA in order to introduce 
it into the citric acid cycle. The components of the pyruvate dehydrogenase protein complex, 
pyruvate dehydrogenase E1 component (AceE), dihydrolipoyllysine residue acetyltransferase 
(AceF) and dihydrolipoyl dehydrogenase (LpdA) were identified on gels of whole cell lysates 
(Fig. 12A, 12B) and on gels of inner and outer membrane-associated proteins (Fig. 12D). 
They were strongly downregulated by ArcA. Of each subunit of the pyruvate dehydrogenase 
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complex several protein spots were identified on these gels presumably due to differences in 
residual secondary structure or posttranslational modifications. The phosphoenolpyruvate 
carboxykinase (PckA) initiating gluconeogenesis from the citric acid cycle intermediate 
oxaloacetate was also identified to be downregulated by ArcA. The protein PckA was 
identified as differentially expressed in several DIGE experiments (Fig. 12A, 12B, 12D, 12E) 
and sequenced from the respective preparative gels. The NADP dependent malic enzyme 
(MaeB) is another enzyme at the interface of glycolysis and citric acid cycle that has been 
identified to be downregulated by ArcA in A. pleuropneumoniae. DIGE analysis of whole cell 
lysates (Fig. 12B) and outer membrane-associated proteins (Fig. 12E) led to the identification 
of MaeB as severely downregulated by ArcA. The protein was identified by mass 
spectrometry from the respective preparative gels. A key enzyme of gluconeogenesis, the 
fructose-1,6-bisphosphatase (Fbp), was also identified as downregulated by ArcA. This 
protein was identified by DIGE analysis and sequenced on gels of whole cell lysates (Fig. 
12A, 12B) inner membrane preparations (Fig. 12D) and on outer membrane-associated 
protein preparations (Fig. 12E). The pyruvate kinase (PykA) transforming 
phosphoenolpyruvate into pyruvate and the formate acetyltransferase (PflB) catalyzing the 
transformation of pyruvate and CoA into formate and acetyl-CoA were identified as 
upregulated by ArcA in A. pleuropneumoniae. PykA was found by 2D DIGE analyses of inner 
and outer membrane-associated proteins (Fig. 12D), and PflB was identified on DIGE gels of 
whole cell lysates (Fig. 12A, 12B) and on gels of inner and outer membrane-associated 
proteins (Fig. 12D). The acetate kinase (AckA) generating ATP by dephosphorylation of 
acetylphosphate is upregulated by ArcA as identified by 2D DIGE of whole cell lysates and 
outer membrane associated proteins (Fig. 12B, 12E).  
The alcohol dehydrogenase 1 (AdhI) which is a homologue to the E. coli protein AdhP 
was identified to be downregulated by ArcA. AdhI was identified by 2D DIGE of gels on which 
protein preparations obtained from whole cell lysates were separated (Fig. 12A, 12B). The 
putative aldehyde dehydrogenase AldA was also identified on gels of whole cell lysates (Fig. 
12A, 12B) as strongly downregulated by ArcA in A. pleuropneumoniae. In contrast, the 
aldehyde-alcohol dehydrogenase 2 of A. pleuropneumoniae wt was found to be upregulated 
by ArcA on 2D DIGE gels of inner and outer membrane associated proteins (Fig. 12D). 
The putative dehydrogenase subunit YkgE was found to be downregulated by ArcA on 
gels of whole cell lysates as well as on gels where outer membrane-associated proteins were 
separated (Fig. 12A, 12B, 12E). The putative electron transport protein YkgF forming a 
putative operon with YkgE was also identified as strongly downregulated by ArcA in DIGE 
analyses of whole cell lysates (Fig. 12C). On the same gel a putative malate quinine 
reductase (Mqo) was identified as strongly downregulated by ArcA. 2D DIGE revealed that 
the anaerobic dimethyl reductase chain A (DmsA) and the trimethylamine N-oxide reductase 
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(TorZ) were upregulated by ArcA. DmsA and TorZ were identified by 2D DIGE of inner and 
outer membrane-associated proteins (Fig. 12D, 12E) with TorZ additionally found by 2D 
DIGE of whole cell lysates (Fig. 12B). The elongation factor Tu (TufB) is upregulated by ArcA 
in A. pleuropneumoniae and was identified by 2D DIGE of gels from inner and outer 
membrane-associated proteins as well as on preparation of secreted proteins (Fig. 12D, 
12F). The translation elongation factor P (Efp) was found to be upregulated by ArcA by 2D 
DIGE of outer membrane-associated proteins (Fig. 12E) 
2D DIGE of whole cell lysates (Fig. 12A, 12B) revealed that the phosphoenolpyruvate 
protein phosphotransferase (PtsI) of A. pleuropneumoniae was upregulated by ArcA. The 
HPr-related protein (PtsH) which is the second of two sugar-non-specific protein constituents 
of the phosphotransferase system was identified as upregulated by ArcA in 2D DIGE of outer 
membrane-associated proteins (Fig. 12E). 
The putative methylation subunit type III restriction modification system (Ape0761) was 
identified on gels of whole cell lysates and on gels of inner and outer membrane-associated 
proteins (Fig. 12B, 12D) as strongly upregulated by ArcA. 
The 30S ribosomal protein S1 was found by 2D DIGE of inner and outer membrane-
associated proteins as downregulated by ArcA in A. pleuropneumoniae (Fig. 12D). On the 
same gel the 50S ribosomal protein (RplI) was found to be more then 10 fold downregulated 
by ArcA; however, this spot slightly failed the significance threshold of the DIGE analysis. A 
further ribosomal protein, the 50S ribosomal protein L6 (RplF), was identified by DIGE on 
gels of whole cell lysates (Fig. 12C) as downregulated by ArcA in A. pleuropneumoniae. 
On gels of secreted proteins (Fig. 12F) the outer membrane protein W (OmpW) appeared 
as strongly downregulated by ArcA in A. pleuropneumoniae. On the same gel the 
hypothetical protein Ape0051 was also identified as downregulated by ArcA. The gene 
encoding this protein exhibiting homology to an outer membrane protein of A. 
actinomycetemcomitans is located just downstream of arcA. 
 
 
D 2.2.2 Comparison between detergent and non detergent-dependent protein 
preparations 
 
Several differentially expressed proteins where identified by 2D DIGE of different protein 
preparations and analyzed by mass spectrometry from the respective preparative gels. In 
most cases calculated differences in expression between A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔarcA were similar (Table 4, 5, 6). However, for some proteins the 2D 
DIGE-based comparison of protein expression between A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔarcA differed considerably depending on the method of protein 
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preparation; thus, differences were observed between the detergent-based protein 
preparations of inner and outer membrane-associated proteins (Fig. 12D) and outer 
membrane associated proteins (Fig. 12E) on the one hand and the non detergent-based 
preparations of whole cell lysates (Fig. 12A, 12B, 12C) and secreted proteins (Fig. 12F) on 
the other hand. 
The outer membrane protein P2 (OmpP2) and the outer membrane protein P5 (OmpA) 
were found by 2D DIGE of inner and outer membrane-associated proteins (Fig. 12D) as 
more then 5-fold upregulated by ArcA. 2D DIGE analysis of outer membrane-associated 
proteins (Fig. 12E) also revealed a significant upregulation of the outer membrane proteins 
OmpP2 and OmpA. However, OmpP2 and OmpA where also identified on 2D DIGE gels of 
whole cell lysates (Fig. 12C). In these preparations, both proteins appeared only slightly and 
not statistically significant upregulated by ArcA. OmpA was also identified by 2D DIGE of 
secreted proteins (Fig. 12F) as slightly but not significantly upregulated whereas OmpP2 
even appeared slightly but not significantly downregulated by ArcA. A similar observation 
was made for the RTX-II toxin determinant A (ApxIIA) which was found to be strongly 
upregulated by ArcA in 2D DIGE analysis of inner and outer membrane-associated proteins 
(Fig. 12D) and outer membrane-associated proteins (Fig. 12E) whereas 2D DIGE analysis of 
secreted proteins (Fig. 12F) revealed only a slight (not significant) upregulation of ApxIIA. 
Additionally the iron-regulated outer membrane protein B (FrpB) and the periplasmic nitrate 
reductase (NapA) were identified by 2D DIGE of inner and outer membrane-associated 
proteins (Fig. 12D) as increased in A. pleuropneumoniae wt by 6.7-fold and 3.2-fold, 
respectively. Both proteins were also identified on gels of whole cell lysates (Fig. 12C) 
revealing a 1.5-fold (not significant) downregulation of FrpB by ArcA and no difference 
between both strains in expression of NapA. 
 
 
D 2.2.3 Comparison of microarray and 2D DIGE analyses 
 
Of 78 protein spots resembling 23 different proteins that were identified by 2D DIGE as 
statistically significantly downregulated by ArcA 22 genes were also identified as 
downregulated significantly by microarray analysis. Only the ATP synthase subunit beta was 
found by 2D DIGE analysis as 1.68-fold downregulated by ArcA and by microarray analysis 
as 1.23-fold upregulated. 2D DIGE revealed 40 protein spots as significantly upregulated by 
ArcA belonging to 17 different proteins for which significant results were also obtained by 
microarray analysis. However, whereas the microarray analysis showed the same kind of 
regulation as the 2D DIGE analysis for 12 genes, expression of 5 genes was found to be 
regulated in the opposite direction (downregulated by ArcA). These 5 genes relate to 8 
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Fig. 14: Comparison of transcript (microarray) and protein (2D DIGE, quantitative PAGE) 
ratios between anaerobically grown A. pleuropneumoniae wt and A. pleuropneumoniae 
ΔarcA. Transcripts as well as proteins that were identified to be upregulated due to ArcA got a 
positive value representing the factor of upregulation (Appendix G 1, Table 4). The log10 of these 
factors is represented by positive values on the y-axis for transcripts and positive values on the 
x-axis for proteins. Transcripts and proteins that were downregulated due to ArcA are indicated 
by a negative number representing the factor of downregulation (Appendix G 2, Table 5). The 
negative log10 of the absolute value is shown as negative value on the y-axis for transcripts and 
as negative values of the x-axis for proteins. Proteomics often led to multiple identification of the 
same protein. Symbols of a certain protein are connected by a yellow line. Dependent of the 
method of preparation different symbols were used as indicated in the diagram. The line of best 
fit was calculated showing a slope close to one. Proteins that deviated strongly from the line of 
best fit are indicated by arrows.  
 
protein spots that were identified as upregulated by ArcA in 2D DIGE; these five proteins 
include ApxIIA, FrpB, and NapA which were shown to be regulated differently depending on 
the mode of preparation (see above and Fig. 14).  
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D 3  The HlyX regulon of A. pleuropneumoniae 
 
D 3.1  Global transcription analysis of A. pleuropneumoniae ΔhlyX 
 
A global gene expression profiling using a DNA microarray analysis was performed for the 
identification of HlyX-regulated genes. Six independent expression profiles of anaerobically 
grown A. pleuropneumoniae wt and A. pleuropneumoniae ΔhlyX, respectively, were analyzed 
and compared. The expression of 234 genes was upregulated more then 2-fold by HlyX, and 
among these the expression of 34 was increased more then 6-fold. An additional 164 genes 
were found to be upregulated by HlyX by a factor between 1.5 and 2. On the other hand 184 
genes were found to by downregulated more then 2-fold by HlyX with none of these genes 
being downregulated more than 6-fold. In addition, 321 genes were downregulated by a 
factor between 1.5 and 2 by HlyX (Fig. 15, Appendix G 3 and  G4). 
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Fig. 15: Summary of microarray results wt vs. ΔhlyX. Each spot represents a gene that has been 
identified to be significantly affected by ArcA (p < 0.05). Spots appearing above the diagonal line 
represent genes that were upregulated by HlyX. Those located below the diagonal line exhibited a 
higher expression level in the hlyX deletion mutant caused by a downregulation due to HlyX in A. 
pleuropneumoniae wt. Green spots indicate genes upregulated by more then 1.5-fold and red spots 
indicate genes upregulated by more then 2-fold due to HlyX. Light blue spots indicate genes 
downregulated by more then 1.5-fold and dark blue spots indicate genes downregulated by more 
then 2-fold due to HlyX. 
 
 
 
 
 
 
 
 
 
 
D 3.1.2 Functional classification of HlyX regulated genes  
 
The 398 genes upregulated by HlyX by more then 1.5 fold and the 505 genes 
downregulated by HlyX by more than 1.5 fold were analyzed with respect to their functional 
classification using the database Cluster of Orthologous Groups of proteins (COGs) 
(http://www.ncbi.nlm.nih.gov/COG/; Tatussov et al., 1997). HlyX controlled the expression of 
genes belonging to almost all prokaryotic categories. In some categories differences 
between up- and downregulated genes were apparent; 51 genes belonging to the category 
“carbohydrate transport and metabolism (G)” were downregulated by HlyX compared to 11 
genes of that category whose expression was upregulated. 25 genes of the category 
“nucleotide transport and metabolism (F)” were downregulated by HlyX compared to 6 genes 
that were upregulated. For the other categories the observed discrepancies between HlyX 
up- and downregulated genes were found to be less pronounced (Fig. 16). 
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Fig. 16: Functional classification of HlyX regulated genes according to the database Cluster 
of Orthologous Groups of Proteins (COGs). The classification has been adopted from the 
“Simple Yet Powerful Genome Browser” database for A. pleuropneumoniae Ser 5 L20 
(http://informatics.bio.nrc.ca/ap5b) 
number of genes 
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D 3.1.2 Analysis of the HlyX regulon 
 
The gene ape0761 was identified as strongest upregulated by HlyX by a factor of almost 
30. It encodes for a putative methylation subunit of a type III restriction-modification system. 
The adjacent gene downstream of ape0761, ape0760 shared homology to a potential type I 
restriction enzyme, a DEAD/DEAH box helicase domain protein. Expression of ape0760 was 
increased nearly 10-fold. Expression of the next gene downstream, ape0758, encoding for a 
hypothetical ATP-dependent helicase was increased 8-fold and a fourth gene, located just 
downstream of ape0758, serC which encodes a phosphoserine aminotransferase was 
upregulated by more than 2.5-fold due to HlyX. 
Different terminal reductases transferring respiratory chain electrons to alternative 
electron acceptors other than oxygen were found to be strongly upregulated by HlyX. The 
three genes dmsA, dmsB and dmsC encoding the anaerobic dimethylsulfoxide reductase 
were found to be upregulated nearly 25-fold, 7.5-fold and 8.5-fold, respectively. The 
periplasmic nitrate reductase is encoded in E. coli by the napFDAGHBC operon. 
Homologues to all of these genes were found in A. pleuropneumoniae and were strongly 
upregulated due to HlyX (more the 5-fold each). The four genes encoding the proteins 
forming the nitrite reductase complex, nrfABCD, were identified to be also strongly 
upregulated by HlyX. The genes ape1625 and ape1626 share homology with E. coli nrfF and 
nrfG encoding for a heme lyase adding heme groups to NrfA; they were also identified to be 
upregulated by HlyX. The genes torZ and torY that are more then 10-fold upregulated by 
HlyX encode an additional reductase, the TMAO reductase. In contrast, three of four genes 
encoding the fumarate reductase enzyme complex, frdABC, are between 1.5 and 2-fold 
downregulated due to HlyX. 
Several genes coding for enzymes which catalyze the oxidation of high energy substrates 
in order to transfer the electrons into the respiratory chain were identified as being HlyX 
regulated. Four genes (hyaAB and hybAB) encoding a Ni/Fe cofactor dependent 
hydrogenase were identified as being more then 10-fold upregulated due to HlyX; 
additionally hyaD, hypB, hypD, hypE and hypF involved in hydrogenase maturation were 
upregulated by HlyX above 2-fold, each. E. coli encodes at least three different 
hydrogenases. BLAST homology search revealed that A. pleuropneumoniae encodes only a 
single hydrogenase which is homologue to hydrogenase 2 of E. coli (hyaAB and hybAB of A. 
pleuropneumoniae are homologue to hybABOC of E. coli). A putative NAD(P)H 
oxidoreductase gene, ape1539, was also found to be about 12-fold upregulated by HlyX. 
Although the glp regulon repressor gene glpR was downregulated by HlyX the glp regulon 
was also downregulated in A. pleuropneumoniae. In E. coli it consists of the glpABC operon 
encoding the glycerol-3-phosphate dehydrogenase enzyme complex; in A. 
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pleuropneumoniae homologues to glpAB were identified, and they are downregulated by 
HlyX. Additionally, the glpFK and glpTQ operons were found to be downregulated by HlyX.   
The gene hcr encoding a respiratory chain NADH reductase and hcp encoding the hybrid-
cluster protein that is reduced due to oxidation of NADH were also found to be positively 
regulated by HlyX. The function of Hcr and Hcp are unknown (van den Berg et al., 2000). 
The adh2 gene of A. pleuropneumoniae shares homology to the adhE gene of E. coli that 
encodes for a protein with three catalytic functions, alcohol dehydrogenase, aldehyde 
dehydrogenase and pyruvate formate–lyase deactivase. Adh2 might contribute to 
fermentation and was found in A. pleuropneumoniae as strongly upregulated by HlyX.  
HlyX controls the expression of genes that encode proteins associated with iron 
acquisition in A. pleuropneumoniae. The genes ape2089, ape2088, ape2087 and ape2086 
are annotated as “outer membrane receptor proteins, mostly iron transport” and were found 
to be upregulated more then 8-fold by HlyX. The tonB dependent transferrin binding protein 
encoding gene tbpA was upregulated about 2.5 fold. A. pleuropneumoniae has two genes 
with homology to tonB genes of other bacteria, tonB1 and tonB2. Their transcription is 
upregulated 2.5-fold and 9-fold, respectively, due to HlyX. Further, two variants of the TonB 
interacting proteins ExbB and ExbD are expressed in A. pleuropneumoniae. The genes expB 
and expB2 as well as expD and expD2 were identified as strongly upregulated by HlyX. The 
ferric iron ABC transporter genes ape0776 and afuA_2 were also upregulated by HlyX 
whereas the afuABC genes were found to be downregulated by a factor of about 3 by HlyX.  
Genes encoding different chaperone proteins including hptG, dnaK, clpB, dnaJ, groEL, 
and groES were found to be upregulated by HlyX. 
The following ribosomal proteins were downregulated in A. pleuropneumoniae by HlyX: 
rpsA, rplS, rpmL, rpsJ, rplI, rplX, rplO, rpsF, rpsM, rplW, rpsQ, rplC, rpsK, rplQ, rpsN, rplV, 
rpsD, rplR, rpsL, rplD, rpsH, rplT, rpsG, rplB, rplE, rplL, rpsC and rplP. 
The strongest downregulated gene (by a factor above 5) was identified as sodA encoding 
the manganese dependent superoxide dismutase which catalyzes the transformation of 
superoxide radicals into hydrogen peroxide. However, a cytochrome c peroxidase gene, ccp, 
that detoxifies hydrogen peroxide by transformation into water, was one of the strongest 
HlyX-upregulated genes (factor above 20). 
HlyX regulated genes were analyzed using the “Pathway Tools Omics Viewer” provided 
on the biocyc homepage (http://biocyc.org). Using this software the A. pleuropneumoniae 
gene names were matched with metabolic pathways known for E. coli. Thereby a pathway 
map was created allowing an overview over metabolic pathways affected by HlyX. If several 
steps of a certain pathway were affected unanimously by HlyX the entire pathway appeared 
to be controlled by HlyX. This led to the identification of pathways that were up- and 
downregulated by HlyX (Fig. 17). 
 Results 
   
 82 
Fig. 17: Pathway map including HlyX regulated genes. A. pleuropneumoniae genes that were 
identified as HlyX regulated were matched into an E. coli pathway map using the “Pathway Tools 
Omics Viewer” (http://biocyc.org). Genes that were more then 1.5-fold downregulated by HlyX 
encode enzymes catalyzing reactions marked in yellow. Genes that were more then 1.5-fold 
upregulated by HlyX encode enzymes catalyzing reactions marked in red. If within a certain 
pathway several enzymes were affected by HlyX unanimously the respective pathway was 
analyzed (numbers).  
Downregulated by HlyX (yellow numbers): 1. flavin biosynthesis; 2. menaquinone biosynthesis; 3. 
tetrapyrrole biosynthesis I; 4. superpathway of gluconate degradation; 5. superpathway pentose 
phosphate pathway; 6. proline degradation I; 7. superpathway of galacturonate and gluconate 
degradation; 8. biotin biosynthesis I; 9. proline biosynthesis I; 10. superpathway of glycolysis, 
pyruvate dehydrogenase, TCA, and glyoxalate bypass; 11. UDP-galactose biosynthesis; 12. 
phospholipid biosynthesis; 13. KDO transfer to lipid IVA; 14. glycogen biosynthesis I (from ADP 
glucose); 15. gluconeogenesis; 16. purine nucleotides de novo biosynthesis; 17. colonic acid 
building blocks biosynthesis; 18. enterobacterial common antigen biosynthesis; 19. UDP-N-acetyl-
D-glucosamine biosynthesis I; 20. glycerol degradation 
Upregulated by HlyX (red numbers): 1. isoleucine biosynthesis from threonin; 2. serine 
biosynthesis; 3. glycine biosynthesis; 4. isoleucine biosynthesis from threonin; 5. salvage 
pathways of pyrimidine deoxyribonucleotides; 6. tryptophan biosynthesis; 7. phenylalanine and 
tyrosine biosynthesis 
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D 3.2  Global protein expression analysis of A. pleuropneumoniae ΔhlyX 
 
2D DIGE and quantitative 1D PAGE were used for the identification of proteins that were 
regulated by HlyX of A. pleuropneumoniae. The respective proteins were identified by 
subsequent mass spectrometry. By applying different protein preparation methods to 
anaerobically grown A. pleuropneumoniae wt and A. pleuropneumoniae ΔhlyX the number of 
proteins identified by 2D DIGE analysis could be increased. 2D DIGE analyses were 
performed from i), ii) whole cell lysates (Fig. 18A, 18B), iii) inner and outer membrane-
associated proteins (Fig. 18C), iv) outer membrane-associated proteins (Fig. 18D), and v) 
secreted proteins (Fig. 18E). Outer membrane proteins were analysed by quantitative 1D 
PAGE (Fig. 19). Expression of 492 proteins was found to be significantly regulated by HlyX 
comparing A. pleuropneumoniae wt and A. pleuropneumoniae ΔhlyX upon anaerobic growth 
(Table 7). Of 241 protein spots that were upregulated by HlyX, 75 were identified by mass 
spectrometry representing 21 different proteins (Table 7, 8). Of 251 spots that were found to 
be downregulated by HlyX, 79 could be identified by mass spectrometry representing 35 
different proteins (Table 7, 9). The 154 protein spots identified in total represented 51 
different proteins (5 proteins were identified either up- as well as downregulated by HlyX, 
dependent on the protein preparation method; Table 7). Additionally, five protein spots that 
were not found to be regulated statistically significant were analyzed by mass spectrometry 
(Table 10). 159 MS analyses were performed for the identification of HlyX regulated proteins; 
104 of these analyses were done by Q-TOF MSMS (Appendix G 6.1), and 55 spots were 
identified by MALDI TOF MS (Appendix G 6.2). 
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secreted proteins 
18E
Fig. 18: 2D DIGE analysis of different protein preparations for comparison of protein 
expression between A. pleuropneuomiae wt (labelled with Cy5 [red]) and A. pleuropneumoniae 
ΔhlyX (labelled with Cy3 [green]).  
Protein preparations and analyses were performed for A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔhlyX as described in Fig. 12. Protein spots identified as significantly (p < 0.05) 
upregulated by HlyX are indicated by arrowheads. Spots identified as significantly downregulated (p < 
0.05) by HlyX are indicated by arrows. Spots indicated by lines were not significantly regulated. Spots 
of interest were excised and analysed by mass spectrometry. 
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Fig. 19: PAGE of an outer membrane protein preparation of A. pleuropneumoniae wt 
(labelled with Cy5 [red]) and A. pleuropneumoniae ΔhlyX (labelled with Cy3 [green]).  
Protein preparations and analyses were performed for A. pleuropneumoniae wt and A. 
pleuropneumoniae ΔhlyX as described in Fig. 13. Protein bands identified as significantly 
(p < 0.05) upregulated by HlyX are indicated by arrowsheads. Band that were identified as 
significantly (p < 0.05) downregulated by HlyX are indicated by arrows. Band indicated by 
lines were not significantly regulated. Bands of interest were excised analysed by mass 
spectrometry. 
LMW: Cy3 labelled low molecular weight marker (Amersham). 
19 
LMW 
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Table 7: Overview protein preparations, DIGE results and mass spectrometry results. 
no. of differentially 
expressed spots a 
no. of proteins 
identified by mass 
spectrometry 
no. of different 
proteins identified 
figure protein preparation IPG strip pI gradient up in wt up in 
ΔhlyX 
up in wt up in 
ΔhlyX 
up in wt up in 
ΔhlyX 
18A whole cell lysate 4 to 7 67 56 16 25 8 16 
18B whole cell lysate 7 to 11 NLb 19 15 4 5 3 5 
18C inner and outer membrane 
associated 
3 to 11 NLb 76 110 28 28 9 15 
18D outer membrane-associated 3 to 11 NLb 63 52 17 11 10 8 
18E secreted 3 to 11 NLb 16 18 7 9 3 6 
19 outer membranes ─ ─ ─ 3 1 3 1 
 total ─ 241 251 75 79 21 35 
     154 51 c 
 
a) obtained by 2D DIGE as statistical significant (Student’s T-test p < 0.05) 
b) non linear 
c) 21 different proteins upregulated plus 35 different proteins downregulated minus 5 proteins 
upregulated and downregulated by HlyX depending on the preparation method   
 
 
 
 
Table 8: Proteins significantly upregulated by HlyX. 
spot a protein b T-test c ratio d MS # e gel # f 
whole cell lysates (Fig. 18A) 
TorZ (1) trimethylamine N oxide reductase precursor   0.0002 26.6 61 7 
TorZ (2) trimethylamine N oxide reductase precursor   0.005 13.23 41 3 
Ape0761 
(1) 
putative methylation subunit  type III restriction 
modification system   0.0072 6.6 209 6 
Ape0761 
(2) 
putative methylation subunit  type III restriction 
modification system   0.004 4.49 210 6 
PflB (1) formate acetyltransferase   0.001 3.17 17 3 
PflB (2) formate acetyltransferase   7.00E-05 3.05 15 3 
PflB (3) formate acetyltransferase   1.50E-05 2.82 18 3 
PheT (1) phenylalanyl tRNA synthetase beta chain   0.0015 2.69 26 3 
PflB (4) formate acetyltransferase   0.00027 2.65 22 3 
PflB (5) formate acetyltransferase   0.0054 2.34 21 3 
PtsI (1) phosphoenolpyruvate protein phosphotransferase   0.0021 2.19 27 3 
PtsI (2) phosphoenolpyruvate protein phosphotransferase   0.0021 2.07 218 6 
PheT (2) phenylalanyl tRNA synthetase beta chain   0.00093 1.81 25 3 
HtrA 
probable periplasmic serine protease do hhoA like 
precursor   0.005 1.57 34 3 
SerS seryl tRNA synthetase   0.005 1.57 35 3 
PfkA 6 phosphofructokinase   0.024 1.18 68 3 
whole cell lysates (Fig. 18B) 
NapA (1) periplasmic nitrate reductase precursor   1.10E-05 17.97 175 9 
NapA (2) periplasmic nitrate reductase precursor   6.00E-05 15.62 168 10 
Ssa1 serotype specific antigen 1 precursor   0.0048 5.86 171 10 
Ape1960 hypothetical protein APL 1832   0.0028 1.74 177 10 
inner and outer membrane-associated proteins (Fig. 18C) 
TorZ (1) trimethylamine-N-oxide reductase precursor  7.00E-06 22.76 M58 11 
TorZ (2) trimethylamine-N-oxide reductase precursor  0.00027 20.57 M57 11 
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NapA (1) periplasmic nitrate reductase precursor   0.00031 17.29 263 11 
NapA (2) periplasmic nitrate reductase precursor   0.00022 16.25 264 11 
NapA (3) periplasmic nitrate reductase precursor  5.80E-05 15.23 M59 11 
DmsA (1) anaerobic dimethyl sulfoxide reductase chain A precursor  4.90E-05 14.17 273 11 
Adh2 (1) aldehyde alcohol dehydrogenase 2   0.0011 13.75 271 11 
Adh2 (2) aldehyde-alcohol dehydrogenase 2  2.20E-05 13.22 M55 11 
Adh2 (3) aldehyde-alcohol dehydrogenase 2  7.60E-05 11.65 M54 11 
TorZ (3) trimethylamine-N-oxide reductase precursor  7.70E-06 10.98 M56 11 
DmsA (2) anaerobic dimethyl sulfoxide reductase chain A precursor  0.00034 10.97 274 11 
Adh2 (4) aldehyde alcohol dehydrogenase 2   0.00046 9.98 265 11 
FrpB iron regulated outer membrane protein B   0.0034 8.8 260 11 
Adh2 (5) aldehyde-alcohol dehydrogenase 2  0.017 8.06 M53 11 
OmpA (1) outer membrane protein P5 precursor   0.0035 5.11 258 11 
OmpA (2) outer membrane protein P5 precursor   0.0043 4.77 256 11 
Ape0761 
putative methylation subunit  type III restriction 
modification system   7.20E-05 4.6 267 11 
OmpA (3) outer membrane protein P5 precursor   0.0041 4.48 255 11 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2    0.022 4.25 254 11 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2    0.013 3.96 253 11 
OmpA (4) outer membrane protein P5 precursor  OMP P5    0.0082 3.93 261 11 
PflB (1) formate acetyltransferase  4.00E-06 3.02 M41 11 
Adh2 (6) aldehyde-alcohol dehydrogenase 2  0.0065 2.98 M52 11 
PflB (2) formate acetyltransferase  2.50E-05 2.96 M42 11 
PflB (3) formate acetyltransferase  1.00E-05 2.88 M40 11 
PflB (4) formate acetyltransferase   0.00061 2.58 287 11 
Adh2 (7) aldehyde-alcohol dehydrogenase 2  0.0027 2.52 M51 11 
PflB (5) formate acetyltransferase   6.40E-05 2.31 268 11 
outer membrane-associated proteins (Fig. 18D) 
TorZ (1) trimethylamine-N-oxide reductase precursor  0.00012 17.3 M90 13 
NapA periplasmic nitrate reductase precursor  0.0053 13.34 M91 13 
TorZ (2) trimethylamine-N-oxide reductase precursor  0.00017 11.19 M21 13 
Adh2 (1) aldehyde-alcohol dehydrogenase 2  0.0017 10.8 M88 13 
TorZ (3) trimethylamine-N-oxide reductase precursor  4.40E-05 10.33 M89 13 
OmpA outer membrane protein P5 precursor  0.0022 10.18 M29 13 
Adh2 (2) aldehyde-alcohol dehydrogenase 2  0.00016 9.12 M87 13 
ApxIIA (1) RTX-II toxin determinant A  0.047 7.86 M13 13 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2    0.0088 5.73 278 12 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2    0.013 5.31 279 12 
PflB (1) formate acetyltransferase   0.025 2.35 M85 13 
PflB (2) formate acetyltransferase   0.03 2.3 M86 13 
PflB (3) formate acetyltransferase   0.04 2.26 M84 13 
Pgk (1) phosphoglycerate kinase   1.50E-05 1.95 M99 13 
AckA acetate kinase   0.0053 1.73 235 13 
PtsI phosphoenolpyruvate protein phosphotransferase   0.032 1.46 M92 13 
Pgk (2) phosphoglycerate kinase   0.023 1.37 M100 13 
secreted proteins (Fig. 18E) 
OmlA outer membrane lipoprotein   0.013 4.13 131 14 
ApxIIA (1) RTX-II toxin determinant A  0.0033 2.27 M06 14 
ApxIIA (2) RTX-II toxin determinant A  0.021 1.87 M07 14 
ApxIIA (3) RTX II toxin determinant A   0.0033 1.78 154 14 
ApxIIA (4) RTX-II toxin determinant A  0.016 1.75 M05 14 
DppA periplasmic dipeptide transport protein   0.031 1.62 146 14 
ApxIIA (5) RTX-II toxin determinant A  0.035 1.62 M04 14 
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outer membrane proteins (Fig. 19) 
Ssa1 serotype specific antigen 1 precursor   0.00204504 10.84 90 17 
FrpB iron regulated outer membrane protein B   0.00998 3.41 75 16 
DmsA anaerobic dimethyl sulfoxide reductase chain A precursor  0.03276463 2.29 91 17 
 
 
Table 9: Proteins significantly downregulated by HlyX. 
spot a protein b T-test c ratio d MS # e gel # f 
whole cell lysates (Fig. 18A) 
SodA (1) manganese superoxide dismutase   7.00E-06 -6.4 5 2 
SodA (2) manganese superoxide dismutase   6.50E-06 -6.05 66 7 
SodA (3) manganese superoxide dismutase   2.90E-05 -5.34 65 7 
AceE (1) pyruvate dehydrogenase E1 component   0.0008 -2.31 30 3 
AceE (2) pyruvate dehydrogenase E1 component   0.0023 -2.04 16 3 
AspA (1) aspartate ammonia lyase   0.013 -1.98 55 3 
AspA (2) aspartate ammonia lyase   0.0023 -1.68 62 5 
PckA (1) phosphoenolpyruvate carboxykinase  ATP    0.00073 -1.63 33 3 
Pgi (1) glucose 6 phosphate isomerase   0.0018 -1.6 47 3 
AceE (3) pyruvate dehydrogenase E1 component  0.016 -1.59 M75 4 
Ape0338 hypothetical protein APL 0319   0.001 -1.57 69 5 
TktA (1) transketolase 2   0.0049 -1.57 38 3 
PckA (2) phosphoenolpyruvate carboxykinase  ATP    0.0063 -1.54 44 3 
TktA (2) transketolase 2   0.0049 -1.5 46 3 
GlmS 
glucosamine  fructose 6 phosphate aminotransferase  
isomerizing    0.027 -1.5 49 3 
AceF 
dihydrolipoyllysine residue acetyltransferase component of 
pyruvate dehydrogenase complex  E2    0.017 -1.48 23 3 
Pgi (2) glucose 6 phosphate isomerase   0.0058 -1.47 43 3 
LpdA dihydrolipoyl dehydrogenase   0.02 -1.44 13 2 
MipB transaldolase   0.011 -1.33 71 3 
AceE (4) pyruvate dehydrogenase E1 component   0.023 -1.33 19 3 
Fbp fructose 1 6 bisphosphatase   0.026 -1.33 59 5 
DeoC deoxyribose phosphate aldolase   0.03 -1.32 215 6 
AckA acetate kinase   0.028 -1.31 53 3 
Ape1591 hybrid peroxiredoxin HyPrx5   0.022 -1.3 72 3 
AdhI Alcohol dehydrogenase 1   0.03 -1.25 12 2 
whole cell lysates (Fig. 18B) 
RplA 50S ribosomal protein L1   0.0057 -14.44 195 10 
RplE 50S ribosomal protein L5   0.013 -13.72 203 10 
RplM 50S ribosomal protein L13   0.019 -9.64 204 10 
YkgF putative electron transport protein   0.048 -1.71 174 9 
GuaB inosine 5  monophosphate dehydrogenase   0.01 -1.57 169 10 
inner and outer membrane-associated proteins (Fig. 18C) 
RplI 50S ribosomal protein L9   0.0021 -8.53 269 11 
RplA 50S ribosomal protein L1  0.012 -2.95 M50 11 
AceF (1) 
dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex (E2)  0.00018 -2.68 M33 11 
AceF (2) 
dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex (E2)  0.0015 -2.65 M32 11 
AceF (3) 
dihydrolipoyllysine residue acetyltransferase component of 
pyruvate dehydrogenase complex  E2    0.00092 -2.62 237 11 
AceF (4) 
dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex (E2)  0.00079 -2.5 M31 11 
AceF (5) 
dihydrolipoyllysine residue acetyltransferase component of 
pyruvate dehydrogenase complex  E2    0.0019 -2.47 236 11 
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AceF (6) 
dihydrolipoyllysine-residue acetyltransferase component of 
pyruvate dehydrogenase complex (E2)  0.0019 -2.45 M30 11 
AceE (1) pyruvate dehydrogenase E1 component  3.60E-05 -2.25 M39 11 
PykA pyruvate kinase   0.00016 -2.24 262 11 
AceF (7) 
dihydrolipoyllysine residue acetyltransferase component of 
pyruvate dehydrogenase complex  E2    0.026 -2.18 283 11 
GlmS 
glucosamine fructose 6 phosphate aminotransferase  
isomerizing    0.043 -1.97 249 11 
TktA Transketolase 2  7.00E-05 -1.9 M36 11 
AceE (2) pyruvate dehydrogenase E1 component   0.033 -1.89 277 11 
AceE (3) pyruvate dehydrogenase E1 component  0.00042 -1.88 M38 11 
Fbp fructose 1 6 bisphosphatase   0.0014 -1.88 266 11 
Pnp polyribonucleotide nucleotidyltransferase   0.03 -1.87 238 11 
TufB elongation factor Tu   0.00054 -1.86 248 11 
PckA (1) phosphoenolpyruvate carboxykinase  ATP    0.0018 -1.78 252 11 
LpdA (1) dihydrolipoyl dehydrogenase  0.024 -1.76 M45 11 
Ape1591 
(1) hybrid peroxiredoxin HyPrx5   0.0062 -1.7 242 11 
LpdA (2) dihydrolipoyl dehydrogenase  0.039 -1.67 M44 11 
Ape1591 
(2) hybrid peroxiredoxin HyPrx5   0.0056 -1.65 243 11 
PckA (2) phosphoenolpyruvate carboxykinase (ATP)  0.0012 -1.64 M35 11 
LpdA (3) dihydrolipoyl dehydrogenase   0.0029 -1.55 291 11 
PrsA ribose phosphate pyrophosphokinase   0.035 -1.5 245 11 
AceE (4) pyruvate dehydrogenase E1 component  0.011 -1.47 M37 11 
GalE UDP glucose 4 epimerase  Mannheimia haemolytica 0.011 -1.34 295 11 
outer membrane-associated proteins (Fig. 18D) 
SodA manganese superoxide dismutase   0.002 -4.8 M103 13 
UshA UshA precursor   0.023 -2.02 M105 13 
HemY HemY-like protein  0.02 -1.99 M104 13 
MipB Transaldolase  0.0068 -1.75 M102 13 
TufB (1) elongation factor Tu   0.0019 -1.69 M96 13 
PckA (1) phosphoenolpyruvate carboxykinase (ATP)  0.006 -1.67 M18 13 
TufB (2) elongation factor Tu   0.0007 -1.65 M95 13 
PckA (2) phosphoenolpyruvate carboxykinase  ATP    0.013 -1.65 M82 13 
PckA (3) phosphoenolpyruvate carboxykinase  ATP    0.0066 -1.51 M83 13 
Asd aspartate-semialdehyde dehydrogenase 0.0051 -1.44 M101 13 
Pgm phosphoglucomutase/phosphomannomutase  0.047 -1.4 M93 13 
secreted proteins (Fig. 18E) 
SodA manganese superoxide dismutase   0.00013 -3.44 138 14 
OmpA (1) outer membrane protein P5 precursor  OMP P5    0.0009 -2.71 153 14 
OmpA (2) outer membrane protein P5 precursor   0.0027 -2.59 161 14 
OmpA (3) outer membrane protein P5 precursor   0.0011 -2.46 151 14 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2    0.036 -1.96 150 14 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2    0.038 -1.93 149 14 
PckA phosphoenolpyruvate carboxykinase (ATP)  0.05 -1.7 M08 14 
TufB elongation factor Tu   0.039 -1.6 148 14 
Ape1960 hypothetical protein APL 1832   0.016 -1.46 129 14 
outer membrane proteins (Fig. 19) 
OmlA outer membrane lipoprotein 0.0048 -2.89 95 17 
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Table 10: Selected proteins not significantly up- or downregulated by HlyX. 
spot a protein b T-test c ratio d MS # e gel # f 
outer membrane-associated proteins (Fig. 18D) 
ApxIIA (2) RTX II toxin determinant A   0.086 8.85 230 13 
ApxIIA (3) RTX II toxin determinant A   0.087 10.07 281 13 
outer membrane proteins (Fig. 19) 
OmpA (1) outer membrane protein P5 precursor  OMP P5    0.423 1.52 92 17 
OmpA (1) outer membrane protein P5 precursor   0.423 1.52 93 17 
OmpP2 (1) outer membrane protein P2 precursor  OMP P2    0.423 1.52 94 17 
OmpP2 (2) outer membrane protein P2 precursor  OMP P2    0.495 1.31 73 15 
OmpA (2) outer membrane protein P5 precursor  OMP P5    0.495 1.31 82 16 
OmpA (2) outer membrane protein P5 precursor   0.495 1.31 84 16 
OmpA (3) outer membrane protein P5 precursor   0.582 1.12 79 16 
[OmpA (3)] outer membrane protein P5 precursor  OMP P5    0.582 1.12 80 16 
 
a) name of protein spot on gel (Fig. 18 A-E, 19) 
b) result of mass spectrometry analysis. 
c) statistical analysis using unpaired Student’s T-test 
d) ratio between A. pleuropneumoniae wt and A. pleuropneumoniae ΔhlyX. Positive values indicate 
upregulation by HlyX, negative values indicate downregulation by HlyX. 
e) number of the mass spectrometric analysis (Appendix G 6) that was performed for the identification 
of the protein of interest from the respective preparative gel f. Simple numbers indicate analysis by Q-
TOF MSMS; numbers beginning with the capital letter M indicate analysis by MALDI-TOF MS. 
f) this number indicates the preparative gel (Appendix G 5) from which the respective protein spot was 
obtained. 
 
 
D 3.2.1 Analysis of differentially expressed proteins 
 
Enzymes catalyzing the transfer of respiratory chain electrons to substrates different than 
oxygen were strongly upregulated anaerobically due to HlyX in A. pleuropneumoniae. The 
TMAO reductase (TorZ) was identified by 2D DIGE of whole cell lysates, inner and outer 
membrane-associated proteins and outer membrane-associated proteins (Fig. 18A, 18C, 
18D) as upregulated more than 20-fold by HlyX. 2D DIGE analyses of these gels also 
revealed the periplasmic nitrate reductase subunit NapA as above 10-fold upregulated by 
HlyX. The anaerobic DMSO reductase subunit DmsA was identified on gels of inner and 
outer membrane- associated proteins (Fig. 18C) as upregulated more than 10-fold by HlyX, 
and quantitative 1D PAGE of outer membrane proteins (Fig. 19) showed a more than 2-fold 
upregulation.  
The aldehyde alcohol dehydrogenase 2 (Adh2), an enzyme possibly being involved in 
fermentation was identified by 2D DIGE of inner and outer membrane-associated proteins 
(Fig. 18C) and outer membrane-associated proteins (Fig. 18D) as more than 10-fold 
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upregulated by HlyX. Additionally the formate acetyltransferase which converts pyruvate into 
formate and acetyl-CoA was identified as more than 3-fold upregulated by HlyX.  
The putative methylation subunit of a type III restriction modification system (Ape0761) 
was also identified by 2D DIGE (Fig. 18A, 18C) as more than 6-fold upregulated by HlyX. 
Furthermore the serotype specific antigen 1 precursor that is a homologue to the 
autotransporter serine protease of A. pleuropneumoniae serotype 1 strain 4047 could be 
identified on gels of whole cell lysates (Fig. 18B) as well as on outer membrane protein gels 
(Fig. 19) as upregulated by HlyX.  
2D DIGE analysis of whole cell lysates (Fig. 18A), outer membrane-associated proteins 
(Fig. 18D), and secreted proteins (Fig. 18E) revealed the manganese superoxide dismutase 
as the protein strongest downregulated by HlyX. The pyruvate dehydrogenase enzyme 
complex comprising AceE, AceF and LpdA and catalyzing the formation of the citric acid 
cycle precursor acetyl-CoA was also found to be downregulated by HlyX (Fig. 18A, 18C). 
The fructose-1,6-bisphosphatase (Fbp) and the phosphoenolpyruvate carboxykinase (PckA), 
both catalyzing essential steps of gluconeogenesis, were identified as slightly downregulated 
by HlyX (Fig. 18A, 18C, 18D, 18E). 
 
 
D 3.2.2 Comparison between detergent and non detergent-dependent protein 
preparations 
 
The quantification of differences in protein expression between A. pleuropneumoniae wt 
and A. pleuropneumoniae ΔhlyX by 2D DIGE analyses showed mostly corresponding results 
for different methods of protein preparation. However, some proteins could be obtained from 
A. pleuropneumoniae wt in considerably higher yields when detergent was used during 
protein preparation. Thus, these proteins became enriched during preparation of inner and 
outer membrane-associated proteins (Fig. 18C) and outer membrane-associated proteins 
(Fig. 18D). 
The iron regulated outer membrane protein B (FrpB) was identified as 8.8-fold 
upregulated due to HlyX on gels of inner and outer membrane-associated proteins (Fig 18C) 
compared to a 3.4-fold upregulation by HlyX obtained upon analysis of gels of outer 
membrane proteins (Fig. 19). Particularly striking was the detergent- based enrichment of the 
ApxIIA toxin from the wt strain compared to the hlyX deletion mutant. Thus, 2D DIGE 
analysis of outer membrane-associated proteins (Fig. 18D) revealed the ApxIIA toxin as 
being 7.9-fold upregulated by HlyX whereas analysis of secreted proteins (Fig. 18E) showed 
only a 1.6 to 2.3-fold upregulation by HlyX. The outer membrane proteins OmpA and OmpP2 
were identified by analysis of inner and outer membrane-associated proteins (Fig 18C). On 
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gels of outer membrane-associated proteins (Fig. 18D) OmpA was found to be more than 10-
fold upregulated by HlyX, and OmpP2 was found as more than 5-fold upregulated. However, 
2D DIGE analysis of the non detergent-based preparation of secreted proteins (Fig. 18D) 
revealed OmpA and OmpP2 as being about 2-fold downregulated by HlyX. A quantitative 
analysis of outer membrane proteins showed only a slight (up to 1.5-fold) upregulation by 
HlyX which was statistically not significant.  
 
 
D 3.2.3 Comparison of microarray and 2D DIGE analyses 
 
The 2D DIGE analysis of protein expression essentially verified the results obtained by 
microarray analysis gene of expression (Fig. 20). 
The transcripts of 19 different proteins that were identified as 65 different spots 
upregulated by HlyX were additionally identified by microarray analysis. For 15 of these 
proteins (55 spots) the transcript was also upregulated by HlyX whereas for four proteins (10 
spots) the transcript was downregulated by HlyX (Fig. 20). The difference between proteomic 
and microarray analysis was most obvious for the ApxIIA toxin. Proteomic analysis of the 
detergent-based preparation of inner and outer membrane-associated proteins (Fig 18C) 
revealed a spot of the ApxIIA as 7.8-fold upregulated by HlyX, proteomic analysis of secreted 
proteins (Fig 18D) showed a upregulation of 5 spots of about 2-fold by HlyX whereas the 
respective transcript was identified to be 2-fold downregulated by HlyX. 
For 60 of 67 protein spots resembling 24 different proteins that were identified by the 
proteomic approach as being downregulated by HlyX the respective transcript was also 
downregulated by HlyX. Seven protein spots that resemble six different proteins were 
identified by 2D DIGE as being downregulated by HlyX whereas their transcripts were found 
to be upregulated by HlyX. The outer membrane lipoprotein (OmlA) was identified by 
proteomic analysis of outer membrane proteins (Fig 19) as being 2.9-fold downregulated by 
HlyX whereas expression of the respective transcript was increased 1.5-fold. However, 2D 
DIGE analysis of secreted proteins (Fig 18D) revealed a 4.1-fold upregulation of OmlA by 
HlyX. 
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Fig. 20: Comparison of transcript (microarray) and protein (2D DIGE, quantitative PAGE) 
ratios between anaerobically grown A. pleuropneumoniae wt and A. pleuropneumoniae 
ΔhlyX. Transcripts as well as proteins that were identified to be upregulated due to HlyX received a 
positive value representing the factor of upregulation (Appendix G 3, Table 8). The log10 of these 
factors is represented by positive values on the y-axis for transcripts and positive values on the x-
axis for proteins. Transcripts and proteins that were downregulated due to HlyX are indicated by a 
negative number representing the factor of downregulation (Appendix G 4, Table 9). The negative 
log10 of the absolute value is shown as negative values on the y-axis for transcripts and as negative 
values of the x-axis for proteins. The line of best fit was calculated showing a slope close to one. 
Proteins that deviated strongly from the line of best fit are indicated by arrows. 
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D 4  Identification of immunogenic proteins of A. pleuropneumoniae 
 
In order to identify immunogenic proteins of A. pleuropneumoniae different protein 
preparations were performed with A. pleuropneumoniae wt grown under anaerobic 
conditions. Inner and outer membrane-associated proteins (Fig. 21), outer membrane-
associated proteins (Fig. 22), and secreted proteins (Fig. 23) were separated by two 
dimensional gel electrophoresis. Outer membrane proteins (Fig. 24) were separated by one 
dimensional PAGE. Then the proteins were blotted and incubated with preimmune sera 
obtained from pigs before experimental infection with A. pleuropneumoniae wt. These pigs 
were tested immunological for absence of antibodies against A. pleuropneumoniae. Proteins 
that were detected with these sera define the experimental background. Convalescent sera 
from pigs 21 days post infection with A. pleuropneumoniae wt contained antibodies that were 
developed against immunogenic proteins during the course of infection. Proteins that were 
detected exclusively by convalescent sera are immunogenic. By comparing the pattern of 
immunostained proteins on the blotting membrane with the pattern of stained proteins in 
gels, spots of interest were identified, and then excised from a preparative gel followed by 
mass spectrometry identification. 
Altogether 16 different proteins of A. pleuropneumoniae were identified as being 
immunogenic from the different protein preparations (Table 11). 
As strongly immunogenic proteins the ApxIIA toxin and the outer membrane proteins 
OmpA and OmpP2 were identified. The secreted ApxIIA toxin appeared as a horizontal 
sequence of spots on 2D gels due to slight differences in their pI values. All of these spots 
were identified from gels of outer membrane-associated proteins and secreted proteins (Fig. 
22, 23). The outer membrane proteins OmpA and OmpP2 were identified on several gels 
(Fig. 21, 22, 23, 24) as targets for antibodies developed upon infection with A. 
pleuropneumoniae. In addition, proteins that are normally located within the bacterial cell like 
the 30S ribosomal protein S1 (RpsA) or the elongation factor Tu (TufB) caused the formation 
of antibodies in infected pigs. 
In the acidic pH range from < 3 up to about 5 on all 2D gels a ladder of horizontal lines 
appeared that was strongly immunogenic and showed almost now cross reaction with sera 
from pigs before infection. The same sequence of bands could be observed on the 1D gel, 
also. These bands did not appear on comparative gels stained with Coomassie blue and 
were not found as labelled with CyDyesTM before blotting. Therefore it is likely that this 
immunogenic material is not protein but rather lipopolysaccharide.  
 
 
 
Results 
   
 97 
21
A 
21
B
 
21
C
 
21
D
 
in
ne
r a
nd
 o
ut
er
 m
em
br
an
e-
as
so
ci
at
ed
 p
ro
te
in
s 
in
ne
r a
nd
 o
ut
er
 m
em
br
an
e-
as
so
ci
at
ed
 p
ro
te
in
s 
in
ne
r a
nd
 o
ut
er
 m
em
br
an
e-
 
as
so
ci
at
ed
 p
ro
te
in
s 
in
ne
r a
nd
 o
ut
er
 m
em
br
an
e-
 
as
so
ci
at
ed
 p
ro
te
in
s 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
   
 98 
22A 
22B 
outer membrane-associated proteins 
outer membrane-associated proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
   
 99 
23A 
23B 
23C 
secreted proteins 
secreted proteins 
secreted proteins 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
   
 100 
24A 24B 
24C 24D 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
   
 101 
Fig. 21: Identification of immunogenic inner and outer membrane-associated proteins. Proteins 
obtained from A. pleuropneumoniae wt were labelled with Cy5 (red) and proteins from A. 
pleuropneumoniae ΔarcA were labelled with Cy3 (green). Equal amounts of A. pleuropneumoniae wt 
and A. pleuropneumoniae ΔarcA proteins were combined with the same amount of an internal 
standard (labelled with Cy 2 [blue], fluorescence not shown) comprising of inner and outer-membrane 
associated proteins from A. pleuropneumoniae wt, ΔarcA and ΔhlyX and were separated 
simultaneously by two dimensional gel electrophoresis. This was done for two independent biological 
repeats of A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA inner and outer membrane-
associated proteins. Fluorescence was detected using a TyphoonTM Trio fluorescence scanner (21A, 
21C). Both gels were blotted. The blot of gel 21A was incubated with a pool of sera from uninfected 
animals (21B). The blot of gel 21C was incubated with a pool of sera from pigs 21 days post 
experimental infection with A. pleuropneumoniae wt (21D). Immunogenic spots were assigned to the 
respective fluorescent spots and then identified from a preparative gel by mass spectrometry. 
 
Fig. 22: Western blot identification of immunogenic outer membrane-associated proteins. 100 
µg of A. pleuropneumoniae wt outer membrane-associated proteins were separated by two 
dimensional gel electrophoresis. The gels were blotted and one blotting membrane was incubated with 
a pool of sera from uninfected pigs (22A). The second membrane was incubated with a pool of sera 
obtained from animals 21 days post experimental infection (22B). The immunogenic protein spots 
were identified on a preparative gel, excised and identified by mass spectrometry.  
 
Fig. 23: Identification of immunogenic secreted proteins. Secreted proteins obtained from A. 
pleuropneumoniae wt (Cy5 [red]) were combined with secreted proteins obtained from A. 
pleuropneumoniae ΔhlyX (Cy3 [green]) and an internal standard comprising secreted proteins from A. 
pleuropneumoniae wt, ΔarcA and ΔhlyX (Cy2 [blue], fluorescence not shown). These proteins were 
separated by two dimensional gel electrophoresis simultaneously. Fluorescence was detected using a 
TyphoonTM Trio fluorescence scanner (23A). Then the gel was blotted and the blotting membrane was 
first incubated with a pool of sera of uninfected pigs (23B) and second with a pool of sera obtained 
from pigs 21 days post infection (23C). 
 
Fig. 24: Identification of immunogenic outer-membrane proteins. A. pleuropneumoniae outer 
membrane proteins were labelled with the green fluorescent dye Cy3. Equal amounts were separated 
in two lanes (lane A, B) of the same gel. Adjacent to each sample a low molecular weight marker 
(LMW) stained with the fluorescent dye Cy3 and a prestained broad range marker (BR) were loaded. 
Fluorescence was detected using a TyphoonTM Trio fluorescence scanner (24A, C). After Western 
blotting one membrane was incubated with a pool of preimmune sera (24B) and the other membrane 
was incubated with a pool of convalescent sera (24D). Same proteins of the LMW marker showed 
cross reaction with the convalescent sera. Immunogenic proteins were identified from a preparative  
gel by mass spectrometry. a: OmpA; b: OmpA and OmpP2; c: OmpA and OmpP2; d: FrpB. 
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Table 11: Immunogenic proteins of A. pleuropneumoniae.  
 
 Protein a Protein b MS # c gel # d 
inner and outer membrane-associated proteins (Fig. 21) 
RpsA 30S ribosomal protein S1   239 11 
PflB formate acetyltransferase   268 11 
PflB formate acetyltransferase  M40 11 
PflB formate acetyltransferase  M41 11 
PflB formate acetyltransferase  M42 11 
LpdA dihydrolipoyl dehydrogenase  M44 11 
LpdA dihydrolipoyl dehydrogenase  M45 11 
DmsA anaerobic dimethyl sulfoxide reductase chain A precursor   274 11 
Adh2 aldehyde alcohol dehydrogenase 2   265 11 
Adh2 aldehyde alcohol dehydrogenase 2   271 11 
OmpA outer membrane protein P5 precursor   256 11 
OmpA outer membrane protein P5 precursor   258 11 
outer membrane-associated proteins (Fig. 22) 
ApxIIA RTX-II toxin determinant A  M13 13 
ApxIIA RTX II toxin determinant A   
M14; 
230 13 
ApxIIA RTX II toxin determinant A   281 13 
PckA phosphoenolpyruvate carboxykinase ATP M18 13 
PckA phosphoenolpyruvate carboxykinase ATP    M82 13 
Pgm phosphoglucomutase/phosphomannomutase  M93 13 
Pgm phosphoglucomutase/phosphomannomutase  M94 13 
TufB elongation factor Tu   M95 13 
TufB elongation factor Tu   M108 13 
TufB elongation factor Tu   M109 13 
FkpA putative FKBP-type peptidyl-prolyl cis-trans isomerase  M107 13 
UshA UshA precursor   M105 13 
OmpP2 Outer membrane protein P2 precursor  OMP P2    278 12 
OmpP2 Outer membrane protein P2 precursor  OMP P2    279 12 
OmpA outer membrane protein P5 precursor   282 13 
OmpA outer membrane protein P5 precursor  M29 13 
Ape1960 hypothetical protein APL_1832  M110 13 
secreted proteins  (Fig. 23) 
ApxIIA RTX-II toxin determinant A  M1 14 
ApxIIA RTX-II toxin determinant A  M2 14 
ApxIIA RTX-II toxin determinant A  M3 14 
ApxIIA RTX-II toxin determinant A  M4 14 
ApxIIA RTX-II toxin determinant A  M5 14 
ApxIIA RTX-II toxin determinant A  M6 14 
ApxIIA RTX-II toxin determinant A  M7 14 
ApxIIA RTX II toxin determinant A   154 14 
FkpA putative FKBP type peptidyl prolyl cis trans isomerase   123 14 
OmpA outer membrane protein P5 precursor   161 14 
OmpA outer membrane protein P5 precursor   151 14 
OmpA outer membrane protein P5 precursor  OMP P5    153 14 
outer membrane proteins (Fig. 24) 
OmpA 
outer membrane protein P5 precursor and outer membrane 
protein P5 precursor OMP P5   79, 80 16 
OmpA, outer membrane protein P2 precursor  OMP P2 and outer 73, 92, 15, 17 
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a) name of protein spot on gels and blots (Fig. 21 - 24) 
b) result of mass spectrometry analysis. 
c) number of the mass spectrometric analysis (Appendix G 6) that was performed for the identification 
of the protein of interest from the respective preparative gel d. Simple numbers indicate analysis by Q-
TOF MSMS; numbers beginning with the capital letter M indicate analysis by MALDI-TOF MS. 
d) This number indicates the preparative gel (Appendix G 5) from which the respective protein spot 
was obtained. 
 
 
 
OmpP2 membrane protein P5 precursor and outer membrane protein 
P5 precursor OMP P5     
93, 94 
OmpA, 
OmpP2 
outer membrane protein P2 precursor  OMP P2 and outer 
membrane protein P5 precursor and outer membrane protein 
P5 precursor OMP P5     
81, 82, 
83, 84, 
85 16 
FrpB iron regulated outer membrane protein B   75 16 
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E  Discussion 
 
Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia 
causing high economic losses worldwide (Fenwick and Henry, 1994). Adaptation of the 
pathogen to its natural niche, the porcine respiratory tract and its pathogenicity are not 
completely understood. Recent studies showed that anaerobic metabolism generally is a 
virulence-associated trait in this respiratory tract pathogen (Baltes et al., 2003, Jacobsen et 
al., 2005, Baltes et al., 2005). Thus, the FNR homologue of A. pleuropneumoniae, HlyX, 
which is a global regulator for adaptation of gene expression to anaerobiosis, has been 
shown to be important for persistence of A. pleuropneumoniae in the infected lung (Baltes et 
al., 2005). 
The aim of this study was to identify genes affected by oxygen-dependent transcription 
factors and to investigate how adaptation to anaerobiosis contributes to bacterial virulence. 
For this purpose, the global transcription factor for adaptation to anaerobic growth conditions, 
ArcA, was deleted in A. pleuropneumoniae. The arcA deletion mutant was characterized in 
vivo and in vitro. Subsequently, the HlyX and ArcA regulons were investigated by microarray 
analyses of anaerobically grown A. pleuropneumoniae, and these analyses were supported 
by a quantitative proteomic approach of different subcellular protein fractions based on 2D 
DIGE and quantitative 1D-PAGE in combination with mass spectrometry.  
 
 
E 1  Characterization of A. pleuropneumoniae ΔarcA in vivo and in vitro 
 
 Since bacteria are able to sense low oxygen concentrations via the ArcAB system 
(Georgellis et al., 2001) and since ArcA-dependent regulation of virulence factors has been 
shown for the intestinal pathogen Vibrio cholerae (Sengupta et al., 2003), it was investigated 
whether a comparable relationship between virulence and ArcA also occurs in a respiratory 
tract pathogen. 
The finding that the constructed A. pleuropneumoniae ΔarcA strain was highly attenuated 
initially led to the hypothesis that the physiological key features described for arcA mutants of 
Enterobacteriaceae (i.e. delayed growth under anaerobic [Sevcik et al., 2001] or under 
aerobic conditions [Oshima et al., 2002] or reduced long term survival [Nystrom et al., 1996]) 
might be responsible. However, contrary to its role in Enterobacteriaceae ArcA of A. 
pleuropneumoniae did neither influence growth nor survival and, therefore, appears to have 
different functions in A. pleuropneumoniae.  
Deletion of ArcA reduced the ability of A. pleuropneumoniae for autoaggregation and 
biofilm formation under oxygen-deprived growth conditions, and both phenotypes are known 
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to be correlated (Schembri et al., 2003). Since biofilm formation has been shown to be 
common for field isolates of A. pleuropneumoniae (Kaplan and Mulks, 2005), it was 
hypothesized that the attenuation of A. pleuropneumoniae ΔarcA might be linked to this 
defect in autoaggregation and biofilm formation. To investigate possible causes for this 
defect, scanning electron microscopy was performed and a difference in threadlike 
extracellular material between A. pleuropneumoniae wt and A. pleuropneumoniae ΔarcA 
could be observed. This extracellular matrix - although present – appears to not be 
appropriately anchored to A. pleuropneumoniae ΔarcA. The matrix might be PGA, a linear 
exopolysaccharide composed of N-acetylglucosamine which, for A. pleuropneumoniae, has 
been described to be involved in biofilm formation by acting as an extracellular adhesin 
(Kaplan et al., 2004; Izano et al., 2007). Alternatively, the structures might be extracellular 
DNA as suggested to be present in Haemophilus (H.) influenzae (Jurcisek and Bakaletz, 
2007) or adhesive pili as shown in Actinobacillus actinomycetemcomitans (Fine et al., 1999). 
A reason for the apparent defect in association of cells and matrix in A. pleuropneumoniae 
ΔarcA might be the lack of an ArcA regulated surface anchor or, alternatively, an 
upregulation of the biofilm releasing enzyme dispersin B (Kaplan et al., 2004) cutting the 
fibres of an extracellular N-acetylglucosamine polymer that binds to the bacterial surface. 
These results, which provide evidence for a direct influence of ArcA on biofilm formation, are 
supported by a recent report showing that the deletion of arcA in E. coli reduces 
competitiveness in biofilm formation (Junker et al., 2006). 
Taken together, these results support the hypothesis that ArcA of A. pleuropneumoniae is 
less important in acute infection but plays an essential role in respiratory tract persistence of 
A. pleuropneumoniae. This implies that an in-depth investigation of the ArcA regulon in the 
respiratory tract pathogen A. pleuropneumoniae might lead to the identification of previously 
unknown persistence-associated factors and metabolic pathways and, therefore, improve our 
understanding of the mechanisms of host-pathogen interaction in chronic and latent infection. 
 
 
E 2  The ArcA regulon of A. pleuropneumoniae 
 
E 2.1  ArcA supports fumarate synthesis and use of fumarate as a terminal 
electron acceptor during anaerobiosis 
 
Adaptation of gene expression to anaerobiosis controlled by the global transcriptional 
regulator ArcA has been shown to be important for virulence in different bacterial species 
(Boulette and Payne, 2007; Rickman et al., 2004; De Souza-Hart et al., 2003). In this study, 
an arcA deletion mutant of A. pleuropneumoniae was shown to be severely attenuated in 
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infection and defective in biofilm formation under oxygen-deprived growth conditions. In order 
to find clues for this phenotype, genome wide transcriptome and proteome analyses of 
anaerobically grown A. pleuropneumoniae wt in comparison to A. pleuropneumoniae ΔarcA 
were performed. 
Based on the results obtained it was hypothesized that, under anaerobic conditions, i) A. 
pleuropneumoniae ArcA modulates the metabolism towards the synthesis of fumarate as 
terminal electron acceptor, and ii) glycerol-3-phosphate is used as reduction equivalent for 
reduction of fumarate and after oxidation to dihydroxy-acetone phosphate, serves as a 
precursor for fumarate synthesis (Fig. 25A).  
The glycolysis enzymes glycerol-3-phosphate dehydrogenase (GapA), phosphoglycerate 
kinase (Pgk), phosphoglyceromutase (GpmA) and pyruvate kinase (PykA) were found to be 
slightly increased whereas transcripts and proteins of the three subunits AceE, AceF and 
LpdA of the pyruvate dehydrogenase complex were identified to be downregulated about 3-
fold by ArcA. The pyruvate dehydrogenase complex catalyzes the oxidative decarboxylation 
of pyruvate in order to generate acetyl-CoA for introduction of reduced carbon atoms into the 
citric acid cycle. However, a BLAST homology search using E. coli citric acid cycle enzymes 
revealed that A. pleuropneumoniae has a truncated citric acid cycle with no homologue for 
the citrate synthase (GltA) and, therefore, acetyl-CoA cannot be fused with oxaloacetate to 
form citrate. In addition, the enzymes catalyzing the transformation of citrate into α-
ketoglutarate (AcnA, AcnB, Icd) are missing on the A. pleuropneumoniae genome. This 
inability to consume acetyl-CoA is hypothesized to lead to an accumulation of pyruvate and 
its precursor phosphoenolpyruvate. Pyruvate can be carboxylated by pyruvate carboxylase 
(Pyc) yielding oxaloacetate. Additionally, phosphoenolpyruvate can be introduced into the 
citric acid cycle intermediate oxaloacetate by phosphoenolpyruvate carboxylase (PepC)-
mediated carboxylation. This requirement for CO2 might be the cause why A. 
pleuropneumoniae grows best under microaerophilic conditions. The use of oxaloacetate for 
gluconeogenesis is unlikely since gluconeogenesis is strongly reduced by ArcA which is 
repressing two major steps. Thus, phosphoenolpyruvate carboxykinase (PckA) and fructose-
1,6-bisphosphatase (Fbp) were found to be repressed by ArcA with the latter exhibiting a 
25.5-fold repression of transcription and a 6.5-fold reduction of translation. Additionally, 
oxaloacetate cannot be consumed by the formation of citrate since A. pleuropneumoniae 
lacks a citrate synthase (GltA). Therefore, oxaloacetate is most likely converted to L-malate 
by malate dehydrogenase (Mdh), an enzyme favoring the NADH-consuming reduction of 
oxaloacetate to malate (Molenaar et al., 2000).  
The membrane bound malate:quinone oxidoreductase (Mqo), an enzyme catalyzing the 
irreversible oxidation of malate (Kather et al., 2000), is severely downregulated (transcript: 
20-fold; protein: 7.5-fold) in A. pleuropneumoniae by ArcA as it has also been observed for E. 
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coli (van der Rest et al., 2000). In addition, malic enzyme (MaeB) catalyzing the oxidative 
decarboxylation of malate into pyruvate was also downregulated (transcript: 4.6 fold; protein 
2.4 to 3.3-fold) by ArcA, and the second decarboxylating malate dehydrogenase (MaeA) 
known from E. coli is missing in A. pleuropneumoniae. Therefore, L-malate is likely to be 
converted into fumarate by the FumC, the only fumarase found in A. pleuropneumoniae. 
Fumarate could then serve as the terminal electron acceptor in an electron transfer reaction 
of the respiratory chain catalyzed by the fumarate reductase enzyme complex (FrdABCD) 
(Boonstra et al., 1978). This hypothesis is supported by the fact that the FrdABCD complex is 
connected to the glycerol-3-phosphate-dehydrogenase through a simple electron transport 
chain (Schryvers and Weiner, 1981) transferring reduction equivalents from glycerol-3-
phosphate to fumarate and thereby generating a proton gradient (Ingledew and Poole 1984) 
and that transcripts of the three proteins comprising the anaerobic glycerol-3-phosphate 
dehydrogenase, GlpABC, were found to be upregulated more then 2-fold by ArcA. This 
enzyme complex catalyzes the oxidation of glycerol-3-phosphate to dihydroxy-acetone 
phosphate which in turn is a glycolysis intermediate and can be converted into fumarate (Fig. 
25A).  
ArcA decreased the expression of dehydrogenases of the respiratory chain which require 
L-lactate (LldD), D-lactate (Dld), proline (PutA) or formate (FdhD, FdxG [APL_0892], FdxG 
[APL_0893], FdxH, FdnI, FdnE) as reduction equivalents. Additionally ArcA, downregulated 
the expression of terminal reductases using nitrite (NrfA, NrfB, NrfC, NrfD, NrfE), nitrate 
(NapA, NapF) or oxygen (CydA, CydB) as oxidation equivalents in the respiratory chain (Fig. 
25B) 
Under anaerobic conditions in the absence of terminal electron acceptors, fermentation is 
an alternative to respiration for maintaining continuous substrate chain phosphorylation 
during glycolysis. Thus, enzymes required for fermentation were identified as induced by 
anaerobiosis in S. aureus (Fuchs et al., 2007). ArcA of A. pleuropneumoniae instead reduced 
the ability for fermentation since the transcription of an alcohol dehydrogenase (AdhI) and an 
aldehyde dehydrogenase (AldA) were repressed during anaerobiosis by about 5 and 16-fold, 
respectively (Fig. 25C). 
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25C 
Fig. 25: Impact of ArcA regulated genes on metabolic pathways. A: Glycolysis and citric 
acid cycle; B: Dehydrogenases, terminal reductases and membrane transporter; C: 
Fermentation. 
(A-C): T = transcript; P1 = protein preparations based on whole cell lysates; P2 = preparation of 
inner and outer membrane-associated proteins. The values within the boxes indicate the degree 
of ArcA dependent regulation (green box = upregulated by ArcA; red box = downregulated by 
ArcA) as obtained by microarray analysis (Transcript) or by 2D DIGE (Protein).  
Dehydrogenases are indicated by a rounded rectangle, terminal reductases are indicated by 
hexagons and membrane transporters are indicated by a pair of rounded rectangles. 
Biochemical pathways were adopted from E. coli K12 (Biocyc, http://www.biocyc.org). The 
genome of A. pleuropneumoniae serotype 5b strain L20 has recently been published (GenBank: 
CP000569) and annotation of the A. pleuropneumoniae genome is available at “Simple Yet 
Powerful Genome browser V 2.3” (http://informatics.bio.nrc.ca/ap5b). E. coli proteins were first 
searched using their annotation against the A. pleuropneumoniae annotated genome. When no 
homologues were found, the amino acid sequence of the E. coli protein was searched against 
the translated A. pleuropneumoniae genome. If A. pleuropneumoniae carried no homologue to 
the respective E. coli protein it is crossed out. 
The pyruvate carboxylase of A. pleuropneumoniae is a homologue to the respective Listeria 
monocytogenes protein. 
These cartoons were made using the Adobe® Illustrator® CS software.  
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Taken together, the ArcA regulon of A. pleuropneumoniae was identified. An ArcA deletion 
mutant of A. pleuropneumoniae was shown to be severely attenuated in infection and an 
analysis of the regulated genes implied that fumarate might be used as a terminal electron 
acceptor. While fumarate uptake is well known (Janausch et al., 2002), the synthesis of 
fumarate in order to use it for respiration as it is implied in this work for A. pleuropneumoniae 
has to my knowledge not been shown before. It has been reported that fumarate respiration 
is highly relevant for persistence and virulence of the enteric pathogen Helicobacter (H.) 
pylori in a mouse model (Ge et al., 2000). Therefore an ArcA regulated pathway promoting 
fumarate respiration under the reducing conditions in the diseased respiratory tract (Cantin et 
al., 1987; Day et al., 2004) is implied to be associated with virulence of A. 
pleuropneumoniae. 
This hypothesis was proven in a follow-up project by Ibrahim Bendallah. He deleted the 
frdA gene encoding the fumarate reductase flavoprotein and tested the deletion mutant in an 
infection experiment of pigs. He could show that deletion of frdA significantly attenuated A. 
pleuropneumoniae in infection. His data strongly support the importance of fumarate 
respiration in virulence (unpublished data). 
Higher eukaryotic organisms do not carry homologues to the bacterial fumarate reductase 
enzyme complex making this enzyme a suitable candidate for chemotherapy. A substance 
called nafuredin that is produced by Aspergillus niger (Ui et al., 2001) has been shown to be 
a potent inhibitor of the helminth fumarate reductase and showed antelminthic activity 
against Haemonchus contortus in in vivo trials with sheep (Omura et al., 2001). The finding 
that the fumarate reductase of A. pleuropneumoniae is important for virulence implies that 
nafuredin could have potential as a novel therapeutic drug to combat at least some bacterial 
infections. 
 
 
E 2.2  Consideration of energy balance of glycerol-3-phosphate dependent 
fumarate reduction 
 
The conversion of glucose (C6) into two molecules of fumarate (C4) requires the 
investment of two molecules CO2. Energy is provided by one molecule phosphoenolpyruvate 
during phosphotransferase system (PTS)-mediated membrane transfer of glucose (Postma 
et al., 1993) and one molecule of ATP (6-phosphofructokinase). Two molecules ATP are 
generated by substrate chain phosphorylation during glycolysis (phosphoglycerate kinase) 
up to phosphoenolpyruvate. Phosphoenolpyruvate can then be carboxylated directly into 
oxaloacetate or by two steps via pyruvate. The latter pathway results in the synthesis of one 
ATP from the dephosphorylation of phosphoenolpyruvate to pyruvate and consumes one 
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ATP while carboxylating pyruvate into oxaloacetate. Taking the phosphoenolpyruvate which 
is invested during PTS-mediated phosphorylation of glucose as an equivalent for one ATP, 
then the net ATP balance is neutral. Per one molecule glucose entering glycolysis, two 
molecules of NADH are synthesized but later the formation of malate from oxaloacetate 
consumes these NADH. Thereby the pool of oxidized NAD+ which is important for glycolysis 
is maintained. 
The oxidation of glycerol-3-phosphate leads to the formation of dihydroxy-acetone 
phosphate, a glycolysis intermediate. If dihydroxy-acetone phosphate is used for fumarate 
synthesis a surplus of one molecule ATP is generated by substrate chain phosphorylation 
(no investment of phosphoenolpyruvate required).  
The midpoint potentials for the glycerol-3-phosphate/dihydroxy-acetone phosphate and 
the fumarate/succinate redox pairs are -0.19 V and 0 V, respectively. The coupling of these 
two systems yields a –ΔG° of about 8.8 kcal (Miki and Lin 1975). This energy facilitates the 
export of approximately two protons from the cytosol into the periplasm thereby generating a 
proton gradient (Miki and Wilson 1978). Considering a stoichiometry of 3 to 4 protons 
transported per ATP synthesized (Fillingame 1990; van Walraven et al., 1996), the oxidation 
of two molecules of glycerol-3-phosphate coupled to the reduction of two molecules of 
fumarate leads to at least one molecule of ATP. 
Taken together, one molecule glycerol-3-phosphate can produce one ATP by substrate 
chain phosphorylation and about 0.5 molecules of ATP by oxidative phosphorylation. 
 
 
E 2.3  Comparison of the A. pleuropneumoniae ArcA regulon with ArcA 
regulons of other bacteria 
 
The ArcA regulon of the close relative H. influenzae has been recently published (Wong et 
al., 2007). Only four genes were identified as being more than 2-fold upregulated by ArcA in 
H. influenzae. None of these positively regulated genes was found to be upregulated 
accordingly in A. pleuropneumoniae but instead 16 different genes were upregulated more 
than twofold. Nineteen genes were downregulated more then 2-fold in H. influenzae 
compared to 42 genes in A. pleuropneumoniae with the L-lactate permease gene (lctP) being 
the strongest negatively affected gene in both organism. Additionally, genes encoding L-
lactate dehydrogenase (lldD) or formate dehydrogenase (fdnI, fdxH, fdhE) were found to be 
downregulated by ArcA in H. influenzae as well as in A. pleuropneumoniae. 
Compared to global expression profiling experiments conducted with E. coli the number of 
ArcA regulated genes in A. pleuropneumoniae is relatively small. In E. coli transcription of 
372 genes (Liu and De Wulf 2004) or 1139 genes (Salmon et al., 2005) were identified as 
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ArcA regulated under anaerobic growth conditions. The E. coli genome is about 2-fold larger 
as the A. pleuropneumoniae genome which, at least in part, accounts for the observed 
differences in size of the ArcA regulons. Additionally, compared to E. coli A. 
pleuropneumoniae inhabits a much more restricted environment (the porcine respiratory 
tract).  
The comparison of ArcA regulated genes in E. coli and in A. pleuropneumoniae revealed 
that there are similarities and differences of the ArcA regulons possibly resulting in divergent 
strategies for anaerobic respiration.  
ArcA of E. coli upregulated cydAB, encoding cytochrome d oxidase (Iuchi et al 1990a). 
This enzyme has a higher affinity for oxygen then cytochrome o oxidase and, therefore, is 
used under low oxygen concentrations (Anraku and Gennis 1987). Unlike E. coli, ArcA of A. 
pleuropneumoniae represses transcription of cydAB as it has also been observed for 
Shewanella (S.) oneidensis (Gralnick et al., 2005). The dmsABC genes encoding the DMSO 
reductase were identified as being upregulated by ArcA of A. pleuropneumoniae as it has 
been reported for the dmsEFAB of S. oneidensis (Gralnick et al., 2005). These genes, 
however, were not found to be ArcA-regulated in E. coli. The strongest ArcA-dependent 
upregulation in A. pleuropneumoniae was observed for a gene cluster encoding a putative 
methylation subunit type III restriction modification system. This regulation has not been 
observed in other organisms, and the function of this cluster is unknown to date.  
 
 
E 3  The HlyX regulon of A. pleuropneumoniae 
 
E 3.1  Adaptation of A. pleuropneumoniae metabolism to anaerobiosis by HlyX 
 
Deletion of hlyX caused a severe attenuation of A. pleuropneumoniae in infection (Baltes 
et al., 2005). In order to identify the molecular mechanisms responsible for the attenuation of 
A. pleuropneumoniae ΔhlyX, the complete regulon was identified; A. pleuropneumoniae wt 
and A. pleuropneumoniae ΔhlyX were grown anaerobically, and gene expression was 
compared by microarray analyses. Additionally, a proteomic approach was performed to 
compare the protein patterns.  
HlyX strongly increased the expression of several terminal reductases including DMSO 
reductase, TMAO reductase, nitrite reductase, and periplasmic nitrate reductase. With the 
exception of the latter, these reductases generate a proton gradient. In contrast, the 
periplasmic nitrate reductase acts as a terminal electron acceptor during anaerobiosis and, 
thereby, supports respiration of different carbon sources (Stewart and Darwin 2002). An A. 
pleuropneumoniae deletion mutant lacking the dimethyl sulfoxide reductase was reduced in 
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virulence (Baltes et al., 2003). Together, these finding indicate that A. pleuropneumoniae 
anaerobically adapts its metabolism by HlyX to use a variety of terminal electron acceptors 
for respiration of which at least some may be of importance during infection.  
Analysis of the HlyX regulon revealed that four genes (hybA, hybB, hyaA and hyaB) 
encoding for a hydrogenase are strongly upregulated (more than 10-fold each). These genes 
exhibit strong homology to the E. coli hydrogenase 2 genes hybA, hybB, hybO and hybC 
(tested by BLAST analysis of the respective E. coli proteins against the A. pleuropneumoniae 
serotype 5b strain L20 complete annotated genome). Additionally, four genes necessary for 
hydrogenase maturation (hypB, hypD, hypE and hypF [Lutz et al., 1991; Reissmann et al., 
2003]) are induced more than 2-fold by HlyX. The A. pleuropneumoniae genome carries no 
homologues to the formate hydrogenylase complex of E. coli that catalyzes the formation of 
hydrogen from formate during fermentative growth. Therefore, one option is that A. 
pleuropneumoniae uses exogenous hydrogen as a reduction equivalent for anaerobic 
growth. A possible source is hydrogen produced in the colon by bacterial fermentation of 
carbohydrates (Maier 2003) as part of this hydrogen is expelled by the lungs (Bond and 
Levitt 1972) and since it has been shown that this hydrogen supports virulence of H. pylori 
(Olson and Maier 2002). The H2-splitting reaction catalyzed by hydrogenase contributes to 
the formation of a proton gradient across the membrane (Vignais et al., 2001). The electrons 
are transferred to different terminal electron acceptors (Laurinavichene and Tsygankov 
2001). A hydrogenase- and fumarate reductase-coupled reaction has been identified to 
transfer electrons from hydrogen to fumarate and thereby generating a proton motive force in 
E. coli (Macy et al., 1976). However, electrons originating from hydrogen appear to not to 
play a major role for anaerobic respiration during infection with A. pleuropneumoniae since 
the deletion of hybB caused no reduction in virulence (Baltes et al., 2004b).  
In addition to its impact on anaerobic metabolism, HlyX of A. pleuropneumoniae is a 
strong regulator of iron acquisition genes. Iron acquisition in Neisseriaceae and 
Pasteurellaceae is mediated by a complicated system allowing utilization of transferrin-bound 
ferric (Fe3+) iron. Transferrin binds to bacterial outer membrane receptors (TbpA, TbpB). The 
iron atom is then transferred into the cytosol by an energy dependent process needing TonB 
and an inner membrane protein complex like ExbBD (Perkins-Balding, et al., 2004). In this 
study the entire system has been identified to be strongly positively regulated by HlyX. The 
reason for the HlyX dependent anaerobic induction of this iron uptake system is unclear. The 
infection with A. pleuropneumoniae causes the formation of encapsulated sequesters in the 
porcine lung. These pathologic areas are poorly supplied with blood and therefore with 
serum soluble transferrin. It seems possible that during evolution of A. pleuropneumoniae the 
transferrin-bound iron uptake system got under control of oxygen dependent regulators since 
the decline in oxygen availability is accompanied in vivo by a decrease in iron supply.  
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E 3.2  Comparison of the A. pleuropneumoniae HlyX regulon with FNR 
regulons of other bacteria 
 
FNR of E. coli affects the expression of 502 genes by more then 2-fold, as shown for 
different growth conditions (Constantinidou et al., 2006). The FNR regulon of the closer 
relative to A. pleuropneumoniae, Neisseria (N.) gonorrhoeae is much smaller and contains 
only 14 genes that are activated as well as six genes that are repressed by FNR (Whitehead 
et al., 2007). In contrast, the HlyX regulon of A. pleuropneumoniae comprising 418 genes 
that are regulated more then 2-fold is large. Although A. pleuropneumoniae ΔhlyX as well as 
the parent strain were harvested in their logarithmic growth phase it can not be excluded that 
at least part of these genes showed an expression difference due to the reduced growth of 
the mutant strain. The gene ape0761 encoding for a putative methylation subunit of a type III 
restriction modification system is the strongest positively regulated gene in the HlyX operon 
(29.8-fold) as well as in the ArcA operon (16.5-fold) of A. pleuropneumoniae. A homologue to 
this gene was also identified as positively regulated by HlyX of N. gonorrhoeae but to a much 
lower extend (2.9-fold) (Whitehead et al., 2007). Terminal reductases were identified to be 
positively regulated by FNR in different bacterial species. Thus, the nitrite reductase is also 
upregulated by HlyX of N. gonorrhoeae (Whitehead et al., 2007). DMSO reductase encoding 
genes were also found to be strongly induced by FNR in Salmonella (S.) enterica (Fink, et 
al., 2007), and, as in A. pleuropneumoniae, FNR is a positive regulator for the expression of 
virulence associated hydrogenases in S. enterica (Zbel et al., 2007).  
Genes encoding for the glycerol-3-phosphate dehydrogenase and fumarate reductase 
enzyme complex that built a short respiratory chain on its own have been identified to be 
positively regulated by FNR in E. coli (Jones and Gunsalus 1987; Iuchi et al., 1990b). 
However, this dehydrogenase / terminal reductase pair is downregulated by HlyX of A. 
pleuropneumoniae and it remains elusive why neither ArcA nor HlyX are able to activate 
frdABCD transcription. One reason could be that transcription from some FNR dependent 
promoters can be inhibited by catabolite repression in the presence of glucose as shown for 
the nrf promoter of E. coli (Browning et al., 2005). Since A. pleuropneumoniae has been 
grown in a rich medium catabolite repression might account for repression of some HlyX 
regulated genes. 
 
 
E 4  Comparison of ArcA- and HlyX-mediated adaptation of gene expression 
 
The ArcAB two-component system and FNR (HlyX in A. pleuropneumoniae) are major 
transcription factors required for bacterial adaptation to anaerobiosis. The regulons of both 
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transcriptions factors have been identified in this study by transcriptomic and proteomic 
analyses. Expression of 903 genes is significantly affected by HlyX more than 1.5-fold, and 
expression of 199 genes is significantly affected by ArcA more than 1.5-fold. Both regulon 
share 114 genes affected by both transcription factors. Consequently, ArcA affects 12.6 % of 
the HlyX regulon, and HlyX affects 57 % of the ArcA regulon. The expression of 103 genes is 
coregulated by ArcA and HlyX (64 positive, 39 negative). However, 11 genes are 
differentially affected by both regulatory proteins. Two subunits of the glycerol-3-phosphate 
dehydrogenase enzymes complex (glpA, glpB) are upregulated by ArcA but downregulated 
by HlyX. The glycerol-3-phosphate dehydrogenase has been considered as being linked to 
the fumarate reductase enzyme complex thereby providing the reduction equivalents 
required for anaerobic use of fumarate as a terminal electron acceptor. The fumarate 
reductase (frdA, frdB, frdC) was also identified to be slightly (below 2-fold) downregulated by 
HlyX. This implies that HlyX, in contrast to ArcA, favors the use of terminal electron 
acceptors different to fumarate under anaerobic growth conditions. This hypothesis is 
supported by the following observations: i) the three genes dmsA, dmsB, dmsC, encoding 
DMSO reductase are strongly upregulated by HlyX but only slightly by ArcA. ii) the genes 
nrfA, nrfB and nrfD encoding a nitrite reductase are downregulated by ArcA but are up to 20-
fold upregulated by HlyX. iii) the gene napA encoding the large subunit of the periplasmic 
nitrate reductase and the napF gene encoding a stimulator for the periplasmic nitrate 
reductase are downregulated by ArcA (1.35-fold and 1.63-fold, respectively) but these genes 
are strongly upregulated by HlyX (14.9-fold and 6.9-fold, respectively). iv) the TMAO 
reductase encoding gene torZ is only 1.12-fold upregulated by ArcA but 11-fold by HlyX. 
Expression of the gene torY encoding the second subunit of TMAO reductase is upregulated 
17.6-fold by HlyX (Fig. 26). 
Considering the degree of up- and downregulation, ArcA is a predominantly negative 
regulator, whereas HlyX mainly acts as a positive regulator in A. pleuropneumoniae under 
anaerobic conditions. HlyX increased the expression of 30 genes by a factor above 7 or 
more, compared to a single gene upregulated to that extend by ArcA. In contrast, no gene is 
repressed by HlyX more than 7 fold compared to 13 genes that are repressed by ArcA more 
than 7-fold despite the fact that the ArcA regulon contains only 22 % of the number of genes 
of the HlyX regulon (Fig. 27). 
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Fig. 26: Comparison of gene regulation by ArcA and HlyX. Transcripts that were found to be 
upregulated by ArcA and upregulated by HlyX got positive values and are shown in the upper 
right quarter of this graph. Transcripts that were downregulated by both regulators got negative 
values and are shown in the lower left quarter. Genes that were not unanimously regulated by 
both transcription factors appear either in the upper left (upregulated by HlyX and 
downregulated by ArcA) or lower right (upregulated by ArcA and downregulated by HlyX) 
quarter of this graph. On the x- and y-axis the ratios of transcripts between A. 
pleuropneumoniae wt and the respective mutant are shown. This ratio was calculated as wt / 
mutant for genes upregulated by the respective transcription factor or as -1 x mutant / wt for 
genes downregulated by the respective transcription factor. Genes whose regulation between 
ArcA and HlyX deviated strongly are highlighted by arrows. 
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Fig. 27: Comparison of the degree of gene regulation by ArcA and HlyX. The ratio between wt 
and mutant is shown on the x-axis. Genes upregulated by ArcA or HlyX got positive values, those 
downregulated got negative values.  
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HlyX and ArcA are activated due to a decline in oxygen availability. It has been reported that 
in E. coli, ArcA exerts its control in a range from 10 to 20% oxygen, whereas FNR is active at 
0 to 10 % oxygen (Tseng et al., 1996). However, another study showed that activity of ArcA 
and FNR increased in a comparable manner as a result of a decline in oxygen tension 
(Becker et al., 1996).  
ArcA regulates the expression of 110 genes under aerobic conditions in E. coli and can be 
activated by interaction with other two-component systems (Oshima et al., 2002). It remains 
unclear whether ArcA and HlyX are active simultaneously in the natural niche of the porcine 
respiratory tract and complement each other. However, a combinatory effect of oxygen and 
various other factors might contribute to selective activation of a certain regulator facilitating 
the best adaptation of A. pleuropneumoniae to its host. 
Identification of ArcA and HlyX regulated genes was conducted by comparing gene and 
protein expression between the wt strain and the respective mutant upon growth under 
anaerobic conditions in a rich medium. This approach is not sufficient to determine whether 
the genes identified are under direct transcriptional control of the respective regulator or 
whether the alteration of expression is an indirect effect caused by deletion of the regulatory 
protein. Additionally, it is likely that different environmental conditions may induce different 
subsets of ArcA or HlyX-regulated genes due to interaction with other regulatory systems. 
However, for the conditions tested, the influence of ArcA and HlyX on gene expression was 
clearly identified permitting conclusions for ArcA and HlyX regulation of gene expression 
under conditions present in the natural environment of the porcine respiratory tract. 
 
 
E 5  Shed membrane vesicles (blebs) appear to be caught in the biofilm 
matrix of A. pleuropneumoniae 
 
A. pleuropneumoniae wt, in contrast to A. pleuropneumoniae ΔarcA, has been shown in 
this study to form autoaggregates under anaerobic conditions and to form biofilm. 
Additionally, it was shown that A. pleuropneumoniae ΔhlyX grew significantly slower then the 
wt strain or the arcA deletion mutant and showed no autoaggregation at 6 h post inoculation 
of an anaerobic liquid culture which was used for protein preparation; however, 
autoaggregation was clearly visible 10 h post inoculation. The 2D DIGE analysis of different 
protein preparations of the three strains generally supported the results obtained by the 
microarray approach. However, for some proteins a considerable enrichment was observed 
solely in the detergent-based protein preparations of A. pleuropneumoniae wt compared to 
A. pleuropneumoniae ΔarcA and A. pleuropneumoniae ΔhlyX and led to the hypothesis that 
this might be due to the autoaggregative growth of the wt strain. Thus, all proteins enriched 
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by detergent from A. pleuropneumoniae wt are predicted to be either located in the 
periplasm, or outer membrane-associated or secreted, including the periplasmic nitrate 
reductase (NapA), the outer membrane protein P2 (OmpP2) and the outer membrane 
proteins P5 and OMP P5 (both were designated as OmpA), the iron regulated outer 
membrane protein B (FrpB), and the ApxIIA toxin. The protein OmpA was identified to be a 
biofilm component of H. influenzae (Gallaher et al., 2006), and OmpA as well as OmpP2 
were found to be expressed in membranes of H. influenzae grown as a biofilm (Murphy and 
Kirkham 2002). OmpA is a regulator of biofilm formation in E. coli (Barrios et al., 2005). The 
possible reason for an enrichment of these proteins in biofilm could be the formation of 
membrane vesicles (blebs). The proteins FrpB, OmpP2 and OmpA are cationic outer 
membrane associated proteins (pI > 8.9), and NapA is a basic periplasmic membrane 
associated protein (pI = 8.2). In addition, a characterization of shed membrane vesicles 
(“blebs”) of N. meningitidis revealed that nearly 75 % of their protein content are outer 
membrane proteins and that the majority of bleb proteins are highly basic. A homologue of 
FrpB of A. pleuropneumoniae was identified as a major bleb component of N. meningitidis 
(Post et al., 2005). The formation of blebs is an envelope stress response occurring in the 
host (McBroom and Kuehn 2007), and blebs have been described as delivery vehicles for 
toxins (Kuehn and Kesty 2005) including ApxI of A. pleuropneumoniae (Negrete-Abascal et 
al., 2000) and quorum sensing signals (Mashburn and Whiteley 2005). It is hypothesized that 
membrane vesicles shed by A. pleuropneumoniae wt are, at least in part, caught in the 
extracellular matrix of clumping bacteria, whereas blebs formed by A. pleuropneumoniae 
ΔarcA and A. pleuropneumoniae ΔhlyX are not retained, since these deletion mutants do not 
autoaggregate. This local enrichment of Apx toxin containing blebs in the biofilm matrix could 
explain the severe local tissue destruction observed during A. pleuropneumoniae infection. 
This tissue destruction supports the release of nutrients and iron from lysed cells and it 
appears not unlikely that bleb associated FrpB contributes to supply iron to A. 
pleuropneumoniae (Beucher et al., 1995).  
Taken together these data imply that one function of biofilm in virulence is the trapping of 
outer membrane vesicles enriched with Apx toxins, the iron scavenging protein FrpB 
(Beucher and Sparling 1995) and possibly other virulence associated factors.  
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G  Appendix 
 
G 1  Genes upregulated by ArcA as obtained by microarray analysis 
 
gene locus tag gene product COG # COG EC # psorb_loc location T-test ratio 
ape0761 APL_0705 
putative methylation subunit, type III restriction-
modification system COG2189 L 2.1.1.72 OuterMembrane 813144..816032 [-] 6.39E-07 16.46
ape0760 APL_0704 hypothetical protein     809428..812742 [-] 1.03E-08 6.72 
ape0758 APL_0703 hypothetical ATP-dependent helicase COG0553 KL  Cytoplasmic 806555..809425 [-] 1.12E-03 5.71 
serC APL_0702 phosphoserine aminotransferase  COG1932 HE 2.6.1.52 Cytoplasmic 805273..806361 [-] 5.08E-08 2.51 
glpB APL_0380 
anaerobic glycerol-3-phosphate dehydrogenase 
subunit B COG3075 E 1.1.99.  432880..434166 [+] 3.42E-03 2.47 
htpG APL_0987 chaperone protein HtpG COG0326 O  Cytoplasmic 1139729..1141606 [-] 9.50E-06 2.34 
dnaK APL_1906 chaperone protein dnaK COG0443 O  Cytoplasmic 2136557..2138455 [-] 4.67E-05 2.32 
glpC APL_0381 
anaerobic glycerol-3-phosphate dehydrogenase 
subunit C COG0247 C 1.1.99.5  434163..435437 [+] 8.57E-04 2.31 
ubiG APL_0285 3-demethylubiquinone-9,3-methyltransferase COG2227 H 2.1.1.64  314720..315424 [-] 5.33E-10 2.30 
ape0999 APL_0920 hypothetical protein     1061681..1062937 [+] 1.66E-05 2.15 
ape1539 APL_1432 putative NAD(P)H oxidoreductase COG2249 R 1.6.99.-  1637523..1638098 [+] 7.92E-05 2.11 
glpA APL_0379 
anaerobic glycerol-3-phosphate dehydrogenase 
subunit A COG0578 C 1.1.99.5 Cytoplasmic 431205..432890 [+] 1.92E-03 2.10 
ape2007 APL_1878 hypothetical protein    OuterMembrane 2106838..2107857 [+] 4.88E-04 2.07 
dmsA APL_1674 
anaerobc dimethyl sulfoxide reductase chain A 
precursor COG0243 C 1.8.99.-  1900092..1902509 [+] 2.28E-05 2.04 
ape1501 APL_1396 hypothetical protein     1596821..1597336 [+] 3.00E-05 2.02 
ape2008 APL_1879 hypothetical protein COG1629    2107994..2109331 [+] 1.40E-04 2.00 
potD2 APL_0368 
spermidine/putrescine-binding periplasmic 
protein 1 precursor COG0687 E  Periplasmic 413401..414483 [+] 6.85E-07 1.98 
infA APL_1228 translation initiation factor IF-1 COG0361 J   1409885..1410103 [-] 2.80E-04 1.98 
gntR APL_0571 HTH-type transcriptional regulator COG1167 KE  Cytoplasmic 643793..645193 [-] 2.59E-05 1.96 
dmsC APL_1676  anaerobic dimethyl sulfoxide reductase chain C COG3302 R  CytoplasmicMembrane 1903138..1903971 [+] 1.58E-07 1.95 
dmsB APL_1675 anaerobic dimethyl sulfoxide reductase chain B COG0437 C  CytoplasmicMembrane 1902519..1903136 [+] 7.48E-07 1.93 
ape0505 APL_0471 hypothetical protein     542535..542828 [-] 7.43E-03 1.79 
afuA_2 APL_0563 Fe3+ ABC transporter, iron-binding protein COG1840 P  Periplasmic 631946..632977 [+] 9.47E-06 1.76 
ape1572 APL_1463 putative ABC transporter     1676054..1676845 [+] 1.00E-02 1.76 
smpA APL_0428 small protein A COG2913 J   485468..485812 [-] 7.16E-05 1.74 
znuA APL_1440 
high-affinity zinc uptake system protein ZnuA 
precursor COG4531 P  Periplasmic 1647160..1648137 [+] 5.94E-06 1.72 
accD APL_0631 
acetyl-coenzyme A carboxylase carboxyl 
transferase subunit beta COG0777 I 6.4.1.2  718567..719460 [+] 2.12E-05 1.72 
groEL APL_1012 60 kDa chaperonin COG0459 O  Cytoplasmic 1178033..1179676 [-] 2.82E-05 1.72 
sspB APL_0657 stringent starvation protein B COG2969 R   751608..752024 [-] 2.84E-12 1.71 
era APL_0544 GTP-binding protein Era-like COG1159 R  Cytoplasmic 614750..615664 [+] 1.06E-07 1.70 
lpxA APL_0407 
Acyl-[acyl-carrier-protein]--UDP-N-
acetylglucosamine O-acyltransferase  COG1043 M 2.3.1.129 Cytoplasmic 464325..465119 [-] 8.48E-05 1.70 
glnA APL_1941 Glutamine synthetase COG0174 E 6.3.1.2 Cytoplasmic 2172693..2174108 [-] 4.68E-11 1.69 
ape0031 APL_0029 ABC transporter periplasmic protein COG0747 E  Periplasmic 33833..35407 [-] 1.01E-03 1.69 
ape0215 APL_0205 predicted rRNA methyltransferase  COG0566 J 2.1.1.-  223489..224526 [-] 1.00E-07 1.69 
dcd APL_0835 deoxycytidine triphosphate deaminase COG0717 F 3.5.4.13 Cytoplasmic 968300..968884 [+] 1.57E-06 1.68 
fis APL_0190 DNA-binding protein Fis COG2901 KL   210047..210343 [+] 4.00E-05 1.66 
dnaJ APL_1905 Chaperone protein dnaJ COG0484 O  Cytoplasmic 2135185..2136327 [-] 2.32E-05 1.66 
ape1150 APL_1061 hypothetical protein     1230590..1231186 [+] 2.86E-03 1.66 
ape1059 APL_0975 hypothetical protein COG0037 D  Cytoplasmic 1128272..1129228 [+] 3.66E-05 1.65 
argD APL_1974 
Diaminobutyrate--2-oxoglutarate 
aminotransferase COG0160 E 2.6.1.76  2200641..2201936 [+] 5.71E-09 1.65 
ape1794 APL_1677 hypothetical protein COG3381 R   1904027..1904632 [+] 1.56E-06 1.65 
recA APL_1143 recombinase A COG0468 L  Cytoplasmic 1318766..1319896 [-] 8.83E-05 1.65 
pdxT APL_0573 glutamine amidotransferase subunit PdxT COG0311 H 2.6.-.-  646167..646742 [+] 5.77E-05 1.64 
ape0978 APL_0905 hypothetical protein     1047346..1047684 [-] 2.27E-03 1.63 
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ilvH APL_0728 acetolactate synthase small subunit COG0440 E 2.2.1.6 Cytoplasmic 836810..837301 [+] 3.89E-05 1.63 
ape2168 APL_2031 hypothetical protein COG0526   Cytoplasmic 2257942..2258436 [-] 3.93E-03 1.63 
pdxS APL_0572 pyridoxal biosynthesis lyase  PdxS COG0214 H 4.-.-.- Cytoplasmic 645280..646167 [+] 2.71E-05 1.63 
ape1328 APL_1231 hypothetical protein    Cytoplasmic 1411876..1412367 [+]  4.24E-04 1.62 
ape0311 APL_0295 hypothetical protein COG1179 H   327747..328511 [+] 3.16E-04 1.62 
recO APL_0545 DNA repair protein RecO COG1381 L   615674..616396 [+] 6.56E-08 1.62 
ape0309 APL_0293 
putative type I site-specific restriction-
modification system, R (restriction) subunit COG0610 V   322648..325785 [+] 2.63E-06 1.62 
ape0487 APL_0453 hypothetical protein     521551..522417 [-] 4.21E-06 1.61 
rnc APL_0543 ribonuclease III COG0571 K 3.1.26.3 Cytoplasmic 614009..614680 [+] 5.69E-09 1.61 
narQ APL_0462 sensor protein NarQ-like COG3850 T 2.7.3.- CytoplasmicMembrane 533862..535577 [+] 6.62E-05 1.61 
cpxR APL_0629 transcriptional regulatory protein CpxR COG0745 TK  Cytoplasmic 716776..717504 [-] 7.52E-04 1.60 
ape1308 APL_1211 hypothetical protein     1393801..1394637 [+] 1.08E-04 1.59 
recJ APL_0459 single-stranded-DNA-specific exonuclease RecJ COG0608 L 3.1.-.- Cytoplasmic 530220..531977 [+] 1.93E-04 1.59 
cysE APL_1511 serine acetyltransferase  COG1045 E 2.3.1.30 Cytoplasmic 1726968..1727783 [+] 3.19E-06 1.59 
trxA APL_1078 thioredoxin COG0526 OC  Cytoplasmic 1247188..1247505 [-] 1.62E-04 1.59 
pheA APL_1033 
P-protein [Includes: Chorismate mutase; 
Prephenate dehydratase] COG0077 E 
4.2.1.51 
and 
5.4.99.5 Cytoplasmic 1198612..1199769 [-] 9.31E-04 1.59 
ape0247 APL_0236 putative lipoprotein  COG3015 MP   254045..254419 [-] 1.11E-03 1.59 
ape0752 APL_0697 putative HTH-type transcriptional regulator COG0583 K  Cytoplasmic 798742..799638 [+] 9.90E-05 1.58 
Ion APL_0376 ATP-dependent protease La  COG0466 O 3.4.21.53 Cytoplasmic 425663..428071 [-] 2.27E-03 1.58 
fabZ APL_0408 
(3R)-hydroxymyristoyl-[acyl-carrier-protein] 
dehydratase COG0764 I 4.2.1.- Cytoplasmic 465147..465611 [-] 4.74E-06 1.58 
fabA APL_1889 
3-hydroxydecanoyl-[acyl-carrier-protein] 
dehydratase COG0764 I 4.2.1.60 Cytoplasmic 2121238..2121768 [-] 6.27E-04 1.57 
clpB APL_1087 chaperone ClpB COG0542 O  Cytoplasmic 1257302..1259875 [+] 1.02E-02 1.55 
ape1017 APL_0937 hypothetical protein    Cytoplasmic 1079048..1079590 [-] 2.66E-04 1.55 
sdaC APL_0856 serine transporter COG0814 E  CytoplasmicMembrane 995022..996251 [+] 3.21E-04 1.55 
uupA APL_0294 ABC transporter ATP-binding protein Uup-1 COG0488 R  CytoplasmicMembrane 325804..327747 [+] 1.38E-04 1.55 
arcA APL_0048 aerobic respiration control protein ArcA COG0745 TK  Cytoplasmic 54844..55560 [+] 5.60E-06 1.54 
asnC APL_1838 Regulatory protein asnC COG1522 K  Cytoplasmic 2062188..2062649 [+] 2.47E-07 1.54 
mukB APL_0581 chromosome partition protein MukB COG3098 D  OuterMembrane 657485..661975 [+] 3.35E-08 1.54 
ape0960 APL_0889 hypothetical protein     1029866..1031281 [+] 7.93E-05 1.54 
sucD APL_0451 
succinyl-CoA ligase [ADP-forming] subunit 
alpha COG0074 C 6.2.1.5 Cytoplasmic 519366..520238 [-] 5.82E-09 1.53 
znuC APL_0456 
high-affinity zinc uptake system ATP-binding 
protein ZnuC COG1121 P  Cytoplasmic 526962..527762 [-] 3.10E-04 1.53 
ape0072 APL_0070 hypothetical protein     83031..83663 [-] 1.42E-04 1.53 
ape0841 APL_0781 putative ATP-dependent helicase COG1199 KL 3.6.1.-  897087..899009 [-] 2.64E-04 1.53 
ppiB APL_0914 peptidyl-prolyl cis-trans isomerase B COG0652 O 5.2.1.8 Cytoplasmic 1055847..1056356 [+] 2.47E-04 1.52 
ape0293 APL_0278 putative Mg-dependent deoxyribonuclease COG0084 L 3.1.21.- Cytoplasmic 306917..307669 [+] 9.13E-05 1.52 
ape0840 APL_0780 hypothetical protein COG1380 R  CytoplasmicMembrane 896661..897020 [-] 2.90E-03 1.52 
mtfA APL_0685 
putative RNA 2'-O-ribose methyltransferase 
MtfA COG2933 R  Cytoplasmic 783146..784237 [-] 9.88E-11 1.52 
ape0497 APL_0463 predicted sortase and related acyltransferases COG1247 M 2.3.1.-  535600..536118 [+] 1.11E-03 1.52 
ape0283 APL_0270 hypothetical protein     298665..299156 [+] 1.05E-04 1.52 
holA APL_0874 DNA polymerase III subunit delta   2.7.7.7  1015440..1016462 [+] 5.43E-08 1.52 
ape1373 APL_1273 
putative fimbrial biogenesis and twitching 
motility protein PilF-like protein COG3063 NU   1464050..1464598 [-] 1.94E-06 1.51 
groES APL_1013 10 kDa chaperonin COG0234 O  Cytoplasmic 1179740..1180030 [-] 5.09E-03 1.51 
serB APL_1230 phosphoserine phosphatase COG0560 E 3.1.3.3  1410957..1411817 [+] 1.95E-06 1.51 
ape0224 APL_0214 hypothetical protein COG1518 L  CytoplasmicMembrane 234640..235596 [-] 6.42E-07 1.51 
cdd APL_1343 cytidine deaminase COG0295 F 3.5.4.5  1542869..1543762 [+] 1.18E-07 1.51 
sdaA APL_0857 L-serine dehydratase COG1760 E 4.3.1.17 Cytoplasmic 996347..997726 [+] 5.32E-05 1.51 
ape1381 APL_1281 hypothetical protein COG2166 R   1472393..1472785 [+] 3.62E-05 1.51 
pssA APL_0043 phosphatidylserine synthase COG1502 I 2.7.8.8  47008..48372 [-] 6.07E-04 1.51 
ape2021 APL_1891 hypothetical protein     2123601..2124047 [+] 8.71E-03 1.50 
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G 2  Genes downregulated by ArcA as obtained by microarray analysis 
gene locus tag gene product COG # COG EC # psorb loc location T-test ratio 
lctP APL_0447 putative L-lactate permease COG1620 C  CytoplasmicMembrane 513511..515106 [-] 2.17E-16 -38.04 
fbp APL_1450 fructose-1,6-bisphosphatase COG0158 G 3.1.3.11  
1662693..1663697 
[+] 8.98E-31 -25.52 
mqo APL_1414 putative malate:quinone oxidoreductase COG0579 R 1.1.99.16  1616829..1618304 [-] 3.55E-10 -19.89 
aldA APL_2011 putative aldehyde dehydrogenase aldA COG1012 C  Cytoplasmic 2236287..2237768 [-] 1.84E-10 -16.71 
ykgE APL_0446 putative dehydrogenase subunit COG0247 C   512616..513341 [-] 1.62E-10 -15.63 
ompW APL_1086 outer membrane protein W precursor COG3047 M  OuterMembrane 1256394..1257041 [-] 2.45E-08 -12.93 
fdxG APL_0892 
formate dehydrogenase, nitrate-inducible, major 
subunit  COG0243 C 1.2.1.2 Periplasmic 
1033523..1034110 
[+] 7.23E-08 -11.86 
fdxH APL_0894 formate dehydrogenase, iron-sulfur subunit  COG0437 C  CytoplasmicMembrane 
1036582..1037481 
[+] 1.17E-05 -11.21 
fdnI APL_0895 
formate dehydrogenase, cytochrome b556 
subunit COG2864 C 1.2.1.2 CytoplasmicMembrane 
1037474..1038145 
[+] 2.25E-05 -11.13 
ape1353 APL_1254 hypothetical protein COG0471 P  CytoplasmicMembrane 1441994..1443385 [-] 3.03E-08 -10.23 
fdxG APL_0893 
formate dehydrogenase, nitrate-inducible, major 
subunit COG0243 C 1.2.1.2 Periplasmic 
1034159..1036582 
[+] 5.19E-07 -10.13 
ykgF APL_0445 putative electron transport protein COG1139 C   511197..512606 [-] 1.55E-08 -9.31 
ape0477 APL_0444 hypothetical protein    Cytoplasmic 510370..511068 [-] 7.91E-08 -7.39 
yedE APL_1977 hypothetical protein COG2391 R  CytoplasmicMembrane 2203946..2205166 [-] 2.96E-03 -6.84 
lldD APL_1849 L-lactate dehydrogenase [cytochrome] COG1304 C   2079893..2081038 [-] 1.14E-06 -6.41 
dld APL_0687  D-lactate dehydrogenase  COG0277 C 1.1.1.28  785117..786808 [+] 1.78E-11 -6.35 
adhI APL_1959 Alcohol dehydrogenase 1 COG1064 R 1.1.1.1 Cytoplasmic 
2189591..2190640 
[+] 1.08E-08 -4.91 
nrdA APL_0992 
ribonucleoside-diphosphate reductase alpha 
subunit COG0209 F 1.17.4.1 OuterMembrane 
1145469..1147739 
[+] 4.77E-04 -4.74 
maeB APL_0486 NADP-dependent malic enzyme (NADP-ME) COG0281 C 1.1.1.40  555322..556590 [+] 1.97E-10 -4.61 
ape0786 APL_0726 carbonic anhydrase COG0288 P 4.2.1.1 Cytoplasmic 834060..834776 [+] 3.23E-11 -4.18 
ape0145 APL_0137 hypothetical protein    CytoplasmicMembrane 138299..139864 [+] 1.06E-11 -3.80 
ape1523 APL_1416 hypothetical protein     
1619045..1619386 
[+] 6.37E-06 -3.75 
yedF APL_1976 hypothetical protein COG0425 O   2203659..2203928 [-] 1.28E-02 -3.57 
ape1797 APL_1680 hypothetical protein COG3550 R   1905515..1906846 [-] 5.39E-04 -3.15 
fdhE APL_0896 formate dehydrogenase accessory protein COG3058 O   
1038255..1039172 
[+] 1.14E-05 -3.13 
lpdA APL_0771 dihydrolipoyl dehydrogenase COG1249 C 1.8.1.4 Cytoplasmic 883954..885378 [-] 2.43E-08 -3.09 
aceE APL_0773 pyruvate dehydrogenase E1 component COG2609 C 1.2.4.1  887432..890086 [-] 5.42E-07 -2.92 
ape1522 APL_1415 hypothetical protein    CytoplasmicMembrane 1618412..1618825 [-] 2.15E-12 -2.76 
aceF APL_0772 
dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase complex 
(E2) COG0508 C 2.3.1.12 Cytoplasmic 885474..887373 [-] 3.36E-08 -2.74 
glpR APL_0823 glycerol-3-phosphate regulon repressor COG1349 KG   951400..952161 [-] 4.85E-09 -2.53 
ape1056 APL_0973 hypothetical protein    CytoplasmicMembrane 1126774..1127511 [-] 1.25E-06 -2.49 
ape1350 APL_1252 hypothetical protein COG0471 P  CytoplasmicMembrane 1438796..1440184 [-] 2.11E-10 -2.46 
mltA APL_0816 
membrane-bound lytic murein transglycolase A 
precursor   3.2.1.-  942188..943282 [-] 1.54E-03 -2.43 
ape1054 APL_0971 putative acyl CoA thioester hydrolase COG1607 I   1125743..1126234 [-] 1.36E-11 -2.38 
ispZ APL_0972 putative intracellular septation protein COG2917 D  CytoplasmicMembrane 1126221..1126772 [-] 3.06E-06 -2.25 
glnE APL_0969 glutamate-ammonia-ligase adenylyltransferase COG1391 OT 2.7.7.42 Cytoplasmic 1122496..1125375 [-] 4.22E-07 -2.25 
ape1053 APL_0970 hypothetical protein    Cytoplasmic 1125450..1125716 [-] 2.54E-09 -2.23 
frpB APL_0276 iron-regulated outer membrane protein B  COG1629 P  OuterMembrane 302893..304863 [+] 3.55E-05 -2.14 
nrfD APL_0103 nitrite reductase transmembrane protein COG3301 P  CytoplasmicMembrane 109216..110184 [+] 1.65E-06 -2.14 
nrfC APL_0102 nitrate reductase COG0437 C   108539..109216 [+] 1.39E-08 -2.08 
ape0688 APL_0637 hypothetical protein    Cytoplasmic 728268..728729 [+] 9.82E-04 -2.05 
mglC APL_1418 
galactoside transport system permease protein 
MglC COG4211 G  CytoplasmicMembrane 1619924..1620934 [-] 7.41E-05 -2.03 
fdhD APL_0891 formate dehydrogenase accessory protein-like COG1526 C  Cytoplasmic 1032298..1033104 [-] 1.93E-12 -1.98 
ape2067 APL_1934 hypothetical protein COG0700   CytoplasmicMembrane 2169338..2169802 [-] 3.84E-07 -1.97 
ubiA APL_0822 4-hydroxybenzoate octaprenyltransferase COG0382 H 2.5.1.- CytoplasmicMembrane 950519..951400 [-] 3.12E-07 -1.96 
mutY APL_1739 A/G-specific adenine glycosylase COG1194 L 3.2.2.-  
1974422..1975567 
[+] 2.41E-05 -1.94 
mscL APL_1592 large-conductance mechanosensitive channel COG1970 M  CytoplasmicMembrane 
1820008..1820397 
[+] 9.47E-07 -1.94 
nrfE APL_1052 cytochrome c-type biogenesis protein NrfE COG1138 O  CytoplasmicMembrane 1220471..1222387 [-] 3.14E-06 -1.93 
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nrfB APL_0101 cytochrome c-type protein NrfB precursor     107892..108539 [+] 3.77E-07 -1.92 
nrdB APL_0993 
ribonucleoside-diphosphate reductase subunit 
beta COG0208 F 1.17.4.1 Cytoplasmic 
1148036..1149166 
[+] 7.47E-04 -1.91 
ape1339 APL_1241 hypothetical protein COG1699 T  CytoplasmicMembrane 
1427864..1429450 
[+] 1.80E-09 -1.91 
yrhG APL_1902 Hypothetical transport protein yrhG COG2116 P  CytoplasmicMembrane 
2132332..2133024 
[+] 5.71E-05 -1.90 
ape2068 APL_1935 hypothetical protein    CytoplasmicMembrane 2169799..2170224 [-] 4.19E-10 -1.81 
ape1519 APL_1413 putative long-chain-fatty-acid--CoA ligase COG1022 I 6.2.1.3 CytoplasmicMembrane 1614873..1616648 [-] 6.84E-04 -1.80 
ccmA APL_1372 
cytochrome c biogenesis ATP-binding export 
protein CcmA COG4133 O  CytoplasmicMembrane 1568850..1569485 [-] 2.07E-05 -1.79 
ape1524 APL_1417 hypothetical protein    CytoplasmicMembrane 
1619428..1619853 
[+] 5.80E-03 -1.78 
ilvM APL_0098 
Acetolactate synthase isozyme II small subunit 
(AHAS-II)   2.2.1.6  104072..104290 [-] 1.17E-04 -1.76 
cyaA APL_1054 adenylate cyclase COG3072 F 4.6.1.1 Cytoplasmic 1224512..1227040 [-] 6.73E-09 -1.76 
ansB APL_0135 probable L-asparaginase periplasmic precursor COG0252 EJ 3.5.1.1 Periplasmic 149916..150965 [-] 5.56E-06 -1.76 
gltS APL_0967 sodium/glutamate symporte carrier protein COG0786 E  CytoplasmicMembrane 
1120735..1121952 
[+] 1.91E-06 -1.75 
nrfA APL_0100 Cytochrome c-552 precursor COG3303 P 1.7.2.2 Periplasmic 106390..107871 [+] 4.45E-04 -1.74 
ape0961 APL_0890 hypothetical protein COG0679 R  CytoplasmicMembrane 1031364..1032296 [-] 9.95E-04 -1.74 
rplW APL_1762 50S ribosomal protein L23 COG0089 J   
1998351..1998656 
[+] 6.28E-06 -1.74 
ccmB APL_1371 heme exporter protein B COG2386 O  CytoplasmicMembrane 1568191..1568853 [-] 4.55E-05 -1.73 
icc APL_1942 protein Icc-like COG1409 R  Cytoplasmic 2174466..2175293 [-] 3.56E-06 -1.72 
ccmC APL_1370 heme exporter protein C COG0755 O  CytoplasmicMembrane 1567409..1568140 [-] 1.89E-05 -1.71 
cydA APL_0297 cytochrome oxidase subunit 1 COG1271 C 1.10.3.- CytoplasmicMembrane 329378..330925 [+] 5.42E-05 -1.71 
tldD APL_1540 TldD-like protein COG0312 R  Cytoplasmic 1753394..1754854 [-] 1.90E-04 -1.71 
ape1960 APL_1832 hypothetical protein COG2041 R   
2055320..2056276 
[+] 1.33E-04 -1.70 
ape1961 APL_1833 hypothetical protein COG2717   CytoplasmicMembrane 
2056276..2056869 
[+] 4.17E-05 -1.70 
ulaA APL_1700 
predicted ascorbate-specific permease IIC 
component   2.7.1.69 CytoplasmicMembrane 1931109..1932890 [-] 1.93E-05 -1.69 
aqpZ APL_1457 aquaporin Z COG0580 G  CytoplasmicMembrane 1671115..1671801 [-] 5.11E-06 -1.69 
cydB APL_0298 cytochrome oxidase subunit 2 COG1294 C 1.10.3.- CytoplasmicMembrane 330942..332078 [+] 3.43E-08 -1.68 
ape1946 APL_1818 hypothetical protein COG1559 R   2040329..2041363 [-] 3.84E-04 -1.67 
kefBC APL_1053 
glutathione-regulated potassium-efflux system 
protein COG0475 P  CytoplasmicMembrane 1222558..1224423 [-] 1.62E-09 -1.66 
nhaA APL_1947 
Na+/H+ antiporter 1 (Sodium/proton antiporter 
1)  COG3004 P  CytoplasmicMembrane 
2177937..2179121 
[+] 1.13E-06 -1.65 
ftsJ APL_0594 
ribosomal RNA large subunit methyltransferase 
J COG0293 J 2.1.1.-  678772..679398 [+] 6.17E-06 -1.65 
ape0917 APL_0848 
putative ABC transporter periplasmic binding 
protein COG0747 E  CytoplasmicMembrane 983413..984987 [+] 3.47E-06 -1.64 
ccmF APL_1367 cytochrome c-type biogenesis protein CcmF COG1138 O  CytoplasmicMembrane 1564521..1566470 [-] 5.30E-06 -1.63 
napF APL_1431 ferredoxin-type protein NapF COG1145 C  Cytoplasmic 1636794..1637324 [-] 1.08E-06 -1.63 
rplD APL_1761 50S ribosomal protein L4 COG0088 J   
1997752..1998354 
[+] 9.90E-09 -1.63 
ape0062 APL_0060 putative N6-adenine-specific DNA  methylase COG0116 L   65092..67230 [+] 5.10E-06 -1.63 
ape2066 APL_1933 
acetylornithine deacetylase/succinyl-
diaminopimelate desuccinylase and related 
deacylases COG0624 E  Cytoplasmic 2168701..2169324 [-] 1.43E-05 -1.62 
rpsJ APL_1759  30S ribosomal protein S10  COG0051 J   
1996773..1997084 
[+] 3.51E-06 -1.62 
pckA APL_0800 phosphoenolpyruvate carboxykinase [ATP] COG1866 C 4.1.1.49 Cytoplasmic 922121..923731 [-] 6.20E-04 -1.61 
ape1478 APL_1373 hypothetical protein COG0593 L  Cytoplasmic 1569626..1570336 [-] 6.15E-04 -1.60 
lipA APL_1593 lipoyl synthase COG0320 H 2.8.1.- Cytoplasmic 1820527..1821519 [-] 2.41E-04 -1.59 
rplC APL_1760 50S ribosomal protein L3 COG0087 J   
1997110..1997736 
[+] 3.88E-05 -1.59 
ape0051 APL_0049 hypothetical protein    OuterMembrane 55612..56130 [+] 1.38E-09 -1.59 
hflK APL_1077 protein HflK COG0330 O 3.4.-.-  1245823..1247013 [-] 1.26E-05 -1.58 
chuW APL_1523 coproporphyrinogen III oxidase COG0635 H 1.3.99.22 Cytoplasmic 1736466..1738283 [-] 1.58E-04 -1.58 
cysZ APL_1304 putative sulfate transport protein CysZ COG2981 E  CytoplasmicMembrane 
1495357..1496238 
[+] 9.28E-06 -1.57 
ape0148 APL_0140 hypothetical protein COG3835 KT  Cytoplasmic 155925..157040 [+] 1.82E-05 -1.57 
galK APL_0995 galactokinase COG0153 G 2.7.1.6 Cytoplasmic 
1150505..1151659 
[+] 9.42E-04 -1.56 
pgaC APL_1923 
biofilm PGA synthesis N-glycosyltransferase 
PgaC COG1215 M  CytoplasmicMembrane 
2160319..2161554 
[+] 2.05E-02 -1.56 
rpe APL_1820 ribulose-phosphate 3-epimerase COG0036 G 5.1.3.1 Cytolasmic 2042459..2043133 [-] 8.34E-06 -1.56 
ligA APL_1302 DNA ligase COG0272 L 6.5.1.2 Cytoplasmic 1492112..1494163 [-] 1.04E-04 -1.55 
afuB APL_1447 Ferric transport system permease protein fpbB COG1178 P  CytoplasmicMembrane 
1657959..1660022 
[+] 1.14E-03 -1.54 
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holB APL_1816 DNA polymerase III subunit delta COG0470 L 2.7.7.7 Cytplasmic 2038713..2039696 [-] 8.37E-04 -1.54 
metC APL_0320 cystathionine beta-lyase COG0626 E 4.4.1.8  356847..358037 [-] 5.77E-05 -1.54 
surE APL_1927 5'-nucleotidase surE COG0496 R 3.1.3.5 Cytoplasmic 
2164002..2164766 
[+] 4.28E-05 -1.54 
ape1343 APL_1245 hypothetical protein    CytoplasmicMembrane 1432923..1433441 [-] 9.19E-07 -1.53 
afuA APL_1446 
ABC-type Fe3+ transport system, periplasmic 
component COG1840 P  Periplasmic 
1656814..1657854 
[+] 9.16E-07 -1.52 
ape0969 APL_0898 putative oxalate/formate antiporter COG0477 GEPR  CytoplasmicMembrane 
1040777..1042325 
[+] 2.08E-04 -1.52 
ccmE APL_1368 cytochrome c-type biogenesis protein CcmE COG2332 O   1566470..1567015 [-] 1.74E-03 -1.51 
putA APL_0106 
bifunctional protein PutA [Includes: Proline 
dehydrogenase; Delta-1-pyrroline-5-carboxylat 
dehydrogenase] COG4230 C 
1.5.1.12 
and 
1.5.99.8 Cytoplasmic 121566..125171 [-] 1.67E-05 -1.50 
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G 3  Genes upregulated by HlyX as obtained by microarray analysis 
 
gene locus_tag gene product COG # COG EC # psorb_loc location T-test ratio 
ape0761 APL_0705 
putative methylation subunit, type III restriction-
modification system COG2189 L 2.1.1.72 OuterMembrane 813144..816032 [-] 8.52E-08 29.81 
hlyX APL_0656 regulatory protein HlyX COG0664 T  Cytoplasmic 750742..751509 [+] 2.26E-07 26.35 
dmsA 
APL_1674 
   
anaerobic dimethyl sulfoxide reductase chain A 
precursor COG0243 C 1.8.99.- Periplasmic 
1900092..1902509 
[+]    1.06E-07 25.35 
nrfA APL_0100 Cytochrome c-552 precursor COG3303 P 1.7.2.2 Periplasmic 
106390..107871 [+] 
   1.93E-06 21.62 
hyaA APL_1331 hydrogenase-2 small chain precursor COG1740 C 1.12.99.6 Periplasmic 
1527737..1528879 
[+] 1.53E-05 20.42 
ccp 
APL_1379 
   cytochrome c peroxidase COG1858 P 1.11.1.5 Periplasmic 
1581367..1582767 
[+]    8.25E-07 20.36 
torY 
APL_0689 
   cytochrome c-type protein TorY COG3005 C  CytoplasmicMembrane 
789616..790734 [-] 
   1.44E-10 17.61 
napA 
APL_1429 
   periplasmic nitrate reductase precursor COG0243 C 1.7.99.4 Periplasmic 
1634007..1636490 
[-]    9.73E-08 14.93 
napG 
APL_1428 
   ferredoxin-type protein napG-like COG1145 C  Cytoplasmic 
1632967..1633872 
[-]    4.79E-08 14.79 
hybB 
APL_1333 
   
putative Ni/Fe-hydrogenase 2 b-type 
cytochrome subunit COG5557 C  CytoplasmicMembrane 
1529902..1531083 
[+]    3.10E-08 12.71 
napH 
APL_1427 
   ferredoxin-type protein NapH-like COG034 C  CytoplasmicMembrane 
1632074..1632967 
[-]    1.82E-08 12.58 
napC 
APL_1425 
   cytochrome c-type protein NapC COG3005 C   
1631007..1631621 
[-]    9.44E-08 12.31 
ape1539 
APL_1432 
   putative NAD(P)H oxidoreductase COG2249 R 1.6.99.-  
1637523..1638098 
[+]    1.05E-05 12.19 
hybA 
APL_1332 
   hydrogenase-2 operon protein HybA precursor COG0437 C  Periplasmic 
1528872..1529909 
[+]    6.55E-09 11.67 
torZ 
APL_0688 
   trimethylamine-N-oxide reductase precursor COG0243 C 1.7.2.3 Periplasmic 
786946..789420 [-] 
   9.76E-09 11.07 
hyaB 
APL_1334 
   hydrogenase-2 large chain precursor COG0374 C 1.12.99.6 Periplasmic 
1531080..1532789 
[+]    2.30E-06 10.50 
napB 
APL_1426 
   nitrate reductase cytochrome c-type subunit COG3043 C  Periplasmic 
1631633..1632055 
[-]    4.60E-13 10.18 
ape0760 
APL_0704 
   hypothetical protein     
809428..812742 [-] 
   8.96E-11 9.56 
ape2089 
APL_1955 
   
outer membrane receptor proteins, mostly Fe 
transport COG1629 P  OuterMembrane 
2184211..2184735 
[+]    9.89E-05 9.42 
tonB2 
APL_0076 
   protein TonB2 COG0810 M  CytoplasmicMembrane 86901..87767 [-] 7.11E-08 9.27 
dmsC 
APL_1676 
   anaerobic dimethyl sulfoxide reductase chain C COG3302 R  CytoplasmicMembrane 
1903138..1903971 
[+]    1.67E-15 8.67 
ape2087 
APL_1953 
   
outer membrane receptor proteins, mostly Fe 
transport COG1629 P  OuterMembrane 
2182851..2183384 
[+]    3.01E-05 8.36 
nrfB 
APL_0101 
   cytochrome c-type protein NrfB precursor     
107892..108539 [+] 
   3.93E-07 8.35 
hcr 
APL_1547 
   NADH oxidoreductase COG1018 C   
1769175..1770194 
[+]    1.52E-07 8.05 
ape2088 
APL_1954 
   
outer membrane receptor proteins, mostly Fe 
transport COG1629 P   
2183478..2184122 
[+]    2.50E-04 8.04 
ape0758 
APL_0703 
   hypothetical ATP-dependent helicase COG0553 KL  Cytoplasmic 806555..809425 [-]   2.00E-07 7.96 
adh2 
APL_1011 
   
aldehyde-alcohol dehydrogenase 2 [Includes: 
Alcohol dehydrogenase; Acetaldehyde 
dehydrogenase] COG1454 C 
1.1.1.1 
1.2.1.10 Cytoplasmic 
1175244..1177859 
[+]    6.73E-07 7.87 
dmsB 
APL_1675 
   anaerobic dimethyl sulfoxide reductase chain B COG0437 C  CytoplasmicMembrane 
1902519..1903136 
[+]    2.48E-06 7.55 
hlpB 
APL_0332 
   lipoprotein HlpB     
368623..369102 [-] 
   6.59E-07 7.26 
nrfC    
APL_0102 
   nitrate reductase COG0437 C   
108539..109216 [+] 
   3.19E-06 7.10 
napF 
APL_1431 
   ferredoxin-type protein NapF COG1145 C  Cytoplasmic 
1636794..1637324 
[-]    7.01E-06 6.89 
ape0031 
APL_0029 
   ABC transporter periplasmic protein COG0747 E  Periplasmic 33833..35407 [-]    5.88E-10 6.67 
visC 
APL_0333 
   putative monooxygenase family protein COG0654 HC   
369238..370383 [-] 
   2.60E-08 6.26 
ape2004 
APL_1875 
   hypothetical protein     
2103986..2104696 
[+]    3.78E-13 6.07 
ape2007 
APL_1878 
   hypothetical protein    OuterMembrane 
2106838..2107857 
[+]    7.69E-11 5.90 
ape2168 
APL_2031 
   Hypothetical protein COG0526   Cytoplasmic 
2257942..2258436 
[-]   1.47E-06 5.73 
napD 
APL_1430 
   putative napD protein COG3062 P  Cytoplasmic 
1636522..1636791 
[-]    3.11E-05 5.68 
ape0312 
APL_0296 
   hypothetical protein     
328590..328922 [-] 
   2.41E-06 5.67 
nrfD 
APL_0103 
   nitrite reductase transmembrane protein COG3301 P  CytoplasmicMembrane 
109216..110184 [+] 
   2.19E-10 5.65 
htpG 
APL_0987 
   chaperone protein HtpG COG0326 O  Cytoplasmic 
1139729..1141606 
[-]    1.03E-06 5.28 
ape0354 
APL_0334 
   hypothetical protein COG1660 R  Cytoplasmic 370507..371367 [-] 2.73E-07 5.17 
ape2008 
APL_1879 
   hypothetical protein COG1629    
2107994..2109331 
[+]    7.45E-08 5.12 
ape0491 
APL_0457 
   hypothetical metalloprotease COG0739 M   
527966..529456 [+] 
   1.72E-05 4.90 
ape1690 
APL_1575 
   hypothetical protein     
1801954..1802508 
[-]    3.61E-11 4.89 
ape2086 
APL_1952 
   
outer membrane receptor proteins, mostly Fe 
transport COG1629 P  OuterMembrane 
2182535..2182882 
[+]    6.71E-05 4.70 
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ape1779 
APL_1662 
   
PTS system mannose-specific EIIAB 
component [Includes: Mannose-specific 
phosphotransferase enzyme IIA component; 
Mannose-specific phosphotransferase enzyme 
IIB component] COG3444 G 2.7.1.69 Cytoplasmic 
1888149..1889117 
[-]    3.19E-09 4.52 
exbD2 
APL_0077 
   biopolymer transport protein ExbD2 COG0848 U  CytoplasmicMembrane 87777..88166 [-]    2.00E-07 4.37 
ape0277 
APL_0264 
   putative ABC transporter ATP-binding protein COG1131 V  CytoplasmicMembrane 
292788..293696 [-] 
   6.32E-07 4.33 
ape2021 
APL_1891 
   hypothetical protein     
2123601..2124047 
[+] 2.57E-06 4.30 
ape0436 
APL_0410 
   hypothetical outer membrane protein COG2825 M  OuterMembrane 466705..467511 [-] 3.65E-08 4.28 
hlp 
APL_0331 
   putative lipoprotein     
367865..368542 [-] 
   1.50E-07 4.26 
ape0972 
APL_0901 
   ribosome-associated inhibitor A COG1544 J  Cytoplasmic 
1044565..1044879 
[+]    8.82E-07 4.13 
exbB2 
APL_0078 
   biopolymer transport protein ExbB2 COG0811 U   88211..88663 [-]    9.77E-06 4.11 
ape1248 
APL_1157 
   putative malate transporter 5'-end COG0471 P  CytoplasmicMembrane 
1333969..1334664 
[-]   5.12E-05 4.08 
ssa1 APL_0364 serotype-specific antigen 1 precursor COG1404 O  OuterMembrane 
404826..407621 [-] 
   1.08E-05 4.02 
hcp 
APL_1546 
   hydroxylamine reductase COG1151 C 1.7.-.- Cytoplasmic 
1767397..1769052 
[+]    5.77E-07 3.97 
lon 
APL_0376 
   ATP-dependent protease La COG0466 O 3.4.21.53 Cytoplasmic 
425663..428071 [-] 
   1.06E-06 3.97 
tmk 
APL_1817 
   thymidylate kinase COG0125 F 2.7.4.9 Cytoplasmic 
2039699..2040325 
[-]    3.69E-07 3.96 
ape1759 
APL_1643 
   hypothetical protein COG2923 P   
1866721..1867092 
[+]    5.72E-07 3.94 
ape2179 
APL_2041 
   Hypothetical protein     
2268504..2269370 
[-]    6.24E-07 3.92 
dnaK 
APL_1906 
   Chaperone protein dnaK OG0443 O   
2136557..2138455 
[-]    2.19E-05 3.90 
lipB 
APL_1594 
   lipoyltransferase COG0321 H 2.3.1.- Cytoplasmic 
1821631..1822287 
[-]    2.05E-06 3.89 
ape1059 
APL_0975 
   hypothetical protein COG0037 D  Cytoplasmic 
1128272..1129228 
[+]    1.25E-04 3.88 
ape1390 
APL_1289 
   hypothetical protein COG2854 Q   
1479067..1479705 
[-]    3.90E-12 3.86 
dsbC 
APL_0458 
   
thiol:disulfide interchange protein DsbC 
precursor COG1651 O 5.3.4.1 Periplasmic 
529475..530170 [+] 
   2.08E-09 3.85 
ape1794 
APL_1677 
   hypothetical protein COG3381 R   
1904027..1904632 
[+]    2.14E-11 3.84 
alr 
APL_0252 
   alanine racemase COG0787 M 5.1.1.1 Cytoplasmic 
274912..276036 [-] 
   3.20E-10 3.81 
lipA 
APL_1593 
   lipoyl synthase COG0320 H 2.8.1.- Cytoplasmic 
1820527..1821519 
[-]    8.13E-07 3.73 
ptsN 
APL_0335 
   PTS system, nitrogen regulatory IIA-like protein COG1762 GT 2.7.1.69 Cytoplasmic 
371386..371898 [-] 
   3.45E-08 3.72 
tolA 
APL_0302 
   
cell envelope integrity inner membrane protein 
TolA COG3064 M   
334285..335580 [+] 
   3.88E-06 3.69 
sdaC 
APL_0856 
   serine transporter COG0814 E  CytoplasmicMembrane 
995022..996251 [+] 
   1.39E-05 3.65 
ape0215 
APL_0205 
   predicted rRNA methyltransferase COG0566 J 2.1.1.-  
223489..224526 [-] 
   8.94E-11 3.65 
ape1959 
APL_1831 
   
DNA-directed RNA polymerase specialized 
sigma subunit, sigma-24 like COG1595 K  Cytoplasmic 
2054650..2055231 
[-]    5.21E-13 3.65 
tusD 
APL_1642 
   sulfurtransferase TusD-like COG1553 P   
1866341..1866718 
[+]    1.36E-10 3.62 
ubiG 
APL_0285 
   3-demethylubiquinone-9 3-methyltransferase COG2227 H 2.1.1.64  
314720..315424 [-] 
   1.49E-10 3.62 
macA 
APL_1814 
   probable macrolide-specific efflux protein COG0845 M   
2036534..2037310 
[-]    2.63E-14 3.57 
yhgB 
APL_0336 
   putative ABC transporter ATP-binding protein COG1137 R  Cytoplasmic 
371948..372673 [-] 
   6.88E-10 3.51 
ape0358 
APL_0338 
   hypothetical protein     
373211..373807 [-] 
   6.64E-08 3.50 
kdsA 
APL_1578 
   2-dehydro-3-deoxyphosphooctonate aldolase COG2877 M 2.5.1.55 Cytoplasmic 
1804277..1805137 
[-]    9.54E-08 3.44 
ape0357 
APL_0337 
   hypothetical protein     
372683..373186 [-] 
   1.27E-07 3.40 
ape1712 
APL_1597 
   possible rare lipoprotein A RlpA-like protein COG0797 M   
1824026..1824589 
[-]    1.24E-08 3.40 
dacA 
APL_1596 
   D-alanyl-D-alanine carboxypeptidase fraction A COG1686 M 3.4.16.4 CytoplasmicMembrane 
1822752..1823930 
[-]    3.46E-06 3.38 
pssA    
APL_0043 
   phosphatidylserine synthase COG1502 I 2.7.8.8  47008..48372 [-]    7.81E-07 3.35 
uspA 
APL_0655 
   universal stress protein A-like COG0589 T  Cytoplasmic 
750053..750478 [-] 
   9.60E-06 3.35 
nadR 
APL_0046 
   transcriptional regulator NadR COG3172 H 2.7.7.1 Cytoplasmic 52696..53976 [+]    5.44E-09 3.34 
rseA 
APL_0395 
   
putative sigma-E factor negative regulatory 
protein COG3073 T   
449684..450307 [+] 
   6.72E-10 3.34 
exbD 
APL_1569 
   biopolymer transport ExbD protein COG0848 U  CytoplasmicMembrane 
1797580..1797990 
[-]    8.84E-12 3.31 
hypB 
APL_1327 
   
hydrogenase isoenzymes nickel incorporation 
protein HypB COG0378 OK  Cytoplasmic 
1522186..1522995 
[+]    8.19E-07 3.24 
ape1065 
APL_0981 
   hypothetical protein COG0859 M   
1134486..1135547 
[+]    3.79E-10 3.20 
exbB 
APL_1570 
   biopolymer transport ExbB protein COG0811 U  CytoplasmicMembrane 
1797990..1798658 
[-] 1.47E-06 3.15 
ape1324 
APL_1227 
   hypothetical protein    Cytoplasmic 
1408957..1409745 
[+]    1.94E-06 3.11 
recA 
APL_1143 
   recombinase A COG0468 L  Cytoplasmic 
1318766..1319896 
[-]    6.11E-07 3.10 
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kdsA 
APL_2040 
   2-dehydro-3-deoxyphosphooctonate aldolase COG2877 M 2.5.1.55 Cytoplasmic 
2267599..2268453 
[-]    6.84E-07 3.06 
holB 
APL_1816 
   DNA polymerase III subunit delta COG0470 L 2.7.7.7 Cytoplasmic 
2038713..2039696 
[-]    1.56E-07 3.04 
ape0776 
APL_0717 
   iron(III) ABC transporter, ATP-binding protein COG4604 P 3.6.3.34  827141..827899 [ 4.89E-09 3.02 
ape0142 
  
APL_0134 
   hypothetical protein     
149191..149835 [+] 
   3.07E-07 3.02 
ilvM 
APL_0098 
   
Acetolactate synthase isozyme II small subunit 
(AHAS-II)   2.2.1.6 Cytoplasmic 
104072..104290 [-] 
   1.15E-05 3.02 
oapA 
APL_1405 
   opacity associated protein A COG3061 M  Extracellular 
1605788..1607179 
[-]    7.34E-07 3.02 
grcA 
APL_0361 
   autonomous glycyl radical cofactor COG3445 R  Cytoplasmic 
402489..402875 [-] 
   1.95E-08 2.99 
ape1965 
APL_1836 
   hypothetical protein     
2059991..2060503 
[+]    1.02E-07 2.94 
rluE    
APL_0088 
   
ribosomal large subunit pseudouridine synthase 
E COG1187 J 5.4.99.12 Cytoplasmic 95649..96344 [-]    7.52E-07 2.93 
ape1342 
  
APL_1244 
   hypothetical protein    Cytoplasmic 
1432223..1432834 
[+]    4.14E-09 2.91 
ape1502 
APL_1397 
   hypothetical protein    Cytoplasmic 
1597474..1598262 
[-]    8.51E-05 2.91 
ape0701 
APL_0650 
   hypothetical protein    Cytoplasmic 
743985..744503 [+] 
   7.72E-11 2.91 
ape2035 
APL_1904 
   hypothetical protein    Cytoplasmic 
2134138..2134926 
[-]    2.05E-04 2.90 
hrpA 
APL_0365 
   ATP-dependent RNA helicase COG1643 L 3.6.1.-  
407842..411741 [-] 
   3.86E-07 2.89 
clpB 
APL_1087 
   chaperone ClpB COG0542 O  Cytoplasmic 
1257302..1259875 
[+]    1.19E-03 2.89 
ape0416 
APL_0392 
   hypothetical protein COG0561 R  Cytoplasmic 
445790..446605 [-] 
   5.35E-06 2.87 
ape1247 
APL_1156 
   putative malate transporter 3'-end COG0471 P  CytoplasmicMembrane 
1333204..1333872 
[-]    2.16E-04 2.86 
ape0384 
APL_0363 
   hypothetical protein     
403856..404728 [-] 
   1.01E-03 2.85 
ape0132 
APL_0124 
   hypothetical protein COG0510 M   
141240..141989 [-] 
   1.94E-09 2.85 
ape1150 
APL_1061 
   hypothetical protein     
1230590..1231186 
[+]   2.43E-05 2.83 
engB 
APL_0094 
   putative GTP-binding protein EngB COG0218 R   99769..100389 [-]    8.23E-06 2.83 
ape0311 
APL_0295 
   hypothetical protein COG1179 H   
327747..328511 [+] 
   4.39E-12 2.82 
ldhA 
APL_2039 
   Glycerate dehydrogenase COG1052 CHR  Cytoplasmic 
2266593..2267543 
[-]    2.02E-06 2.81 
cpxR 
APL_0629 
   transcriptional regulatory protein CpxR COG0745 TK  Cytoplasmic 
716776..717504 [-] 
   2.26E-09 2.81 
ape1558 APL_1451 hypothetical protein    Cytoplasmic 
1663853..1664464 
[-]    2.20E-04 2.81 
hslU    
APL_1735 
   
ATP-dependent hsl protease ATP-binding 
subunit hslU COG1220 O  Cytoplasmic 
1970984..1972306 
[-]    2.14E-06 2.80 
narP 
APL_0059 
   nitrate/nitrite response regulator protein COG2197 TK  Cytoplasmic 64259..64888 [-]    1.18E-08 2.79 
ape0099 
  
APL_0096 
   zinc transporter family protein ZIP COG0428 P  CytoplasmicMembrane 
101138..101968 [-] 
   1.30E-07 2.79 
sdaA 
APL_0857 
   L-serine dehydratase COG1760 E 4.3.1.17 Cytoplasmic 
996347..997726 [+] 
   4.54E-06 2.79 
macA 
APL_0391 
   probable macrolide-specific efflux protein COG0845 M  CytoplasmicMembrane 
444512..445693 [-] 
   1.17E-06 2.79 
gcvA 
APL_0131 
   
glycine cleavage system transcriptional 
activator-like COG0583 K  Cytoplasmic 
146637..147527 [+] 
   3.60E-08 2.78 
sanA   
APL_0442 
   SanA protein    CytoplasmicMembrane 
499069..499755 [+] 
   1.92E-13 2.77 
hisI    
APL_2028 
   
Histidine biosynthesis bifunctional protein hisIE 
[Includes: Phosphoribosyl-AMP cyclohydrolase 
(PRA-CH); Phosphoribosyl-ATP 
pyrophosphatase (PRA-PH)] COG0139 E 
3.5.4.19 
3.6.1.31 Cytoplasmic 
2255532..2256176 
[+]    1.67E-05 2.73 
grxA   
APL_0054 
   glutaredoxin COG0695 O  Cytoplasmic 60795..61058 [+] 1.67E-06 2.71 
tonB1 APL_1571 periplasmic protein COG0810 M   
1798680..1799420 
[-]    1.30E-05 2.71 
prc 
APL_0120 
   tail-specific protease precursor COG0793 M 3.4.21.102 Cytoplasmic 
136190..138202 [+] 
   9.17E-06 2.70 
ape1778 
APL_1661 
   mannose permease IIC component COG3715 G  CytoplasmicMembrane 
1887340..1888134 
[-]    1.71E-04 2.69 
sygB 
APL_1803 
   Glycyl-tRNA synthetase beta chain COG0751 J 6.1.1.14  
2025782..2027851 
[+]    1.42E-11 2.68 
tbpA 
APL_1567 
   transferrin-binding protein 1 Tbp1 COG1629 P  OuterMembrane 
1793088..1795895 
[-]    1.43E-07 2.68 
ape0309 
APL_0293 
   
putative type I site-specific restriction-
modification system, R (restriction) subunit COG0610 V   
322648..325785 [+] 
   6.61E-13 2.68 
ape0308 
APL_0292 
   hypothetical protein     
322055..322642 [+] 
   1.65E-07 2.68 
ape1626 
APL_1516 
   cytochrome c biogenesis factor-like COG4235 O   
1732016..1732930 
[+]    5.16E-07 2.67 
mglB 
APL_0450 
   
D-galactose-binding periplasmic protein 
precursor COG1879 G  Periplasmic 
518260..519231 [+] 
   9.28E-05 2.67 
typA 
APL_0053 
   GTP-binding protein COG1217 T  Cytoplasmic 58930..60636 [+]    1.30E-05 2.67 
pheA 
APL_1033 
   
P-protein [Includes: Chorismate mutase; 
Prephenate dehydratase] COG0077 E 
4.2.1.51 
5.4.99.5 Cytoplasmic 
1198612..1199769 
[-]    5.78E-08 2.65 
hypD 
APL_1328 
   
hydrogenase isoenzymes formation protein 
HypD COG0409 O  Cytoplasmic 
1523007..1524122 
[+]    9.50E-08 2.65 
ape2139 
APL_2002 
   Hypothetical protein COG0457   OuterMembrane 
2226751..2228220 
[-]    1.46E-08 2.62 
ape0049 
APL_0047 
   hypothetical diadenosine tetraphosphatase COG0639 T   53973..54671 [+]    4.67E-06 2.62 
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ape1757 
APL_1641 
   hypothetical protein     
1865682..1866341 
[+]    4.74E-06 2.61 
ape1710 
APL_1595 
   hypothetical protein    Cytoplasmic 
1822319..1822618 
[-]    6.51E-05 2.61 
frpB 
APL_0276 
   iron-regulated outer membrane protein B COG1629 P  OuterMembrane 
302893..304863 [+] 
   3.96E-05 2.60 
serC 
APL_0702 
   phosphoserine aminotransferase COG1932 HE  Cytoplasmic 
805273..806361 [-] 
   2.02E-07 2.59 
sirA 
APL_0092 
   sulfurtransferase COG0425 O  Cytoplasmic 99038..99277 [+]    4.91E-05 2.59 
hypF 
APL_1330 
   carbamoyltransferase HypF COG0068 O   
1525217..1527502 
[-]    3.56E-06 2.57 
ape1151 
  
APL_1062 
   hypothetical protein     
1231227..1231601 
[+]    1.39E-03 2.57 
lpxA 
APL_0407 
   
Acyl-[acyl-carrier-protein]--UDP-N-
acetylglucosamine O-acyltransferase COG1043 M 2.3.1.129 Cytoplasmic 
464325..465119 [-] 
   5.38E-12 2.57 
ape1854 
APL_1729 
   hypothetical protein    OuterMembrane 
1965725..1967146 
[+]    1.90E-07 2.56 
ape0350 
APL_0330 
   hypothetical protein     
367332..367808 [-] 
   1.80E-06 2.55 
ape1930 
APL_1802 
   hypothetical protein     
2025340..2025744 
[+]    1.17E-04 2.53 
ape1548 
  
APL_1441 
   hypothetical protein    Cytoplasmic 
1648236..1648847 
[-]    8.24E-05 2.52 
ape0134 
APL_0126 
   HIT-like protein COG0537 FGR  Cytoplasmic 
142362..142727 [-] 
   3.11E-07 2.52 
ape1138 
APL_1049 
   hypothetical protein COG4235 O   
1218778..1219524 
[-]    1.61E-06 2.52 
ung 
APL_0362 
   uracil-DNA glycosylase COG0692 L 3.2.2.-  
403081..403758 [+] 
   2.18E-04 2.51 
surA 
APL_0400 
   peptidyl-prolyl cis-trans isomerase SurA COG0760 O 5.2.1.8 Periplasmic 454398..455348 [-]   1.22E-04 2.50 
mazG 
APL_0630 
   predicted pyrophosphatase COG1694 R  Cytoplasmic 
717629..718228 [-] 
   2.15E-07 2.50 
ape1946 
APL_1818 
   hypothetical protein COG1559 R   
2040329..2041363 
[-]    1.76E-05 2.49 
apxID 
APL_1442 
   RTX-I toxin secretion component COG0845 M   
1649278..1650714 
[-]    5.15E-10 2.48 
ape1943 
APL_1815 
   hypothetical protein COG3713 M  OuterMembrane 
2037606..2038382 
[-]    1.46E-07 2.47 
fis 
APL_0190 
   DNA-binding protein Fis COG2901 KL   
210047..210343 [+] 
   1.64E-04 2.46 
ape0140 
APL_0132 
   putative haloacid dehalogenase-like hydrolase COG1011 R   147527..148207 [+] 1.90E-09 2.45 
ileS 
APL_0044 
   isoleucyl-tRNA synthetase COG0060 J 6.1.1.5 Cytoplasmic 48524..51340 [-]    4.84E-14 2.41 
valS 
APL_1502 
   valyl-tRNA synthetase COG0525 J 6.1.1.9 Cytoplasmic 
1717631..1720495 
[-]    6.07E-08 2.41 
infA 
APL_1228 
   translation initiation factor IF-1 COG0361 J  Cytoplasmic 
1409885..1410103 
[-]    5.32E-04 2.41 
lolC 
APL_2038 
   
Lipoprotein-releasing system transmembrane 
protein lolC COG4591 M  CytoplasmicMembrane 
2265296..2266468 
[-]    7.66E-06 2.39 
ape1514 
APL_1409 
   predicted CueR-like transcriptional regulator COG0789 K  Cytoplasmic 
1611389..1612009 
[-]    9.28E-05 2.38 
ape0096 
APL_0093 
   hypothetical protein    Cytoplasmic 99327..99767 [-]    2.12E-05 2.38 
fumC 
APL_1757 
   Fumarate hydratase class II COG0114 C 4.2.1.2 Cytoplasmic 1994160..1995554 [ 1.84E-08 2.38 
oapB    
APL_1404 
   opacity associated protein B     
1605262..1605666 
[-]    1.36E-09 2.38 
ape0272 
APL_0259 
   
predicted oligoketide cyclase/lipid transport 
protein COG2867 I   288879..289313 [-] 6.66E-05 2.38 
hgbA 
APL_1047 
   hemoglobin-binding protein A precursor COG1629 P  OuterMembrane 
1215150..1217993 
[-]    2.55E-04 2.35 
ape1760 
APL_1644 
   hypothetical protein COG2168 P   
1867105..1867374 
[+]    5.86E-04 2.35 
cpxC   
APL_1583 
   
capsule polysaccharide export inner-membrane 
protein COG3524 M   
1810436..1811593 
[+]    3.64E-07 2.35 
hslV 
APL_1736 
   ATP-dependent protease hslV COG5405 O 3.4.25.- Cytoplasmic 
1972361..1972882 
[-]    7.93E-06 2.34 
era 
APL_0544 
   GTP-binding protein Era-like COG1159 R  Cytoplasmic 
614750..615664 [+] 
   9.85E-08 2.34 
ape1938 
  
APL_1810 
   Putative Mg-dependent DNAse COG0084 L 3.1.21.-  
2031836..2032624 
[-]    6.49E-07 2.32 
ape2181 
APL_2043 
   hypothetical protein     
2270245..2270772 
[-] 3.82E-09 2.30 
ape1239 
APL_1148 
   putative periplasmic protein     
1324003..1324452 
[+]    1.12E-04 2.30 
lpxD   
APL_0409 
   
UDP-3-O-[3-hydroxymyristoyl] glucosamine N-
acyltransferase COG1044 M 2.3.1.- Cytoplasmic 
465680..466705 [-] 
   4.15E-08 2.30 
yhbZ 
APL_0040 
   hypothetical GTP-binding protein COG0536 R  Cytoplasmic 44225..45400 [+]   1.02E-05 2.30 
hypE 
APL_1329 
   
hydrogenase isoenzymes formation protein 
HypE COG0309 O  Cytoplasmic 
1524124..1525137 
[+]    4.27E-05 2.29 
nudC   
APL_0087 
   NADH pyrophosphatase COG2816 L 3.6.1.- Cytoplasmic 94861..95631 [-]    3.15E-04 2.28 
ape1385 
APL_1285 
   hypothetical protein COG0607 P   
1476170..1476538 
[+]    9.61E-04 2.28 
recJ   
APL_0459 
   single-stranded-DNA-specific exonuclease Rec COG0608 L 3.1.-.- Cytoplasmic 
530220..531977 [+] 
   7.96E-05 2.28 
htrA 
APL_1293 
   
probable periplasmic serine protease do/hhoA-
like precursor COG0265 O 3.4.21.- Periplasmic 
1482162..1483556 
[+]    9.89E-05 2.28 
bioD1 
APL_0614 
   dethiobiotin synthetase 1 COG0132 H 6.3.3.3  
700088..700807 [-] 
   4.75E-09 2.28 
ape0641 
APL_0590 
   hypothetical protein COG3955 M   
672412..673032 [-] 
   2.85E-07 2.27 
ape0121 
   
APL_0113 
   hypothetical protein     
131234..131824 [+] 
   1.01E-06 2.26 
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hemK 
APL_2042 
   protein HemK-like COG2890 J 2.1.1.-  
2269371..2270243 
[-]    1.09E-06 2.26 
cysB 
APL_0133 
   HTH-type transcriptional regulator CysB COG0583 K  Cytoplasmic 
148207..149190 [+] 
   2.13E-06 2.26 
rsmB 
APL_1560 
   
ribosomal RNA small subunit methyltransferase 
B COG0144 J 2.1.1.- Cytoplasmic 
1784135..1785433 
[-]    7.24E-05 2.25 
ape1859 
APL_1734 
   hypothetical protein    CytoplasmicMembrane 
1970132..1970911 
[-]    1.09E-06 2.24 
ape0133 APL_0125 hypothetical protein COG5633 R   141986..142360 1.38E-06 2.24 
tehB 
APL_1350 
   tellurite resistance protein TehB-like COG0500 QR   
1548925..1549797 
[+]    3.34E-10 2.23 
ape0999 
APL_0920 
   hypothetical protein     
1061681..1062937 
[+]    3.60E-08 2.23 
gntR 
APL_0571 
   HTH-type transcriptional regulator COG1167 KE  Cytoplasmic 
643793..645193 [.] 
   9.05E-11 2.22 
ape1777 
  
APL_1660 
   mannose permease IID component COG3716 G  CytoplasmicMembrane 
1886502..1887329 
[-]    3.74E-10 2.22 
amiB 
APL_1136 
   
putative N-acetylmuramoyl-L-alanine amidase 
AmiB precursor COG0860 M 3.5.1.28  
1312068..1313213 
[+]    1.54E-06 2.21 
ape0813 
APL_0753 
   putative esterase/lipase COG0596 R 3.1.-.-  
863424..864209 [+] 
   7.70E-08 2.21 
dnaX 
APL_0265 
   DNA polymerase III subunit gamma/tau COG2812 L 2.7.7.7  
293696..295762 [-] 
   3.59E-04 2.21 
groEL 
APL_1012 
   60 kDa chaperonin COG0459 O  Cytoplasmic 
1178033..1179676 
[-]    4.05E-05 2.21 
tehA    
APL_1212 
   tellurite resistance protein TehA COG1275 P  CytoplasmicMembrane 
1394716..1395663 
[-]    1.43E-03 2.20 
rnhB 
APL_0129 
   ribonuclease HII COG0164 L 3.1.26.4  
144477..145070 [-] 
   6.83E-07 2.20 
ape1601 
APL_1491 
   hypothetical protein     
1706547..1707902 
[-]    4.26E-05 2.19 
lolD 
APL_2037 
   
Lipoprotein-releasing system ATP-binding 
protein lolD COG1136 V  CytoplasmicMembrane 
2264515..2265228 
[-]    1.49E-06 2.18 
ape0089 
APL_0086 
   hypothetical protein     94362..94787 [+]    3.70E-07 2.18 
ape1850 
APL_1726 
   hypothetical protein    Cytoplasmic 
1956260..1956808 
[+]    9.97E-03 2.17 
uupA 
APL_0294 
   ABC transporter ATP-binding protein Uup-1 COG0488 R  CytoplasmicMembrane 
325804..327747 [+] 
   8.12E-12 2.17 
hyaD 
APL_1335 
   hydrogenase 2 maturation protease COG0680 C  Cytoplasmic 
1532789..1533286 
[+]    1.97E-06 2.15 
ppiB 
APL_0914 
   peptidyl-prolyl cis-trans isomerase B COG0652 O 5.2.1.8 Cytoplasmic 
1055847..1056356 
[+]    4.42E-08 2.15 
rho    
APL_0247 
   transcription termination factor Rho COG1158 K  Cytoplasmic 
267745..269007 [-] 
   2.26E-10 2.15 
ape0158 
APL_0149 
   hypothetical protein COG0694 O  Cytoplasmic 
167032..167631 [-] 
   2.02E-05 2.15 
ape0276 
APL_0263 
   putative ABC transport system permease COG0842 V  CytoplasmicMembrane 
292023..292784 [-] 
   1.28E-05 2.15 
afuA_2 
APL_0563 
   Fe3+ ABC transporter, iron-binding protein COG1840 P  Periplasmic 
631946..632977 [+] 
  2.31E-05 2.14 
sohB 
APL_0008 
   putative protease SohB COG0616 OU 3.4.21.- Cytoplasmic 8624..9679 [+]    5.81E-06 2.14 
ape0453 
  
APL_0426 
   hypothetical protein     
483270..483728 [-] 
   2.75E-03 2.14 
ape1501 
APL_1396 
   hypothetical protein     
1596821..1597336 
[+]    3.11E-09 2.13 
ape0223 
APL_0213 
   hypothetical protein COG1203 R  CytoplasmicMembrane 
231296..234643 [-] 
   1.37E-09 2.13 
ape1858 
APL_1733 
   hypothetical protein COG4902    
1969302..1969952 
[+]    1.00E-08 2.12 
pepN 
APL_1340 
   aminopeptidase N COG0308 E 3.4.11.2 Cytoplasmic 
1538998..1541607 
[+]    5.71E-09 2.11 
fabZ 
APL_0408 
   
(3R)-hydroxymyristoyl-[acyl-carrier-protein] 
dehydratase COG0764 I 4.2.1.- Cytoplasmic 
465147..465611 [-] 
   3.39E-10 2.11 
ape1827 
APL_1707 
   hypothetical protein     
1939172..1939606 
[+]    1.79E-04 2.09 
ape0257 
APL_0246 
   truncated transferrin-binding protein 1 precursor COG1629 P  OuterMembrane 
264910..267177 [+] 
   4.66E-09 2.09 
rpoZ 
APL_1826 
   DNA-directed RNA polymerase omega subunit COG1758 K 2.7.7.6 Cytoplasmic 
2049150..2049425 
[-]    2.74E-04 2.09 
ape0805 
APL_0745 
   putative alkaline phosphatase COG1785 P   
851211..852221 [+] 
   5.55E-07 2.07 
engC 
APL_0130 
   putative GTPase EngC COG1162 R 3.6.1.- Cytoplasmic 
145093..146127 [-] 
   8.01E-08 2.05 
serA 
APL_1452 
   D-3-phosphoglycerate dehydrogenase COG0111 HE 1.1.1.95 Cytoplasmic 
1664928..1666157 
[-]    1.97E-07 2.05 
fkpA   
APL_1640 
   
putative FKBP-type peptidyl-prolyl cis-trans 
isomerase COG0545 O 5.2.1.8 Periplasmic 
1864839..1865570 
[+]    5.41E-06 2.04 
ape0720 
APL_0668 
   hypothetical protein COG2822 P   
763097..763909 [+] 
   5.03E-07 2.04 
murI 
APL_1841 
   glutamate racemase COG0796 M 5.1.1.3  
2064220..2065017 
[+]    1.45E-08 2.04 
pmbA 
APL_0729 
   antibiotic maturation factor COG0312 R  Cytoplasmic 
837571..838920 [-] 
   4.48E-10 2.02 
srmB 
APL_2008 
   ATP-dependent RNA helicase COG0513 LKJ 2.7.7.- Cytoplasmic 
2232346..2233683 
[+]    5.85E-10 2.01 
infB 
APL_0639 
   translation initiation factor IF-2 COG0532 J  Cytoplasmic 
730249..732774 [+] 
   3.11E-05 2.00 
ape1328 
APL_1231 
   hypothetical protein    Cytoplasmic 
1411876..1412367 
[.]    5.16E-05 2.00 
dsbE 
APL_1514 
   thiol:disulfide interchange protein DsbE COG0526 OC  Periplasmic 
1731002..1731544 
[+]    8.43E-06 2.00 
ape0674 
APL_0623 
   hypothetical protein    Cytoplasmic 
710915..711133 [-] 
   1.16E-03 1.99 
coaA 
APL_1513 
   pantothenate kinase COG1072 H 2.7.1.33 Cytoplasmic 
1729917..1730867 
[+]    2.25E-05 1.99 
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dnaJ 
APL_1905 
   Chaperone protein dnaJ COG0484 O  Cytoplasmic 
2135185..2136327 
[-]   2.47E-04 1.98 
ape0506 
APL_0472 
   hypothetical protein    Cytoplasmic 
542837..543121 [-] 
   9.42E-06 1.98 
gshA 
APL_1408 
   
glutathione biosynthesis bifunctional protein 
GshAB COG2918 H 6.3.2.2  
1609024..1611297 
[+]    2.74E-05 1.97 
lpsA   
APL_1118 
   
lipooligosaccharide biosynthesis protein LpsA 
3'-end COG3306 M   
1295110..1295580 
[-]    3.84E-08 1.97 
lolE 
APL_2036 
   
lipoprotein-releasing system transmembrane 
protein COG4591 M  CytoplasmicMembrane 
2263265..2264515 
[-]    1.43E-06 1.96 
ape1308 
APL_1211 
   hypothetical protein     
1393801..1394637 
[+]    5.59E-09 1.96 
groES 
APL_1013 
   10 kDa chaperonin COG0234 O  Cytoplasmic 
1179740..1180030 
[-]    1.29E-03 1.96 
cpxB   
APL_1584 
   
capsule polysaccharide export inner-membrane 
protein COG1682 GM  CytoplasmicMembrane 
1811593..1812390 
[+]    6.34E-06 1.96 
ape1017 
APL_0937 
   hypothetical protein    Cytoplasmic 
1079048..1079590 
[-]    3.32E-05 1.96 
ilvC 
APL_1853 
   Ketol-acid reductoisomerase COG0059 EH 1.1.1.86  
2084660..2086141 
[-]    7.98E-08 1.95 
ape1381 
APL_1281 
   hypothetical protein COG2166 R   
1472393..1472785 
[+]    4.65E-05 1.95 
ompP4   
APL_0389 
   lipoprotein E precursor COG2503 R   
442506..443321 [-] 
   4.89E-06 1.94 
ape1041 
APL_0959 
   hemagglutinin/hemolysin-like protein COG3210 U  OuterMembrane 
1104021..1111811 
[-]    6.92E-13 1.94 
ape0840 
APL_0780 
   hypothetical protein COG1380 R  CytoplasmicMembrane 
896661..897020 [-] 
   1.74E-05 1.94 
tyrA 
APL_0184 
   T-protein COG0287 E 
5.4.99.5 
1.3.1.12 Cytoplasmic 
203301..204422 [-] 
   1.83E-05 1.93 
smpA 
APL_0428 
   small protein A COG2913 J   
485468..485812 [-] 
   3.07E-06 1.93 
ape1984 
APL_1855 
   hypothetical protein COG1305 E   
2087796..2088896 
[+] 1.52E-04 1.93 
ape0907 
APL_0838 
   
hypothetical ABC transporter ATP-binding 
protein COG1131 V  CytoplasmicMembrane 
970713..973454 [+] 
   1.85E-06 1.93 
ape0909 
APL_0840 
   predicted outer membrane protein COG1538 MU  OuterMembrane 
974597..975991 [+] 
   2.56E-05 1.92 
ape0072 
APL_0070 
   hypothetical protein     83031..83663 [-]    6.48E-09 1.92 
hisF   
APL_2027 
   
Imidazole glycerol phosphate synthase subunit 
hisF COG0107 E 4.1.3.- Cytoplasmic 
2254771..2255403 
[+]    1.58E-07 1.91 
ape1186 
APL_1096 
   hypothetical protein COG3525 G  Periplasmic 
1267582..1268715 
[+]    3.17E-04 1.91 
ape2091 
APL_1957 
   Lipoprotein_5 domain containing protein     
2185963..2187207 
[-]    3.87E-06 1.91 
argS 
APL_0039 
   arginyl-tRNA synthetase COG0018 J  Cytoplasmic 42435..44081 [+] 1.71E-04 1.89 
ape1999 
APL_1870 
   hypothetical protein COG3087 D  CytoplasmicMembrane 
2099777..2100700 
[-]    1.33E-06 1.89 
recX   
APL_1142 
   regulatory protein RecX COG2137 R   
1318240..1318695 
[-]    3.70E-05 1.89 
ape0214 
APL_0204 
   putative threonine efflux protein COG1280 E  CytoplasmicMembrane 
222804..223430 [+] 
   9.20E-05 1.89 
ap2140 
APL_2003 
   Hypothetical protein COG0561 R   
2228336..2229145 
[-]    5.68E-06 1.89 
ape1057 
APL_0974 
   hypothetical protein     
1127670..1128104 
[+]    1.93E-04 1.88 
secA 
APL_0239 
   preprotein translocase secA subunit COG0653 U  Cytoplasmic 
255285..258002 [+] 
   1.33E-03 1.88 
ape0863 
APL_0799 
   hypothetical protein    Cytoplasmic 
921300..921911 [+] 
   2.95E-04 1.87 
hofQ    
APL_0200 
   type II secretory pathway, component HofQ COG4796 U  OuterMembrane 
219442..220740 [+] 
   8.06E-06 1.87 
ape1231 
APL_1140 
   hypothetical protein COG0009 J  Cytoplasmic 
1316862..1317416 
[-]    4.48E-04 1.86 
pflB   
APL_1036 
   formate acetyltransferase COG1882 C 2.3.1.54 Cytoplasmic 
1202932..1205244 
[-]    6.11E-07 1.86 
recO 
APL_0545 
   DNA repair protein RecO COG1381 L   
615674..616396 [+] 
   2.74E-08 1.86 
ksgA    
APL_0399 
   dimethyladenosine transferase COG0030 J 2.1.1.- Cytoplasmic 453463..454332 [-] 4.05E-03 1.86 
hybE    
APL_1336 
   hydrogenase-2 operon protein HybE     
1533279..1533782 
[+]    9.59E-08 1.85 
ape1188 
APL_1098 
   
putative 6-pyruvoyl tetrahydrobiopterin 
synthase COG0720 H 4.2.3.12 Cytoplasmic 
1269524..1269946 
[+]    1.09E-06 1.85 
ape0224 
APL_0214 
   hypothetical protein COG1518 L  CytoplasmicMembrane 
234640..235596 [-] 
   2.57E-05 1.85 
ape0505 
APL_0471 
   hypothetical protein     
542535..542828 [-] 
   3.22E-05 1.84 
ape1919 
APL_1791 
   
putative periplasmic iron/siderophore binding 
protein COG0614 P   
2014341..2015456 
[+]    4.68E-03 1.84 
ape1625 
APL_1515 
   hypothetical protein COG3088 O   
1731549..1732016 
[+]    1.21E-05 1.83 
trkA 
APL_1559 
   Trk system potassium uptake protein TrkA COG0569 P   
1782709..1784085 
[-]    2.95E-04 1.82 
ape1228 
APL_1138 
   hypothetical protein    Cytoplasmic 
1314969..1315220 
[-]    3.53E-06 1.82 
cysE 
APL_1511 
   serine acetyltransferase COG1045 E 2.3.1.30 Cytoplasmic 
1726968..1727783 
[+]    7.19E-06 1.81 
ape2166 
APL_2029 
   Hypothetical protein COG1738   CytoplasmicMembrane 
2256297..2256962 
[+]    4.57E-05 1.80 
ribF    
APL_0045 
   riboflavin biosynthesis protein COG0196 H 
2.7.1.26 
2.7.7.2 Cytoplasmic 51401..52363 [-]    5.32E-05 1.79 
fhuC 
APL_2013 
   Ferrichrome transport ATP-binding protein fhuC COG1120 PH 3.6.3.34 Cytoplasmic 
2238869..2239549 
[+]    1.39E-04 1.79 
pepO   
APL_1913 
   neutral endopeptidase COG3590 O 3.4.24.- Cytoplasmic 
2146964..2148991 
[+]    8.60E-07 1.79 
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ispA 
APL_0807 
   geranyltranstransferase COG0142 H 2.5.1.10 Cytoplasmic 
929306..930199 [+] 
   1.50E-04 1.79 
moeB 
APL_0311 
   molybdopterin biosynthesis protein MoeB COG0476 H  Cytoplasmic 
345389..346135 [+] 
   8.11E-07 1.78 
folK 
APL_0177 
   
2-amino-4-hydroxy-6-
hydroxymethyldihydropteridine 
pyrophosphokinase COG0801 H 2.7.6.3  
195781..196251 [+] 
   2.27E-03 1.78 
slmA 
APL_1967 
   HTH-type protein slmA COG1309 K   
2195478..2196086 
[-]    1.79E-05 1.78 
ape0752 
APL_0697 
   putative HTH-type transcriptional regulator COG0583 K  Cytoplasmic 
798742..799638 [+] 
   1.15E-09 1.78 
ape0271 
   
APL_0258 
   hypothetical protein    Cytoplasmic 
288590..288886 [-] 
   1.21E-05 1.78 
ape0247 
APL_0236 
   putative lipoprotein COG3015 MP   
254045..254419 [-] 
   1.90E-04 1.77 
ape1161 
APL_1072 
   Maf-like protein COG0424 D  Cytoplasmic 
1240429..1241019 
[-]    8.08E-06 1.77 
ape0841 
APL_0781 
   putative ATP-dependent helicase COG1199 KL 3.6.1.-  
897087..899009 [-] 
   2.77E-06 1.77 
ape0362 
APL_0342 
   hypothetical protein     
378173..378733 [-] 
   4.96E-05 1.76 
phoB 
APL_1257 
   
phosphate regulon transcriptional regulatory 
protein PhoB COG0745 TK  Cytoplasmic 
1446864..1447505 
[-]    7.68E-07 1.76 
fdhE   
APL_0896 
   formate dehydrogenase accessory protein COG3058 O   
1038255..1039172 
[+]    2.68E-04 1.76 
ape0721 
   
APL_0669 
   putative iron dependent peroxidase COG2837 P   
763924..765114 [+] 
   7.61E-04 1.76 
hybG 
APL_1337 
   hydrogenase-2 operon protein HybG COG0298 O  Cytoplasmic 
1533810..1534088 
[+]    4.14E-04 1.75 
ape0325 
APL_0308 
   hypothetical membrane protein    CytoplasmicMembrane 
340397..341443 [+] 
  1.15E-04 1.75 
yfeD 
APL_0127 
   
putative iron transport system membrane 
protein COG1108 P  CytoplasmicMembrane 
142799..143629 [-] 
   3.98E-08 1.75 
ape1706 
APL_1591 
   hypothetical protein COG4635 CH   
1819377..1819904 
[+]    2.09E-04 1.75 
ape1310 
APL_1213 
   hypothetical protein COG0637 R  Cytoplasmic 
1395762..1396412 
[-]    1.35E-03 1.74 
ape0932 
   
APL_0863 
   hypothetical protein     
1003441..1003605 
[+]    5.78E-04 1.74 
ape0030 
   
APL_0028 
   ABC transporter permease protein COG0601 EP  CytoplasmicMembrane 32792..33739 [-]    3.87E-04 1.73 
ape1884 
APL_1758 
   possible DNA transformation protein COG3070 K  Cytoplasmic 
1995709..1996365 
[-]    1.41E-04 1.72 
znuC 
APL_0456 
   
high-affinity zinc uptake system ATP-binding 
protein ZnuC COG1121 P  Cytoplasmic 
526962..527762 [-] 
   7.63E-04 1.72 
ape1998 
APL_1869 
   hypothetical protein    Cytoplasmic 
2098821..2099300 
[-]    6.07E-07 1.72 
dxr    
APL_0406 
   
1-deoxy-D-xylulose 5-phosphate 
reductoisomerase COG0743 I 1.1.1.267 Cytoplasmic 
463075..464265 [+] 
   6.52E-07 1.71 
dtd 
APL_1949 
   D-tyrosyl-tRNA(Tyr) deacylase COG1490 J 3.1.-.-  
2179788..2180222 
[-]    2.59E-06 1.71 
ape0933 
APL_0864 
   hypothetical protein     
1003602..1004054 
[+]    1.85E-05 1.71 
ape0676 
  
APL_0625 
   hypothetical protein    Cytoplasmic 
712379..713152 [-] 
   3.11E-10 1.71 
prfA   
APL_2044 
   Peptide chain release factor 1 (RF-1) COG0216 J  Cytoplasmic 
2270835..2271836 
[-]    8.06E-05 1.70 
ape1957 
APL_1829 
   hypothetical protein    Cytoplasmic 
2052185..2052472 
[-]    3.92E-06 1.70 
ape1686 
APL_1572 
   hypothetical protein     
1799696..1799944 
[-]    9.13E-05 1.69 
recD    
APL_0253 
   exodeoxyribonuclease V alpha chain COG0507 L 3.1.11.5  
276157..278094 [+] 
   1.77E-07 1.69 
selB    
APL_1561 
   selenocysteine-specific elongation factor COG3276 J  Cytoplasmic 
1785447..1787282 
[-]    6.57E-05 1.69 
serB 
APL_1230 
   phosphoserine phosphatase COG0560 E 3.1.3.3  
1410957..1411817 
[+]    3.03E-06 1.68 
ape1542 
   
APL_1435 
   hypothetical protein    CytoplasmicMembrane 
1639673..1640185 
[-]    1.52E-07 1.68 
ape1795 
APL_1678 
   putative ferredoxin COG1145 C   
1904636..1905145 
[+]    1.89E-02 1.68 
ape0470 
APL_0440 
   hypothetical protein COG0121 R  Cytoplasmic 
496824..497621 [+] 
   2.78E-04 1.68 
ape1332 
APL_1234 
   hypothetical protein    Periplasmic 
1418016..1418900 
[-]    2.05E-06 1.67 
ape0908 
APL_0839 
   predicted inner membrane transport permease COG0842 V  CytoplasmicMembrane 
973456..974580 [+] 
   8.89E-06 1.67 
trxA 
APL_1078 
   thioredoxin COG0526 OC  Cytoplasmic 
1247188..1247505 
[-]    3.16E-04 1.67 
glnB 
APL_1518 
   nitrogen regulatory protein P-II COG0347 E  Cytoplasmic 
1733706..1734044 
[+]    2.84E-06 1.67 
mscS 
APL_1880 
   Small-conductance mechanosensitive channel COG0668 M  CytoplasmicMembrane 
2109487..2110398 
[+]    3.53E-09 1.67 
ape0772 
APL_0715 
   ABC transport system permease protein COG4606 P  CytoplasmicMembrane 
825251..826198 [+] 
   6.56E-05 1.66 
rumA 
APL_1112 
   23S rRNA (uracil-5-)-methyltransferase RumB COG2265 J 2.1.1.-  
1289023..1290198 
[+]    2.27E-06 1.66 
lspA 
APL_1519 
   lipoprotein signal peptidase COG0597 MU 3.4.23.36 CytoplasmicMembrane 
1734123..1734605 
[+]    2.06E-05 1.66 
ape1824 
APL_1705 
   FKBP-type peptidyl-prolyl cis-trans isomerase COG0545 O 5.2.1.8 OuterMembrane 
1937132..1937761 
[-]    3.35E-03 1.65 
ape0208 
APL_0198 
   hypothetical protein    Cytoplasmic 
218506..219033 [+] 
   1.41E-02 1.65 
tdk 
APL_0622 
   thymidine kinase COG1435 F 2.7.1.21 Cytoplasmic 
710274..710855 [-] 
   1.49E-02 1.64 
ape0245 
APL_0234 
   putative lipoprotein COG3056 M   
252622..253212 [-] 
   2.00E-04 1.64 
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accD 
APL_0631 
   
acetyl-coenzyme A carboxylase carboxyl 
transferase subunit beta COG0777 I 6.4.1.2  
718567..719460 [+] 
   1.08E-04 1.64 
cdd   
APL_1343 
   cytidine deaminase COG0295 F 3.5.4.5  
1542869..1543762 
[+]    9.71E-07 1.64 
ape0978 
APL_0905 
   hypothetical protein     
1047346..1047684 
[-]    8.00E-05 1.63 
ape0152 
APL_0144 
   
predicted ATP-dependent endonuclease of the 
OLD family COG3593 L  Cytoplasmic 
159936..161495 [-] 
   2.21E-09 1.63 
ape1776 
APL_1659 
   hypothetical protein     
1886037..1886414 
[-]    1.54E-05 1.63 
ape1863 
APL_1738 
   lactoylglutathione lyase and related lyases COG0346 E 4.4.1.5 Cytoplasmic 
1973932..1974324 
[-]    7.05E-06 1.63 
yfeC   
APL_0128 
   
putative iron transport system membrane 
protein COG1108 P  CytoplasmicMembrane 
143622..144476 [-] 
   3.43E-09 1.63 
D15    
APL_0411 
   protective surface antigen D15 precursor COG4775 M  OuterMembrane 
467627..470008 [-] 
   3.12E-06 1.63 
trpCF 
APL_0859 
   
tryptophan biosynthesis protein trpCF [Includes: 
Indole-3-glycerol phosphate synthase; N-(5'-
phospho-ribosyl)anthranilate isomerase] COG0134 E 
4.1.1.48 
5.3.1.24  
1000124..1001533 
[-]    6.54E-07 1.63 
macB   
APL_0626 
   
putative macrolide-specific ABC-type efflux 
carrier COG0577 V  CytoplasmicMembrane 
713244..715166 [-] 
   4.02E-06 1.62 
thiP 
APL_1321 
   
thiamine transport system permease protein 
ThiP COG1178 P  CytoplasmicMembrane 
1513393..1515018 
[-]    1.44E-04 1.62 
ape1369 
   
APL_1269 
   putative ribonuclease COG3719 J   
1458764..1459531 
[+]    1.27E-03 1.62 
ape0771 
APL_0714 
   ABC transport system periplasmic protein COG4607 P  Periplasmic 
824256..825164 [+] 
   5.23E-06 1.62 
xylA   
APL_1908 
   Xylose isomerase COG2115 G 5.3.1.5 Cytoplasmic 
2140373..2141692 
[-]    1.81E-03 1.62 
pepQ 
APL_0091 
   Xaa-Pro dipeptidase COG0006 E 3.4.13.9  97683..99014 [-]   8.92E-06 1.62 
ape0457 
APL_0429 
   nucleoid-associated protein NdpA COG3081 R  Cytoplasmic 485883..486884 [-] 1.22E-08 1.62 
ape1815 
APL_1697 
   hypothetical protein    OuterMembrane 
1928704..1929798 
[-]    3.01E-04 1.61 
ape0906 
  
APL_0837 
   hypothetical protein COG0845 M  OuterMembrane 
969648..970709 [+] 
   8.55E-03 1.61 
ape0029 
APL_0027 
   nickel transport system permease protein COG1173 EP  CytoplasmicMembrane 32004..32789 [-]    1.10E-04 1.61 
hslO 
APL_1315 
   heat shock-like protein 33 COG1281 O  Cytoplasmic 
1505774..1506664 
[+]    1.09E-03 1.60 
moaE   
APL_0693 
   molybdopterin-converting factor subunit 2 COG0314 H   
793098..793553 [+] 
   4.55E-05 1.60 
alaS 
APL_0654 
   alanyl-tRNA synthetase COG0013 J 6.1.1.7 Cytoplasmic 
747203..749827 [-] 
   4.18E-06 1.60 
aroF 
APL_0185 
   
phospho-2-dehydro-3-deoxyheptonate 
aldolase, Tyr-sensitive COG0722 E 2.5.1.54  
204535..205596 [-] 
   2.97E-05 1.59 
ape0846 
   
APL_0784 
   hypothetical protein     
903161..903979 [-] 
   6.70E-08 1.59 
ptsH 
APL_1322 
   PTS system phosphocarrier protein HPr COG1925 G  Cytoplasmic 
1515255..1515512 
[+]    8.03E-03 1.59 
truC 
APL_0862 
   tRNA pseudouridine synthase C COG0564 J 5.4.99.12 Cytoplasmic 
1002696..1003439 
[+]    1.51E-06 1.59 
proQ 
APL_0119 
   proQ-like protein COG3109 T   
135550..136098 [+] 
   7.13E-04 1.59 
ape1679 
APL_1565 
   putative gluconolactonase COG3386 G 3.1.1.17  
1791594..1792037 
[-]    1.94E-02 1.59 
ape1870 
APL_1745 
   hypothetical protein COG3636 K  Cytoplasmic 
1982555..1982863 
[-]    7.73E-05 1.59 
psiE   
APL_0069 
   phosphate-starvation-inducible protein PsiE    CytoplasmicMembrane 82543..82953 [-]    8.75E-06 1.58 
ape0209 
APL_0199 
   hypothetical protein     
219026..219430 [+] 
   1.06E-02 1.57 
ape0124 
APL_0116 
   133224..133808 [+]        
133224..133808 [+] 
   2.33E-10 1.57 
ape1775 
  
APL_1658 
   hypothetical protein     
1885558..1886034 
[-]    5.43E-05 1.57 
ape0256 
   
APL_0245 
   
transferrin binding protein-like solute binding 
protein    OuterMembrane 
263186..264895 [+] 
   4.07E-06 1.57 
ape0543 
APL_0501 
   possible DNA methylase     
570693..571217 [+] 
   4.92E-03 1.56 
yecO 
APL_0754 
   
S-adenosyl-L-methionine-dependent 
methyltransferase COG0500 QR  Cytoplasmic 
864217..864942 [+] 
   8.83E-05 1.56 
fic   
APL_0860 
   filamentation induced by cAMP protein Fic-like    Cytoplasmic 
1001711..1002376 
[+]    4.64E-04 1.56 
rec2 
APL_0766 
   recombination protein 2 COG0658 R  CytoplasmicMembrane 
875330..877624 [-] 
   2.68E-05 1.56 
mtn    
APL_1637 
   MTA/SAH nucleosidase COG0775 F 
3.2.2.16 
3.2.2.9  
1863055..1863753 
[-]    9.04E-03 1.56 
ape2034 
   
APL_1903 
   hypothetical protein COG2819 R   
2133195..2134019 
[+]    1.71E-08 1.55 
rnb    
APL_0757 
   exoribonuclease 2 COG4776 K 3.1.13.1 Cytoplasmic 
866787..868763 [+] 
   4.08E-03 1.55 
dcd 
APL_0835 
   deoxycytidine triphosphate deaminase COG0717 F 3.5.4.13 Cytoplasmic 
968300..968884 [+] 
   8.12E-03 1.55 
ape2052 
APL_1920 
   site-specific recombinase COG4389 L  CytoplasmicMembrane 
2153314..2155281 
[+]    7.45E-06 1.55 
ape1648 
APL_1536 
   N-acetylmuramic acid 6-phosphate etherase COG2103 R   
1750596..1751510 
[+]    8.55E-05 1.55 
murC   
APL_0019 
   UDP-N-acetylmuramate--L-alanine ligase COG0773 M 6.3.2.8 Cytoplasmic 21880..23307 [+]    1.37E-04 1.55 
ape0028 
APL_0026 
   ABC transporter ATP-binding protein COG1123 R  CytoplasmicMembrane 30601..32004 [-]    6.12E-05 1.54 
moeA 
APL_0310 
   molybdopterin biosynthesis protein MoeA COG0303 H   
344138..345379 [+] 
   1.99E-06 1.54 
xseA 
APL_0817 
   putative exodeoxyribonuclease VII large subunit COG1570 L 3.1.11.6  
943691..945151 [+] 
   2.47E-05 1.53 
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aroE 
APL_1139 
   shikimate dehydrogenase COG0169 E 1.1.1.25 Cytoplasmic 
1316034..1316855 
[-]    1.44E-07 1.53 
recG 
APL_1827 
   ATP-dependent DNA helicase recG COG1200 LK 3.6.1.-  
2049552..2051633 
[-]    5.60E-07 1.52 
ape1825 
APL_1706 
   hypothetical protein    CytoplasmicMembrane 
1938143..1938826 
[+]   2.92E-05 1.52 
ape0960 
APL_0889 
   hypothetical protein     
1029866..1031281 
[+]    2.87E-05 1.52 
kdkA   
APL_0904 
   3-deoxy-D-manno-octulosonic acid kinase COG0515 RTKL 2.7.1.- Cytoplasmic 
1046562..1047266 
[+]    3.16E-08 1.52 
dcuB2 
APL_1316 
   anaerobic C4-dicarboxylate transporter DcuB COG2704 R  CytoplasmicMembrane 
1506732..1508066 
[-]    1.13E-04 1.51 
djlA 
APL_0306 
   DnaJ-like protein DjlA COG1076 O  Cytoplasmic 
338438..339298 [+] 
   1.67E-05 1.51 
ape1857 
APL_1732 
   hypothetical protein COG3059   CytoplasmicMembrane 
1968640..1969056 
[-]    5.58E-05 1.51 
scrR   
APL_2032 
   
Sucrose operon repressor (Scr operon 
regulatory protein) COG1609 K  Cytoplasmic 
2258469..2259488 
[-]    1.19E-04 1.51 
flp1 
APL_0559 
   fimbrial protein Flp precursor COG3847 U   
627628..627858 [-] 
   4.55E-04 1.50 
ape0283 
APL_0270 
   hypothetical protein     
298665..299156 [+] 
   4.72E-04 1.50 
apxIB 
APL_1443 
   toxin RTX-I translocation ATP-binding protein COG2274 V  CytoplasmicMembrane 
1650723..1652846 
[-]   6.76E-03 1.50 
ruvB   
APL_0284 
   
holliday junction ATP-dependent DNA helicase 
RuvB COG2255 L  Cytoplasmic 
313779..314663 [+] 
   2.31E-07 1.50 
ape0444 
APL_0418 
   hypothetical protein COG1534 J   
475651..476052 [-] 
   7.22E-03 1.50 
ape1307 
APL_1210 
   hypothetical protein COG1670 J   
1393091..1393801 
[+]    8.83E-03 1.50 
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gene locus_tag gene product COG # COG EC # psorb_loc location T-test ratio 
sodA 
APL_0251 
   manganese superoxide dismutase COG0605 P 1.15.1.1 Cytoplasmic 274183..274824 [+]    9.47E-07 -5.37 
ape0688 
APL_0637 
   hypothetical protein    Cytoplasmic 728268..728729 [+]    1.27E-05 -5.32 
ptnD 
APL_1393 
   mannose permease IID component COG3716 G  CytoplasmicMembrane 
1594164..1595000 
[+]    7.08E-13 -5.19 
ape1496 
APL_1391 
   
PTS system mannose-specific EIIAB 
component [Includes: Mannose-specific 
phosphotransferase enzyme IIA component; 
Mannose-specific phosphotransferase enzyme 
IIB component] COG3444 G 2.7.1.69 Cytoplasmic 
1592366..1593337 
[+]    3.32E-06 -5.04 
glmS   
APL_1631 
   
Glucosamine--fructose-6-phosphate 
aminotransferase [isomerizing] COG0449 M 2.6.1.16 Cytoplasmic 
1855480..1857312 [-] 
   1.21E-05 -4.89 
ptnC 
APL_1392 
   mannose permease IIC component COG3715 G  CytoplasmicMembrane 
1593350..1594150 
[+]    2.23E-05 -4.45 
pryE 
APL_0318 
   orotate phosphoribosyltransferase COG0461 F 2.4.2.10  354902..355543 [+]    5.05E-06 -4.33 
nrdA 
APL_0992 
   
ribonucleoside-diphosphate reductase alpha 
subunit COG0209 F 1.17.4.1 OuterMembrane 
1145469..1147739 
[+]    2.40E-05 -4.16 
ape1747 
APL_1632 
   
predicted transcriptional regulator of sugar 
metabolism COG1349 KG  Cytoplasmic 
1857436..1858194 [-] 
   2.35E-06 -4.12 
ape2067 
  
APL_1934 
   hypothetical protein COG0700   CytoplasmicMembrane 
2169338..2169802 [-] 
   1.20E-05 -3.98 
apfC 
APL_0878 
   fimbrial biogenesis protein COG1459 NU  CytoplasmicMembrane 
1018037..1019239 [-] 
   2.74E-05 -3.86 
ape1478 
  
APL_1373 
   hypothetical protein COG0593 L  Cytoplasmic 
1569626..1570336 [-] 
   5.07E-07 -3.77 
ape0338 
APL_0319 
   hypothetical protein COG0620 E  Cytoplasmic 355682..356770 [+]    1.75E-06 -3.59 
dhaL 
APL_0082 
   
PTS-dependent dihydroxyacetone kinase, ADP-
binding subunit DhaL COG2376 G 2.7.1.-  90557..91183 [-]    6.06E-10 -3.59 
dhaK 
APL_0083 
   
PTS-dependent dihydroxyacetone kinase, 
dihydroxyacetone-binding subunit DhaK COG2376 G 2.7.1.-  91185..92255 [-]    5.95E-06 -3.48 
ihfB 
APL_0739 
   integration host factor beta-subunit COG0776 L   844554..844835 [-]    9.89E-06 -3.43 
ape2068 
APL_1935 
   hypothetical protein    CytoplasmicMembrane 
2169799..2170224 [-] 
   1.68E-05 -3.34 
fruK 
APL_0344 
   1-phosphofructokinase COG1105 G 2.7.1.56 Cytoplasmic 380652..381599 [-]    1.02E-08 -3.33 
ape2066 
  
APL_1933 
   
acetylornithine deacetylase/succinyl-
diaminopimelate desuccinylase and related 
deacylases COG0624 E  Cytoplasmic 
2168701..2169324 [-] 
   4.37E-09 -3.32 
ape0172 
APL_0163 
   
anaerobic ribonucleoside triphosphate 
reductase COG1328 F   180719..182578 [-]    3.20E-05 -3.27 
metC    
APL_0320 
   cystathionine beta-lyase COG0626 E 4.4.1.8  356847..358037 [-]    1.07E-05 -3.22 
ulaG 
APL_1701 
   L-ascorbate-6-phosphate lactonase UlaG-like COG2220 R  Cytoplasmic 
1933388..1934479 
[+]    1.50E-06 -3.17 
pyrD 
APL_0774 
   dihydroorotate dehydrogenase COG0167 F 1.3.3.1 Cytoplasmic 890441..891448 [-]    1.49E-08 -3.16 
ape0917 
APL_0848 
   
putative ABC transporter periplasmic binding 
protein COG0747 E  CytoplasmicMembrane 983413..984987 [+]    3.52E-05 -3.09 
afuA 
APL_1446 
   
ABC-type Fe3+ transport system, periplasmic 
component COG1840 P  Periplasmic 
1656814..1657854 
[+]    7.34E-06 -3.08 
ansB 
APL_0135 
   probable L-asparaginase periplasmic precursor COG0252 EJ 3.5.1.1 Periplasmic 149916..150965 [-]    3.68E-10 -3.07 
ape1770 
APL_1653 
   hypothetical protein COG3312 C  CytoplasmicMembrane 
1879898..1880281 [-] 
   2.16E-07 -3.07 
aceE    
APL_0773 
   pyruvate dehydrogenase E1 component COG2609 C 1.2.4.1  887432..890086 [-]    7.10E-08 -3.05 
fbp    
APL_1450 
   fructose-1,6-bisphosphatase COG0158 G 3.1.3.11  
1662693..1663697 
[+]    1.72E-13 -3.04 
ape0574 
   
APL_0528 
   putative transporter COG1115 E  CytoplasmicMembrane 601844..603292 [+]    1.22E-06 -3.01 
afuB    
APL_1447 
   Ferric transport system permease protein fbpB COG1178 P  CytoplasmicMembrane 
1657959..1660022 
[+]    1.72E-06 -3.01 
fruB    
APL_0345 
   
multiphosphoryl transfer protein (Includes: 
Phosphocarrier protein HPr; PTS system 
fructose-specific EIIA component) COG4668 G 2.7.1.69 Cytoplasmic 381614..383122 [-]    1.38E-07 -2.97 
lpdA 
APL_0771 
   dihydrolipoyl dehydrogenase COG1249 C 1.8.1.4 Cytoplasmic 883954..885378 [-]    2.22E-08 -2.96 
ribD 
APL_0382 
   
riboflavin biosynthesis protein (Includes: 
Diaminohydroxyphosphoribosylaminopyrimidine 
deaminase; 5-amino-6-(5-
phosphoribosylamino)uracil reductase) COG1985 H 
1.1.1.193 
3.5.4.26 Cytoplasmic 435609..436841 [+]    2.69E-06 -2.96 
ape0778 
  
APL_0719 
   putative phosphate permease COG0306 P  CytoplasmicMembrane 828778..830040 [+]    2.51E-06 -2.94 
ape0777 
APL_0718 
   hypothetical protein COG1392 P  Cytoplasmic 828088..828768 [+]    3.95E-07 -2.92 
fruA 
APL_0343 
   
PTS system fructose-specific EIIBC component 
(Includes: Fructose-specific 
phosphotransferase enzyme IIB component; 
Fructose permease IIC component) COG1299 G  CytoplasmicMembrane 378909..380570 [-]    4.52E-06 -2.92 
putA 
APL_0106 
   
bifunctional protein PutA [Includes: Proline 
dehydrogenase; Delta-1-pyrroline-5-carboxylate 
dehydrogenase] COG4230 C 
1.5.1.12 
1.5.99.8 Cytoplasmic 121566..125171 [-]    1.29E-09 -2.86 
rpsA    
APL_0740 
   30S ribosomal protein S1 COG0539 J  Cytoplasmic 844909..846573 [-]    4.73E-04 -2.85 
ape1042 
APL_0960 
   putative hemolysin activation/secretion protein COG2831 U  OuterMembrane 
1111859..1112911 [-] 
  1.30E-06 -2.84 
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afuC 
APL_1448 
   ferric ABC transporter ATP-binding protein COG3842 E 3.6.3.30  
1660069..1661115 
[+]    3.18E-07 -2.83 
rpe 
APL_1820 
   ribulose-phosphate 3-epimerase COG0036 G 5.1.3.1 Cytoplasmic 
2042459..2043133 [-] 
   4.01E-05 -2.81 
ape0940 
APL_0870 
   putative C4-dicarboxylate transporter COG3069 C  CytoplasmicMembrane 
1009886..1011178 [-] 
   1.66E-05 -2.79 
atpB 
APL_1652 
   ATP synthase A chain COG0356 C 3.6.3.14 CytoplasmicMembrane 
1879085..1879873 [-] 
   1.01E-06 -2.79 
ape0173 
APL_0164 
   hypothetical protein COG0602 O   182583..183050 [-]    5.35E-06 -2.79 
tktA    
APL_0983 
   transketolase 2 COG0021 G 2.2.1.1 Cytoplasmic 
1136203..1138209 
[+]    3.08E-05 -2.76 
rplS    
APL_1789 
   50S ribosomal protein L19 COG0335 J  Cytoplasmic 
2012412..2012762 
[+]    1.09E-10 -2.76 
tpiA 
APL_1925 
   Triosephosphate isomerase COG0149 G 5.3.1.1  
2161944..2162714 [-] 
   1.69E-06 -2.75 
gpt 
APL_0255 
   xanthine phosphoribosyltransferase COG0503 F 2.4.2.22 Cytoplasmic 285869..286342 [+]    1.21E-09 -2.75 
ape1523 
APL_1416 
   hypothetical protein     
1619045..1619386 
[+]    2.73E-05 -2.75 
pqiA 
APL_1854 
   hypothetical protein    CytoplasmicMembrane 
2086378..2087619 
[+]    1.10E-07 -2.72 
ape0573 
APL_0527 
   
predicted ABC-type transport system, 
permease component COG2215 R  CytoplasmicMembrane 600881..601744 [+]    2.61E-09 -2.72 
gmk 
APL_0256 
   guanylate kinase COG0194 F 2.7.4.8 Cytoplasmic 286426..287046 [+]    4.52E-06 -2.72 
trmD 
APL_1788 
   tRNA (guanine-N(1)-)-methyltransferase COG0336 J 2.1.1.31 Cytoplasmic 
2011631..2012386 
[+]    4.14E-07 -2.71 
atpF 
APL_1650 
   ATP synthase B chain COG0711 C 3.6.3.14  
1878182..1878652 [-] 
   2.29E-06 -2.68 
ape0233 
APL_0222 
   putative lipoprotein     244701..245360 [+]    1.70E-05 -2.67 
metR 
APL_1158 
   HTH-type transcriptional regulator MetR COG0583 K  Cytoplasmic 
1334889..1335818 
[+]    1.08E-06 -2.66 
betT 
APL_1209 
   putative choline-glycine betaine transporter COG1292 M  CytoplasmicMembrane 1390767..1392794 [ 7.25E-07 -2.65 
apfD 
APL_0877 
   fimbrial leader peptidase COG1989 NOU  CytoplasmicMembrane 
1017372..1018010 [-] 
   4.56E-05 -2.65 
atpE    
APL_1651 
   ATP synthase subunit C COG0636 C 3.6.3.14 CytoplasmicMembrane 
1878712..1878966 [-] 
   4.48E-13 -2.65 
ape0231 
APL_0220 
   putative lipoprotein COG1462 M   243658..244332 [+]    3.32E-07 -2.61 
atpH APL_1649 ATP synthase delta chain COG0712 C 3.6.3.14 Cytoplasmic 
1877635..1878168 [-] 
   4.52E-07 -2.60 
dhaM APL_0081 
PTS-dependent dihydroxyacetone kinase, 
phosphotransferase subunit DhaM    90141..90548 [-] 3.28E-06 -2.60 
ape1194 
APL_1104 
   hypothetical protein COG0795 R  CytoplasmicMembrane 
1276024..1277106 
[+]    7.19E-11 -2.56 
arcD APL_1083 putative arginine/ornithine antiporter COG0531 E  CytoplasmicMembrane 
1252962..1254368 
[+]    7.30E-10 -2.56 
gidB 
APL_1654 
   methyltransferase GidB COG0357 M 2.1.-.-  
1880642..1881259 [-] 
   2.10E-07 -2.56 
ape1320 
APL_1223 
   putative inner membrane protein COG2252 R  CytoplasmicMembrane 
1405767..1407062 
[+]    8.21E-08 -2.55 
rimM 
APL_1787 
   16S rRNA-processing protein rimM COG0806 J  Cytoplasmic 
2011046..2011573 
[+]    4.96E-05 -2.55 
deaD 
APL_0575 
   cold-shock DEAD box protein A-like COG0513 LKJ  Cytoplasmic 647423..649282 [-]    5.21E-07 -2.55 
aceF   
APL_0772 
   
dihydrolipoyllysine-residue acetyltransferase 
component of pyruvate dehydrogenase 
complex (E2) COG0508 C 2.3.1.12 Cytoplasmic 885474..887372 [-]    2.86E-06 -2.53 
purD    
APL_1172 
   phosphoribosylamine--glycine ligase COG0151 F 6.3.4.13  
1347552..1348838 
[+]    5.16E-06 -2.52 
ape0795 
APL_0735 
   hypothetical protein COG0023 J   841891..842202 [-] 2.27E-08 -2.52 
ape1075 
  
APL_0991 
   hypothetical protein COG1408 R  CytoplasmicMembrane 
1144177..1145256 
[+]    1.06E-14 -2.49 
aspA   
APL_1091 
   aspartate ammonia-lyase COG1027 E 4.3.1.1 Cytoplasmic 
1261854..1263278 [-] 
   3.02E-05 -2.47 
ape0827 
APL_0767 
   hypothetical symporter COG3633 E  CytoplasmicMembrane 877724..878938 [-]    4.23E-04 -2.46 
lpxK 
APL_1278 
   tetraacyldisaccharide 4'-kinase COG1663 M 2.7.1.130  
1469348..1470328 [-] 
   2.88E-08 -2.46 
pntB 
APL_0841 
   NAD(P) transhydrogenase subunit beta COG1282 C 1.6.1.2 CytoplasmicMembrane 976069..977517 [-]    6.06E-05 -2.45 
ape1499 
APL_1394 
   hypothetical protein    CytoplasmicMembrane 
1595099..1595557 
[+]    2.71E-08 -2.44 
ape2065 
APL_1932 
   putative carboxypeptidase COG0624 E  Cytoplasmic 
2168196..2168642 [-] 
   1.35E-06 -2.44 
mreB    
APL_0435 
   rod shape-determining protein MreB COG1077 D  Cytoplasmic 491720..492772 [+]    9.64E-07 -2.43 
adhC 
APL_1208 
   putative alcohol dehydrogenase class 3 COG1062 C 
1.1.1.1 
1.1.1.284 Cytoplasmic 
1389494..1390612 [-] 
   1.35E-08 -2.41 
priB 
APL_1170 
   primosomal replication protein n COG2965 L   
1346539..1346913 [-] 
   8.27E-10 -2.39 
ape0798 
  
APL_0738 
   hypothetical protein     844195..844485 [-]    3.36E-06 -2.39 
mreC   
APL_0436 
   rod shape-determining protein MreC COG1792 M   492889..493938 [+]    5.07E-07 -2.38 
ape0636 
APL_0585 
   hypothetical protein COG1309 K  Cytoplasmic 665452..666030 [+]    5.89E-06 -2.38 
ape0868 
   
APL_0804 
   hypothetical protein COG1368 M  CytoplasmicMembrane 926126..928102 [-]    1.83E-05 -2.36 
plsX 
APL_1385 
   fatty acid/phospholipid synthesis protein PlsX COG0416 I   
1585942..1586976 [-] 
   1.96E-08 -2.36 
ape1193 
APL_1103 
   hypothetical protein COG0795 R  CytoplasmicMembrane 
1274992..1276023 
[+]    1.71E-06 -2.35 
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ape0670 
APL_0619 
   hypothetical protein COG2321 R   706979..707842 [+]    4.72E-07 -2.34 
oadB 
APL_1377 
   oxaloacetate decarboxylase beta chain COG1883 C 4.1.1.3 CytoplasmicMembrane 
1579435..1580739 
[+]    4.07E-08 -2.33 
surE   
APL_1927 
   5'-nucleotidase surE COG0496 R 3.1.3.5 Cytoplasmic 
2164002..2164766 
[+]    8.17E-07 -2.32 
pepE 
APL_0871 
   peptidase E COG3340 E 3.4.13.21 Cytoplasmic 
1011189..1011893 [-] 
   5.23E-05 -2.32 
ape1221 
APL_1131 
   hypothetical protein COG3307 M  CytoplasmicMembrane 
1307881..1309230 
[+]    1.02E-08 -2.31 
atpC 
APL_1645 
   ATP synthase epsilon chain COG0355 C 3.6.3.14 Cytoplasmic 
1873346..1873765 [-] 
   5.69E-05 -2.30 
tldD 
APL_1540 
   TldD-like protein COG0312 R  Cytoplasmic 
1753394..1754854 [-] 
   1.95E-05 -2.30 
ape1218 
   APL_112 membrane protein COG0628 R  CytoplasmicMembrane 
1304670..1305722 [-] 
   3.22E-04 -2.30 
atpG   
APL_1647 
   ATP synthase gamma chain COG0224 C 3.6.3.14  
1875192..1876058 [-] 
   4.36E-06 -2.29 
ape0331 
APL_0313 
   
deoxyguanosinetriphosphate 
triphosphohydrolase-like protein COG0232 F 3.1.5.1 Cytoplasmic 347915..349240 [+]    5.78E-06 -2.29 
pnuC    
APL_1173 
   nicotinamide mononucleotide transporter COG3201 H  CytoplasmicMembrane 
1348930..1349622 [-] 
   4.75E-06 -2.29 
pntA 
APL_0842 
   NAD(P) transhydrogenase subunit alpha COG3288 C 1.6.1.2 CytoplasmicMembrane 977528..979066 [-]    2.91E-05 -2.28 
ape0662 
APL_0611 
   putative lipoprotein COG0791 M   697885..698409 [+]    1.27E-06 -2.28 
degS 
APL_0742 
   protease DegS precursor COG0265 O 3.4.21.- Periplasmic 847374..848405 [-]    1.72E-05 -2.28 
acpP 
APL_1819 
   acyl carrier protein COG0236 IQ  Cytoplasmic 
2041962..2042195 [-] 
   3.59E-09 -2.27 
ulaA   
APL_1700 
   
Predicted ascorbate-specific permease IIC 
component    CytoplasmicMembrane 
1931109..1932890 [-] 
   9.12E-07 -2.27 
oadA 
APL_1376 
   oxaloacetate decarboxylase alpha chain COG5016 C 4.1.1.3  
1577610..1579418 
[+]    3.97E-08 -2.26 
galK 
APL_0995 
   galactokinase COG0153 G 2.7.1.6 Cytoplasmic 
1150505..1151659 
[+]    5.38E-05 -2.25 
ape1414 
APL_1313 
   putative ADP compounds hydrolase COG0494 LR 3.6.1.- Cytoplasmic 
1504539..1505096 [-] 
   5.21E-09 -2.25 
ape2061 
APL_1929 
   lipoprotein COG0739 M   
2165362..2165937 
[+]    2.01E-06 -2.25 
smf 
APL_1712 
   Protein smf (DNA-processing chain A) COG0758 LU  Cytoplasmic 
1942973..1944127 
[+]    2.31E-08 -2.25 
nqrC 
APL_0152 
   
Na(+)-translocating NADH-quinone reductase 
subunit C COG2869 C 1.6.5.-  170675..171448 [+]    2.87E-09 -2.24 
rpmI 
APL_0224 
   50S ribosomal protein L35 COG0291 J   246366..246563 [+]    2.99E-05 -2.24 
mreD 
APL_0437 
   rod shape-determining protein MreD COG2891 M  CytoplasmicMembrane 493938..494426 [+]    1.04E-08 -2.23 
secG 
APL_0743 
   protein-export membrane protein COG1314 U  CytoplasmicMembrane 848654..848980 [-]    4.42E-06 -2.23 
ape0916 
APL_0847 
   
oxygen-independent coproporphyrinogen III 
oxidase-like protein COG0635 H 1.3.99.22 Cytoplasmic 981993..983150 [-]    1.86E-05 -2.23 
rpsJ 
APL_1759 
   30S ribosomal protein S10 COG0051 J   
1996773..1997084 
[+]    7.33E-05 -2.23 
ape1401 
APL_1300 
   hypothetical protein COG0477 GEPR  CytoplasmicMembrane 
1489613..1490893 [-] 
   1.08E-05 -2.22 
ftsJ 
APL_0594 
   
ribosomal RNA large subunit methyltransferase 
J COG0293 J 2.1.1.-  678772..679398 [+]    3.19E-07 -2.22 
rplI 
APL_1169 
   50S ribosomal protein L9 COG0359 J  Cytoplasmic 
1345870..1346319 [-] 
   1.35E-10 -2.21 
abgB 
APL_0869 
   aminobenzoyl-glutamate utilization-like protein COG1473 R  Cytoplasmic 
1008524..1009792 [-] 
   8.39E-06 -2.20 
ape1102 
APL_1017 
   hypothetical protein    CytoplasmicMembrane 
1183417..1184061 
[+]    2.67E-08 -2.20 
ape0779 
  
APL_0720 
   hypothetical protein COG3103 T   830104..830709 [+]    6.09E-10 -2.20 
kpsF 
APL_1576 
   arabinose-5-phosphate isomerase COG0794 M  Cytoplasmic 
1802526..1803461 [-] 
   7.74E-08 -2.18 
atpD   
APL_1646 
   ATP synthase subunit beta COG0055 C 3.6.3.14 Cytoplasmic 1873805..1875178 [-] 2.18E-10 -2.17 
rbsB 
APL_1672 
   D-ribose-binding periplasmic protein precursor COG1879 G  Periplasmic 
1898002..1898874 
[+]    1.51E-05 -2.17 
gidA 
APL_1655 
   
tRNA uridine 5-carboxymethylaminomethyl 
modification enzyme GidA COG0445 D   
1881359..1883251 [-] 
   5.25E-09 -2.16 
ape0786 
APL_0726 
   carbonic anhydrase COG0288 P 4.2.1.1 Cytoplasmic 834060..834776 [+]    5.76E-07 -2.16 
ape1492 
APL_1387 
   hypothetical protein COG1399 R  Cytoplasmic 
1587189..1587716 [-] 
   1.55E-09 -2.16 
norM 
APL_0369 
   putative multidrug resistance protein NorM COG0534 V  CytoplasmicMembrane 414627..416018 [+]    9.23E-06 -2.15 
cmkA 
APL_0741 
   cytidylate kinase COG0283 F 2.7.4.14 Cytoplasmic 846670..847344 [-]    8.71E-07 -2.14 
ape1319 
APL_1222 
   aspartate-semialdehyde dehydrogenase COG0136 E   
1404705..1405706 
[+]    5.14E-08 -2.14 
rplX 
APL_1770 
   50S ribosomal protein L24 COG0198 J  Cytoplasmic 
2002361..2002672 
[+]    8.94E-09 -2.13 
sbcB    
APL_0673 
   exodeoxyribonuclease I COG2925 L 3.1.11.1 Cytoplasmic 767214..768758 [-]    3.70E-07 -2.13 
ape1410 
   
APL_1309 
   putative permease COG0477 GEPR  CytoplasmicMembrane 
1499927..1501249 [-] 
   7.00E-07 -2.13 
tatC 
APL_1987 
   
Sec-independent protein translocase protein 
tatC COG0805 U  CytoplasmicMembrane 
2214043..2214615 
[+]    3.76E-11 -2.13 
fabI 
APL_0755 
   enoyl-[acyl-carrier-protein] reductase [NADH] COG0623 I 1.3.1.9 Cytoplasmic 865141..865929 [+]    4.79E-06 -2.13 
glpT 
APL_0377 
   glycerol-3-phosphate transporter COG2271 G  CytoplasmicMembrane 428217..429662 [-]    1.50E-08 -2.12 
pgl 
APL_1310 
   6-phosphogluconolactonase COG0363 G 3.1.1.31 Cytoplasmic 
1501382..1502080 [-] 
   4.04E-11 -2.12 
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mpl    
APL_1449 
   
UDP-N-acetylmuramate:L-alanyl-gamma-D-
glutamyl-meso-diaminopimelate ligase COG0773 M 6.3.2.-  
1661206..1662570 [-] 
   1.22E-09 -2.12 
hemC 
APL_1010 
   porphobilinogen deaminase COG0181 H 2.5.1.61 Cytoplasmic 
1174046..1174975 [-] 
   4.00E-05 -2.12 
ape0459 
   
APL_0431 
   hypothetical protein    Cytoplasmic 487394..488131 [+]   1.45E-05 -2.12 
rnfA 
APL_0165 
   electron transport complex protein RnfA COG4657 C  CytoplasmicMembrane 183432..184013 [+]    3.85E-07 -2.12 
ape1350 
APL_1252 
   hypothetical protein COG0471 P  CytoplasmicMembrane 
1438796..1440184 [-] 
   6.61E-05 -2.11 
dsbB   
APL_0321 
   disulfide bond formation protein B COG1495 O  CytoplasmicMembrane 358114..358653 [-]    1.61E-04 -2.11 
galM   
APL_0996 
   aldose 1-epimerase COG2017 G  Periplasmic 
1151717..1152685 
[+]    8.43E-06 -2.11 
tyrP-A    
APL_0596 
   tyrosine-specific transport protein 1 COG0814 E  CytoplasmicMembrane 681662..682876 [+]    7.09E-06 -2.11 
palA    
APL_0304 
   outer membrane protein precursor PalA COG2885 M  OuterMembrane 336904..337374 [+]    1.86E-07 -2.11 
nqrD 
APL_0153 
   
Na(+)-translocating NADH-quinone reductase 
subunit D COG1347 C 1.6.5.- CytoplasmicMembrane 171448..172071 [+]    3.56E-07 -2.10 
dnaE 
APL_1105 
   DNA polymerase III subunit alpha COG0587 L 2.7.7.7 Cytoplasmic 
1277313..1280789 
[+]    3.63E-07 -2.10 
ppx 
APL_0708 
   exopolyphosphatase COG0248 FP 3.6.1.11 Cytoplasmic 817862..819370 [-]    6.24E-07 -2.10 
ape1173 
APL_1084 
   hypothetical protein    CytoplasmicMembrane 
1254377..1255156 
[+]    4.88E-05 -2.09 
ape1346 
APL_1248 
   AzlC family protein COG1296 E  CytoplasmicMembrane APL_1248    6.93E-07 -2.09 
apxIIA 
APL_0956 
   RTX-II toxin determinant A    Extracellular 
1095621..1098488 [-] 
   4.87E-04 -2.09 
ape1651 
APL_1539 
   hypothetical protein    Cytoplasmic 
1753013..1753273 [-] 
   1.24E-07 -2.08 
nqrE 
APL_0154 
   
Na(+)-translocating NADH-quinone reductase 
subunit E COG2209 C 1.6.5.- CytoplasmicMembrane 172073..172669 [+]    2.58E-06 -2.08 
ampD 
APL_0316 
   signalling protein AmpD COG3023 V  Cytoplasmic 353304..353852 [-]    1.40E-06 -2.08 
rplO 
APL_1778 
   50S ribosomal protein L15 COG0200 J  Cytoplasmic 
2005599..2006033 
[+] 3.05E-08 -2.08 
ape1060 
APL_0976 
   hypothetical protein COG2056 R  CytoplasmicMembrane 
1129435..1130811 
[+]    1.91E-06 -2.08 
hbpA 
APL_2010 
   Heme-binding protein A COG0747 E  Periplasmic 
2234459..2236096 [-] 
   8.79E-06 -2.07 
acrB    
APL_0587 
   acriflavine resistance protein COG0841 V  CytoplasmicMembrane 667281..670400 [+]    6.80E-06 -2.07 
ape2120 
APL_1983 
   hypothetical protein    Cytoplasmic 
2210703..2211335 
[+]    1.04E-10 -2.07 
tatB 
APL_1986 
   
sec-independent protein translocase-like 
protein TatB COG1826 U   
2213292..2213879 
[+]    3.49E-06 -2.06 
galT 
APL_0994 
   galactose-1-phosphate uridylyltransferase COG1085 C 2.7.7.12  
1149428..1150477 
[+]    7.61E-04 -2.06 
guaB 
APL_0593 
   inosine-5'-monophosphate dehydrogenase COG0516 F 1.1.1.205 Cytoplasmic 677056..678519 [-]    2.12E-06 -2.05 
tnaB 
APL_1410 
   tTryptophan-specific transport protein COG0814 E  CytoplasmicMembrane 
1612209..1613411 
[+]    1.69E-04 -2.05 
ape1339 
APL_1241 
   hypothetical protein COG1966 T  CytoplasmicMembrane 
1427864..1429450 
[+]    4.66E-07 -2.05 
menF 
APL_1042 
   menaquinone-specific isochorismate synthase COG1169 HQ 5.4.4.2  
1209987..1211267 [-] 
   3.11E-06 -2.04 
priA 
APL_1032 
   primosomal protein N' COG1198 L   
1196311..1198527 [-] 
   8.55E-09 -2.04 
perM 
APL_0763 
   putative permease perM-like COG0628 R  CytoplasmicMembrane 872142..873203 [+]    5.99E-05 -2.04 
nusA 
APL_0638 
   transcription elongation protein NusA COG0195 K  Cytoplasmic 728746..730227 [+]    1.14E-03 -2.04 
rpsM 
APL_1781 
   30S ribosomal protein S13 COG0099 J  Cytoplasmic 
2007635..2007991 
[+]    4.50E-06 -2.04 
rplW    
APL_1762 
   50S ribosomal protein L23 COG0089 J   
1998351..1998656 
[+]    3.69E-04 -2.03 
ape1101 APL_1016 putative nucleoside transporter COG1972 F  CytoplasmicMembrane 
1181936..1183204 [-] 
   4.18E-07 -2.03 
rpsF 
APL_1171 
   30S ribosomal protein S6 COG0360 J  Cytoplasmic 
1346888..1347262 [-] 
   5.35E-08 -2.03 
tyrP-B 
APL_0597 
   tyrosine-specific transport protein 2 COG0814 E  CytoplasmicMembrane 682972..684189 [+]    3.87E-07 -2.03 
cydC   
APL_0826 
   transport ATP-binding protein CydC COG4987 CO  CytoplasmicMembrane 954450..956117 [-]    6.31E-06 -2.03 
glpA 
APL_0379 
   
anaerobic glycerol-3-phosphate dehydrogenase 
subunit A COG0578 C 1.1.99.5 Cytoplasmic 431205..432890 [+]    4.85E-04 -2.03 
ape0572 
APL_0526 
   hypothetical protein COG3683 R   600117..600758 [+]    1.31E-06 -2.02 
mltA 
APL_0816 
   
membrane-bound lytic murein transglycosylase 
A precursor COG2821 M 3.2.1.-  942188..943282 [-]    9.18E-06 -2.02 
ape1646 
APL_1534 
   putative transport system permease protein COG0477 GEPR  CytoplasmicMembrane 
1748274..1749338 [-] 
   3.24E-05 -2.02 
tgt 
APL_0723 
   queuine tRNA-ribosyltransferase COG0343 J 2.4.2.29  831585..832733 [-]    1.32E-09 -2.01 
ape2060 
APL_1928 
   Hypothetical protein    CytoplasmicMembrane 
2164766..2165350 
[+]    8.49E-04 -2.01 
ape1833 
   
APL_1713 
   hypothetical protein    CytoplasmicMembrane 
1944171..1946177 [-] 
   1.10E-06 -2.01 
truD 
APL_1926 
   tRNA pseudouridine synthase D    Cytoplasmic 
2162989..2164002 
[+]    4.94E-07 -2.01 
glpQ 
APL_0378 
   glycerophosphoryl diester phosphodiesterase COG0584 C 3.1.4.46  429865..430953 [-]    6.58E-06 -2.01 
rpsQ 
APL_1769 
   30S ribosomal protein S17 COG0186 J  Cytoplasmic 
2001485..2001739 
[+]    1.36E-05 -2.00 
ape1054 
APL_0971 
   putative acyl CoA thioester hydrolase COG1607 I 3.1.2.-  
1125743..1126234 [-] 
   1.07E-05 -2.00 
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dnaQ 
APL_1282 
   DNA polymerase III subunit epsilo COG0847 L 2.7.7.7 Cytoplasmic 
1473144..1473917 [-] 
  1.84E-07 -2.00 
ape1091 
  
APL_1006 
   hypothetical protein    CytoplasmicMembrane 
1169734..1170603 
[+]    4.41E-06 -1.99 
ape1321 
APL_1224 
   hypothetical protein COG1553 P   
1407172..1407522 
[+]    2.18E-09 -1.99 
secF 
APL_1068 
   protein-export membrane protein SecF COG0341 U  CytoplasmicMembrane 
1236707..1237681 
[+]    2.84E-09 -1.98 
glgP 
APL_0350 
   glycogen phosphorylase COG0058 G 2.4.1.1 Cytoplasmic 390609..393113 [+]    1.27E-08 -1.98 
rplC    
APL_1760 
   50S ribosomal protein L3 COG0087 J   
1997110..1997736 
[+]    1.77E-06 -1.98 
wecA 
APL_1554 
   
putative undecaprenyl-phosphate alpha-N-
acetylglucosaminyl 1-phosphate transferase COG0472 M 2.7.8.- CytoplasmicMembrane 
1776632..1777705 [-] 
   6.49E-10 -1.98 
cbiQ 
APL_1621 
   putative ABC transport permease protein CbiQ COG0619 P  CytoplasmicMembrane 
1845340..1845957 [-] 
   1.34E-05 -1.97 
ape0483 
APL_0449 
   putative integral membrane protein COG1757 C  CytoplasmicMembrane 516537..518054 [+]    5.85E-04 -1.97 
ispZ 
APL_0972 
   putative intracellular septation protein COG2917 D  CytoplasmicMembrane 
1126221..1126772 [-] 
   3.54E-07 -1.97 
ape0637 
APL_0586 
   putative RND efflux membrane fusion protein COG0845 M   666063..667268 [+]    2.46E-05 -1.97 
glgA 
APL_0349 
   glycogen synthase COG0297 G 2.4.1.21 Cytoplasmic 389143..390579 [+]    4.31E-10 -1.97 
ubiD 
APL_1439 
   3-octaprenyl-4-hydroxybenzoate carboxy-lyase COG0043 H 4.1.1.-  
1645551..1647014 [-] 
   4.98E-07 -1.97 
uraA 
APL_0105 
   putative uracil permease COG2233 F  CytoplasmicMembrane 120177..121406 [-]    4.17E-08 -1.96 
asnS 
APL_0675 
   asparaginyl-tRNA synthetase COG0017 J 6.1.1.22 Cytoplasmic 770614..772017 [+]    3.57E-05 -1.96 
cydD 
APL_0827 
   transport ATP-binding protein CydD COG4988 CO  CytoplasmicMembrane 956128..957870 [-]    4.78E-07 -1.96 
wecB 
APL_1552 
   UDP-N-acetylglucosamine 2-epimerase COG0381 M 5.1.3.14 Cytoplasmic 
1774599..1775678 [-] 
   4.27E-06 -1.96 
rpsK 
APL_1782 
   30S ribosomal protein S11 COG0100 J   
2008008..2008397 
[+]    1.65E-05 -1.95 
pgsA 
APL_0275 
   phosphatidylglycerophosphate synthase COG0558 I 2.7.8.5 CytoplasmicMembrane 302222..302773 [+]    5.02E-07 -1.95 
glpF    
APL_0374 
   glycerol uptake facilitator protein COG0580 G  CytoplasmicMembrane 423214..423996 [+]    1.26E-03 -1.95 
ape1160 
  
APL_1071 
   hypothetical protein COG2252 R  CytoplasmicMembrane 
1239071..1240372 
[+]   2.58E-07 -1.95 
potB 
APL_0281 
   
spermidine/putrescine transport system 
permease protein potB COG1176 E  CytoplasmicMembrane 311260..312126 [+]    5.07E-09 -1.94 
kpsF 
APL_0387 
   arabinose-5-phosphate isomerase COG0794 M  Cytoplasmic 440036..440971 [-]    5.22E-07 -1.94 
rpoA 
APL_1784 
   DNA-directed RNA polymerase alpha chain COG0202 K 2.7.7.6 Cytoplasmic 
2009118..2010104 
[+]    1.19E-07 -1.93 
rnfB    
APL_0166 
   electron transport complex protein RnfB COG2878 C  Cytoplasmic 184034..184624 [+]    2.84E-07 -1.93 
aspS 
APL_1149 
   aspartyl-tRNA synthetase COG0173 J 6.1.1.12 Cytoplasmic 
1324625..1326400 
[+]    3.78E-07 -1.92 
ape1377 
   APL_1277 hypothetical protein    Cytoplasmic 
1469179..1469346 [-] 
   3.48E-02 -1.92 
ubiB 
APL_1984 
   Probable ubiquinone biosynthesis protein ubiB COG0661 R   
2211332..2212966 
[+]    2.11E-05 -1.92 
pulJ   
APL_1887 
   hypothetical protein COG4795 U  Cytoplasmic 
2119962..2120495 [-] 
   4.90E-04 -1.92 
dnaQ    
APL_0182 
   
DNA polymerase III, epsilon subunit and related 
3'-5' exonucleases COG0847 L 3.1.13.-  200701..201357 [+]    2.49E-05 -1.92 
oxaA 
APL_1424 
   inner membrane protein OxaA COG0706 U  CytoplasmicMembrane 
1629241..1630722 
[+]    2.54E-07 -1.92 
kefBC    
APL_1053 
   
glutathione-regulated potassium-efflux system 
protein COG0475 P  CytoplasmicMembrane 
1222558..1224423 [-] 
   2.58E-12 -1.92 
bolA    
APL_0235 
   stress-induced morphogen (activity unknown) COG0271 T   253341..253652 [+]    4.12E-06 -1.92 
ape1023 
APL_0943 
   hypothetical adenine-specific methylase COG2890 J 2.1.1.72 Cytoplasmic 
1084230..1085174 
[+]    2.12E-06 -1.92 
ape1524 
APL_1417 
   hypothetical protein    CytoplasmicMembrane 
1619428..1619853 
[+]    1.96E-06 -1.92 
purE 
APL_0659 
   
phosphoribosylaminoimidazole carboxylase 
catalytic subunit COG0041 F 4.1.1.21  752887..753381 [+]    4.05E-06 -1.91 
ape0740 
APL_0686 
   hypothetical protein    CytoplasmicMembrane 784609..785013 [-]    2.83E-02 -1.91 
dnaB 
APL_0713 
   replicative DNA helicase COG0305 L 3.6.1.-  822616..824076 [-]    3.10E-06 -1.91 
ape0188 
APL_0179 
   hypothetical protein COG1301 C   196507..199203 [-]    1.33E-09 -1.91 
vacJ 
APL_1918 
   lipoprotein VacJ-like precursor COG2853 M   
2151556..2152305 
[+]    2.60E-05 -1.91 
uppS 
APL_0414 
   undecaprenyl pyrophosphate synthetase COG0020 I 2.5.1.31  472284..472997 [-]    3.38E-05 -1.91 
ape1043 
  
APL_0961 
   putative hemolysin activation/secretion protein COG2831 U  OuterMembrane 
1112918..1113625 [-] 
   5.16E-05 -1.91 
ape1012 
APL_0932 
   putative HTH-type transcriptional regulator COG1959 K  Cytoplasmic 
1073111..1073563 [-] 
   7.58E-07 -1.91 
rplQ 
APL_1785 
   50S ribosomal protein L17 COG0203 J   
2010213..2010527 
[+]    2.33E-07 -1.91 
glmU 
APL_0588 
   
bifunctional protein GlmU (Includes: UDP-N-
acetylglucosamine pyrophosphorylase; 
Glucosamine-1-phosphate N-acetyltransferase) COG1207 M 
2.3.1.157 
2.7.7.23 Cytoplasmic 670619..671992 [+]    4.51E-08 -1.91 
nusB 
APL_0201 
   transcription antitermination protein NusB COG0781 K  Cytoplasmic 220866..221279 [+]    2.26E-06 -1.91 
ape2011 
APL_1882 
   hypothetical protein     
2111784..2112536 
[+]    2.02E-07 -1.90 
cbiM 
APL_1622 
   
predicted ABC transport permease protein 
CbiM COG0310 P  CytoplasmicMembrane 
1845964..1846572 [-] 
   1.26E-06 -1.90 
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mepA    
APL_0747 
   
penicillin-insensitive murein endopeptidase 
precursor COG3770 M 3.4.24.-  852612..853442 [-]    2.33E-05 -1.90 
ape1920 
APL_1792 
   Fe(III) dicitrate ABC transporter, permease COG0609 P  CytoplasmicMembrane 
2015459..2016340 
[+]    1.90E-06 -1.90 
kdtA 
APL_1132 
   3-deoxy-D-manno-octulosonic-acid transferase COG1519 M 2.-.-.-  
1309230..1310510 
[+]    2.45E-06 -1.89 
prsA 
APL_0775 
   ribose-phosphate pyrophosphokinase COG0462 FE 2.7.6.1  891522..892472 [-]    2.17E-04 -1.89 
ubiA    
APL_0822 
   4-hydroxybenzoate octaprenyltransferase COG0382 H 2.5.1.- CytoplasmicMembrane 950519..951400 [-]    3.40E-06 -1.89 
cyaA 
APL_1054 
   adenylate cyclase COG3072 F 4.6.1.1 Cytoplasmic 
1224512..1227040 [-] 
   7.11E-10 -1.89 
hisC   
APL_0700 
   histidinol-phosphate aminotransferase 2 COG0079 E 2.6.1.9 Cytoplasmic 802505..803599 [-]    1.89E-06 -1.88 
lgt    
APL_1895 
   Prolipoprotein diacylglyceryl transferase COG0682 M 2.4.99.- CytoplasmicMembrane 
2126510..2127304 [-] 
   5.82E-07 -1.88 
ape1056 
APL_0973 
   hypothetical protein    CytoplasmicMembrane 
1126774..1127511 [-] 
   6.39E-08 -1.88 
ape2069 
APL_1936 
   hypothetical protein     
2170294..2170437 [-] 
   3.25E-03 -1.88 
cysQ 
APL_1312 
   CysQ-like protein COG1218 P   
1503711..1504526 [-] 
   4.17E-08 -1.88 
ape0790 
APL_0730 
   hypothetical protein    Cytoplasmic 839028..839558 [+]    3.84E-04 -1.87 
lysR   
APL_1860 
   LysR protein COG0583 K  Cytoplasmic 
2091060..2091962 
[+]    3.96E-04 -1.87 
glpK 
APL_0375 
   glycerol kinase COG0554 C 2.7.1.30 Cytoplasmic 424031..425542 [+]    3.47E-07 -1.87 
rpsN 
APL_1772 
   30S ribosomal protein S14 COG0199 J   
2003241..2003546 
[+]    1.00E-06 -1.87 
ykgE 
APL_0446 
   putative dehydrogenase subunit COG0247 C  Cytoplasmic 512616..513341 [-]    1.23E-05 -1.87 
pyrH    
APL_0569 
   uridylate kinase COG0528 F 2.7.4.- Cytoplasmic 642261..642974 [+]    3.70E-10 -1.87 
ispB 
APL_1995 
   octaprenyl-diphosphate synthase COG0142 H 2.5.1.- Cytoplasmic 
2221125..2222120 [-] 
   3.83E-05 -1.86 
ape2026 
APL_1896 
   hypothetical protein COG0730 R  CytoplasmicMembrane 
2127357..2128148 [-] 
   6.23E-06 -1.86 
rplV 
APL_1765 
   50S ribosomal protein L22 COG0091 J  Cytoplasmic 
1999812..2000144 
[+]    2.13E-07 -1.86 
ubiE 
APL_1982 
   
Ubiquinone/menaquinone biosynthesis 
methyltransferase ubiE COG2226 H 2.1.1.-  
2209901..2210677 
[+]    2.58E-06 -1.86 
aroA 
APL_0699 
   3-phosphoshikimate 1-carboxyvinyltransferase COG0128 E   801193..802491 [-]    3.94E-05 -1.86 
ape1444 
APL_1341 
   hypothetical protein    CytoplasmicMembrane 
1541745..1542335 [-] 
   4.55E-04 -1.85 
wecC 
APL_1551 
   UDP-N-acetyl-D-mannosamine dehydrogenase COG0677 M 1.1.1.-  
1773249..1774520 [-] 
   1.02E-06 -1.85 
secD 
APL_1067 
   protein-export membrane protein SecD COG0342 U  CytoplasmicMembrane 
1234882..1236696 
[+]    1.45E-06 -1.85 
folE 
APL_0903 
   GTP cyclohydrolase I COG0302 H 3.5.4.16 Cytoplasmic 
1045805..1046461 [-] 
   1.17E-04 -1.85 
ushA 
APL_0769 
   
UshA precursor (Includes: UDP-sugar 
hydrolase; 5'-nucleotidase) COG0737 F 
3.1.3.5 
3.6.1.45 Periplasmic 879630..881273 [+]    7.65E-06 -1.84 
gyrB 
APL_0821 
   DNA gyrase subunit B COG0187 L 5.99.1.3  947874..950306 [-]    5.01E-07 -1.84 
gpmB 
APL_0230 
   
phosphoglycerate mutase/fructose-2, 6-
bisphosphatase COG0406 G 5.4.2.1  249991..250623 [+]    5.99E-07 -1.84 
ape1117 
  
APL_1030 
   hypothetical protein COG5039 GM  Cytoplasmic 
1194351..1195316 [-] 
   6.54E-05 -1.84 
gloA 
APL_0181 
   lactoylglutathione lyase COG0346 E 4.4.1.5  200154..200561 [+]    6.00E-08 -1.83 
rpsD   
APL_1783 
   30S ribosomal protein S4 COG0522 J   
2008426..2009052 
[+]    6.58E-07 -1.83 
ape1667 
APL_1553 
   hypothetical protein COG3765 M   
1775719..1776597 [-] 
   3.15E-05 -1.83 
ape1299 
APL_1203 
   hypothetical protein    Cytoplasmic 
1386211..1386774 
[+]    7.97E-08 -1.83 
fabD 
APL_1993 
   
Malonyl CoA-acyl carrier protein transacylase 
(MCT) COG0331 I 2.3.1.39  
2219340..2220275 [-] 
   5.40E-07 -1.83 
frdB    
APL_1528 
   fumarate reductase iron-sulfur protein COG0479 C 1.3.99.1  
1741547..1742281 [-] 
   5.68E-07 -1.83 
ape1302 
APL_1205 
   putative glutathione S-transferase COG0625 O   
1387841..1388524 [-] 
   6.82E-09 -1.83 
ape0716 
APL_0664 
   hypothetical protein COG1373 R   758756..759979 [-]    3.14E-06 -1.83 
glpR 
APL_0823 
   glycerol-3-phosphate regulon repressor COG1349 KG   951400..952161 [-]    8.67E-05 -1.83 
ubiX 
APL_0732 
   3-octaprenyl-4-hydroxybenzoate carboxy-lyase COG0163 H 4.1.1.- Cytoplasmic 840034..840606 [+]    1.79E-04 -1.83 
ape0879 
APL_0814 
   hypothetical protein COG0500 QR  Cytoplasmic 940675..941637 [+]    7.20E-04 -1.83 
potA 
APL_0280 
   
spermidine/putrescine import ATP-binding 
protein PotA COG3842 E 3.6.3.31 Cytoplasmic 310158..311273 [+]    9.42E-10 -1.82 
yhiR 
APL_0317 
   hypothetical protein COG2961 R   353973..354815 [+]    2.10E-07 -1.82 
ape1084 
APL_0999 
   hypothetical protein     
1161732..1162208 [-] 
   8.61E-07 -1.82 
ape0468 
APL_0438 
   hypothetical protein COG2256 L   494439..495779 [+]    1.94E-06 -1.82 
truA    
APL_0902 
   tRNA pseudouridine synthase A COG0101 J 5.4.99.12  
1044941..1045726 [-] 
   1.22E-03 -1.82 
ape1650 
APL_1538 
   predicted acetyltransferase COG0454 KR   
1752542..1753009 [-] 
   8.56E-08 -1.82 
glpB 
APL_0380 
   
anaerobic glycerol-3-phosphate dehydrogenase 
subunit B COG3075 E 1.1.99.5  432880..434166 [+]    6.29E-05 -1.81 
pulG 
APL_1888 
   hypothetical protein COG2165 NU   
2120620..2121150 [-] 
  1.73E-04 -1.81 
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ape1020 
APL_0940 
   hypothetical protein     
1080982..1081641 [-] 
   3.57E-07 -1.81 
cpdB 
APL_0646 
   
2',3'-cyclic-nucleotide 2'-phosphodiesterase 
precursor COG0737 F 3.1.4.16 Periplasmic 739513..741489 [+]    8.99E-04 -1.80 
rseC 
APL_0396 
   putative sigma-E factor regulatory protein COG3086 T   450532..450960 [+]    6.86E-07 -1.80 
ape1053 
APL_0970 
   hypothetical protein    Cytoplasmic 
1125450..1125716 [-] 
   1.09E-07 -1.80 
ape1459 
APL_1356 
   putative sodium/calcium exchange protein COG0530 P  CytoplasmicMembrane 
1553553..1554512 
[+]    1.29E-08 -1.80 
rplR   
APL_1775 
   50S ribosomal protein L18 COG0256 J  Cytoplasmic 
2004540..2004893 
[+]    2.33E-06 -1.79 
ape0892 
APL_0825 
   hypothetical protein COG2915 R   953653..954285 [-]    1.65E-05 -1.79 
mukF 
APL_0579 
   chromosome partition protein MukF COG3006 D  Cytoplasmic 655340..656671 [+]    3.61E-06 -1.79 
yajC 
APL_1066 
   preprotein translocase subunit YajC COG1862 U   
1234526..1234822 
[+]    4.08E-07 -1.79 
rpsL 
APL_1401 
   30S ribosomal protein S12 COG0048 J   
1602612..1602986 [-] 
   5.86E-07 -1.79 
rplD    
APL_1761 
   50S ribosomal protein L4 COG0088 J   
1997752..1998354 
[+]    8.28E-08 -1.78 
rpoC    
APL_1728 
   DNA-directed RNA polymerase beta' chain COG0086 K 2.7.7.6 Cytoplasmic 
1961382..1965620 
[+]   8.48E-06 -1.78 
lysS 
APL_0809 
   lysyl-tRNA synthetase COG1190 J 6.1.1.6 Cytoplasmic 930728..932230 [-]    2.19E-05 -1.78 
wecD 
APL_1550 
   putative TDP-D-fucosamine acetyltransferase COG0454 KR   
1772626..1773249 [-] 
   1.09E-05 -1.78 
ape0377 
APL_0356 
   hypothetical protein     399116..399502 [-]    1.42E-04 -1.78 
mtlA 
APL_1630 
   
PTS system mannitol-specific EIICBA 
component [Includes: Mannitol permease IIC 
component; Mannitol-specific 
phosphotransferase enzyme IIB component; 
Mannitol-specific phosphotransferase enzyme 
IIA component] COG2213 G 2.7.1.69 CytoplasmicMembrane 
1853283..1855172 [-] 
   2.43E-04 -1.78 
ape0822 
APL_0762 
   hypothetical protein COG0500 QR  Cytoplasmic 871328..872083 [+]    1.79E-05 -1.77 
tyrR 
APL_0797 
   transcriptional regulatory protein TyrR COG3283 KE  Cytoplasmic 918871..920019 [-]    4.63E-07 -1.77 
ulaA 
APL_1714 
   
ascorbate-specific permease IIC component 
UlaA    CytoplasmicMembrane 1946399..1947754 [-] 5.63E-04 -1.77 
ape0239 
   
APL_0228 
   hypothetical protein COG1253 R  CytoplasmicMembrane 247952..249247 [-]    2.15E-08 -1.77 
glpT 
APL_1835 
   Glycerol-3-phosphate transporter COG2271 G  CytoplasmicMembrane 
2058079..2059236 [-] 
   6.65E-06 -1.77 
sapC 
APL_0794 
   
peptide transport system permease protein 
SapC COG4171 V  CytoplasmicMembrane 915325..916212 [-]    1.08E-08 -1.77 
purB 
APL_0824 
   adenylosuccinate lyase COG0015 F 4.3.2.2  952229..953596 [-]    4.55E-07 -1.77 
ape2077 
APL_1943 
   ADP-ribose pyrophosphatase COG0494 LR 3.6.1.13 Cytoplasmic 
2175500..2176123 [-] 
   3.36E-09 -1.77 
selD 
APL_0327 
   selenide, water dikinase COG0709 E 2.7.9.3 Cytoplasmic 364716..365633 [+]    3.84E-03 -1.76 
ape1216 
   
APL_1126 
   
putative micrococcal nuclease 
(thermonuclease)-like COG1525 L   
1302072..1302770 [-] 
   4.39E-07 -1.76 
ape0288 
APL_0274 
   hypothetical protein COG0670 R  CytoplasmicMembrane 301375..302040 [-]    9.71E-07 -1.76 
coaE 
APL_0876 
   dephospho-CoA kinase COG0237 H 2.7.1.24 Cytoplasmic 
1016712..1017350 [-] 
   4.31E-04 -1.76 
ape1128 
APL_1041 
   hypothetical protein    CytoplasmicMembrane 
1209040..1209948 
[+]    5.14E-03 -1.76 
argC 
APL_0242 
   
N-acetyl-gamma-glutamyl-phosphate reductase 
(AGPR) COG0002 E 1.2.1.38  259949..260893 [+]    2.52E-06 -1.76 
mutT 
APL_0328 
   
putative NTP pyrophosphohydrolase 
(MutT/Nudix family) COG0494 LR 3.6.-.- Cytoplasmic 365638..366093 [+]    1.68E-05 -1.75 
rpsH    
APL_1773 
   30S ribosomal protein S8 COG0096 J   
2003583..2003975 
[+]    3.77E-07 -1.75 
zwf 
APL_1311 
   glucose-6-phosphate 1-dehydrogenase COG0364 G 1.1.1.49  
1502152..1503639 [-] 
   1.80E-07 -1.75 
rplT 
APL_0225 
   50S ribosomal protein L20 COG0292 J   246631..246984 [+]    2.13E-04 -1.75 
sapF 
APL_1249 
   
peptide transport system ATP-binding protein 
SapF COG4167 V   1435370..1436170 [-] 4.83E-07 -1.75 
ape1106 
APL_1021 
   alpha-glucosidase 2 COG1501 G 3.2.1.20  
1186618..1188096 
[+]    3.54E-08 -1.74 
leuD 
APL_0138 
   3-isopropylmalate dehydratase small subunit COG0066 E 4.2.1.33 Cytoplasmic 153561..154163 [-]    1.34E-10 -1.74 
trmE    
APL_1490 
   tRNA modification GTPase TrmE COG0486 R  Cytoplasmic 
1705081..1706439 
[+]    6.48E-05 -1.74 
hflK   
APL_1077 
   protein HflK COG0330 O 3.4.-.-  
1245823..1247013 [-] 
   1.73E-05 -1.74 
nudH 
APL_1897 
   
Probable (di)nucleoside polyphosphate 
hydrolase COG0494 LR 3.6.1.-  
2128145..2128765 [-] 
   4.10E-07 -1.74 
malT    
APL_1233 
   HTH-type transcriptional regulator MalT COG2909 K   
1415184..1417901 [-] 
   1.37E-05 -1.74 
aroG 
APL_0620 
   phospho-2-dehydro-3-deoxyheptonate aldolase COG0722 E 2.5.1.54 Cytoplasmic 707965..709038 [+]    7.95E-07 -1.73 
ape1716 
APL_1601 
   hypothetical protein    Cytoplasmic 
1828414..1828728 [-] 
   5.32E-03 -1.73 
glnE 
APL_0969 
   glutamate-ammonia-ligase adenylyltransferase COG1391 OT 2.7.7.42 Cytoplasmic 
1122496..1125375 [-] 
   2.26E-04 -1.73 
suhB 
APL_0206 
   Inositol-1-monophosphatase (IMPase) COG0483 G 3.1.3.25 Cytoplasmic 224692..225504 [+]    1.27E-07 -1.73 
purM    
APL_1095 
   phosphoribosylformylglycinamidine cyclo-ligase COG0150 F 6.3.3.1  
1266330..1267367 [-] 
   3.24E-05 -1.73 
ape1487 
APL_1382 
   hypothetical protein    Cytoplasmic 
1583783..1584124 [-] 
   2.24E-05 -1.72 
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rpsG    
APL_1400 
   30S ribosomal protein S7 COG0049 J   
1602005..1602475 [-] 
   1.64E-06 -1.72 
arcB 
APL_1317 
   ornithine carbamoyltransferase, catabolic COG0078 E 2.1.3.3 Cytoplasmic 
1508919..1509923 
[+]    5.56E-06 -1.72 
rbsK    
APL_1673 
   ribokinase COG0524 G 2.7.1.15 Cytoplasmic 
1898947..1899858 
[+]    1.00E-06 -1.72 
ape1918 
APL_1790 
   Protein HI0396    Cytoplasmic 
2012932..2014125 [-] 
   1.86E-05 -1.72 
hflX 
APL_1962 
   GTP-binding protein hflX COG2262 R  Cytoplasmic 
2192241..2193464 
[+]    3.36E-03 -1.72 
ape0053 
APL_0051 
   
3-deoxy-D-manno-octulosonate 8-phosphate 
phosphatase COG1778 R 3.1.3.45 Cytoplasmic 57311..57847 [-]    4.04E-08 -1.71 
hflC 
APL_1076 
   protein HflC COG0330 O 3.4.-.- Cytoplasmic 
1244933..1245820 [-] 
   1.12E-09 -1.71 
pflA 
APL_1035 
   pyruvate formate-lyase 1-activating enzyme COG1180 O 1.97.1.4 Cytoplasmic 
1202068..1202805 [-] 
   2.34E-06 -1.71 
mutS 
APL_1602 
   DNA mismatch repair protein MutS COG0249 L   
1828954..1831548 [-] 
   1.37E-03 -1.71 
msrB 
APL_0433 
   methionine sulfoxide reductase B COG0229 O 1.8.4.12 Cytoplasmic 489902..490297 [-]    1.55E-04 -1.71 
mipB 
APL_0062 
   transaldolase COG0176 G 2.2.1.2  67907..68854 [-]    2.61E-06 -1.71 
ape0824 
APL_0764 
   hypothetical protein     873233..874162 [+]    6.33E-06 -1.70 
nqrB 
APL_0151 
   
Na(+)-translocating NADH-quinone reductase 
subunit B COG1805 C 1.6.5.- CytoplasmicMembrane 169440..170672 [+]    2.35E-05 -1.70 
cbiO 
APL_1620 
   
predicted ABC transport ATP-binding protein 
CbiO COG1122 P   
1844688..1845317 [-] 
   9.08E-06 -1.70 
ansB 
APL_0660 
   probable L-asparaginase COG0252 EJ 3.5.1.1 Cytoplasmic 753391..754356 [+]    1.27E-05 -1.70 
fabG 
APL_1992 
   
3-oxoacyl-[acyl-carrier-protein] reductase (3-
ketoacyl-acyl carrier protein reductase) COG1028 IQR  Cytoplasmic 
2218496..2219221 [-] 
   6.20E-07 -1.70 
ape1285 
APL_1190 
   putative transcriptional regulator LysR-like COG0583 K  Cytoplasmic 
1368533..1369432 [-] 
   2.74E-07 -1.70 
murB 
APL_1851 
   
UDP-N-acetylenolpyruvoylglucosamine 
reductase COG0812 M 1.1.1.158 Cytoplasmic 
2081993..2083027 [-] 
   3.74E-06 -1.70 
rnpA 
APL_1939 
   ribonuclease P COG0594 J 3.1.26.5  
2172077..2172379 
[+]    3.96E-04 -1.70 
hcaT   
APL_0159 
   putative 3-phenylpropionic acid transporter COG0477 GEPR  CytoplasmicMembrane 176876..178030 [-]    9.91E-07 -1.70 
greB 
APL_0386 
   transcription elongation factor GreB COG0782 K  Cytoplasmic 439538..440026 [-]    6.61E-09 -1.70 
dgkA 
APL_0768 
   diacylglycerol kinase COG0818 M 2.7.1.107 CytoplasmicMembrane 879187..879549 [+]    3.67E-05 -1.70 
nhaA 
APL_1947 
   
Na(+)/H(+) antiporter 1 (Sodium/proton 
antiporter 1) COG3004 P  CytoplasmicMembrane 
2177937..2179121 
[+]    3.28E-06 -1.69 
tyrS 
APL_1476 
   tyrosyl-tRNA synthetase COG0162 J 6.1.1.1 Cytoplasmic 
1690213..1691403 [-] 
   7.39E-05 -1.69 
ape0724 
   
APL_0672 
   hypothetical protein COG3663 L   766607..767197 [-]    2.57E-04 -1.69 
rpoB    
APL_1727 
   DNA-directed RNA polymerase beta chain COG0085 K 2.7.7.6 Cytoplasmic 
1957228..1961256 
[+]    4.08E-04 -1.69 
hemL 
APL_1555 
   glutamate-1-semialdehyde 2,1-aminomutase COG0001 H 5.4.3.8 CytoplasmicMembrane 
1778004..1779284 
[+]    6.29E-04 -1.69 
ccmA 
APL_1372 
   
cytochrome c biogenesis ATP-binding export 
protein CcmA COG4133 O 3.6.3.41 CytoplasmicMembrane 
1568850..1569485 [-] 
   2.48E-06 -1.69 
ape1300 
APL_1204 
   esterase COG0627 R 3.1.1.-  
1386848..1387705 [-] 
   2.87E-06 -1.69 
rplB    
APL_1763 
   50S ribosomal protein L2 COG0090 J   
1998677..1999498 
[+]    6.95E-06 -1.69 
namA 
APL_1191 
   NADPH dehydrogenase COG1902 C  Cytoplasmic 
1369523..1370584 
[+]    1.37E-03 -1.68 
cbiL 
APL_1623 
   putative cytoplasmic membrane protein CbiL     
1846573..1847055 [-] 
   1.32E-05 -1.68 
ape0349 
   
APL_0329 
   2-octaprenyl-6-methoxyphenol hydroxylase COG0654 HC 1.14.13.-  366103..367302 [+]    1.33E-08 -1.68 
ape0901 
APL_0833 
   hypothetical protein COG1279 R  CytoplasmicMembrane 966885..967520 [-]    6.25E-04 -1.68 
ape0171 
APL_0162 
   putative phosphatase COG0637 R  Cytoplasmic 179938..180543 [+]    1.36E-10 -1.68 
ape1322 
   
APL_1225 
   hypothetical protein COG2081 R  CytoplasmicMembrane 
1407522..1408241 
[+]    2.23E-06 -1.68 
rdgC    
APL_0161 
   recombination-associated protein RdgC COG2974 L  Cytoplasmic 179020..179928 [+]    2.63E-06 -1.68 
ape1345 
APL_1247 
   hypothetical protein    CytoplasmicMembrane 
1434344..1434637 [-] 
   2.41E-05 -1.68 
ape0876 
APL_0811 
   hypothetical protein    Cytoplasmic 934070..935833 [+]    3.40E-12 -1.68 
rraA 
APL_1901 
   Regulator of ribonuclease activity A COG0684 H  Cytoplasmic 
2131532..2132029 [-] 
   1.05E-03 -1.68 
eda 
APL_1018 
   
putative KHG/KDPG aldolase [Includes: 4-
hydroxy-2-oxoglutarate aldolase; 2-dehydro-3-
deoxy-phosphogluconate aldolase] COG0800 G 4.1.2.14 Cytoplasmic 
1184113..1184754 [-] 
   7.96E-07 -1.68 
parC 
APL_0578 
   DNA topoisomerase 4 subunit A COG0188 L 5.99.1.- Cytoplasmic 652954..655200 [+]    1.35E-06 -1.67 
ape0927 
   
APL_0858 
   hypothetical protein COG0665 E   997904..999919 [-]    2.98E-04 -1.67 
lpxL 
APL_0900 
   lipid A biosynthesis lauroyl acyltransferase COG1560 M 2.3.1.- CytoplasmicMembrane 
1043459..1044400 [-] 
   4.35E-05 -1.67 
ompP2A 
  
APL_0006 
   outer membrane protein P2 COG3203 M  OuterMembrane 6134..7264 [-]    4.01E-04 -1.67 
vacB 
APL_1478 
   ribonuclease R COG0557 K 3.1.-.-  
1692326..1694683 [-] 
   2.04E-07 -1.67 
ape0920 
APL_0851 
   ABC transporter, ATP-binding subunit COG4608 E   988016..988822 [+]    7.66E-06 -1.67 
hemD 
APL_1009 
   putative uroporphyrinogen-III synthase COG1587 H 4.2.1.75  1173273..1174037 [-] 3.89E-07 -1.67 
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mutL    
APL_1958 
   DNA mismatch repair protein mutL COG0323 L   
2187521..2189389 
[+]    4.27E-06 -1.66 
ape1591 
APL_1482 
   hybrid peroxiredoxin HyPrx5 COG0678 O   
1696909..1697640 
[+]    9.22E-07 -1.66 
pepP 
APL_0663 
   Xaa-Pro aminopeptidase COG0006 E 3.4.11.9 Cytoplasmic 757061..758347 [-]    3.22E-07 -1.66 
ape1488 
APL_1383 
   tRNA (guanine-N(7)-)-methyltransferase COG0220 R 2.1.1.33 Cytoplasmic 
1584180..1584932 [-] 
   1.06E-07 -1.66 
dusA    
APL_0146 
   tRNA-dihydrouridine synthase A COG0042 J 1.-.-.- Cytoplasmic 162938..163915 [-]    1.29E-04 -1.66 
ackA 
APL_0645 
   acetate kinase COG0282 C 2.7.2.1 Cytoplasmic 738008..739216 [-]    9.77E-06 -1.66 
malK 
APL_1236 
   
maltose/maltodextrin import ATP-binding 
protein MalK COG3839 G 3.6.3.19 Cytoplasmic 
1420312..1421451 [-] 
   3.19E-03 -1.66 
sapA    
APL_0796 
   
peptide transport periplasmic protein SapA 
precursor COG4166 E   917164..918861 [-]    8.86E-06 -1.65 
ape1522 
APL_1415 
   hypothetical protein    CytoplasmicMembrane 
1618412..1618825 [-] 
   7.14E-05 -1.65 
rne 
APL_1436 
   ribonuclease E COG1530 J 3.1.4.- Cytoplasmic 
1640346..1643333 [-] 
   4.62E-10 -1.65 
mtlD 
APL_1629 
   mannitol-1-phosphate 5-dehydrogenase COG0246 G 1.1.1.17 Cytoplasmic 
1852057..1853196 [-] 
   1.15E-04 -1.65 
putP 
APL_0107 
   sodium/proline symporter COG0591 ER  CytoplasmicMembrane 125274..126788 [-]    3.24E-04 -1.65 
ape1662 
APL_1548 
   hypothetical protein COG2244 R  CytoplasmicMembrane 
1770236..1771486 [-] 
   4.18E-06 -1.65 
ape0635 
   
APL_0584 
   hypothetical protein     665021..665242 [-]    8.93E-04 -1.65 
cdsA 
APL_0413 
   phosphatidate cytidylyltransferase COG0575 I 2.7.7.41 CytoplasmicMembrane 471390..472259 [-]    4.30E-06 -1.65 
bioA 
APL_0942 
   
adenosylmethionine-8-amino-7-oxononanoate 
aminotransferase COG0161 H 2.6.1.62  
1082841..1084139 [-] 
   1.99E-06 -1.64 
rplE    
APL_1771 
   50S ribosomal protein L5 COG0094 J  Cytoplasmic 
2002690..2003229 
[+]    1.99E-06 -1.64 
recB 
APL_0370 
   exodeoxyribonuclease V beta chain COG1074 L 3.1.11.5  416034..419642 [+ 6.35E-08 -1.64 
ape1130 
  
APL_1043 
   probable aminotransferase COG0436 E 2.6.1.1 Cytoplasmic 
1211431..1212648 
[+]    1.17E-05 -1.64 
nqrF    
APL_0155 
   
Na(+)-translocating NADH-quinone reductase 
subunit F COG2871 C 1.6.5.-  172680..173909 [+]    2.46E-08 -1.63 
ape0619 
   
APL_0568 
  hypothetical protein COG2194 R  CytoplasmicMembrane 640596..642149 [-]    5.25E-05 -1.63 
ape1588 
APL_1479 
   thioredoxin-like protein COG0526 OC   
1694751..1695266 [-] 
   1.90E-06 -1.63 
ape1168 
APL_1079 
   putative purine permease COG2233 F  CytoplasmicMembrane 
1247641..1248933 [-] 
  1.25E-04 -1.62 
ntpA 
APL_1150 
   dATP pyrophosphohydrolase COG0494 LR 3.6.1.-  
1326434..1326904 
[+]    2.72E-07 -1.62 
rplL    
APL_1721 
   50S ribosomal protein L7/L12 COG0222 J   
1951568..1951936 
[+]    1.58E-06 -1.62 
holC 
APL_1505 
   DNA polymerase III subunit chi COG2927 L 2.7.7.7  
1721997..1722434 [-] 
   3.22E-05 -1.62 
rbsC 
APL_1671 
   ribose transport system permease protein RbsC COG1172 G   
1897019..1897978 
[+]    6.70E-07 -1.62 
bioC 
APL_0939 
   biotin synthesis protein COG0500 QR  Cytoplasmic 
1080224..1080994 [-] 
   6.10E-08 -1.62 
hemB 
APL_1988 
   delta-aminolevulinic acid dehydratase COG0113 H 4.2.1.24 Cytoplasmic 
2214675..2215694 
[+]    4.72E-05 -1.62 
ape1383 
APL_1283 
   ABC transporter ATP-binding protein COG0488 R  CytoplasmicMembrane 
1474004..1475674 [-] 
   2.80E-03 -1.62 
ape2078 
APL_1944 
   Predicted membrane protein COG3223   CytoplasmicMembrane 
2176133..2176552 [-] 
   6.31E-03 -1.62 
kdgK 
APL_1019 
   2-dehydro-3-deoxygluconokinase COG0524 G 2.7.1.45  
1184769..1185713 [-] 
   9.01E-09 -1.62 
ape0396 
APL_0373 
   hypothetical protein     422376..422978 [+]    1.95E-05 -1.61 
ape0156 
APL_0147 
   
ribonucleoside-diphosphate reductase beta 
chain COG0208 F 1.17.4.1 Cytoplasmic 164268..165245 [+]    6.30E-05 -1.61 
utp    
APL_1619 
   urea transport protein ApUT COG4413 E  CytoplasmicMembrane 
1843761..1844576 [-] 
   8.97E-06 -1.61 
plsC   
APL_1488 
   1-acyl-sn-glycerol-3-phosphate acyltransferase COG0204 I 2.3.1.51 CytoplasmicMembrane 
1703581..1704315 [-] 
   1.30E-05 -1.61 
apbE 
APL_0156 
   
thiamine biosynthesis lipoprotein ApbE 
precursor COG1477 H   174116..175147 [+]    3.92E-05 -1.61 
ape0797 
APL_0737 
   hypothetical protein COG2956 G  Cytoplasmic 842999..844195 [-]    1.67E-06 -1.61 
atpA   
APL_1648 
   ATP synthase subunit alpha COG0056 C 3.6.3.14  
1876081..1877622 [-] 
   1.06E-02 -1.60 
mglA 
APL_1419 
   galactoside transport ATP-binding protein MglA COG1129 G 3.6.3.17 CytoplasmicMembrane 
1620951..1622450 [-] 
   2.05E-06 -1.60 
artQ 
APL_1352 
   
arginine transport system permease protein 
ArtQ COG4215 E  CytoplasmicMembrane 1550608..1551279 [ 5.29E-05 -1.60 
ape0856 
   
APL_0792 
   hypothetical protein     913424..914191 [-]    3.69E-09 -1.60 
pckA   
APL_0800 
   phosphoenolpyruvate carboxykinase [ATP] COG1866 C 4.1.1.49 Cytoplasmic 922121..923731 [-]    1.86E-03 -1.60 
fabH 
APL_1384 
   3-oxoacyl-[acyl-carrier-protein] synthase 3 COG0332 I 2.3.1.41  
1584980..1585930 [-] 
   1.08E-04 -1.60 
ape2135 
APL_1998 
   Hypothetical protein    CytoplasmicMembrane 
2224143..2224556 
[+]    1.82E-06 -1.60 
xthA   
APL_0977 
   exodeoxyribonuclease III COG0708 L 3.1.11.2 Cytoplasmic 
1130902..1131705 
[+]   3.61E-05 -1.60 
ape0502 
APL_0468 
   probable NADP-dependent dehydrogenase COG4221 R 1.-.-.- Cytoplasmic 539525..540274 [+]    2.30E-04 -1.60 
ape1353 
APL_1254 
   hypothetical protein COG0471 P  CytoplasmicMembrane 
1441994..1443385 [-] 
   5.00E-08 -1.60 
glpX 
APL_0624 
   fructose-1,6-bisphosphatase class II GlpX COG1494 G 3.1.3.11  711318..712316 [+]    2.34E-04 -1.59 
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ape0556 
APL_0512 
   hypothetical protein     581915..582217 [+]    7.64E-03 -1.59 
ape0969 
APL_0898 
   putative oxalate/formate antiporter COG0477 GEPR  CytoplasmicMembrane 
1040777..1042315 
[+]    9.87E-08 -1.59 
ape1323 
APL_1226 
   hypothetical protein COG2081 R  Cytoplasmic 
1408272..1408709 
[+]    2.37E-06 -1.59 
fdxH 
APL_0894 
   formate dehydrogenase, iron-sulfur subunit COG0437 C  CytoplasmicMembrane 
1036582..1037481 
[+]    6.49E-06 -1.59 
icc    
APL_1942 
   protein Icc-like COG1409 R  Cytoplasmic 
2174466..2175293 [-] 
  1.60E-06 -1.59 
ppa   
APL_1899 
   Inorganic pyrophosphatase COG0221 C 3.6.1.1 Cytoplasmic 
2130174..2130701 [-] 
   7.59E-05 -1.58 
ape1810 
APL_1692 
   
putative ABC transporter, permease protein, 
amino acid COG0765 E  CytoplasmicMembrane 
1922877..1923545 
[+]    6.63E-06 -1.58 
ape1220 
APL_1130 
   putative protease COG0826 O 3.4.-.- Cytoplasmic 
1306339..1307736 
[+]    5.85E-05 -1.58 
gor    
APL_1243 
   glutathione reductase COG1249 C 1.8.1.7 Cytoplasmic 
1430369..1431739 [-] 
   2.50E-07 -1.58 
rpsC   
APL_1766 
   30S ribosomal protein S3 COG0092 J   
2000163..2000870 
[+]    4.08E-04 -1.58 
rplP 
APL_1767 
   50S ribosomal protein L16 COG0197 J   
2000884..2001294 
[+]    3.03E-05 -1.58 
prmA    
APL_1537 
   ribosomal protein L11 methyltransferase COG2264 J 2.1.1.- Cytoplasmic 
1751577..1752458 [-] 
   6.72E-05 -1.58 
glnD    
APL_0598 
   uridylyltransferase COG2844 O 2.7.7.59 Cytoplasmic 684296..686848 [+] 2.64E-06 -1.58 
ribE    
APL_0383 
   riboflavin synthase alpha chain COG0307 H 2.5.1.9 Cytoplasmic 436964..437611 [+]    2.11E-06 -1.57 
poxA 
APL_1530 
   putative lysyl-tRNA synthetase COG2269 J 6.1.1.6 Cytoplasmic 
1744436..1745419 
[+]    6.27E-06 -1.57 
frdC 
APL_1527 
   fumarate reductase subunit C COG3029 C 1.3.99.1 CytoplasmicMembrane 
1741146..1741538 [-] 
   1.07E-06 -1.57 
uxaC 
APL_1020 
   uronate isomerase COG1904 G 5.3.1.12  
1185726..1186316 [-] 
   5.52E-06 -1.57 
cydA 
APL_0297 
   cytochrome oxidase subunit 1 COG1271 C 1.10.3.- CytoplasmicMembrane 329378..330925 [+]    3.91E-07 -1.57 
glgB 
APL_0346 
   1,4-alpha-glucan branching enzyme COG0296 G 2.4.1.18 Cytoplasmic 383383..385716 [+]    5.49E-07 -1.57 
cvpA 
APL_0424 
   colicin V production protein COG1286 R  CytoplasmicMembrane 481167..481670 [+]    1.85E-08 -1.56 
ape1715 
  
APL_1600 
   hypothetical protein     
1827924..1828391 [-] 
   2.15E-02 -1.56 
cydB   
APL_0298 
   cytochrome oxidase subunit 2 COG1294 C 1.10.3.- CytoplasmicMembrane 330942..332078 [+]    9.53E-05 -1.56 
dsbD 
APL_1359 
   
thiol:disulfide interchange protein DsbD 
precursor COG4232 OC 1.8.1.8 CytoplasmicMembrane 
1555432..1557183 
[+]    1.94E-03 -1.56 
ape1751 
APL_1636 
   hypothetical protein COG0621 J  Cytoplasmic 
1861550..1862881 [-] 
   1.78E-02 -1.56 
ribH   
APL_0385 
   6,7-dimethyl-8-ribityllumazine synthase COG0054 H   438988..439449 [+]    2.89E-05 -1.56 
ape1303 
APL_1206 
   plasmid stability-like protein COG1487 R   
1388658..1389077 [-] 
   2.52E-06 -1.56 
leuB 
APL_0432 
   3-isopropylmalate dehydrogenase COG0473 CE 1.1.1.85 Cytoplasmic 488696..489778 [+]    3.88E-08 -1.55 
glgC 
APL_0348 
   glucose-1-phosphate adenylyltransferase COG0448 G 2.7.7.27  387724..389040 [+]    8.96E-05 -1.55 
lnt 
APL_0371 
   apolipoprotein N-acyltransferase COG0815 M 2.3.1.- CytoplasmicMembrane 419720..421231 [-]    1.81E-06 -1.55 
ftnA 
APL_1069 
   ferritin-like protein 1 COG1528 P  Cytoplasmic 
1237828..1238334 
[+]    9.06E-08 -1.55 
secY 
APL_1779 
   Preprotein translocase secY subunit COG0201 U  CytoplasmicMembrane 
2006037..2007359 
[+]    1.72E-03 -1.55 
ape0557 
APL_0513 
   putative phage tail component     582220..582747 [+]    1.88E-02 -1.55 
mlc 
APL_0615 
   
putative transcriptional repressor of 
carbohydrate metabolism COG1940 KG   700861..702051 [-]    2.56E-03 -1.55 
ape1116 
APL_1029 
   hypothetical protein COG2244 R  CytoplasmicMembrane 
1193165..1194310 [-] 
   7.31E-07 -1.55 
engA 
APL_0403 
   GTP-binding protein EngA COG1160 R  Cytoplasmic 457528..459048 [-]    6.07E-03 -1.55 
gnd 
APL_1305 
   
6-phosphogluconate dehydrogenase, 
decarboxylating COG0362 G 1.1.1.44 Cytoplasmic 
1496719..1498173 [-] 
   8.41E-07 -1.55 
uvrD 
APL_1326 
   DNA helicase II COG0210 L 3.6.1.- Cytoplasmic 
1519784..1521982 
[+]    1.95E-04 -1.54 
ape0378 
  
APL_0357 
   hypothetical protein COG3381 R   399573..400142 [-]    1.02E-08 -1.54 
ape0189 
   
APL_0180 
   hypothetical protein    CytoplasmicMembrane 199236..200000 [-]    4.99E-04 -1.54 
ape2153 
   
APL_2016 
   Ferrioxamine B receptor precursor COG1629 P  OuterMembrane 
2242636..2244489 
[+]    2.70E-03 -1.54 
ape0961 
APL_0890 
   hypothetical protein COG0679 R  CytoplasmicMembrane 
1031364..1032296 [-] 
   3.02E-04 -1.54 
frdA 
APL_1529 
   fumarate reductase flavoprotein subunit COG1053 C 1.3.99.1 Periplasmic 
1742294..1744093 [-] 
   6.55E-03 -1.53 
ape0921 
APL_0852 
   putative FAD flavoprotein oxidase COG1053 C   988874..990472 [+]    1.17E-09 -1.53 
lamB1    
APL_1235 
   maltoporin-1 precursor COG4580 G  OuterMembrane 
1418968..1420242 [-] 
   2.50E-05 -1.53 
ape2024 
APL_1894 
   hypothetical protein     
2126121..2126351 [-] 
   7.02E-03 -1.53 
ape1027 
APL_0947 
   transposase     
1087883..1089004 [-] 
   3.77E-05 -1.53 
pgm 
APL_0591 
   phosphoglucomutase/phosphomannomutase COG1109 G 5.4.2.8  673326..674984 [+]    3.68E-05 -1.53 
slyB 
APL_0037 
   outer membrane lipoprotein COG3133 M  CytoplasmicMembrane 41169..41633 [-]    2.13E-03 -1.53 
artM 
APL_1351 
   
arginine transport system permease protein 
ArtM COG4160 E  CytoplasmicMembrane 
1549925..1550608 [-] 
   2.66E-07 -1.53 
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ape1118 
   
APL_1031 
   hypothetical protein     
1195472..1196212 
[+]    4.76E-07 -1.53 
ape1340 
APL_1242 
   putative deoxyribonuclease COG0084 L 3.1.21.-  
1429516..1430310 
[+]    6.62E-04 -1.52 
galE 
APL_1301 
   UDP-glucose 4-epimerase COG1087 M 5.1.3.2 Cytoplasmic 
1491032..1492048 [-] 
   3.21E-08 -1.52 
ape0011 
APL_0009 
   hypothetical protein     9914..10372 [+]    5.28E-05 -1.52 
menD 
APL_1750 
   Menaquinone biosynthesis protein menD COG1165 H 2.5.1.64  
1986901..1988607 [-] 
   8.60E-06 -1.52 
sapD   
APL_0793 
   
peptide transport system ATP-binding protein 
SapD COG4170 V  CytoplasmicMembrane 914274..915311 [-]   2.20E-05 -1.52 
lbgB    
APL_0979 
   
putative D-glycero-D-manno-heptosyl 
transferase COG0859 M   1132654..1133694 [-] 2.01E-07 -1.52 
asnA    
APL_1837 
   aspartate-ammonia ligase COG2502 E 6.3.1.1 Cytoplasmic 
2061014..2062006 [-] 
   1.60E-03 -1.52 
fdhD 
APL_0891 
   formate dehydrogenase accessory protein-like COG1526 C  Cytoplasmic 
1032298..1033104 [-] 
   1.83E-04 -1.52 
proC 
APL_0160 
   pyrroline-5-carboxylate reductase COG0345 E 1.5.1.2  178027..178857 [-]    4.39E-06 -1.52 
bioF 
APL_0941 
   8-amino-7-oxononanoate synthase COG0156 H 2.3.1.47  
1081651..1082814 [-] 
   1.90E-03 -1.52 
nusG 
APL_1717 
   Transcription antitermination protein nusG COG0250 K  Cytoplasmic 
1948786..1949316 
[+]    2.53E-03 -1.52 
sppA 
APL_1268 
   protease 4 COG0616 OU 3.4.21.-  
1456773..1458629 
[+]    3.88E-05 -1.51 
gltS 
APL_0967 
   sodium/glutamate symport carrier protein COG0786 E  CytoplasmicMembrane 
1120735..1121952 
[+]    5.08E-05 -1.51 
wecE 
APL_1549 
   TDP-4-keto-6-deoxy-D-glucose transaminase COG0399 M   
1771474..1772619 [-] 
   2.29E-04 -1.51 
ape0237 
  
APL_0226 
   hypothetical protein     247033..247569 [+]    3.99E-03 -1.51 
bcp 
APL_0846 
   putative peroxiredoxin Bcp COG1225 O   981448..981918 [-]    1.38E-05 -1.51 
rsmC    
APL_2005 
   
Ribosomal RNA small subunit 
methyltransferase C COG2813 J 2.1.1.52 Cytoplasmic 
2230377..2231366 [-] 
   4.06E-06 -1.51 
rph    
APL_0055 
   ribonuclease PH COG0689 J 2.7.7.56 Cytoplasmic 61124..61840 [-]    2.18E-04 -1.51 
fdnI 
APL_0895 
   
formate dehydrogenase, cytochrome b556 
subunit COG2864 C 1.2.1.2 CytoplasmicMembrane 
1037474..1038145 
[+]    3.42E-03 -1.51 
mqo   
APL_1414 
   putative malate:quinone oxidoreductase COG0579 R 1.1.99.16  
1616829..1618304 [-] 
   2.12E-08 -1.51 
fadR 
APL_0323 
   fatty acid metabolism regulator protein COG2186 K  Cytoplasmic 360456..361184 [+]    7.01E-07 -1.50 
ape1257 
APL_1166 
   
putative ubiquinone/menaquinone biosynthesis 
methyltransferase COG0500 QR   
1343503..1344258 
[+]    1.68E-10 -1.50 
purK 
APL_0661 
   
phosphoribosylaminoimidazole carboxylase 
ATPase subunit COG0026 F 4.1.1.21 Cytoplasmic 754466..755554 [+]    4.00E-05 -1.50 
purT 
APL_1106 
   
putative phosphoribosylglycinamide 
formyltransferase 2 COG0027 F 2.1.2.- Cytoplasmic 
1281666..1282847 [-] 
   1.27E-03 -1.50 
proA 
APL_1951 
   Gamma-glutamyl phosphate reductase COG0014 E 1.2.1.41 Cytoplasmic 
2181067..2182305 [-] 
   9.78E-05 -1.50 
ape1392 
   
APL_1291 
   hypothetical protein COG0767 Q  CytoplasmicMembrane 
1480329..1481033 [-] 
   3.01E-06 -1.50 
ape1471 
APL_1366 
   hypothetical protein COG4623 M   
1562283..1563650 [-] 
   1.93E-06 -1.50 
ape0612 
APL_0561 
   hypothetical protein     629789..630211 [+]    6.33E-03 -1.50 
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G 6  Mass Spectrometry 
 
G 6.1  Q-TOF MSMS 
 
Results of Q-TOF tandem mass spectrometry 
MS 
# a 
gel 
# b accesion # 
proba-
bility 
[%] c 
matched 
peptides d 
cover-
age  
[%] e 
mW [Da] pI 
average 
mass 
error 
[ppm] f
protein g 
1 1 126207970 100 7 22.75 44901.09 5.21 19.127 NADP dependent malic enzyme  NADP ME    
2 1 126208914 100 7 25.45 36913.55 5.55 5.568 fructose 1 6 bisphosphatase   
3 1 126207928 100 5 25.43 25535.22 5.42 53.739 hypothetical protein APL 0444   
4 1 126207930 100 5 22.82 26335.58 7.91 36.807 putative dehydrogenase subunit   
5 2 126207739 100 2 14.09 23741.85 6.71 22.496 manganese superoxide dismutase   
6 2 126208488 100 7 37.08 25998.07 5.12 8.456 purine nucleoside phosphorylase DeoD like protein  
7 2 126209301 100 6 34.25 27258.83 6.32 7.283 uridine phosphorylase   
8 2 126208914 100 5 17.07 36913.55 5.55 35.397 fructose 1 6 bisphosphatase   
9 2 126208308 100 4 21.59 25889.46 6.35 12.395 
2 3 bisphosphoglycerate dependent 
phosphoglycerate mutase   
10 2 126209088 100 1 5.70 25572.24 7.09 4.261 putative periplasmic binding protein CbiK   
11 2 126209359 100 2 11.43 19453.88 4.95 7.567 inorganic pyrophosphatase   
12 2 126209413 100 5 18.05 36743.72 6.02 8.922 alcohol dehydrogenase 1   
13 2 126208249 100 2 6.33 50520.37 6.11 8.572 dihydrolipoyl dehydrogenase   
14 3 126208251 100 7 8.48 98856.58 5.57 70.921 pyruvate dehydrogenase E1 component   
15 3 126208510 100 8 14.68 86119.01 5.89 36.074 formate acetyltransferase   
16 3 126208251 100 3 5.09 98856.58 5.57 52.572 pyruvate dehydrogenase E1 component   
17 3 126208510 100 10 16.75 86119.01 5.89 14.5 formate acetyltransferase   
18 3 126208510 100 6 8.44 86119.01 5.89 43.692 formate acetyltransferase   
19 3 126208251 100 4 6.11 98856.58 5.57 36.589 pyruvate dehydrogenase E1 component   
20 3 126208348 100 3 5.34 97687.67 5.45 29.496 leucyl tRNA synthetase   
21 3 126208510 100 2 3.90 86119.01 5.89 40.661 formate acetyltransferase   
22 3 126208510 100 8 14.16 86119.01 5.89 13.676 formate acetyltransferase   
23 3 126208250 100 6 9.34 66103.72 5.08 7.837 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 
24 3 126208059 100 11 17.76 77349.28 5.00 23.59 polyribonucleotide nucleotidyltransferase   
25 3 126208091 100 9 17.74 86309.02 5.18 7.268 phenylalanyl tRNA synthetase beta chain   
26 3 126208091 100 4 7.42 86309.02 5.18 9.936 phenylalanyl tRNA synthetase beta chain   
27 3 126208787 100 8 15.01 62702.77 4.81 16.392 phosphoenolpyruvate protein phosphotransferase   
28 3 126208485 0 1 1.26 95276.65 6.95 51.661 aldehyde alcohol dehydrogenase 2   
29 3 126208073 100 6 14.67 59738.73 5.16 37.014 phosphoglucomutase phosphomannomutase   
30 3 126208251 100 9 10.75 98856.58 5.57 45.976 pyruvate dehydrogenase E1 component   
31 3 126208250 100 2 3.48 66103.72 5.08 84.076 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 
32 3 126208439 100 1 5.73 22137.64 9.11 15.964 hypothetical protein APL 0965   
33 3 126208276 100 13 34.33 59390.11 5.41 10.339 phosphoenolpyruvate carboxykinase  ATP    
34 3 126208759 100 4 12.28 49169.02 6.37 3.829 
probable periplasmic serine protease do hhoA like 
precursor   
35 3 126208344 100 3 6.67 48334.86 5.70 6.893 seryl tRNA synthetase   
36 3 126208127 100 9 33.58 43555.48 5.98 3.542 acetate kinase   
37 3 126207872 100 1 2.09 46371.36 5.65 4.362 peptidase B   
38 3 126208457 100 12 23.80 73216.57 5.72 36.494 transketolase 2   
39 3 126208249 100 2 5.70 50520.37 6.11 43.72 dihydrolipoyl dehydrogenase   
40 3 126209465 100 3 7.51 53794.55 5.62 44.068 putative aldehyde dehydrogenase aldA   
41 3 126208168 100 4 5.95 91194.05 7.12 10.807 trimethylamine N oxide reductase precursor   
42 3 126208249 100 1 3.80 50520.37 6.11 5.877 dihydrolipoyl dehydrogenase   
43 3 126208607 100 6 13.74 60376.76 6.62 4.406 glucose 6 phosphate isomerase   
44 3 126208276 100 11 29.29 59390.11 5.41 45.039 phosphoenolpyruvate carboxykinase  ATP    
45 3 126208439 100 1 5.73 22137.64 9.11 20.005 hypothetical protein APL 0965   
46 3 126208457 100 9 17.07 73216.57 5.72 59.553 transketolase 2   
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47 3 126208607 100 11 28.57 60376.76 6.62 8.496 glucose 6 phosphate isomerase   
48 3 126209095 100 4 10.98 67158.64 5.54 9.517 
glucosamine  fructose 6 phosphate 
aminotransferase  isomerizing    
49 3 126209095 100 8 19.51 67158.64 5.54 6.71 
glucosamine  fructose 6 phosphate 
aminotransferase  isomerizing    
50 3 126209095 100 12 30.82 67158.64 5.54 8.791 
glucosamine  fructose 6 phosphate 
aminotransferase  isomerizing    
51 3 126209095 100 7 19.02 67158.64 5.54 12.358 
glucosamine  fructose 6 phosphate 
aminotransferase  isomerizing    
52 3 126208741 100 3 8.56 54156.15 5.94 5.604 glutamyl tRNA synthetase   
53 3 126208127 100 11 42.29 43555.48 5.98 7.61 acetate kinase   
54 3 126207742 100 6 19.01 52903.67 5.62 4.529 aminoacyl histidine dipeptidase   
55 3 126208563 100 7 20.00 51649.58 5.29 6.977 aspartate ammonia lyase   
56 3 126209095 100 2 4.43 67158.64 5.54 18.73 
glucosamine  fructose 6 phosphate 
aminotransferase  isomerizing    
57 2 126208762 100 2 10.10 33325.92 5.93 8.562 malate dehydrogenase   
58 2 126207851 100 3 18.69 21826.06 4.64 45.273 heat shock protein  HSP 70 cofactor    
59 5 126208914 100 3 10.18 36913.55 5.55 7.834 fructose 1 6 bisphosphatase   
60 5 126209465 100 2 6.09 53794.55 5.62 35.278 putative aldehyde dehydrogenase aldA   
61 7 126208168 100 2 2.79 91194.05 7.12 40.527 trimethylamine N oxide reductase precursor   
62 5 126208563 100 3 6.74 51649.58 5.29 11.282 aspartate ammonia lyase   
63 5 126207970 100 5 12.32 44901.09 5.21 8.24 NADP dependent malic enzyme  NADP ME    
64 3 126208168 100 1 1.46 91194.05 7.12 21.599 trimethylamine N oxide reductase precursor   
65 7 126207739 100 4 24.88 23741.85 6.71 10.021 manganese superoxide dismutase   
66 7 126207739 100 2 13.62 23741.85 6.71 50.387 manganese superoxide dismutase   
67 7 126207739 100 1 4.70 23741.85 6.71 5.422 manganese superoxide dismutase   
68 3 126208594 100 2 10.49 35492.30 6.46 17.785 6 phosphofructokinase   
69 5 126207803 100 4 10.50 40820.23 5.42 6.62 hypothetical protein APL 0319   
70 5 126207505 100 1 2.04 44072.73 9.40 52.877 cell division protein FtsW   
71 3 126207550 100 6 20.00 34772.19 5.21 19.148 transaldolase   
72 3 126208946 100 4 18.44 26683.22 5.25 41.718 hybrid peroxiredoxin HyPrx5   
73 15 126208129 100 3 7.26 39570.96 9.13 6.136 outer membrane protein P2 precursor  OMP P2    
74 15 126207764 100 2 3.96 73081.29 9.78 11.869 iron regulated outer membrane protein B   
75 16 126207764 100 5 10.98 73081.29 9.78 18.404 iron regulated outer membrane protein B   
76 16 126209399 100 5 18.68 52290.10 5.20 15.391 glutamine synthetase   
77 16 126208542 100 1 6.67 19000.47 4.89 12.929 ferritin like protein 2   
78 16 126208558 100 3 28.37 22923.01 8.48 4.701 outer membrane protein W precursor   
79 16 126208885 100 7 16.03 39507.21 8.92 10.003 outer membrane protein P5 precursor   
80 16 126209314 100 5 11.54 38708.01 9.72 15.591 outer membrane protein P5 precursor  OMP P5    
81 16 126208129 100 1 4.75 39570.96 9.13 7.043 outer membrane protein P2 precursor  OMP P2    
82 16 126209314 51 1 2.75 38708.01 9.72 17.136 outer membrane protein P5 precursor  OMP P5    
83 16 126208885 50 1 2.72 39507.21 8.92 17.136 outer membrane protein P5 precursor   
84 16 126208885 100 3 9.24 39507.21 8.92 24.627 outer membrane protein P5 precursor   
85 16 126208129 100 1 2.51 39570.96 9.13 12.696 outer membrane protein P2 precursor  OMP P2    
86 16 126209314 0 1 3.30 38708.01 9.72 19.529 outer membrane protein P5 precursor  OMP P5    
87 16 126208129 100 1 4.75 39570.96 9.13 1.771 outer membrane protein P2 precursor  OMP P2    
88 ns 126208249 100 7 20.25 50520.37 6.11 11.673 dihydrolipoyl dehydrogenase   
89 17 126207895 100 8 15.39 89087.97 6.63 12.135 protective surface antigen D15 precursor   
89b 17 126208885 100 1 6.52 39507.21 8.92 7.059 outer membrane protein P5 precursor   
90 17 126207848 100 7 8.05 103746.56 9.53 12.565 serotype specific antigen 1 precursor   
90b 17 126208485 100 1 2.07 95276.65 6.95 22.966 aldehyde alcohol dehydrogenase 2   
91 17 126209138 100 1 1.62 89674.50 7.60 18.27 
anaerobic dimethyl sulfoxide reductase chain A 
precursor   
92 17 126209314 100 7 26.92 38708.01 9.72 35.283 outer membrane protein P5 precursor  OMP P5    
93 17 126208885 100 1 6.52 39507.21 8.92 36.759 outer membrane protein P5 precursor   
94 17 126208129 100 1 4.75 39570.96 9.13 39.725 outer membrane protein P2 precursor  OMP P2    
95 17 3927875 100 2 7.40 39683.28 6.78 5.01 outer membrane lipoprotein   
96 8 126208755 100 5 18.87 23548.30 9.68 8.805 hypothetical protein APL 1289   
97 8 126209294 100 2 10.69 36086.64 9.25 8.609 hypothetical protein APL 1832   
98 8 126207750 100 8 48.41 27734.61 9.24 19.793 molybdate binding periplasmic protein precursor   
99 8 126208189 100 2 31.53 13351.78 9.41 20.602 hypothetical protein APL 0709   
100 18 126208432 100 16 28.98 102443.53 5.53 16.279 RTX II toxin determinant A   
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101 8 126208075 100 4 11.29 52016.22 8.14 21.127 inosine 5  monophosphate dehydrogenase   
102 8 126208885 100 2 9.24 39507.21 8.92 34.211 outer membrane protein P5 precursor   
103 8 126209314 0 1 2.75 38708.01 9.72 40.801 outer membrane protein P5 precursor  OMP P5    
104 8 126208885 100 1 6.52 39507.21 8.92 33.332 outer membrane protein P5 precursor   
105 8 126208755 100 1 5.19 23548.30 9.68 5.195 hypothetical protein APL 1289   
106 8 126208129 100 4 15.64 39570.96 9.13 12.77 outer membrane protein P2 precursor  OMP P2    
107 8 126207929 100 4 12.37 51994.79 8.17 21.82 putative electron transport protein   
108 8 126209294 100 2 7.55 36086.64 9.25 3.92 hypothetical protein APL 1832   
109 8 126208247 100 1 1.83 60857.33 7.05 10.201 UshA precursor   
110 19 126207764 100 14 29.42 73081.29 9.78 10.161 iron regulated outer membrane protein B   
111 19 126207848 100 3 4.61 103746.56 9.53 2.878 serotype specific antigen 1 precursor   
112 19 126209031 100 2 3.32 106656.44 9.41 2.949 transferrin binding protein 1 Tbp1   
113 19 126207895 100 9 18.03 89087.97 6.63 7.122 protective surface antigen D15 precursor   
114 19 78883538 60 7 19.78 72694.38 6.80 7.228 outer membrane ferric hydroxamate receptor FhuA  
115 19 126209399 100 4 11.89 52290.10 5.20 10.886 glutamine synthetase   
116 19 126208521 100 13 17.93 107589.00 8.92 33.327 hemoglobin binding protein A precursor   
117 19 126208436 100 3 5.66 89767.17 7.99 1.288 organic solvent tolerance protein precursor   
118 19 126207764 100 12 27.29 73081.29 9.78 8.993 iron regulated outer membrane protein B   
119 19 126208885 100 2 10.33 39507.21 8.92 9.057 outer membrane protein P5 precursor   
120 19 126209314 100 1 3.85 38708.01 9.72 2.176 outer membrane protein P5 precursor  OMP P5    
121 19 126209314 100 3 13.19 38708.01 9.72 3.567 outer membrane protein P5 precursor  OMP P5    
122 14 126208558 100 3 18.61 22923.01 8.48 16.746 outer membrane protein W precursor   
123 14 126209104 100 4 20.58 26478.89 7.33 35.563 
putative FKBP type peptidyl prolyl cis trans 
isomerase   
124 14 126207492 100 1 6.32 20194.19 6.75 12.192 superoxide dismutase  Cu Zn  precursor   
125 14 126208247 100 6 11.70 60857.33 7.05 17.572 UshA precursor   
126 14 126208128 100 2 3.19 72535.22 6.36 34.881 
2  3  cyclic nucleotide 2  phosphodiesterase 
precursor   
127 14 126208904 100 3 10.15 35710.29 6.50 7.103 
high affinity zinc uptake system protein ZnuA 
precursor   
128 14 126208194 100 4 14.57 32490.47 8.51 4.759 ABC transport system periplasmic protein   
129 14 126209294 100 1 4.40 36086.64 9.25 5.061 hypothetical protein APL 1832   
130 14 126207537 100 3 20.35 18203.46 9.87 6.63 hypothetical protein APL 0049   
131 14 3927875 100 3 10.41 39683.28 6.78 8.458 outer membrane lipoprotein   
132 14 126209385 100 3 12.89 26505.78 5.58 9.353 Triosephosphate isomerase   
133 14 126209136 100 1 4.83 30115.26 8.49 0.982 D ribose binding periplasmic protein precursor   
134 14 126207760 100 4 19.46 32849.36 8.34 5.258 
iron  chelated  ABC transporter  periplasmic binding 
protein   
135 14 126208308 100 4 23.79 25889.46 6.35 7.905 
2 3 bisphosphoglycerate dependent 
phosphoglycerate mutase   
136 14 126209088 100 4 19.74 25572.24 7.09 10.437 putative periplasmic binding protein CbiK   
137 14 126209052 100 2 8.86 34474.57 6.81 10.178 predicted TRAP transporter solute receptor   
138 14 126207739 100 1 6.10 23741.85 6.71 17.986 manganese superoxide dismutase   
139 14 126208049 100 3 15.19 30222.63 5.26 17.594 elongation factor Ts   
140 14 126208884 100 3 11.52 35417.66 5.77 7.038 D galactose binding periplasmic protein precursor   
141 14 126209330 100 2 8.96 23473.09 8.67 2.747 thiol disulfide interchange protein dsbA precursor   
142 14 126208572 100 3 18.92 21892.33 8.60 17.973 hypothetical protein APL 1100   
143 14 126208432 100 1 1.05 102443.53 5.53 62.935 RTX II toxin determinant A   
144 14 126208910 100 2 5.49 37835.43 8.07 12.602 
ABC type Fe3  transport system  periplasmic 
component   
145 14 126207918 100 3 11.38 35691.35 6.99 17.091 glyceraldehyde 3 phosphate dehydrogenase   
146 14 126207552 100 2 4.50 59965.18 8.03 20.193 periplasmic dipeptide transport protein   
147 14 126208247 100 2 4.94 60857.33 7.05 20.816 UshA precursor   
148 14 126208862 50 1 3.30 43439.30 5.40 28.329 elongation factor Tu   
149 14 126208129 100 2 5.03 39570.96 9.13 17.547 outer membrane protein P2 precursor  OMP P2    
150 14 126208129 100 4 8.10 39570.96 9.13 10.827 outer membrane protein P2 precursor  OMP P2    
151 14 126208885 100 6 18.21 39507.21 8.92 11.955 outer membrane protein P5 precursor   
152 14 126209314 0 2 3.30 38708.01 9.72 12.785 outer membrane protein P5 precursor  OMP P5    
153 14 126209314 100 6 18.13 38708.01 9.72 13.131 outer membrane protein P5 precursor  OMP P5    
154 14 126208432 100 6 7.22 102443.53 5.53 30.916 RTX II toxin determinant A   
155 14 126208958 100 1 4.76 20732.61 5.71 2.492 fine tangled pili major subunit   
156 14 75429133 34 1 4.79 20960.85 5.90 2.492 
starvation inducible DNA binding protein  
Actinobacillus succinogenes 
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157 14 126207911 100 5 12.78 48462.46 6.65 12.104 NADP specific glutamate dehydrogenase   
158 14 126209314 100 1 3.57 38708.01 9.72 24.883 outer membrane protein P5 precursor  OMP P5    
159 14 126207550 100 3 11.11 34772.19 5.21 36.949 transaldolase   
160 14 126208762 100 6 24.29 33325.92 5.93 42.702 malate dehydrogenase   
161 14 126208885 100 4 15.22 39507.21 8.92 7.518 outer membrane protein P5 precursor   
162 14 126209314 0 1 2.75 38708.01 9.72 8.033 outer membrane protein P5 precursor  OMP P5    
163 14 126209314 100 6 18.96 38708.01 9.72 21.522 outer membrane protein P5 precursor  OMP P5    
164 14 126208885 0 1 3.26 39507.21 8.92 22.493 outer membrane protein P5 precursor   
165 14 126209314 100 4 11.81 38708.01 9.72 6.385 outer membrane protein P5 precursor  OMP P5    
166 14 126207493 100 2 7.03 40395.02 5.60 23.551 aspartate semialdehyde dehydrogenase Asd   
167 9 126208755 100 5 19.81 23548.30 9.68 18.001 hypothetical protein APL 1289   
168 10 126208893 100 3 3.99 93511.73 8.21 29.727 periplasmic nitrate reductase precursor   
169 10 126208075 100 4 15.61 52016.22 8.14 44.941 inosine 5  monophosphate dehydrogenase   
170 9 126208878 100 1 3.26 54039.78 8.61 7.222 putative malate quinone oxidoreductase   
171 10 126207848 100 1 1.40 103746.56 9.53 17.348 serotype specific antigen 1 precursor   
172 9 126207929 100 3 7.46 51994.79 8.17 8.309 putative electron transport protein   
173 10 126207764 100 3 5.79 73081.29 9.78 15.448 iron regulated outer membrane protein B   
174 9 126207929 100 3 7.46 51994.79 8.17 31.222 putative electron transport protein   
175 9 126208893 100 3 3.75 93511.73 8.21 28.21 periplasmic nitrate reductase precursor   
176 9 126208737 100 1 2.10 47195.81 8.52 10.853 NADH dehydrogenase   
177 10 126209294 100 2 6.60 36086.64 9.25 14.709 hypothetical protein APL 1832   
178 10 126209294 100 3 11.01 36086.64 9.25 17.545 hypothetical protein APL 1832   
179 10 126207750 100 4 23.02 27734.61 9.24 34.298 molybdate binding periplasmic protein precursor   
180 10 126209121 100 5 22.31 27931.77 9.15 42.872 putative amino acid ABC transporter binding protein  
181 10 126208755 100 3 13.68 23548.30 9.68 73.733 hypothetical protein APL 1289   
182 10 126208755 100 3 13.68 23548.30 9.68 50.564 hypothetical protein APL 1289   
183 10 126208129 100 2 5.03 39570.96 9.13 19.415 outer membrane protein P2 precursor  OMP P2    
184 10 126208129 100 2 5.03 39570.96 9.13 18.855 outer membrane protein P2 precursor  OMP P2    
185 10 126208885 100 2 5.44 39507.21 8.92 8.077 outer membrane protein P5 precursor   
186 10 126209314 0 1 3.30 38708.01 9.72 4.179 outer membrane protein P5 precursor  OMP P5    
187 10 126208885 100 4 11.69 39507.21 8.92 6.051 outer membrane protein P5 precursor   
188 10 126209314 0 1 3.30 38708.01 9.72 5.66 outer membrane protein P5 precursor  OMP P5    
189 10 126209314 100 5 15.66 38708.01 9.72 4.734 outer membrane protein P5 precursor  OMP P5    
190 10 126208225 100 1 4.71 29881.10 9.49 2.739 
penicillin insensitive murein endopeptidase 
precursor   
191 10 126209427 100 3 17.74 22060.36 8.87 8.398 hypothetical protein APL 1973   
192 10 141824 25 2 10.69 18447.65 9.50 7.438 hemolysin C 
193 10 126209382 100 1 2.03 67941.92 9.35 97.956 biofilm PGA synthesis lipoprotein PgaB precursor   
194 10 126207531 100 4 11.01 52973.98 9.46 8.261 phosphatidylserine synthase   
195 10 126209183 100 2 11.35 23931.86 
10.1
1 9.844 50S ribosomal protein L1   
196 10 126209224 100 2 13.46 22368.94 
10.2
2 6.408 50S ribosomal protein L3   
197 10 126209314 100 2 6.59 38708.01 9.72 22.013 outer membrane protein P5 precursor  OMP P5    
198 10 126209230 100 1 5.11 25880.03 
10.5
6 5.658 30S ribosomal protein S3   
199 10 126209247 100 2 12.98 23769.80 
10.3
5 32.602 30S ribosomal protein S4   
200 10 126207622 100 6 33.18 24429.50 9.73 52.405 hypothetical protein APL 0134   
201 10 126207607 100 4 35.17 20150.67 9.92 54.116 proQ like protein   
202 10 126209238 100 3 22.60 18861.12 
10.0
2 20.27 50S ribosomal protein L6   
203 10 126209235 100 2 14.53 20341.76 9.88 25.512 50S ribosomal protein L5   
204 10 126208082 100 2 14.79 16041.56 9.90 31.366 50S ribosomal protein L13   
205 10 126207537 100 4 27.91 18203.46 9.87 31.764 hypothetical protein APL 0049   
206 10 126207602 100 3 37.78 9491.17 9.97 39.102 DNA binding protein HU   
207 10 126208622 100 2 14.94 18289.27 8.94 7.994 hypothetical protein APL 1152   
208 10 126207602 100 1 16.67 9491.17 9.97 6.301 DNA binding protein HU   
209 6 126208185 100 5 6.55 111611.50 5.38 21.772 
putative methylation subunit  type III restriction 
modification system   
210 6 126208185 100 3 3.22 111611.50 5.38 13.925 
putative methylation subunit  type III restriction 
modification system   
211 6 126208787 100 3 4.89 62702.77 4.81 21.005 phosphoenolpyruvate protein phosphotransferase   
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212 6 126209366 100 7 10.44 67899.06 4.76 6.596 chaperone protein dnaK   
213 6 126208635 100 5 17.18 40646.80 4.86 26.904 hypothetical protein APL 1167   
214 6 126208401 100 3 5.19 66662.80 4.94 27.524 chaperone protein HscA like protein   
215 6 126208489 100 3 10.47 27662.39 5.63 21.371 deoxyribose phosphate aldolase   
216 6 126208420 100 3 22.79 17397.96 4.70 38.349 transcription elongation factor GreA   
217 6 126209446 100 1 4.98 25117.05 5.57 34.72 
3 oxoacyl  acyl carrier protein  reductase  3 ketoacyl 
acyl carrier protein reductase    
218 6 126208787 100 4 6.28 62702.77 4.81 7.532 phosphoenolpyruvate protein phosphotransferase   
219 6 126208958 100 2 18.52 20732.61 5.71 10.957 fine tangled pili major subunit   
220 6 126208059 100 3 5.59 77349.28 5.00 13.79 polyribonucleotide nucleotidyltransferase   
221 6 126209101 100 3 16.38 24396.73 4.84 19.436 MTA SAH nucleosidase   
222 6 126208764 100 3 16.82 23465.22 5.29 16.308 adenylate kinase   
223 6 126209174 100 4 11.36 34748.10 5.16 14.321 ADP L glycero D manno heptose 6 epimerase   
224 6 126208541 100 3 22.02 19274.59 4.80 30.465 ferritin like protein 1   
225 6 126207522 100 4 12.67 39848.44 4.79 33.433 GTP dependent nucleic acid binding protein EngD   
226 6 126208717 100 4 11.25 41144.76 5.01 10.697 phosphoglycerate kinase   
227 6 126208567 100 1 3.19 36843.92 5.00 21.903 phosphoribosylformylglycinamidine cyclo ligase   
228 6 126208563 100 5 11.79 51649.58 5.29 11.099 aspartate ammonia lyase   
229 6 126208348 100 3 3.60 97687.67 5.45 3.448 leucyl tRNA synthetase   
230 13 126208432 100 4 5.13 102443.53 5.53 3.876 RTX II toxin determinant A   
231 13 126207970 100 1 2.61 44901.09 5.21 6.019 NADP dependent malic enzyme  NADP ME    
232 6 126209248 100 5 18.24 36517.12 5.26 10.099 DNA directed RNA polymerase alpha chain   
233 13 56606845 17 1 3.54 34104.49 5.43 2.201 UDP glucose 4 epimerase  Mannheimia haemolytica
234 13 126207930 100 1 4.15 26335.58 7.91 67.806 putative dehydrogenase subunit   
235 13 126208127 100 1 3.48 43555.48 5.98 58.717 acetate kinase   
236 11 126208250 100 4 7.12 66103.72 5.08 7.818 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 
237 11 126208250 100 4 4.91 66103.72 5.08 11.055 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 
238 11 126208059 100 5 8.95 77349.28 5.00 10.636 polyribonucleotide nucleotidyltransferase   
239 11 126208220 100 2 4.69 60113.39 5.08 33.482 30S ribosomal protein S1   
240 11 126209110 100 3 10.72 49646.57 5.00 40.184 ATP synthase subunit beta   
241 11 126208971 100 2 5.77 47991.97 4.99 36.933 trigger factor   
242 11 126208946 100 5 22.13 26683.22 5.25 9.752 hybrid peroxiredoxin HyPrx5   
243 11 126208946 100 6 31.15 26683.22 5.25 8.298 hybrid peroxiredoxin HyPrx5   
244 11 126209399 100 5 13.16 52290.10 5.20 7.069 glutamine synthetase   
245 11 126208253 100 5 15.51 34185.94 5.29 13.927 ribose phosphate pyrophosphokinase   
246 11 126208527 100 2 2.46 42443.08 5.17 14.214 3 oxoacyl  acyl carrier protein  synthase 1   
247 11 126208209 100 1 2.45 49090.83 5.25 1.326 antibiotic maturation factor   
248 11 126208862 50 3 9.14 43439.30 5.40 7.456 elongation factor Tu   
249 11 126209095 100 3 8.20 67158.64 5.54 5.767 
glucosamine  fructose 6 phosphate 
aminotransferase  isomerizing    
250 11 126209095 100 3 7.71 67158.64 5.54 35.571 
glucosamine  fructose 6 phosphate 
aminotransferase  isomerizing    
251 11 126208749 100 1 1.98 62451.12 5.53 21.087 ABC transporter ATP binding protein   
252 11 126208276 100 2 4.66 59390.11 5.41 17.284 phosphoenolpyruvate carboxykinase  ATP    
253 11 126208129 100 5 14.53 39570.96 9.13 15.492 outer membrane protein P2 precursor  OMP P2    
254 11 126208129 100 6 14.53 39570.96 9.13 16.212 outer membrane protein P2 precursor  OMP P2    
255 11 126208885 100 2 5.98 39507.21 8.92 26.229 outer membrane protein P5 precursor   
256 11 126208885 100 5 14.13 39507.21 8.92 13.946 outer membrane protein P5 precursor   
257 11 126209314 0 2 5.77 38708.01 9.72 19.408 outer membrane protein P5 precursor  OMP P5    
258 11 126208885 100 5 14.13 39507.21 8.92 12.018 outer membrane protein P5 precursor   
259 11 126209314 0 2 5.77 38708.01 9.72 17.515 outer membrane protein P5 precursor  OMP P5    
260 11 126207764 100 4 7.17 73081.29 9.78 9.421 iron regulated outer membrane protein B   
261 11 126209314 100 3 10.44 38708.01 9.72 13.865 outer membrane protein P5 precursor  OMP P5    
262 11 126207675 100 3 7.52 51479.88 6.40 20.823 pyruvate kinase   
263 11 126208893 100 4 5.68 93511.73 8.21 41.277 periplasmic nitrate reductase precursor   
264 11 126208893 100 2 3.02 93511.73 8.21 6.633 periplasmic nitrate reductase precursor   
265 11 126208485 100 5 6.89 95276.65 6.95 13.84 aldehyde alcohol dehydrogenase 2   
266 11 126208914 100 3 9.88 36913.55 5.55 37.764 fructose 1 6 bisphosphatase   
267 11 126208185 100 2 2.08 111611.50 5.38 47.349 
putative methylation subunit  type III restriction 
modification system   
Q-TOF MSMS 
   
 174 
 
a) the MS# is a continuous numbering of mass spectra 
b) this number indicates the preparative gel (Appendix G 5) from which the protein spot was obtained. 
c) the probability was calculated using a ProteinLynx Global Server based algorithm which gives very 
low rates of false positive results. 
d) this number indicates the number of peptides that were analyzed by tandem mass spectrometry; 
each peptide was fragmented and the amino acid sequence was obtained by databank comparison to 
A. pleuropneumoniae serotype 5 strain L20. 
e) (number of amino acids in all identified peptides / number of amino acids of the entire protein) x 100 
f) the arithmetic mean value of deviations from their calculated mass for all analyzed peptides is the 
average mass error. 
g) the A. pleuropneumoniae serotype 5b strain L20 protein database was usually applied for database 
searches; if no protein was found then the mass spectra were searched against the entire NCBI non 
redundant protein database; hits obtained different to A. pleuropneumoniae serotype 5b strain L20 are 
mentioned. 
268 11 126208510 100 5 6.88 86119.01 5.89 42.944 formate acetyltransferase   
269 11 126208637 100 3 27.52 15246.15 6.61 48.774 50S ribosomal protein L9   
270 11 126207813 100 1 2.01 43934.26 7.68 32.932 2 octaprenyl 6 methoxyphenol hydroxylase   
271 11 126208485 100 2 2.64 95276.65 6.95 16.128 aldehyde alcohol dehydrogenase 2   
272 11 126208168 100 2 2.79 91194.05 7.12 11.503 trimethylamine N oxide reductase precursor   
273 11 126209138 100 1 1.62 89674.50 7.60 1.137 
anaerobic dimethyl sulfoxide reductase chain A 
precursor   
274 11 126209138 100 3 4.22 89674.50 7.60 5.909 
anaerobic dimethyl sulfoxide reductase chain A 
precursor   
275 11 126208432 100 6 7.53 102443.53 5.53 6.568 RTX II toxin determinant A   
276 11 126207727 100 2 2.54 102431.94 5.41 4.435 preprotein translocase secA subunit   
277 11 126208251 100 3 3.39 98856.58 5.57 15.778 pyruvate dehydrogenase E1 component   
278 12 126208129 100 5 14.25 39570.96 9.13 8.881 outer membrane protein P2 precursor  OMP P2    
279 12 126208129 100 1 2.51 39570.96 9.13 11.231 outer membrane protein P2 precursor  OMP P2    
280 12 126208885 100 2 5.98 39507.21 8.92 12.693 outer membrane protein P5 precursor   
281 13 126208432 100 4 4.92 102443.53 5.53 15.218 RTX II toxin determinant A   
282 13 126208885 100 1 3.80 39507.21 8.92 12.155 outer membrane protein P5 precursor   
283 11 126208250 100 3 4.91 66103.72 5.08 61.643 
dihydrolipoyllysine residue acetyltransferase 
component of pyruvate dehydrogenase complex  E2 
284 11 126208527 100 1 2.22 42443.08 5.17 65.754 3 oxoacyl  acyl carrier protein  synthase 1   
285 11 126208527 100 1 2.46 42443.08 5.17 1.165 3 oxoacyl  acyl carrier protein  synthase 1   
286 11 126208126 100 4 5.76 76675.17 5.63 8.882 phosphate acetyltransferase   
287 11 126208510 100 3 4.42 86119.01 5.89 5.714 formate acetyltransferase   
288 11 126208249 100 3 6.75 50520.37 6.11 13.881 dihydrolipoyl dehydrogenase   
289 11 126208745 100 2 6.21 46332.25 5.50 13.579 ATP dependent Clp protease ATP binding subunit   
290 11 126208249 100 3 7.81 50520.37 6.11 19.039 dihydrolipoyl dehydrogenase   
291 11 126208249 100 3 7.81 50520.37 6.11 28.041 dihydrolipoyl dehydrogenase   
292 11 126209301 100 2 13.78 27258.83 6.32 21.881 uridine phosphorylase   
293 11 126209299 100 1 3.94 37397.37 6.23 2.68 aspartate ammonia ligase   
294 11 126208090 100 1 3.05 37600.17 5.76 20.245 phenylalanyl tRNA synthetase alpha chain   
295 11 56606845 17 1 3.54 34104.49 5.43 0.533 UDP glucose 4 epimerase  Mannheimia haemolytica
296 11 56606845 17 1 3.54 34104.49 5.43 22.206 UDP glucose 4 epimerase  Mannheimia haemolytica
297 11 126208181 100 4 11.37 46156.41 5.95 7.988 O acetylhomoserine  thiol  lyase   
298 11 126208163 100 2 6.88 41578.40 6.31 5.795 cystathionine gamma synthase   
299 11 126209299 100 4 13.64 37397.37 6.23 3.225 aspartate ammonia ligase   
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G 6.2  MALDI-TOF MS 
 
Results of MALDI-TOF mass spectrometry 
MS 
# a 
gel 
# b 
accession 
# 
mW 
[Da] score 
c expect d matched peptides e protein 
f 
M01 14 126208432  102444 149 6.80E-09 24 RTX-II toxin determinant A 
M02 14 126208432  102444 193 2.7e-13   27 RTX-II toxin determinant A 
M03 14 126208432  102444 149 6.8e-09   13 RTX-II toxin determinant A 
M04 14 126208432  102444 255 1.7e-19   46 RTX-II toxin determinant A 
M05 14 126208432  102444 234 2.1e-17   25 RTX-II toxin determinant A 
M06 14 126208432  102444 205 1.7e-14   34 RTX-II toxin determinant A 
M07 14 126208432  102444 210 5.4e-15   29 RTX-II toxin determinant A 
M08 14 126208276 59618 103 0.00027   10 phosphoenolpyruvate carboxykinase (ATP) 
M09 14 126208862 43553 141 4.3e-08   11 elongation factor Tu 
M10 14 126208585 46000 111 4.3e-05   9 enolase 
M11 14 126097509 41259 146 1.3e-08   20 phosphoglycerate kinase 
M12 14 126208716 39278 251 4.3e-19   18 fructose-bisphosphate aldolase 
M13 13 126208432 102444 83 0.026   13 RTX-II toxin determinant A 
M14 13 126208432 102444 113 2.7e-05   11 RTX-II toxin determinant A 
M15 13 126208251 99028 83  0.028   13 pyruvate dehydrogenase E1 component 
M16 13 126208251 99028 84 0.021   12 pyruvate dehydrogenase E1 component 
M17 13 126208863 77515 184 2.1e-12   17 elongation factor G 
M18 13 126208276 59618 121 4.3e-06   12 phosphoenolpyruvate carboxykinase (ATP) 
M19 13 126207608 75970 108 8.5e-05   13 tail-specific protease precursor 
M20 13 126209343 109587 86 0.015   8 protease 3 precursor 
M21 13 126208168 91536 106 0.00013   14 trimethylamine-N-oxide reductase precursor 
M22 13 126207970 45300 90 0.0048   7 NADP-dependent malic enzyme (NADP-ME) 
M23 13 126208914 37028 88 0.0078   8 fructose-1,6-bisphosphatase 
M24 13 126208914 37028 86 0.014   10 fructose-1,6-bisphosphatase 
M25 13 126208158 20918 86 0.014   5 elongation factor P 
M26 13 126097696 35824 76 0.12  4 high-affinity zinc uptake system protein ZnuA precursor 
M27 13 126207918  35862 84 0.024   7 glyceraldehyde-3-phosphate dehydrogenase 
M28 13 126208786 8910 89  0.0069   3 PTS system phosphocarrier protein HPr 
M29 13 126208885 39621 115 1.7e-05   8 outer membrane protein P5 precursor 
M30 11 126208250 66161 87 0.0098   6 
dihydrolipoyllysine-residue acetyltransferase component 
of pyruvate dehydrogenase complex (E2) 
M31 11 126208250 66161 109 6.8e-05   12 
dihydrolipoyllysine-residue acetyltransferase component 
of pyruvate dehydrogenase complex (E2) 
M32 11 126208250 66161 82 0.034   13 
dihydrolipoyllysine-residue acetyltransferase component 
of pyruvate dehydrogenase complex (E2) 
M33 11 126208250 66161 81 0.044   15 
dihydrolipoyllysine-residue acetyltransferase component 
of pyruvate dehydrogenase complex (E2) 
M34 11 126208220 60227 106 1.30E-04 11 30S ribosomal protein S1 
M35 11 126208276 59618 142 3.4e-08   10 phosphoenolpyruvate carboxykinase (ATP) 
M36 11 126208457 73616 116 1.3e-05   13 transketolase 2 
M37 11 126208251 99028 94 0.0023   15 pyruvate dehydrogenase E1 component 
M38 11 126208251 99028 238 8.5e-18   24 pyruvate dehydrogenase E1 component 
M39 11 126208251 99028 87 0.01   21 pyruvate dehydrogenase E1 component 
M40 11 126208510 86575 229 6.8e-17   22 formate acetyltransferase 
M41 11 126208510 86575 96 0.0012   14 formate acetyltransferase 
M42 11 126208510 86575 172 3.4e-11   20 formate acetyltransferase 
M43 11 126208918 47625 182 3.4e-12   16 phosphoglucosamine mutase. 
M44 11 126208249 50920 124 2.1e-06   11 dihydrolipoyl dehydrogenase 
M45 11 126208249 50920 144 2.1e-08   11 dihydrolipoyl dehydrogenase 
M46 11 126208755 23548 81 4.10E-02 7 hypothetical protein APL_1289 
M47 11 126209224 22369 98 0.00091   10 50S ribosomal protein L3 
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M48 11 126209109 15216 64 2.10E+00 4 ATP synthase epsilon chain 
M49 11 126209294 36144 82 0.036   6 hypothetical protein APL_1832 
M50 11 126209183 23932 83 0.028   8 50S ribosomal protein L1 
M51 11 126208485 95904 149 6.8e-09   16 aldehyde-alcohol dehydrogenase 2 
M52 11 126208485 95904 86 0.015   13 aldehyde-alcohol dehydrogenase 2 
M53 11 126208485 95904 129 6.8e-07   17 aldehyde-alcohol dehydrogenase 2 
M54 11 126208485 95904 125 1.70E-06 12 aldehyde-alcohol dehydrogenase 2 
M55 11 126208485 95904 82 0.032   13 aldehyde-alcohol dehydrogenase 2 
M56 11 126208168 91536 99 0.00072   11 trimethylamine-N-oxide reductase precursor 
M57 11 126208168 91536 179 6.8e-12   27 trimethylamine-N-oxide reductase precursor 
M58 11 126208168 91536 164 2.1e-10   18 trimethylamine-N-oxide reductase precursor 
M59 11 126208893 94310 121 4.3e-06   16 periplasmic nitrate reductase precursor 
M60 11 126208048 26263 108 8.5e-05   8 30S ribosomal protein S2 
M61 11 126207918 35862 84 0.02   5 glyceraldehyde-3-phosphate dehydrogenase 
M62 11 126207918 35862 82 0.032   6 glyceraldehyde-3-phosphate dehydrogenase 
M63 11 126208594 35777 147 1.1e-08   15 6-phosphofructokinase 
M64 11 126208485 95904 117 1.1e-05   21 aldehyde-alcohol dehydrogenase 2 
M65 11 126208168 91536 88 0.0081   18 trimethylamine-N-oxide reductase precursor 
M66 11 126209237 14146 81 0.041   5 30S ribosomal protein S8 
M67 11 126209327 49601 153 2.7e-09   24 Biotin carboxylase 
M68 11 33151818 49603 93 0.0028   16 
acetyl-CoA carboxylase [Haemophilus ducreyi 
35000HP] 
M69 11 126209095 67449 230 5.4e-17   26 
glucosamine--fructose-6-phosphate aminotransferase 
(isomerizing) 
M70 11 126208862 43553 146 1.3e-08   18 elongation factor Tu 
M71 11 126209191 150016 227 1.10E-16 33 DNA-directed RNA polymerase beta chain 
M72 11 126209191 150016 102 0.00034   23 DNA-directed RNA polymerase beta chain 
M73 11 126209192 157462 92 0.0038   29 DNA-directed RNA polymerase beta' chain 
M74 11 126209314 38822 164 2.1e-10   14 Outer membrane protein P5 precursor (OMP P5) 
M75 4 126208251 99028 190 5.4e-13   40 pyruvate dehydrogenase E1 component 
M76 4 126208348 98201 86 0.012   14 leucyl-tRNA synthetase 
M77 4 126208251 99028 69 7.40E-01 12 pyruvate dehydrogenase E1 component 
M78 4 126208709 49393 181 4.3e-12   20 glutathione reductase 
M79 4 126207911 48805 93 0.0028   9 NADP-specific glutamate dehydrogenase 
M80 4 126207532 106437 152 3.4e-09   30 isoleucyl-tRNA synthetase 
M81 4 126207532 106437 122 3.4e-06   25 isoleucyl-tRNA synthetase 
M82 13 126208276 59618 109 6.9e-05   11 phosphoenolpyruvate carboxykinase  ATP   
M83 13 126208276 59618 97  0.0011   10 phosphoenolpyruvate carboxykinase  ATP   
M84 13 126208510 86575 141 4.3e-08   16 formate acetyltransferase  
M85 13 126208510 86575 169 6.9e-11   20 formate acetyltransferase  
M86 13 126208510 86575 165 1.7e-10   22 formate acetyltransferase  
M87 13 126208485  95904 78 0.081   12 aldehyde-alcohol dehydrogenase 2 
M88 13 126208485  95904 86 0.014   9 aldehyde-alcohol dehydrogenase 2 
M89 13 126208168 91536 192 3.4e-13   26 trimethylamine-N-oxide reductase precursor 
M90 13 126208168 91536 90 0.0052   9 trimethylamine-N-oxide reductase precursor 
M91 13 126208893 94310 86 0.014   12 periplasmic nitrate reductase precursor 
M92 13 126208787 62760 87 0.012   8 phosphoenolpyruvate protein phosphotransferase  
M93 13 126208073 59910 113 2.7e-05   16 phosphoglucomutase/phosphomannomutase 
M94 13 126208073 59910 121 4.3e-06   18 phosphoglucomutase/phosphomannomutase 
M95 13 126208862 43553 147 1.1e-08   24 elongation factor Tu  
M96 13 126208862 43553 93  0.0025   12 elongation factor Tu  
M97 13 126208752 45904 111 4.3e-05   11 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 
M98 13 126208127 43784 88 0.0083   9 acetate kinase 
M99 13 126208717 41259 104 0.00022   8 phosphoglycerate kinase  
M100 13 126208717 41259 111 4.3e-05   11 phosphoglycerate kinase  
M101 13 126207493 40623 95 0.0017   6 aspartate-semialdehyde dehydrogenase 
M102 13 126207550 34943 90 0.0061   6 transaldolase 
M103 13 126207739 23913 58 9.10E+00 3 manganese superoxide dismutase  
M104 13 126208481 47361 92 0.0037   6 HemY-like protein 
M105 13 126208247 61028 162 3.4e-10   16 UshA precursor  
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a) the MS# is a continuous numbering of mass spectra and begins in case of MALDI-TOF MS analysis 
with the capital letter M. 
b) this number indicates the preparative gel (Appendix G 5) from which the respective protein spot was 
obtained. 
c) this score was calculated using the matrix science algorithm on the matrix science homepage 
(http://www.matrixscience.com/search_form_select.html). 
d) the expect value was calculated using the matrix science algorithm on the matrix science 
homepage and represent the probability that the obtained result is false positive. A value below 0.05 
indicates statistical significance. 
e) the number of peptides of the respective protein that were found by mass spectrometry 
f) if not mentioned extra, then the hit was obtained for an A. pleuropneumoniae serotype 5 strain L20 
protein. 
 
 
M106 13 126208607 60548 81 0.04   8 glucose-6-phosphate isomerase 
M107 13 126209104 26479 114 2.2e-05   12 putative FKBP-type peptidyl-prolyl cis-trans isomerase 
M108 13 126208862 43553 91 0.004   12 elongation factor Tu  
M109 13 126208862 43553 122 3.5e-06   13 elongation factor Tu  
M110 13 126209294 36144 99 0.00074   11 hypothetical protein APL_1832 
Animal experiment 
   
 178  
 
 
 
 Silver staining for identification of differences in protein pattern 
   
 179  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Silver staining for identification of differences in protein pattern 
   
 180  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Silver staining for identification of differences in protein pattern 
   
 181  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Silver staining for identification of differences in protein pattern 
   
 182  
Appendix G 8: Silver staining of 2D gels. A. pleuropneumoniae wt, ΔarcA and ΔhlyX were grown for 
4 times independently (A-D) in anaerobic liquid medium. Proteins were precipitated directly from whole 
cell lysates. The same protein preparations were also used for 2D DIGE later on. In order to proof the 
preparations and to figure out if the samples were suited for 2D DIGE, each preparation was analyzed 
by 2D gel electrophoresis. On each gel 50 µg protein was loaded. Proteins were stained with silver 
nitrate using a modified protocol of the silver staining method of Blum (Rabilloud 1999). By comparing 
the silver stained gels it is possible to identify some differentially regulated protein spots. However, for 
this purpose 2D DIGE and spot pattern analysis with DeCyderTM 2D 6.5 software is a much more 
powerful tool (as shown in “results” of this thesis).  
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